Equitable Financial Life Insurance 10-K 11 Mar 14 2013 FY Annual report Financial data

DOCUMENT_AND_ENTITY_INFORMATIO

DOCUMENT AND ENTITY INFORMATION (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 10, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-K	'
Document Period End Date	31-Dec-13	'
Document Fiscal Period Focus	'FY	'
Document Fiscal Year Focus	'2013	'
Amendment Flag	'false	'
Entity Registrant Name	'AXA EQUITABLE LIFE INSURANCE CO	'
Entity Central Index Key	'0000727920	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Well Known Seasoned Issuer	'No	'
Entity Common Stock Shares Outstanding	'	2,000,000
Entity Public Float	$0	'

CONSOLIDATED_BALANCE_SHEET

CONSOLIDATED BALANCE SHEET (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
ASSETS [Abstract]	'	'
Fixed maturities available for sale, at fair value	$29,419	$33,607
Mortgage Loans On Real Estate	5,684	5,059
Equity real estate, held for the production of income	3	4
Policy Loans	3,434	3,512
Other equity investments	1,863	1,643
Trading securities	4,221	2,309
Other invested assets	1,353	1,828
Total investments	45,977	47,962
Cash and cash equivalents	2,283	3,162
Cash and securities segregated, at fair value	981	1,551
Broker-dealer related receivables	1,539	1,605
Deferred policy acquisition costs	3,874	3,728
Goodwill and other intangible assets, net	3,703	3,673
Amounts due from reinsurers	3,934	3,847
Due From Affiliates	1,088	1,037
Guaranteed minimum income benefit reinsurance contract asset, at fair value	6,747	11,044
Other assets	4,418	5,095
Separate Account Assets	108,857	94,139
Total Assets	183,401	176,843
LIABILITIES [Abstract]	'	'
Policyholders' account balances	30,340	28,263
Future policy benefits, policyholders account balances	21,697	22,687
Broker-dealer related payables	538	664
Amounts due to reinsurers	71	75
Customers related payables	1,698	2,562
Short-term and long-term debt	468	523
Loans from affiliates	825	1,325
Current and deferred income taxes	2,813	5,172
Other liabilities	2,653	3,503
Separate Accounts' liabilities	108,857	94,139
Liabilities	169,960	158,913
Commitments and contingent liabilities (Notes 2, 7, 10, 11, 12, 13, 16, 17)	0	0
AXA Equitable Equity:	'	'
Common stock, $.01 par value, 2,000 million shares authorized, 436.2 million shares issued and outstanding	2	2
Capital in excess of par value	5,934	5,992
Retained earnings	5,205	9,125
Accumulated other comprehensive income (loss)	-603	317
Total AXA Equitable Equity	10,538	15,436
Noncontrolling interest	2,903	2,494
Equity	13,441	17,930
Total Liabilities and Equity	$183,401	$176,843

CONSOLIDATED_STATEMENTS_OF_BAL

CONSOLIDATED STATEMENTS OF BALANCE SHEET (PARENTHETICAL) (USD $)	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED BALANCE SHEETS	'	'
Common Stock par value	$1.25	$1.25
Common Stock authorized	2,000,000	2,000,000
Common Stock issued	2,000,000	2,000,000
Common Stock outstanding	2,000,000	2,000,000

CONSOLIDATED_STATEMENTS_OF_EAR

CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
REVENUES [Abstract]	'	'	'
Universal life and investment-type product policy fee income	$3,546	$3,334	$3,312
Premiums earned	496	514	533
Net investment income (loss): [Abstract]	'	'	'
Investment income (loss) from derivative instruments	-2,866	-978	2,374
Other Investment Income (Loss)	2,237	2,316	2,128
Net Investment Income (Loss)	-629	1,338	4,502
Investment gains (losses), net: [Abstract]	'	'	'
Total other-than-temporary impairment losses	-81	-96	-36
Portion of loss recognized in other comprehensive income (loss)	15	2	4
Net impairment losses recognized	-66	-94	-32
Other investment gains (losses), net	-33	-3	-15
Gain Loss On Investments	-99	-97	-47
Commissions, fees and other income	3,823	3,574	3,631
Increase (decrease) in the fair value of the reinsurance contract asset	-4,297	497	5,941
Total revenues	2,840	9,160	17,872
BENEFITS AND OTHER DEDUCTIONS [Abstract]	'	'	'
Policyholders' benefits	1,691	2,989	4,360
Interest credited to policyholders' account balances	1,373	1,166	999
Compensation and benefits	1,743	1,672	2,263
Commissions	1,160	1,248	1,195
Distribution related payments	423	367	303
Amortization of deferred sales commissions	41	40	38
Interest expense	88	108	106
Amortization of deferred policy acquisition costs	580	576	3,620
Capitalization of deferred policy acquisition costs	-655	-718	-759
Rent expense	169	201	240
Amortization of other intangible assets	24	24	24
Other operating costs and expenses	1,512	1,429	1,359
Total benefits and other deductions	8,149	9,102	13,748
Earnings (loss) from continuing operations, before income taxes	-5,309	58	4,124
Income tax (expense) benefit	2,073	158	-1,298
Net earnings (loss)	-3,236	216	2,826
Less: net (earnings) loss attributable to the noncontrolling interest	-337	-121	101
Net Earnings (Loss) Attributable to AXA Equitable	($3,573)	$95	$2,927

CONSOLIDATED_STATEMENT_OF_COMP

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)	'	'	'
Net earnings (loss)	($3,236)	$216	$2,826
Other comprehensive income (loss) net of income taxes:	'	'	'
Change in unrealized gains (losses), net of reclassifications	-1,211	580	366
Change in defined benefits pension plans	299	26	-74
Total other comprehensive income (loss), net of income taxes	-912	606	292
Total other comprehensive income (loss), net of income taxes	-4,148	822	3,118
Comprehensive income attributable to noncontrolling interest	-345	-113	122
Comprehensive Income (Loss) Attributable to Equitable	($4,493)	$709	$3,240

CONSOLIDATED_STATEMENTS_OF_EQU

CONSOLIDATED STATEMENTS OF EQUITY (USD $)	Total	Parent [Member]	Common Stock [Member]	Capital in excess of par value [Member]	Retained earnings [Member]	Accumulated other comprehensive income (loss) [Member]	Noncontrolling interest [Member]
In Millions
Beginning of year at Dec. 31, 2010	'	'	$2	$5,593	$6,844	($610)	$3,118
Purchase/issuance/sale of AllianceBernstein Units to noncontrolling interest	'	'	'	'	'	'	1
Net earnings (loss)	2,826	'	'	'	2,927	'	-101
Other comprehensive income (loss)	292	'	'	'	'	313	-21
The purchase of Holding units and issuance of Holding units	'	'	'	'	'	'	1
Purchase of noncontrolling interest in consolidated entity	'	'	'	'	'	'	-31
Repurchase of AllianceBernstein Holding units	'	'	'	'	'	'	-140
Dividends and distributions	'	'	'	'	379	'	-312
Other	'	'	'	150	'	'	189
End of year at Dec. 31, 2011	17,543	14,840	2	5,743	9,392	-297	2,703
Net earnings (loss)	216	'	'	'	95	'	121
Other comprehensive income (loss)	606	'	'	'	'	614	-8
Repurchase of AllianceBernstein Holding units	'	'	'	'	'	'	-145
Dividends and distributions	'	'	'	'	362	'	-219
Other	'	'	'	249	'	'	42
End of year at Dec. 31, 2012	17,930	15,436	2	5,992	9,125	317	2,494
Net earnings (loss)	-3,236	'	'	'	-3,573	'	337
Other comprehensive income (loss)	-912	'	'	'	'	-920	8
Repurchase of AllianceBernstein Holding units	'	'	'	'	'	'	-76
Dividends and distributions	'	'	'	'	347	'	-306
Dividend Of Units Of Investment In Noncontrolling Interest To Parent	'	'	'	'	'	'	-113
Other	'	'	'	-58	'	'	333
End of year at Dec. 31, 2013	$13,441	$10,538	$2	$5,934	$5,205	($603)	$2,903

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
STATEMENTS OF CASH FLOWS [Abstract]	'	'	'
Net earnings (loss)	($3,236)	$216	$2,826
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities: [Abstract]	'	'	'
Interest credited to policyholders' account balances	1,373	1,166	999
Universal life and investment-type product policy fee income	-3,546	-3,334	-3,312
Net change in broker-dealer and customer related receivables/payables	-740	383	266
(Income) loss related to derivative instruments	2,866	978	-2,374
Change in reinsurance recoverable with affiliate	-176	-207	-242
Investment (gains) losses, net	99	97	47
Change in segregated cash and securities, net	571	-272	-170
Change in deferred policy acquisition costs	-74	-142	2,861
Change in future policy benefits	-384	876	2,110
Change in current and deferred income taxes	-1,754	-254	1,226
Change in the fair value of the reinsurance contract asset	4,297	-497	-5,941
Real Estate Asset Write Off Charge	56	42	5
Amortization of deferred compensation	159	22	418
Amortization of deferred sales commissions	41	40	38
Other depreciation and amortization	122	157	146
Amortization of reinsurance cost	280	47	211
Amortization of other intangibles	24	24	24
Other, net	180	-122	-76
Net cash provided by (used in) operating activities	158	-780	-938
Cash flows from investing activities: [Abstract]	'	'	'
Maturities and repayments of fixed maturities and mortgage loans on real estate	3,691	3,551	3,435
Sales of investments	3,442	1,951	1,141
Purchases of investments	-7,956	-7,893	-7,970
Cash settlements related to derivative instruments	-2,500	-287	1,429
Change in short-term investments	0	34	16
Decrease In Loans Due To Affiliates	5	4	0
Increase In Loans Due To Affiliates	-56	0	0
Change in capitalized software, leasehold improvements and EDP equipment	-67	-66	-104
Other, net	12	14	25
Net cash provided by (used in) investing activities	-3,429	-2,692	-2,028
Cash flows from financing activities: [Abstract]	'	'	'
Policyholders account balances deposits	5,469	5,437	4,461
Policyholders account balances withdrawals and transfers to Separate Accounts	-1,188	-982	-821
Change in short-term financings	-55	-122	220
Change in collateralized pledged liabilities	-663	-288	989
Change in collateralized pledged assets	-18	-5	99
Repayments of loans from affiliates	-500	'	'
Capital contribution	0	195	0
Shareholder dividends paid	-234	-362	-379
Repurchase of AllianceBernstein Holdings units	-113	-238	-221
Distribution to non-controlling interests in consolidated subsidiaries	-306	-219	-312
Other, net	0	-9	2
Net cash provided by (used in) financing activities	2,392	3,407	4,038
Change in cash and cash equivalents	-879	-65	1,072
Cash and cash equivalents, beginning of year	3,162	3,227	2,155
Cash and Cash Equivalents, End of Year	2,283	3,162	3,227
Supplemental Cash Flow Information [Abstract]	'	'	'
Interest Paid	91	107	107
Income Taxes (Refunded) Paid	($214)	$271	$36

ORGANIZATION

ORGANIZATION	12 Months Ended
	Dec. 31, 2013
Organization [Abstract]	'
ORGANIZATION	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
	1)        ORGANIZATION
	AXA Equitable Life Insurance Company (“AXA Equitable,” and collectively with its consolidated subsidiaries the “Company”) is an indirect, wholly owned subsidiary of AXA Financial, Inc. (“AXA Financial,” and collectively with its consolidated subsidiaries, “AXA Financial Group”). AXA Financial is an indirect wholly owned subsidiary of AXA, a French holding company for an international group of insurance and related financial services companies.
	The Company conducts operations in two business segments: the Insurance and Investment Management segments. The Company's management evaluates the performance of each of these segments independently and allocates resources based on current and future requirements of each segment.
	Insurance
	The Insurance segment offers a variety of traditional, variable and interest-sensitive life insurance products and variable and fixed-interest annuity products principally to individuals and small and medium size businesses and professional and trade associations. This segment also includes Separate Accounts for individual insurance and annuity products.
	The Company's insurance business is conducted principally by AXA Equitable.
	Investment Management
	The Investment Management segment is principally comprised of the investment management business of AllianceBernstein L.P., a Delaware limited partnership (together with its consolidated subsidiaries “AllianceBernstein”). AllianceBernstein provides research, diversified investment management and related services globally to a broad range of clients. This segment also includes institutional Separate Accounts principally managed by AllianceBernstein that provide various investment options for large group pension clients, primarily defined benefit and contribution plans, through pooled or single group accounts.
	AllianceBernstein is a private partnership for Federal income tax purposes and, accordingly, is not subject to Federal and state corporate income taxes. However, AllianceBernstein is subject to a 4.0% New York City unincorporated business tax (“UBT”). Domestic corporate subsidiaries of AllianceBernstein are subject to Federal, state and local income taxes. Foreign corporate subsidiaries are generally subject to taxes in the foreign jurisdictions where they are located. The Company provides Federal and state income taxes on the undistributed earnings of non-U.S. corporate subsidiaries except to the extent that such earnings are permanently invested outside the United States.
	At December 31, 2013 and 2012, the Company's economic interest in AllianceBernstein was 32.7% and 39.5%, respectively. At December 31, 2013 and 2012, respectively, AXA and its subsidiaries' economic interest in AllianceBernstein (including AXA Financial Group) was approximately 63.7% and 65.5%. AXA Equitable as the General Partner of the limited partnership consolidates AllianceBernstein in the Company's consolidated financial statements.
	In the first quarter of 2011, AXA sold its 50% interest in AllianceBernstein's consolidated Australian joint venture to an unaffiliated third party as part of a larger transaction. On March 31, 2011, AllianceBernstein purchased that 50% interest from the unaffiliated third party, making this Australian entity an indirect wholly-owned subsidiary. AllianceBernstein purchased the remaining 50% interest for $21 million. As a result, the Company's Noncontrolling interest decreased $27 million and AXA Equitable's equity increased $6 million.

SIGNIFICANT_ACCOUNTING_POLICIE

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
Significant Accounting Policies [Abstract]	'
SIGNIFICANT ACCOUNTING POLICIES	'
	2)       SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation and Principles of Consolidation
	The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions (including normal, recurring accruals) that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. The accompanying consolidated financial statements reflect all adjustments necessary in the opinion of management for a fair presentation of the consolidated financial position of the Company and its consolidated results of operations and cash flows for the periods presented.
	The accompanying consolidated financial statements include the accounts of AXA Equitable and its subsidiary engaged in insurance related businesses (collectively, the “Insurance Group”); other subsidiaries, principally AllianceBernstein; and those investment companies, partnerships and joint ventures in which AXA Equitable or its subsidiaries has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation.
	Accounting for Variable Annuities with GMDB and GMIB Features
	Future claims exposure on products with guaranteed minimum death benefit (“GMDB”) and guaranteed minimum income benefit (“GMIB”) features are sensitive to movements in the equity markets and interest rates. The Company has in place various hedging programs utilizing derivatives that are designed to mitigate the impact of movements in equity markets and interest rates. Under U.S. GAAP, the accounting for these various hedging programs do not qualify for hedge accounting treatment. As a result, changes in the value of the derivatives will be recognized in the period in which they occur while offsetting changes in reserves and deferred policy acquisition costs (“DAC”) will be recognized over time in accordance with policies described below under “Policyholders' Account Balances and Future Policy Benefits” and “DAC”. These differences in recognition contribute to earnings volatility.
	GMIB reinsurance contracts are used to cede to affiliated and non-affiliated reinsurers a portion of the exposure on variable annuity products that offer the GMIB feature. Under U.S. GAAP, the GMIB reinsurance contracts are accounted for as derivatives and are reported at fair value. Under U.S. GAAP, gross reserves for GMIB are calculated on the basis of assumptions related to projected benefits and related contract charges over the lives of the contracts and therefore will not immediately reflect the offsetting impact on future claims exposure resulting from the same capital market and/or interest rate fluctuations that cause gains or losses on the fair value of the GMIB reinsurance contracts. The changes in the fair value of the GMIB reinsurance contracts are recorded in the period in which they occur while offsetting changes in gross reserves and DAC for GMIB are recognized over time in accordance with policies described below under “Policyholders' Account Balances and Future Policy Benefits” and “DAC”. These differences in recognition contribute to earnings volatility.
	Accounting and Consolidation of VIE's
	At December 31, 2013 and 2012, respectively, the Insurance Group's General Account held $3 million and $1 million of investment assets issued by VIEs and determined to be significant variable interests under Financial Accounting Standards Board (“FASB”) guidance Consolidation of Variable Interest Entities – Revised. At December 31, 2013 and 2012, respectively, as reported in the consolidated balance sheet, these investments included $3 million and $1 million of other equity investments (principally investment limited partnership interests) and are subject to ongoing review for impairment in value. These VIEs do not require consolidation because management has determined that the Insurance Group is not the primary beneficiary. These variable interests at December 31, 2013 represent the Insurance Group's maximum exposure to loss from its direct involvement with the VIEs. The Insurance Group has no further economic interest in these VIEs in the form of related guarantees, commitments, derivatives, credit enhancements or similar instruments and obligations.
	For all new investment products and entities developed by AllianceBernstein (other than Collaterized Debt Obligations (“CDOs”), AllianceBernstein first determines whether the entity is a VIE, which involves determining an entity's variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, AllianceBernstein then identifies the primary beneficiary of the VIE. If AllianceBernstein is deemed to be the primary beneficiary of the VIE, then AllianceBernstein and the Company consolidate the entity.
	AllianceBernstein provides seed capital to its investment teams to develop new products and services for their clients. AllianceBernstein's original seed investment typically represents all or a majority of the equity investment in the new product is temporary in nature. AllianceBernstein evaluates its seed investments on a quarterly basis and consolidates such investments as required pursuant to U.S. GAAP.
	Management of AllianceBernstein reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client assets under management (“AUM”) to determine the entities that AllianceBernstein is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships.
	AllianceBernstein earned investment management fees on client AUM of these entities but derived no other benefit from those assets and cannot utilize those assets in its operations.
	At December 31, 2013, AllianceBernstein had significant variable interests in certain other structured products and hedge funds with approximately $26 million in client AUM. However, these VIEs do not require consolidation because management has determined that AllianceBernstein is not the primary beneficiary of the expected losses or expected residual returns of these entities. AllianceBernstein's maximum exposure to loss in these entities is limited to its investments of $200,000 in and prospective investment management fees earned from these entities.
	Consolidations
	All significant intercompany transactions and balances have been eliminated in consolidation. The years “2013”, “2012” and “2011” refer to the years ended December 31, 2013, 2012 and 2011, respectively.
	Adoption of New Accounting Pronouncements
	In February 2013, the FASB issued new guidance to improve the reporting of reclassifications out of accumulated other comprehensive income (“AOCI”). The amendments in this guidance require an entity to report the effect of significant reclassifications out of AOCI on the respective line items in the statement of earnings (loss) if the amount being reclassified is required to be reclassified in its entirety to net earnings (loss). For other amounts that are not required to be reclassified in their entirety to net earnings in the same reporting period, an entity is required to cross-reference other disclosures that provide additional detail about those amounts. The guidance requires disclosure of reclassification information either in the notes or the face of the financial statements provided the information is presented in one location. This guidance was effective for interim and annual periods beginning after December 31, 2012. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
	In July 2012, the FASB issued new guidance on testing indefinite-lived intangible assets for impairment.  The guidance is intended to reduce the cost and complexity of the annual indefinite-lived intangible assets impairment test by providing entities with the option of performing a "qualitative" assessment to determine whether further impairment testing is necessary. The guidance was effective for annual and interim indefinite-lived intangible assets impairment tests performed for fiscal years beginning after September 15, 2012. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements.
	In December 2011, the FASB issued new and enhanced disclosures about offsetting (netting) of financial instruments and derivatives, including repurchase/reverse repurchase agreements and securities lending/borrowing arrangements, to converge with those required by International Financial Reporting Standards (“IFRS”). The disclosures require presentation in tabular format of gross and net information about assets and liabilities that either are offset (presented net) on the balance sheet or are subject to master netting agreements or similar arrangements providing rights of setoff, such as global master repurchase, securities lending, and derivative clearing agreements, irrespective of whether the assets and liabilities are offset. Financial instruments subject only to collateral agreements are excluded from the scope of these requirements, however, the tabular disclosures are required to include the fair values of financial collateral, including cash, related to master netting agreements or similar arrangements. In January 2013, the FASB issued new guidance limiting the scope of the new balance sheet offsetting disclosures to derivatives, repurchase agreements, and securities lending transactions to the extent that they are (1) offset in the financial statements or (2) subject to an enforceable master netting arrangement or similar agreement. This guidance was effective for interim and annual periods beginning after January 1, 2013 and was applied retrospectively to all comparative prior periods presented. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
	In September 2011, the FASB issued new guidance on testing goodwill for impairment.  The guidance is intended to reduce the cost and complexity of the annual goodwill impairment test by providing entities with the option of performing a "qualitative" assessment to determine whether further impairment testing is necessary. The guidance was effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements.
	In June 2011, the FASB issued new guidance to amend the existing alternatives for presenting Other comprehensive income (loss) (“OCI”) and its components in financial statements. The amendments eliminate the current option to report OCI and its components in the statement of changes in equity. An entity can elect to present items of net earnings (loss) and OCI in one continuous statement or in two separate, but consecutive statements. This guidance will not change the items that constitute net earnings (loss) and OCI, when an item of OCI must be reclassified to net earnings (loss). This guidance was effective for interim and annual periods beginning after December 15, 2011. Consistent with this guidance, the Company currently presents items of net earnings (loss) and OCI in two consecutive statements.
	In May 2011, the FASB amended its guidance on fair value measurements and disclosure requirements to enhance comparability between U.S. GAAP and IFRS. The changes to the existing guidance include how and when the valuation premise of highest and best use applies, the application of premiums and discounts, as well as new required disclosures. This guidance was effective for reporting periods beginning after December 15, 2011. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
	In April 2011, the FASB issued new guidance for a creditor's determination of whether a restructuring is a troubled debt restructuring (“TDR”). The new guidance provided additional guidance to creditors for evaluating whether a modification or restructuring of a receivable is a TDR. The new guidance required creditors to evaluate modifications and restructurings of receivables using a more principles-based approach, which may result in more modifications and restructurings being considered TDR. The financial reporting implications of being classified as a TDR are that the creditor is required to:
	Consider the receivable impaired when calculating the allowance for credit losses; and
	Provide additional disclosures about its troubled debt restructuring activities in accordance with the requirements of recently issued guidance on disclosures about the credit quality of financing receivables and the allowance for credit losses.
	The new guidance was effective for the first interim or annual period beginning on or after June 15, 2011. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
	Future Adoption of New Accounting Pronouncements
	The FASB issued new guidance that allows investors to elect to use the proportional amortization method to account for investments in qualified affordable housing projects if certain conditions are met. Under this method, which replaces the effective yield method, an investor amortizes the cost of its investment, in proportion to the tax credits and other tax benefits it receives, to income tax expense. The guidance also introduces disclosure requirements for all investments in qualified affordable housing projects, regardless of the accounting method used for those investments. The guidance is effective for annual periods beginning after December 15, 2014. Management does not expect implementation of this guidance will have a material impact on the Company's consolidated financial statements.
	In July 2013, the FASB issued new guidance on the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The amendments in this guidance state that an unrecognized tax benefit, or a portion thereof, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. An exception to this guidance would be where a net operating loss carryforward or similar tax loss or credit carryforward would not be available under the tax law to settle any additional income taxes that would result from the disallowance of a tax position, or the tax law does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose. In such a case, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. This guidance is effective for interim and annual periods beginning after December 15, 2013. Management does not expect implementation of this guidance will have a material impact on the Company's consolidated financial statements.
	Closed Block
	As a result of demutualization, the Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders.
	Assets allocated to the Closed Block inure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of AXA Equitable. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of AXA Equitable's General Account, any of its Separate Accounts or any affiliate of AXA Equitable without the approval of the Superintendent of The New York State Department of Financial Services, (the “NYSDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account.
	The excess of Closed Block liabilities over Closed Block assets (adjusted to exclude the impact of related amounts in AOCI) represents the expected maximum future post-tax earnings from the Closed Block that would be recognized in income from continuing operations over the period the policies and contracts in the Closed Block remain in force. As of January 1, 2001, the Company has developed an actuarial calculation of the expected timing of the Closed Block's earnings.
	If the actual cumulative earnings from the Closed Block are greater than the expected cumulative earnings, only the expected earnings will be recognized in net income. Actual cumulative earnings in excess of expected cumulative earnings at any point in time are recorded as a policyholder dividend obligation because they will ultimately be paid to Closed Block policyholders as an additional policyholder dividend unless offset by future performance that is less favorable than originally expected. If a policyholder dividend obligation has been previously established and the actual Closed Block earnings in a subsequent period are less than the expected earnings for that period, the policyholder dividend obligation would be reduced (but not below zero). If, over the period the policies and contracts in the Closed Block remain in force, the actual cumulative earnings of the Closed Block are less than the expected cumulative earnings, only actual earnings would be recognized in income from continuing operations. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside the Closed Block.
	Many expenses related to Closed Block operations, including amortization of DAC, are charged to operations outside of the Closed Block; accordingly, net revenues of the Closed Block do not represent the actual profitability of the Closed Block operations. Operating costs and expenses outside of the Closed Block are, therefore, disproportionate to the business outside of the Closed Block.
	Investments
	The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in OCI. The amortized cost of fixed maturities is adjusted for impairments in value deemed to be other than temporary which are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock, and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer.
	The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment.
	The Company's management, with the assistance of its investment advisors, monitors the investment performance of its portfolio and reviews AFS securities with unrealized losses for other-than-temporary impairments (“OTTI”). Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company's Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security is expected to recover. This assessment includes, but is not limited to, consideration of the duration and severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity, and continued viability of the issuer and, for equity securities only, the intent and ability to hold the investment until recovery, and results in identification of specific securities for which OTTI is recognized.
	If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting OTTI is recognized in earnings (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management's best estimate of projected future cash flows at the effective interest rate implicit in the debt security prior to impairment. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. For mortgage- and asset-backed securities, projected future cash flows also include assumptions regarding prepayments and underlying collateral value.
	Real estate held for the production of income, including real estate acquired in satisfaction of debt, is stated at depreciated cost less valuation allowances. At the date of foreclosure (including in-substance foreclosure), real estate acquired in satisfaction of debt is valued at estimated fair value. Impaired real estate is written down to fair value with the impairment loss being included in Investment gains (losses), net.
	Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years.
	Policy loans are stated at unpaid principal balances.
	Partnerships, investment companies and joint venture interests that the Company has control of and has a majority economic interest in (that is, greater than 50% of the economic return generated by the entity) or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity basis of accounting and are reported either with equity real estate or other equity investments, as appropriate. The Company records its interests in certain of these partnerships on a one quarter lag.
	Equity securities, which include common stock, and non-redeemable preferred stock classified as AFS securities, are carried at fair value and are included in other equity investments with changes in fair value reported in OCI.
	Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with unrealized gains (losses) reported in Net earnings (loss).
	Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At December 31, 2013 and 2012, the carrying value of COLI was $770 million and $715 million, respectively, and is reported in Other invested assets in the consolidated balance sheets.
	Short-term investments are reported at amortized cost that approximates fair value and are included in Other invested assets.
	Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value.
	All securities owned, including United States government and agency securities, mortgage-backed securities and futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis.
	Derivatives
	Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter market. All derivative positions are carried in the consolidated balance sheets at fair value, generally by obtaining quoted market prices or through the use of valuation models.
	Freestanding derivative contracts are reported in the consolidated balance sheets either as assets within “Other invested assets” or as liabilities within “Other liabilities.” The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. The Company uses derivatives to manage asset/liability risk but has not designated those economic relationships under the criteria to qualify for hedge accounting treatment. All changes in the fair value of the Company's freestanding derivative positions, including net receipts and payments, are included in “Investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities.
	The Company is a party to financial instruments and other contracts that contain “embedded” derivative instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are “clearly and closely related” to the economic characteristics of the remaining component of the “host contract” and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When those criteria are satisfied, the resulting embedded derivative is bifurcated from the host contract, carried in the consolidated balance sheets at fair value, and changes in its fair value are recognized immediately and captioned in the consolidated statements of earnings (loss) according to the nature of the related host contract. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company instead may elect to carry the entire instrument at fair value.
	Valuation Allowances for Mortgage Loans:
	For commercial and agricultural loans, an allowance for credit loss is typically recommended when management believes it is probable that principal and interest will not be collected according to the contractual terms. Factors that influence management's judgment in determining allowance for credit losses include the following:
	Loan-to-value ratio – Derived from current loan balance divided by the fair market value of the property.  An allowance for credit loss is typically recommended when the loan-to-value ratio is in excess of 100%.   In the case where the loan-to-value is in excess of 100%, the allowance for credit loss is derived by taking the difference between the fair market value (less cost of sale) and the current loan balance.
	Debt service coverage ratio – Derived from actual net operating income divided by annual debt service.  If the ratio is below 1.0x, then the income from the property does not support the debt.
	Occupancy – Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance.
	Lease expirations – The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio.  In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor.
	Maturity – Loans that are not fully amortizing and have upcoming maturities within the next 12 to 24 months are monitored in conjunction with the capital markets to determine the borrower's ability to refinance the debt and/or pay off the balloon balance.
	Borrower/tenant related issues – Financial concerns, potential bankruptcy, or words or actions that indicate imminent default or abandonment of property.
Payment status – current vs. delinquent – A history of delinquent payments may be a cause for concern.
Property condition – Significant deferred maintenance observed during Lender's annual site inspections.
Other – Any other factors such as current economic conditions may call into question the performance of the loan.
Mortgage loans on real estate are stated at unpaid principal balances, net of unamortized discounts and valuation allowances. Valuation allowances are based on the present value of expected future cash flows discounted at the loan's original effective interest rate or on its collateral value if the loan is collateral dependent. However, if foreclosure is or becomes probable, the collateral value measurement method is used.
Mortgage loans also are individually evaluated quarterly by the IUS Committee for impairment, including an assessment of related collateral value. Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problems but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being restructured. The decision whether to classify a performing mortgage loan as a potential problem involves significant subjective judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property.
For problem mortgage loans a valuation allowance is established to provide for the risk of credit losses inherent in the lending process. The allowance includes loan specific reserves for loans determined to be non-performing as a result of the loan review process. A non-performing loan is defined as a loan for which it is probable that amounts due according to the contractual terms of the loan agreement will not be collected. The loan specific portion of the loss allowance is based on the Company's assessment as to ultimate collectability of loan principal and interest. Valuation allowances for a non-performing loan are recorded based on the present value of expected future cash flows discounted at the loan's effective interest rate or based on the fair value of the collateral if the loan is collateral dependent. The valuation allowance for mortgage loans can increase or decrease from period to period based on such factors.
Impaired mortgage loans without provision for losses are loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Changes in the present value attributable to changes in the amount or timing of expected cash flows are reported as investment gains or losses.
Mortgage loans on real estate are placed on nonaccrual status once management believes the collection of accrued interest is doubtful. Once mortgage loans on real estate are classified as nonaccrual loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan on real estate has been restructured to where the collection of interest is considered likely. At December 31, 2013 and 2012, the carrying values of commercial and agricultural mortgage loans on real estate that had been classified as nonaccrual loans were $93 million and $0 million for commercial and $0 million and $2 million for agricultural, respectively.
Troubled Debt Restructuring
When a loan modification is determined to be a troubled debt restructuring, the impairment of the loan is re-measured by discounting the expected cash flows to be received based on the modified terms using the loan's original effective yield, and the allowance for loss is adjusted accordingly. Subsequent to the modification, income is recognized prospectively based on the modified terms of the loans. Additionally, the loan continues to be subject to the credit review process noted above.
Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses)
Net investment income (loss) and realized investment gains (losses), net (together “investment results”) related to certain participating group annuity contracts which are passed through to the contractholders are offset by amounts reflected as interest credited to policyholders' account balances.
Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the valuation allowances are included in Investment gains (losses), net.
Realized and unrealized holding gains (losses) on trading securities are reflected in Net investment income (loss).
Unrealized investment gains (losses) on fixed maturities and equity securities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, amounts attributable to certain pension operations, Closed Blocks' policyholders dividend obligation, insurance liability loss recognition and DAC related to universal life (“UL”) policies, investment-type products and participating traditional life policies.
Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities and equity securities classified as AFS and do not reflect any change in fair value of policyholders' account balances and future policy benefits.
Fair Value of Financial Instruments
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance established a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
Level 1       Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2       Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.
Level 3       Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity's own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.
The Company defines fair value as the unadjusted quoted market prices for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company's entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.
Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.
Recognition of Insurance Income and Related Expenses
Premiums from UL and investment-type contracts are reported as deposits to policyholders' account balances. Revenues from these contracts consist of fees assessed during the period against policyholders' account balances for mortality charges, policy administration charges and surrender charges. Policy benefits and claims that are charged to expense include benefit claims incurred in the period in excess of related policyholders' account balances.
Premiums from participating and non-participating traditional life and annuity policies with life contingencies generally are recognized in income when due. Benefits and expenses are matched with such income so as to result in the recognition of profits over the life of the contracts. This match is accomplished by means of the provision for liabilities for future policy benefits and the deferral and subsequent amortization of policy acquisition costs.
For contracts with a single premium or a limited number of premium payments due over a significantly shorter period than the total period over which benefits are provided, premiums are recorded as revenue when due with any excess profit deferred and recognized in income in a constant relationship to insurance in-force or, for annuities, the amount of expected future benefit payments.
Premiums from individual health contracts are recognized as income over the period to which the premiums relate in proportion to the amount of insurance protection provided.
DAC
Acquisition costs that vary with and are primarily related to the acquisition of new and renewal insurance business, reflecting incremental direct costs of contract acquisition with independent third parties or employees that are essential to the contract transaction, as well as the portion of employee compensation, including payroll fringe benefits and other costs directly related to underwriting, policy issuance and processing, medical inspection, and contract selling for successfully negotiated contracts including commissions, underwriting, agency and policy issue expenses, are deferred. DAC is subject to recoverability testing at the time of policy issue and loss recognition testing at the end of each accounting period.
After the initial establishment of reserves, premium deficiency and loss recognition tests are performed each period end using best estimate assumptions as of the testing date without provisions for adverse deviation. When the liabilities for future policy benefits plus the present value of expected future gross premiums for the aggregate product group are insufficient to provide for expected future policy benefits and expenses for that line of business (i.e., reserves net of any DAC asset), DAC would first be written off and thereafter, if required, a premium deficiency reserve would be established by a charge to earnings.
In accordance with the guidance for the accounting and reporting by insurance enterprises for certain long-duration contracts and participating contracts and for realized gains and losses from the sale of investments, current and expected future profit margins for products covered by this guidance are examined regularly in determining the amortization of DAC. Due primarily to the significant decline in Separate Accounts balances during 2008 and a change in the estimate of average gross short-term annual return on Separate Accounts balances to 9.0%, future estimated gross profits at December 31, 2008 for certain issue years for the Accumulator® products were expected to be negative as the increases in the fair values of derivatives used to hedge certain risks related to these products would be recognized in current earnings while the related reserves do not fully and immediately reflect the impact of equity and interest market fluctuations. As required under U.S. GAAP, for those issue years with future estimated negative gross profits, the DAC amortization method was permanently changed in fourth quarter 2008 from one based on estimated gross profits to one based on estimated assessments for the Accumulator® products, subject to loss recognition testing. In second quarter 2011, the DAC amortization method was changed to one based on estimated assessments for all issue years for the Accumulator® products due to continued volatility of margins and the continued emergence of periods of negative margins.
DAC associated with UL and investment-type products, other than Accumulator® products is amortized over the expected total life of the contract group as a constant percentage of estimated gross profits arising principally from investment results, Separate Account fees, mortality and expense margins and surrender charges based on historical and anticipated future experience, updated at the end of each accounting period. When estimated gross profits are expected to be negative for multiple years of a contract life, DAC is amortized using the present value of estimated assessments. The effect on the amortization of DAC of revisions to estimated gross profits or assessments is reflected in earnings (loss) in the period such estimated gross profits or assessments are revised. A decrease in expected gross profits or assessments would accelerate DAC amortization. Conversely, an increase in expected gross profits or assessments would slow DAC amortization. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date.
A significant assumption in the amortization of DAC on variable annuities and variable and interest-sensitive life insurance relates to projected future Separate Account performance. Management sets estimated future gross profit or assessment assumptions related to Separate Account performance using a long-term view of expected average market returns by applying a reversion to the mean approach, a commonly used industry practice. This future return approach influences the projection of fees earned, as well as other sources of estimated gross profits. Returns that are higher than expectations for a given period produce higher than expected account balances, increase the fees earned resulting in higher expected future gross profits and lower DAC amortization for the period. The opposite occurs when returns are lower than expected.
In applying this approach to develop estimates of future returns, it is assumed that the market will return to an average gross long-term return estimate, developed with reference to historical long-term equity market performance. Currently, the average gross long-term return estimate is measured from December 31, 2008. Management has set limitations as to maximum and minimum future rate of return assumptions, as well as a limitation on the duration of use of these maximum or minimum rates of return. At December 31, 2013, the average gross short-term and long-term annual return estimate on variable and interest-sensitive life insurance and variable annuities was 9.0% (6.68)% net of product weighted average Separate Account fees), and the gross maximum and minimum short-term annual rate of return limitations were 15.0% (12.68)% net of product weighted average Separate Account fees) and 0.0% (-2.32% net of product weighted average Separate Account fees), respectively. The maximum duration over which these rate limitations may be applied is 5 years. This approach will continue to be applied in future periods. These assumptions of long-term growth are subject to assessment of the reasonableness of resulting estimates of future return assumptions.
If actual market returns continue at levels that would result in assuming future market returns of 15.0% for more than 5 years in order to reach the average gross long-term return estimate, the application of the 5 year maximum duration limitation would result in an acceleration of DAC amortization. Conversely, actual market returns resulting in assumed future market returns of 0.0% for more than 5 years would result in a required deceleration of DAC amortization. At December 31, 2013, current projections of future average gross market returns assume a 0.0% annualized return for the next seven quarters, which is the minimum limitations grading to a reversion to the mean of 9.0% in fifteen quarters.
In addition, projections of future mortality assumptions related to variable and interest-sensitive life products are based on a long-term average of actual experience. This assumption is updated quarterly to reflect recent experience as it emerges. Improvement of life mortality in future periods from that currently projected would result in future deceleration of DAC amortization. Conversely, deterioration of life mortality in future periods from that currently projected would result in future acceleration of DAC amortization.
Other significant assumptions underlying gross profit estimates for UL and investment type products relate to contract persistency and General Account investment spread.
For participating traditional life policies (substantially all of which are in the Closed Block), DAC is amortized over the expected total life of the contract group as a constant percentage based on the present value of the estimated gross margin amounts expected to be realized over the life of the contracts using the expected investment yield. At December 31, 2013, the average rate of assumed investment yields, excluding policy loans, was 5.3% grading to 5.0% over 10 years. Estimated gross margins include anticipated premiums and investment results less claims and administrative expenses, changes in the net level premium reserve and expected annual policyholder dividends. The effect on the accumulated amortization of DAC of revisions to estimated gross margins is reflected in earnings in the period such estimated gross margins are revised. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date. Many of the factors that affect gross margins are included in the determination of the Company's dividends to these policyholders. DAC adjustments related to participating traditional life policies do not create significant volatility in results of operations as the Closed Block recognizes a cumulative policyholder dividend obligation expense in “Policyholders' dividends,” for the excess of actual cumulative earnings over expected cumulative earnings as determined at the time of demutualization.
DAC associated with non-participating traditional life policies is amortized in proportion to anticipated premiums. Assumptions as to anticipated premiums are estimated at the date of policy issue and are consistently applied during the life of the contracts. Deviations from estimated experience are reflected in earnings (loss) in the period such deviations occur. For these contracts, the amortization periods generally are for the total life of the policy. DAC related to these policies is subject to recoverability testing as part of AXA Financial Group's premium deficiency testing. If a premium deficiency exists, DAC is reduced by the amount of the deficiency or to zero through a charge to current period earnings (loss). If the deficiency exceeds the DAC balance, the reserve for future policy benefits is increased by the excess, reflected in earnings (loss) in the period such deficiency occurs.
Contractholder Bonus Interest Credits
Contractholder bonus interest credits are offered on certain deferred annuity products in the form of either immediate bonus interest credited or enhanced interest crediting rates for a period of time. The interest crediting expense associated with these contractholder bonus interest credits is deferred and amortized over the lives of the underlying contracts in a manner consistent with the amortization of DAC. Unamortized balances are included in Other assets.
Policyholders' Account Balances and Future Policy Benefits
Policyholders' account balances for UL and investment-type contracts are equal to the policy account values. The policy account values represent an accumulation of gross premium payments plus credited interest less expense and mortality charges and withdrawals.
The Company has issued and continues to offer certain variable annuity products with GMDB and Guaranteed income benefit (“GIB”) features. The Company previously issued certain variable annuity products with Guaranteed withdrawal benefit for life (“GWBL”) and other features. The Company also issues certain variable annuity products that contain a GMIB feature which, if elected by the policyholder after a stipulated waiting period from contract issuance, guarantees a minimum lifetime annuity based on predetermined annuity purchase rates that may be in excess of what the contract account value can purchase at then-current annuity purchase rates. This minimum lifetime annuity is based on predetermined annuity purchase rates applied to a GMIB base. Reserves for GMDB and GMIB obligations are calculated on the basis of actuarial assumptions related to projected benefits and related contract charges generally over the lives of the contracts using assumptions consistent with those used in estimating gross profits for purposes of amortizing DAC. The determination of this estimated liability is based on models that involve numerous estimates and subjective judgments, including those regarding expected market rates of return and volatility, contract surrender and withdrawal rates, mortality experience, and, for contracts with the GMIB feature, GMIB election rates. Assumptions regarding Separate Account performance used for purposes of this calculation are set using a long-term view of expected average market returns by applying a reversion to the mean approach, consistent with that used for DAC amortization. There can be no assurance that actual experience will be consistent with management's estimates.
For reinsurance contracts other than those covering GMIB exposure, reinsurance recoverable balances are calculated using methodologies and assumptions that are consistent with those used to calculate the direct liabilities.
For participating traditional life policies, future policy benefit liabilities are calculated using a net level premium method on the basis of actuarial assumptions equal to guaranteed mortality and dividend fund interest rates. The liability for annual dividends represents the accrual of annual dividends earned. Terminal dividends are accrued in proportion to gross margins over the life of the contract.
For non-participating traditional life insurance policies, future policy benefit liabilities are estimated using a net level premium method on the basis of actuarial assumptions as to mortality, persistency and interest established at policy issue. Assumptions established at policy issue as to mortality and persistency are based on the Insurance Group's experience that, together with interest and expense assumptions, includes a margin for adverse deviation. Benefit liabilities for traditional annuities during the accumulation period are equal to accumulated contractholders' fund balances and, after annuitization, are equal to the present value of expected future payments. Interest rates used in establishing such liabilities range from 2.25% to 10.9% for life insurance liabilities and from 1.57% to 11.25% for annuity liabilities.
Individual health benefit liabilities for active lives are estimated using the net level premium method and assumptions as to future morbidity, withdrawals and interest. Benefit liabilities for disabled lives are estimated using the present value of benefits method and experience assumptions as to claim terminations, expenses and interest. While management believes its disability income (“DI”) reserves have been calculated on a reasonable basis and are adequate, there can be no assurance reserves will be sufficient to provide for future liabilities.
When the liabilities for future policy benefits plus the present value of expected future gross premiums for a product are insufficient to provide for expected future policy benefits and expenses for that product, DAC is written off and thereafter, if required, a premium deficiency reserve is established by a charge to earnings.
Policyholders' Dividends
The amount of policyholders' dividends to be paid (including dividends on policies included in the Closed Block) is determined annually by AXA Equitable's board of directors. The aggregate amount of policyholders' dividends is related to actual interest, mortality, morbidity and expense experience for the year and judgment as to the appropriate level of statutory surplus to be retained by AXA Equitable.
At December 31, 2013, participating policies, including those in the Closed Block, represent approximately 5.2% ($21,194 million) of directly written life insurance in-force, net of amounts ceded.
Separate Accounts
Generally, Separate Accounts established under New York State Insurance Law are not chargeable with liabilities that arise from any other business of the Insurance Group. Separate Accounts assets are subject to General Account claims only to the extent Separate Accounts assets exceed Separate Accounts liabilities. Assets and liabilities of the Separate Accounts represent the net deposits and accumulated net investment earnings (loss) less fees, held primarily for the benefit of contractholders, and for which the Insurance Group does not bear the investment risk. Separate Accounts' assets and liabilities are shown on separate lines in the consolidated balance sheets. Assets held in Separate Accounts are reported at quoted market values or, where quoted values are not readily available or accessible for these securities, their fair value measures most often are determined through the use of model pricing that effectively discounts prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security's duration, also taking into consideration issuer-specific credit quality and liquidity. The assets and liabilities of six Separate Accounts are presented and accounted for as General Account assets and liabilities due to the fact that not all of the investment performance in those Separate Accounts is passed through to policyholders. Investment assets in these Separate Accounts principally consist of fixed maturities that are classified as AFS in the accompanying consolidated financial statements.
The investment results of Separate Accounts, including unrealized gains (losses), on which the Insurance Group does not bear the investment risk are reflected directly in Separate Accounts liabilities and are not reported in revenues in the consolidated statements of earnings (loss). For 2013, 2012 and 2011, investment results of such Separate Accounts were gains (losses) of $19,022 million, $10,110 million and $(2,928) million, respectively.
Deposits to Separate Accounts are reported as increases in Separate Accounts liabilities and are not reported in revenues. Mortality, policy administration and surrender charges on all policies including those funded by Separate Accounts are included in revenues.
The Company reports the General Account's interests in Separate Accounts as Other equity investments in the consolidated balance sheets.
Recognition of Investment Management Revenues and Related Expenses
Commissions, fees and other income principally include the Investment Management segment's investment advisory and service fees, distribution revenues and institutional research services revenue. Investment advisory and service base fees, generally calculated as a percentage, referred to as basis points (“BPs”), of assets under management, are recorded as revenue as the related services are performed; they include brokerage transactions charges received by Sanford C. Bernstein & Co. LLC (“SCB LLC”) for certain retail, private client and institutional investment client transactions. Certain investment advisory contracts, including those associated with hedge funds, provide for a performance-based fee, in addition to or in lieu of a base fee which is calculated as either a percentage of absolute investment results or a percentage of the investment results in excess of a stated benchmark over a specified period of time. Performance-based fees are recorded as a component of revenue at the end of each contract's measurement period. Institutional research services revenue consists of brokerage transaction charges received by SCB LLC and Sanford C. Bernstein Limited (“SCBL”) for independent research and brokerage-related services provided to institutional investors. Brokerage transaction charges earned and related expenses are recorded on a trade date basis. Distribution revenues and shareholder servicing fees are accrued as earned.
Commissions paid to financial intermediaries in connection with the sale of shares of open-end AllianceBernstein sponsored mutual funds sold without a front-end sales charge (“back-end load shares”) are capitalized as deferred sales commissions and amortized over periods not exceeding five and one-half years for U.S. fund shares and four years for non-U.S. fund shares, the periods of time during which the deferred sales commissions are generally recovered. These commissions are recovered from distribution services fees received from those funds and from contingent deferred sales commissions (“CDSC”) received from shareholders of those funds upon the redemption of their shares. CDSC cash recoveries are recorded as reductions of unamortized deferred sales commissions when received. Effective January 31, 2009, back-end load shares are no longer offered to new investors by AllianceBernstein's U.S. funds. Management tests the deferred sales commission asset for recoverability quarterly and determined that the balance as of December 31, 2013 was not impaired.
AllianceBernstein's management determines recoverability by estimating undiscounted future cash flows to be realized from this asset, as compared to its recorded amount, as well as the estimated remaining life of the deferred sales commission asset over which undiscounted future cash flows are expected to be received. Undiscounted future cash flows consist of ongoing distribution services fees and CDSC. Distribution services fees are calculated as a percentage of average assets under management related to back-end load shares. CDSC are based on the lower of cost or current value, at the time of redemption, of back-end load shares redeemed and the point at which redeemed during the applicable minimum holding period under the mutual fund distribution system.
Significant assumptions utilized to estimate future average assets under management and undiscounted future cash flows from back-end load shares include expected future market levels and redemption rates. Market assumptions are selected using a long-term view of expected average market returns based on historical returns of broad market indices. Future redemption rate assumptions are determined by reference to actual redemption experience over the five-year, three-year and one-year periods and current quarterly periods ended December 31, 2013. These assumptions are updated periodically. Estimates of undiscounted future cash flows and the remaining life of the deferred sales commission asset are made from these assumptions and the aggregate undiscounted cash flows are compared to the recorded value of the deferred sales commission asset. If AllianceBernstein's management determines in the future that the deferred sales commission asset is not recoverable, an impairment condition would exist and a loss would be measured as the amount by which the recorded amount of the asset exceeds its estimated fair value. Estimated fair value is determined using AllianceBernstein's management's best estimate of future cash flows discounted to a present value amount.
Goodwill and Other Intangible Assets
Goodwill represents the excess of the purchase price over the fair value of identifiable net assets of acquired companies, and relates principally to the Bernstein Acquisition and purchases of AllianceBernstein units. In accordance with the guidance for Goodwill and Other Intangible Assets, goodwill is tested annually for impairment and at interim periods if events or circumstances indicate an impairment could have occurred.
Intangible assets related to the Bernstein Acquisition and purchases of AllianceBernstein Units include values assigned to contracts of businesses acquired based on their estimated fair value at the time of acquisition, less accumulated amortization. These intangible assets are generally amortized on a straight-line basis over their estimated useful life of approximately 20 years. All intangible assets are periodically reviewed for impairment as events or changes in circumstances indicate that the carrying value may not be recoverable. If the carrying value exceeds fair value, additional impairment tests are performed to measure the amount of the impairment loss, if any.
Other Accounting Policies
Capitalized internal-use software, included in Other assets in the consolidated balance sheets, is amortized on a straight-line basis over the estimated useful life of the software that ranges between three and five years. If an impairment is determined to have occurred, software capitalization is accelerated for the remaining balance deemed to be impaired.
AXA Financial and certain of its consolidated subsidiaries and affiliates, including the Company, file a consolidated Federal income tax return. Current Federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. Deferred income tax assets and liabilities are recognized based on the difference between financial statement carrying amounts and income tax bases of assets and liabilities using enacted income tax rates and laws.

INVESTMENTS

INVESTMENTS	12 Months Ended
	Dec. 31, 2013
Investments Disclosure [Abstract]	'
INVESTMENTS	'
	3)        INVESTMENTS
	Fixed Maturities and Equity Securities
	The following table provides information relating to fixed maturities and equity securities classified as AFS:
	Available-for-Sale Securities by Classification
								Gross			Gross
					Amortized			Unrealized			Unrealized			Fair			OTTI
					Cost			Gains			Losses			Value			in AOCI(3)
					(In Millions)
	December 31, 2013:
	Fixed Maturity Securities:
		Corporate			$	21,516		$	1,387		$	213		$	22,690		$	0
		U.S. Treasury, government
			and agency			3,584			22			477			3,129			0
		States and political subdivisions				444			35			2			477			0
		Foreign governments				392			46			5			433			0
		Commercial mortgage-backed				971			10			265			716			23
		Residential mortgage-backed(1)				914			34			1			947			0
		Asset-backed(2)				132			11			3			140			4
		Redeemable preferred stock				883			55			51			887			0
			Total Fixed Maturities			28,836			1,600			1,017			29,419			27
	Equity securities					37			0			3			34			0
	Total at December 31, 2013				$	28,873		$	1,600		$	1,020		$	29,453		$	27
	December 31, 2012:
	Fixed Maturity Securities:
		Corporate			$	20,854		$	2,364		$	20		$	23,198		$	0
		U.S. Treasury, government
			and agency			4,664			517			1			5,180			0
		States and political subdivisions				445			85			0			530			0
		Foreign governments				454			76			0			530			0
		Commercial mortgage-backed				1,175			16			291			900			13
		Residential mortgage-backed(1)				1,864			85			0			1,949			0
		Asset-backed(2)				175			12			5			182			5
		Redeemable preferred stock				1,089			60			11			1,138			0
			Total Fixed Maturities			30,720			3,215			328			33,607			18
	Equity securities					23			1			0			24			0
	Total at December 31, 2012				$	30,743		$	3,216		$	328		$	33,631		$	18
	Includes publicly traded agency pass-through securities and collateralized mortgage obligations.
	Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
	Amounts represent OTTI losses in AOCI, which were not included in earnings (loss) in accordance with current accounting guidance.
	At December 31, 2013 and 2012, respectively, the Company had trading fixed maturities with an amortized cost of $243 million and $194 million and carrying values of $238 million and $202 million. Gross unrealized gains on trading fixed maturities were $2 million and $12 million and gross unrealized losses were $7 million and $4 million for 2013 and 2012, respectively.
	The contractual maturities of AFS fixed maturities (excluding redeemable preferred stock) at December 31, 2013 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
	Available-for-Sale Fixed Maturities
	Contractual Maturities at December 31, 2013
				Amortized Cost			Fair Value
				(In Millions)
	Due in one year or less			$	953		$	969
	Due in years two through five				7,786			8,387
	Due in years six through ten				10,232			10,561
	Due after ten years				6,965			6,812
		Subtotal			25,936			26,729
	Commercial mortgage-backed securities				971			716
	Residential mortgage-backed securities				914			947
	Asset-backed securities				132			140
	Total			$	27,953		$	28,532
	The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during 2013, 2012 and 2011:
					December 31,
					2013			2012			2011
					(In Millions)
	Proceeds from sales				$	3,220		$	139		$	340
	Gross gains on sales				$	71		$	13		$	6
	Gross losses on sales				$	-88		$	-12		$	-9
	Total OTTI				$	-81		$	-96		$	-36
	Non-credit losses recognized in OCI					15			2			4
Credit losses recognized in earnings (loss)				$	-66		$	-94		$	-32
The following table sets forth the amount of credit loss impairments on fixed maturity securities held by the Company at the dates indicated and the corresponding changes in such amounts.
Fixed Maturities - Credit Loss Impairments
		2013			2012
		(In Millions)
Balances at January 1,		$	-372		$	-332
Previously recognized impairments on securities that matured, paid, prepaid or sold			67			54
Recognized impairments on securities impaired to fair value this period(1)			0			0
Impairments recognized this period on securities not previously impaired			-59			-62
Additional impairments this period on securities previously impaired			-6			-32
Increases due to passage of time on previously recorded credit losses			0			0
Accretion of previously recognized impairments due to increases in expected cash flows			0			0
Balances at December 31,		$	-370		$	-372
Represents circumstances where the Company determined in the current period that it intends to sell the security or it is more likely than not that it will be required to sell the security before recovery of the security's amortized cost.
Net unrealized investment gains (losses) on fixed maturities and equity securities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated:
				December 31,
				2013			2012
				(In Millions)
AFS Securities:
	Fixed maturities:
		With OTTI loss		$	-28		$	-12
		All other			610			2,899
	Equity securities				-3			1
Net Unrealized Gains (Losses)				$	579		$	2,888
Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net earnings (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a rollforward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturity securities on which an OTTI loss has been recognized, and all other:
Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses
																	AOCI Gain
					Net												(Loss) Related
					Unrealized									Deferred			to Net
					Gains									Income			Unrealized
					(Losses) on						Policyholders			Tax Asset			Investment
					Investments			DAC			Liabilities			(Liability)			Gains (Losses)
					(In Millions)
Balance, January 1, 2013					$	-12		$	1		$	4		$	2		$	-5
Net investment gains (losses) arising
	during the period					-14			0			0			0			-14
Reclassification adjustment for OTTI losses:
		Included in Net earnings (loss)				13			0			0			0			13
		Excluded from Net earnings (loss)(1)				-15			0			0			0			-15
Impact of net unrealized investment
	gains (losses) on:
		DAC				0			1			0			0			1
		Deferred income taxes				0			0			0			3			3
		Policyholders liabilities				0			0			6			0			6
Balance, December 31, 2013					$	-28		$	2		$	10		$	5		$	-11
Balance, January 1, 2012					$	-47		$	5		$	6		$	12		$	-24
Net investment gains (losses) arising
	during the period					5			0			0			0			5
Reclassification adjustment for OTTI losses:
		Included in Net earnings (loss)				32			0			0			0			32
		Excluded from Net earnings (loss)(1)				-2			0			0			0			-2
Impact of net unrealized investment
	gains (losses) on:
		DAC				0			-4			0			0			-4
		Deferred income taxes				0			0			0			-10			-10
		Policyholders liabilities				0			0			-2			0			-2
Balance, December 31, 2012					$	-12		$	1		$	4		$	2		$	-5
(1)       Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in earnings (loss) for securities with no prior OTTI loss.
All Other Net Unrealized Investment Gains (Losses) in AOCI
																	AOCI Gain
					Net												(Loss) Related
					Unrealized									Deferred			to Net
					Gains									Income			Unrealized
					(Losses) on						Policyholders			Tax Asset			Investment
					Investments			DAC			Liabilities			(Liability)			Gains (Losses)
					(In Millions)
Balance, January 1, 2013					$	2,900		$	-179		$	-603		$	-741		$	1,377
Net investment gains (losses) arising
	during the period					-2,370			0			0			0			-2,370
Reclassification adjustment for OTTI losses:
		Included in Net earnings (loss)				62			0			0			0			62
		Excluded from Net earnings (loss)(1)				15			0			0			0			15
Impact of net unrealized investment
	gains (losses) on:
		DAC				0			72			0			0			72
		Deferred income taxes				0			0			0			651			651
		Policyholders liabilities				0			0			358			0			358
Balance, December 31, 2013					$	607		$	-107		$	-245		$	-90		$	165
Balance, January 1, 2012					$	1,831		$	-207		$	-385		$	-433		$	806
Net investment gains (losses) arising
	during the period					1,008			0			0			0			1,008
Reclassification adjustment for OTTI losses:
		Included in Net earnings (loss)				59			0			0			0			59
		Excluded from Net earnings (loss)(1)				2			0			0			0			2
Impact of net unrealized investment
	gains (losses) on:
		DAC				0			28			0			0			28
		Deferred income taxes				0			0			0			-308			-308
		Policyholders liabilities				0			0			-218			0			-218
Balance, December 31, 2012					$	2,900		$	-179		$	-603		$	-741		$	1,377
Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in earnings (loss) for securities with no prior OTTI loss.
The following tables disclose the fair values and gross unrealized losses of the 747 issues at December 31, 2013 and the 402 issues at December 31, 2012 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:
				Less Than 12 Months						12 Months or Longer						Total
							Gross						Gross						Gross
							Unrealized						Unrealized						Unrealized
				Fair Value			Losses			Fair Value			Losses			Fair Value			Losses
				(In Millions)
December 31, 2013:
Fixed Maturity Securities:
	Corporate			$	4,381		$	-187		$	248		$	-26		$	4,629		$	-213
	U.S. Treasury, government
		and agency			2,645			-477			0			0			2,645			-477
	States and political subdivisions				36			-2			0			0			36			-2
	Foreign governments				68			-4			7			-1			75			-5
	Commercial mortgage-backed				30			-5			529			-260			559			-265
	Residential mortgage-backed				260			-1			1			0			261			-1
	Asset-backed				2			0			28			-3			30			-3
	Redeemable preferred stock				232			-49			79			-2			311			-51
Total				$	7,654		$	-725		$	892		$	-292		$	8,546		$	-1,017
December 31, 2012:
Fixed Maturity Securities:
	Corporate			$	562		$	-5		$	208		$	-15		$	770		$	-20
	U.S. Treasury, government
		and agency			513			-1			0			0			513			-1
	States and political subdivisions				20			0			0			0			20			0
	Foreign governments				6			0			2			0			8			0
	Commercial mortgage-backed				7			-3			805			-288			812			-291
	Residential mortgage-backed				27			0			1			0			28			0
	Asset-backed				8			0			36			-5			44			-5
	Redeemable preferred stock				143			-1			327			-10			470			-11
Total				$	1,286		$	-10		$	1,379		$	-318		$	2,665		$	-328
##RE
The Company's investments in fixed maturity securities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of AXA Equitable, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.3% of total investments. The largest exposures to a single issuer of corporate securities held at December 31, 2013 and 2012 were $158 million and $138 million, respectively. Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium grade), 4 or 5 (below investment grade) or 6 (in or near default). At December 31, 2013 and 2012, respectively, approximately $1,913 million and $2,095 million, or 6.6% and 6.8%, of the $28,836 million and $30,720 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized losses of $215 million and $224 million at December 31, 2013 and 2012, respectively.
The Company does not originate, purchase or warehouse residential mortgages and is not in the mortgage servicing business. The Company's fixed maturity investment portfolio includes residential mortgage backed securities (“RMBS”) backed by subprime and Alt-A residential mortgages, comprised of loans made by banks or mortgage lenders to residential borrowers with lower credit ratings. The criteria used to categorize such subprime borrowers include Fair Isaac Credit Organization (“FICO”) scores, interest rates charged, debt-to-income ratios and loan-to-value ratios. Alt-A residential mortgages are mortgage loans where the risk profile falls between prime and subprime; borrowers typically have clean credit histories but the mortgage loan has an increased risk profile due to higher loan-to-value and debt-to-income ratios and/or inadequate documentation of the borrowers' income. At December 31, 2013 and 2012, respectively, the Company owned $10 million and $17 million in RMBS backed by subprime residential mortgage loans, and $8 million and $11 million in RMBS backed by Alt-A residential mortgage loans. RMBS backed by subprime and Alt-A residential mortgages are fixed income investments supporting General Account liabilities.
At December 31, 2013, the carrying value of fixed maturities that were non-income producing for the twelve months preceding that date was $17 million.
At December 31, 2013 and 2012, respectively, the amortized cost of the Company's trading account securities was $4,225 million and $2,265 million with respective fair values of $4,221 million and $2,309 million. Also at December 31, 2013 and 2012, respectively, Other equity investments included the General Account's investment in Separate Accounts which had carrying values of $192 million and $58 million and costs of $183 million and $57 million as well as other equity securities with carrying values of $34 million and $24 million and costs of $37 million and $23 million.
In 2013, 2012 and 2011, respectively, net unrealized and realized holding gains (losses) on trading account equity securities, including earnings (losses) on the General Account's investment in Separate Accounts, of $48 million, $69 million and $(42) million, respectively, were included in Net investment income (loss) in the consolidated statements of earnings (loss).
Mortgage Loans
The payment terms of mortgage loans on real estate may from time to time be restructured or modified. The investment in restructured mortgage loans on real estate, based on amortized cost, amounted to $135 million and $126 million at December 31, 2013 and 2012, respectively. Gross interest income on these loans included in net investment income (loss) totaled $2 million, $7 million and $7 million in 2013, 2012 and 2011, respectively. Gross interest income on restructured mortgage loans on real estate that would have been recorded in accordance with the original terms of such loans amounted to $7 million, $8 million and $7 million in 2013, 2012 and 2011, respectively.
Troubled Debt Restructurings
In 2011, one of the 2 loans shown in the table below was modified to interest only payments until October 5, 2013. On October 10, 2013, this loan was further modified to interest only payments through June 5, 2014, at which time the loan reverts to its normal amortizing payment. In 2012, the second loan was modified retroactive to the July 1, 2012 payment and was converted to interest only payments through maturity in August 2014. Due to the nature of the modifications, short-term principal amortization relief, the modifications have no financial impact. The fair market value of the underlying real estate collateral is the primary factor in determining the allowance for credit losses and as such, modifications of loan terms typically have no direct impact on the allowance for credit losses.
Troubled Debt Restructuring - Modifications
31-Dec-13
			Number			Outstanding Recorded Investment
			of Loans			Pre-Modification			Post - Modification
						(Dollars In Millions)
	Commercial mortgage loans			2			126			135
There were no default payments on the above loans during 2013.
There were no agricultural troubled debt restructuring mortgage loans in 2013.
Valuation Allowances for Mortgage Loans:
Allowance for credit losses for mortgage loans for 2013, 2012 and 2011 are as follows:
			Commercial Mortgage Loans
			2013			2012			2011
Allowance for credit losses:			(In Millions)
Beginning Balance, January 1,			$	34		$	32		$	18
	Charge-offs			0			0			0
	Recoveries			-2			-24			-8
	Provision			10			26			22
Ending Balance, December 31,			$	42		$	34		$	32
Ending Balance, December 31,:
	Individually Evaluated for Impairment		$	42		$	34		$	32
There were no allowances for credit losses for agricultural mortgage loans in 2013, 2012 and 2011.
The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. The following tables provide information relating to the loan-to-value and debt service coverage ratio for commercial and agricultural mortgage loans at December 31, 2013 and 2012, respectively.
Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
31-Dec-13
					Debt Service Coverage Ratio
																				Less		Total
					Greater			1.8x to			1.5x to			1.2x to			1.0x to			than		Mortgage
Loan-to-Value Ratio:(2)					than 2.0x			2.0x			1.8x			1.5x			1.2x			1.0x		Loans
					(In Millions)
Commercial Mortgage Loans(1)
0% - 50%					$	285		$	0		$	0		$	0		$	36		$	0	$	321
50% - 70%						360			573			671			533			135			0		2,272
70% - 90%						116			0			313			240			105			219		993
90% plus						135			0			0			60			27			48		270
Total Commercial
	Mortgage Loans				$	896		$	573		$	984		$	833		$	303		$	267	$	3,856
Agricultural Mortgage Loans(1)
0% - 50%					$	185		$	82		$	214		$	410		$	208		$	49	$	1,148
50% - 70%						127			50			193			164			149			39		722
70% - 90%						0			0			0			0			0			0		0
90% plus						0			0			0			0			0			0		0
Total Agricultural
	Mortgage Loans				$	312		$	132		$	407		$	574		$	357		$	88	$	1,870
Total Mortgage Loans(1)
0% - 50%					$	470		$	82		$	214		$	410		$	244		$	49	$	1,469
50% - 70%						487			623			864			697			284			39		2,994
70% - 90%						116			0			313			240			105			219		993
90% plus						135			0			0			60			27			48		270
Total Mortgage Loans					$	1,208		$	705		$	1,391		$	1,407		$	660		$	355	$	5,726
The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.
The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.
Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
31-Dec-12
					Debt Service Coverage Ratio
																				Less		Total
					Greater			1.8x to			1.5x to			1.2x to			1.0x to			than		Mortgage
Loan-to-Value Ratio:(2)					than 2.0x			2.0x			1.8x			1.5x			1.2x			1.0x		Loans
					(In Millions)
Commercial Mortgage Loans(1)
0% - 50%					$	269		$	21		$	0		$	0		$	27		$	0	$	317
50% - 70%						370			75			619			655			0			0		1,719
70% - 90%						61			102			235			445			131			15		989
90% plus						0			0			0			156			89			165		410
Total Commercial
	Mortgage Loans				$	700		$	198		$	854		$	1,256		$	247		$	180	$	3,435
Agricultural Mortgage Loans(1)
0% - 50%					$	179		$	84		$	211		$	308		$	177		$	49	$	1,008
50% - 70%						122			29			136			188			116			50		641
70% - 90%						0			0			0			1			0			8		9
90% plus						0			0			0			0			0			0		0
Total Agricultural
	Mortgage Loans				$	301		$	113		$	347		$	497		$	293		$	107	$	1,658
Total Mortgage Loans(1)
0% - 50%					$	448		$	105		$	211		$	308		$	204		$	49	$	1,325
50% - 70%						492			104			755			843			116			50		2,360
70% - 90%						61			102			235			446			131			23		998
90% plus						0			0			0			156			89			165		410
Total Mortgage Loans					$	1,001		$	311		$	1,201		$	1,753		$	540		$	287	$	5,093
The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.
The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.
The following table provides information relating to the aging analysis of past due mortgage loans at December 31, 2013 and 2012, respectively.
Age Analysis of Past Due Mortgage Loans
																						Recorded
																						Investment
											90									Total		> 90 Days
					30-59			60-89			Days									Financing		and
					Days			Days			Or >			Total			Current			Receivables		Accruing
					(In Millions)
31-Dec-13
	Commercial				$	0		$	0		$	0		$	0		$	3,856		$	3,856	$	0
	Agricultural					5			4			14			23			1,847			1,870		14
Total Mortgage Loans					$	5		$	4		$	14		$	23		$	5,703		$	5,726	$	14
31-Dec-12
	Commercial				$	0		$	0		$	0		$	0		$	3,435		$	3,435	$	0
	Agricultural					6			1			10			17			1,641			1,658		9
Total Mortgage Loans					$	6		$	1		$	10		$	17		$	5,076		$	5,093	$	9
The following table provides information relating to impaired loans at December 31, 2013 and 2012, respectively.
								Impaired Mortgage Loans
								Unpaid						Average			Interest
					Recorded			Principal			Related			Recorded			Income
					Investment			Balance			Allowance			Investment(1)			Recognized
					(In Millions)
December 31, 2013:
With no related allowance recorded:
	Commercial mortgage loans - other				$	0		$	0		$	0		$	0		$	0
	Agricultural mortgage loans					0			0			0			1			0
Total					$	0		$	0		$	0		$	1		$	0
With related allowance recorded:
	Commercial mortgage loans - other				$	135		$	135		$	-42		$	139		$	2
	Agricultural mortgage loans					0			0			0			0			0
Total					$	135		$	135		$	-42		$	139		$	2
December 31, 2012:
With no related allowance recorded:
	Commercial mortgage loans - other				$	0		$	0		$	0		$	0		$	0
	Agricultural mortgage loans					2			2			0			3			0
Total					$	2		$	2		$	0		$	3		$	0
With related allowance recorded:
	Commercial mortgage loans - other				$	170		$	170		$	-34		$	178		$	10
	Agricultural mortgage loans					0			0			0			0			0
Total					$	170		$	170		$	-34		$	178		$	10
Represents a five-quarter average of recorded amortized cost.
Equity Real Estate
The Insurance Group's investment in equity real estate is through investments in real estate joint ventures.
Equity Method Investments
Included in other equity investments are interests in limited partnership interests and investment companies accounted for under the equity method with a total carrying value of $1,596 million and $1,520 million, respectively, at December 31, 2013 and 2012. Included in equity real estate are interests in real estate joint ventures accounted for under the equity method with a total carrying value of $3 million and $0 million, respectively, at December 31, 2013 and 2012. The Company's total equity in net earnings (losses) for these real estate joint ventures and limited partnership interests was $206 million, $170 million and $179 million, respectively, for 2013, 2012 and 2011.
Summarized below is the combined financial information only for those real estate joint ventures and for those limited partnership interests accounted for under the equity method in which the Company has an investment of $10 million or greater and an equity interest of 10.0% or greater (6 and 3 individual ventures at December 31, 2013 and 2012, respectively) and the Company's carrying value and equity in net earnings (loss) for those real estate joint ventures and limited partnership interests:
			December 31,
			2013			2012
			(In Millions)
BALANCE SHEETS
Investments in real estate, at depreciated cost			$	231		$	233
Investments in securities, generally at fair value				482			54
Cash and cash equivalents				7			8
Other assets				14			14
Total Assets			$	734		$	309
Borrowed funds - third party			$	159		$	162
Other liabilities				10			11
Total liabilities				169			173
Partners’ capital				565			136
Total Liabilities and Partners’ Capital			$	734		$	309
The Company’s Carrying Value in These Entities Included Above			$	216		$	63
			2013			2012			2011
			(In Millions)
STATEMENTS OF EARNINGS (LOSS)
Revenues of real estate joint ventures			$	25		$	26		$	111
Net revenues of other limited partnership interests				11			3			6
Interest expense - third party				0			0			-21
Other expenses				-22			-19			-61
Net Earnings (Loss)			$	14		$	10		$	35
The Company's Equity in Net Earnings (Loss) of These
	Entities Included Above		$	9		$	18		$	20
Derivatives and Offsetting Assets and Liabilities
The Company uses derivatives for asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by the NYSDFS. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits' exposures attributable to movements in the equity and fixed income markets.
Derivatives utilized to hedge exposure to Variable Annuities with Guarantee Features
The Company has issued and continues to offer certain variable annuity products with GMDB, GMIB and GIB features. The Company had previously issued certain variable annuity products with guaranteed withdrawal benefit for life (“GWBL”), guaranteed minimum withdrawal benefit (“GMWB”) and guaranteed minimum accumulation benefit (“GMAB”) features (collectively, “GWBL and other features”). The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders' account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB benefits, in the event of annuitization, being higher than what accumulated policyholders' account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with the GIB and GWBL and other features is that under-performance of the financial markets could result in the GIB and GWBL and other features' benefits being higher than what accumulated policyholders' account balances would support.
For GMDB, GMIB, GIB and GWBL and other features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected assumptions for mortality, lapse and surrender, withdrawal and contractholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMDB, GMIB, GIB and GWBL and other features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps. The Company has purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company.
At the end of 2012, AXA Equitable adjusted its outlook for future interest rate scenarios for some variable annuities with hedged GMDB and GMIB guarantees, as measured under AXA Equitable's economic hedging framework, leading to a reduction in AXA Equitable's estimate of its interest rate exposure. The reduced interest rate exposure led to AXA Equitable reducing the size of its interest rate hedges, as well as a change to the maturity profile of the hedge instruments. In addition, AXA Equitable began to fully unwind its swap and swaption positions hedging exposure to interest rate volatility completing a full unwind of the related GMDB and GMIB position in the first quarter 2013, and completing the full unwind of swaps and swaptions in the second quarter 2013.
The Company periodically, including during 2013, has had in place a hedge program to partially protect against declining interest rates with respect to a part of its projected variable annuity sales.
Derivatives utilized to hedge crediting exposure on SCS, SIO, MSO and IUL products/investment options
The Company also uses equity index options on the S&P 500, Russell 2000, Morgan Stanley Capital International (“MSCI”), Europe, Australasia and Far East (“EAFE”), MSCI Emerging Markets (“EM”) and NASDAQ indices as well as options on Gold, Oil and a Real Estate index for the purpose of hedging crediting rate exposure in its Structured Capital Strategies® (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST® variable annuity series (“SIO”), Market Stabilizer Option® (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. This involves entering into a package of calls and/or put options whose payoff mimics the crediting rate embedded in individual segments of the products. For the SCS variable annuity product, a portion of the exposure is hedged using asset swaps.
Derivatives utilized to hedge risks associated with interest margins on Interest Sensitive Life and Annuity Contracts
Margins or “spreads” on interest-sensitive life insurance and annuity contracts are affected by interest rate fluctuations as the yield on portfolio investments, primarily fixed maturities, are intended to support required payments under these contracts, including interest rates credited to their policy and contract holders. The Company uses swaptions and swaps to reduce the risk associated with interest margins on these interest-sensitive contracts. At December 31, 2013, there were no positions outstanding for these programs.
Derivatives utilized to hedge equity market risks associated with the General Account's investments in Separate Accounts
The Company's General Account investment in Separate Account equity funds exposes the Company to equity market risk which is partially hedged through equity-index futures contracts to minimize such risk.
Derivatives utilized for General Account Investment Portfolio
Beginning in the second quarter 2013, the Company implemented a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible under its investment guidelines through the sale of credit default swaps. Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity's bonds of similar maturity. These credit derivatives have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company has transacted the sale of credit default swaps exclusively in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty's option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these credit default swaps. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the dollar-equivalent of the derivative notional amount. The Standard North American CDS Contract (“SNAC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative.
Periodically the Company purchases 30-year, Treasury Inflation Protected Securities (“TIPS”) as General Account investments, and simultaneously enters into asset swap contracts (“ASW”), to result in payment of the variable principal at maturity and semi-annual coupons of the TIPS to the swap counterparty (pay variable) in return for fixed amounts (receive fixed). These swap contracts, when considered in combination with the TIPS, together result in a net position that is intended to replicate a fixed-coupon cash bond with a yield higher than a term-equivalent US Treasury bond.
The tables below present quantitative disclosures about the Company's derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments.
Derivative Instruments by Category
	At or For the Year Ended December 31, 2013
						Fair Value
												Gains (Losses)
			Notional			Asset			Liability			Reported In
			Amount			Derivatives			Derivatives			Earnings (Loss)
			(In Millions)
Freestanding derivatives:
Equity contracts:(1)
	Futures		$	4,935		$	0		$	3		$	-1,434
	Swaps			1,293			0			51			-316
	Options			7,506			1,056			593			366
Interest rate contracts:(1)
	Floors			2,400			193			0			-5
	Swaps			9,823			216			212			-1,010
	Futures			10,763			0			0			-314
	Swaptions			0			0			0			-154
Credit contracts:(1)
	Credit default swaps			342			10			1			4
Other freestanding contracts:(1)
	Foreign currency Contracts			112			1			1			-3
	Net investment income (loss)												-2,866
Embedded derivatives:
GMIB reinsurance contracts				0			6,746			0			-4,297
GIB and GWBL and other features(2)				0			0			0			265
SCS, SIO, MSO and IUL indexed features(3)				0			0			346			-429
Balances, December 31, 2013			$	37,174		$	8,222		$	1,207		$	-7,327
Reported in Other invested assets in the consolidated balance sheets.
Reported in Future policy benefits and other policyholders' liabilities in the consolidated balance sheets.
SCS and SIO are reported in Policyholders' account balances; MSO and IUL are reported in Future policyholders' benefits and other policyholders' liabilities in the consolidated balance sheets.
Derivative Instruments by Category
	At or For the Year Ended December 31, 2012
						Fair Value
												Gains (Losses)
			Notional			Asset			Liability			Reported In
			Amount			Derivatives			Derivatives			Earnings (Loss)
			(In Millions)
Freestanding derivatives:
Equity contracts:(1)
	Futures		$	6,189		$	0		$	2		$	-1,058
	Swaps			965			2			56			-320
	Options			3,492			443			219			66
Interest rate contracts:(1)
	Floors			2,700			291			0			68
	Swaps			18,239			554			353			402
	Futures			14,033			0			0			84
	Swaptions			7,608			502			0			-220
Other freestanding contracts:(1)
	Foreign currency contracts			81			1			0			0
	Net investment income (loss)												-978
Embedded derivatives:
	GMIB reinsurance contracts			0			11,044			0			497
	GIB and GWBL and other features (2)			0			0			265			26
Balances, December 31, 2012			$	53,307		$	12,837		$	895		$	-455
Reported in Other invested assets in the consolidated balance sheets.
Reported in Future policy benefits and other policyholders' liabilities in the consolidated
balance sheets.
At December 31, 2013, the Company had open exchange-traded futures positions on the S&P 500, Russell 2000, NASDAQ 100 and Emerging Market indices, having initial margin requirements of $194 million. At December 31, 2013, the Company had exchange-traded futures positions on the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, and on Eurodollars futures, having initial margin requirements of $58 million. At that same date, the Company had open exchange-traded future positions on the Euro Stoxx, FTSE 100, Topix and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, and Yen/U.S. dollar having initial margin requirements of $6 million. All outstanding equity-based and treasury futures contracts at December 31, 2013 are exchange-traded and net settled daily in cash. Although notional amount is the most commonly used measure of volume in the derivatives market, it is not used as a measure of credit risk. A derivative with positive fair value (a derivative asset) indicates existence of credit risk because the counterparty would owe money to the Company if the contract were closed at the reporting date. Alternatively, a derivative contract with negative fair value (a derivative liability) indicates the Company would owe money to the counterparty if the contract were closed at the reporting date. To reduce credit exposures in over-the-counter (“OTC”) derivative transactions the Company generally enters into master agreements that provide for a netting of financial exposures with the counterparty and allow for collateral arrangements. The Company further controls and minimizes its counterparty exposure through a credit appraisal and approval process.
The standardized “ISDA Master Agreement” under which the Company conducts its OTC derivative transactions includes provisions for payment netting. In the normal course of business activities, if there is more than one derivative transaction with a single counterparty, the Company will set-off the cash flows of those derivatives into a single amount to be exchanged in settlement of the resulting net payable or receivable with that counterparty. In the event of default, insolvency, or other similar event pre-defined under the ISDA Master Agreement that would result in termination of OTC derivatives transactions before their maturity, netting procedures would be applied to calculate a single net payable or receivable with the counterparty.
Under the ISDA Master Agreement, the Company generally has executed a Credit Support Annex (“CSA”) with each of its OTC derivative counterparties that require both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities or those issued by government agencies. These CSAs are bilateral agreements that require collateral postings by the party “out-of-the-money” or in a net derivative liability position. Various thresholds for the amount and timing of collateralization of net liability positions are applicable. Consequently, the credit exposure of the Company's OTC derivative contracts is limited to the net positive estimated fair value of those contracts at the reporting date after taking into consideration the existence of netting agreements and any collateral received pursuant to CSAs. Derivatives are recognized at fair value in the consolidated balance sheets and are reported either as assets in Other invested assets or as liabilities in Other liabilities, except for embedded insurance-related derivatives as earlier described above and derivatives transacted with a related counterparty. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed.
At December 31, 2013 and 2012, respectively, the Company held $607 million and $1,165 million in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. This unrestricted cash collateral is reported in Cash and cash equivalents, and the obligation to return it is reported in Other liabilities in the consolidated balance sheets. The aggregate fair value of all collateralized derivative transactions that were in a liability position at December 31, 2013 and 2012, respectively, were $42 million and $5 million, for which the Company posted collateral of $35 million and $5 million at December 31, 2013 and 2012, respectively, in the normal operation of its collateral arrangements. Certain of the Company's ISDA Master Agreements contain contingent provisions that permit the counterparty to terminate the ISDA Master Agreement if the Company's credit rating falls below a specified threshold, however, the occurrence of such credit event would not impose additional collateral requirements.
On June 10, 2013, new derivative regulations under Title VII of the Dodd-Frank Wall Street Reform and Consumer Protection Act went into effect, requiring financial entities, including U.S. life insurers, to clear newly executed OTC interest rate swaps with central clearing houses, and to post larger sums of higher quality collateral, among other provisions. Counterparties subject to these new regulations are required to post initial margin to the clearing house as well as variation margin to cover any daily negative mark-to-market movements in the value of newly executed OTC interest rate swap contracts. Centrally cleared OTC interest rate swap contracts, protected by initial margin requirements and higher quality collateral-eligible assets, are expected to reduce the risk of loss in the event of counterparty default. The Company has counterparty exposure to the clearing house and its clearing broker for futures and OTC derivative contracts. Since the introduction of these new derivative regulations, there have been no significant impacts from the Company's compliance as existing derivative positions are grandfathered. Similarly, the Company does not expect the new regulations to materially increase the amount or change the quality of collateral that otherwise would have been imposed directly with its counterparties under CSAs.
The following table presents information about the Insurance Segment's offsetting of financial assets and liabilities and derivative instruments at December 31, 2013.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At December 31, 2013
							Gross
				Gross			Amounts			Net Amounts
				Amounts			Offset in the			Presented in the
				Recognized			Balance Sheets			Balance Sheets
				(In Millions)
ASSETS(1)
Description
Derivatives:
Equity contracts				$	1,056		$	642		$	414
Interest rate contracts					344			211			133
Credit contracts					9			0			9
		Total Derivatives, subject to an ISDA Master Agreement			1,409			853			556
Total Derivatives, not subject to an ISDA Master Agreement					64			0			64
		Total Derivatives			1,473			853			620
Other financial instruments					733			0			733
		Other invested assets		$	2,206		$	853		$	1,353
LIABILITIES(2)
Description
Derivatives:
Equity contracts				$	642		$	642		$	0
Interest rate contracts					211			211			0
Credit contracts					0			0			0
		Total Derivatives, subject to an ISDA Master Agreement			853			853			0
Total Derivatives, not subject to an ISDA Master Agreement					0			0			0
		Total Derivatives			853			853			0
Other financial liabilities					2,653			0			2,653
		Other liabilities		$	3,506		$	853		$	2,653
Excludes Investment Management segment's $3 million net derivative assets and $84 million of securities borrowed.
Excludes Investment Management segment's $8 million net derivative liability and $65 million of securities loaned.
The following table presents information about the Insurance segment's gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2013.
Gross Collateral Amounts Not Offset in the Consolidated Balance Sheets
At December 31, 2013
				Net Amounts		Collateral (Received)/Held
				Presented in the			Financial						Net
				Balance Sheets			Instruments			Cash			Amounts
				(In Millions)
Counterparty A				$	46		$	0		$	-46		$	0
Counterparty B					17			0			-17			0
Counterparty C					28			0			-28			0
Counterparty D					175			0			-175			0
Counterparty E					47			0			-47			0
Counterparty F					-28			0			28			0
Counterparty G					134			-134			0			0
Counterparty H					4			0			-4			0
Counterparty I					-2			0			2			0
Counterparty J					-12			0			12			0
Counterparty K					41			0			-38			3
Counterparty L					72			0			-69			3
Counterparty M					30			0			-30			0
Counterparty N					64			0			0			64
Counterparty Q					4			0			-4			0
		Total Derivatives		$	620		$	-134		$	-416		$	70
Other financial instruments					733			0			0			733
		Other invested assets		$	1,353		$	-134		$	-416		$	803
The following table presents information about the Insurance segment's offsetting of financial assets and liabilities and derivative instruments at December 31, 2012.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At December 31, 2012
							Gross
				Gross			Amounts			Net Amounts
				Amounts			Offset in the			Presented in the
				Recognized			Balance Sheets			Balance Sheets
				(In Millions)
ASSETS(1)
Description
Derivatives:
Equity contracts				$	444		$	272		$	172
Interest rate contracts					1,251			351			900
		Total Derivatives, subject to an ISDA Master Agreement			1,695			623			1,072
Total Derivatives, not subject to an ISDA Master Agreement					96			0			96
		Total Derivatives			1,791			623			1,168
Other financial instruments					660			0			660
		Other invested assets		$	2,451		$	623		$	1,828
LIABILITIES(2)
Description
Derivatives:
Equity contracts				$	272		$	272		$	0
Interest rate contracts					351			351			0
		Total Derivatives, subject to an ISDA Master Agreement			623			623			0
Total Derivatives, not subject to an ISDA Master Agreement					0			0			0
		Total Derivatives			623			623			0
Other financial liabilities					3,503			0			3,503
		Other liabilities		$	4,126		$	623		$	3,503
Excludes Investment Management segment's $2 million net derivative assets and $106 million of securities borrowed.
Excludes Investment Management segment's $7 million net derivative liability and $13 million of securities loaned.
Gross Collateral Amounts Not Offset in the Consolidated Balance Sheets
At December 31, 2012
				Net Amounts		Collateral (Received)/Held
				Presented in the			Financial						Net
				Balance Sheets			Instruments			Cash			Amounts
				(In Millions)
Counterparty A				$	30		$	0		$	-30		$	0
Counterparty B					32			0			-29			3
Counterparty C					55			0			-55			0
Counterparty D					310			0			-310			0
Counterparty E					38			0			-38			0
Counterparty F					326			0			-326			0
Counterparty G					55			0			-55			0
Counterparty H					-5			0			5			0
Counterparty I					98			0			-98			0
Counterparty J					19			0			-19			0
Counterparty K					15			0			-3			12
Counterparty L					48			-46			0			2
Counterparty M					51			0			-51			0
Counterparty N					96			0			0			96
		Total Derivatives		$	1,168		$	-46		$	-1,009		$	113
Other financial instruments					660			0			0			660
		Other invested assets		$	1,828		$	-46		$	-1,009		$	773
Net Investment Income (Loss)
The following table breaks out Net investment income (loss) by asset category:
			2013			2012			2011
			(In Millions)
Fixed maturities			$	1,462		$	1,529		$	1,555
Mortgage loans on real estate				284			264			241
Equity real estate				1			14			19
Other equity investments				234			189			116
Policy loans				219			226			229
Short-term investments				1			15			5
Derivative investments				-2,866			-978			2,374
Broker-dealer related receivables				14			14			13
Trading securities				48			85			-29
Other investment income				34			33			37
	Gross investment income (loss)			-569			1,391			4,560
Investment expenses				-57			-50			-55
Interest expense				-3			-3			-3
Net Investment Income (Loss)			$	-629		$	1,338		$	4,502
For 2013, 2012 and 2011, respectively, Net investment income (loss) from derivatives included $(2,829) million, $(232) million and $1,303 million of realized gains (losses) on contracts closed during those periods and $(37) million, $(746) million and $1,071 million of unrealized gains (losses) on derivative positions at each respective year end.
Investment Gains (Losses), Net
Investment gains (losses), net including changes in the valuation allowances and OTTI are as follows:
		2013			2012			2011
		(In Millions)
Fixed maturities		$	-75		$	-89		$	-29
Mortgage loans on real estate			-7			-7			-14
Other equity investments			-17			-13			-4
Other			0			12			0
Investment Gains (Losses), Net		$	-99		$	-97		$	-47
For 2013, 2012 and 2011, respectively, investment results passed through to certain participating group annuity contracts as interest credited to policyholders' account balances totaled $8 million, $6 million and $10 million.

GOODWILL_AND_OTHER_INTANGIBLE_

GOODWILL AND OTHER INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2013
Goodwill And Other Intangible Assets [Abstract]	'
GOODWILL AND OTHER INTANGIBLE ASSETS	'
	5
	4)       GOODWILL AND OTHER INTANGIBLE ASSETS
	The carrying value of goodwill related to AllianceBernstein totaled $3,504 million and $3,472 million at December 31, 2013 and 2012, respectively. The Company annually tests this goodwill for recoverability at December 31, first by comparing the fair value of its investment in AllianceBernstein, the reporting unit, to its carrying value and further by measuring the amount of impairment loss only if the result indicates a potential impairment. The Company also assesses this goodwill for recoverability at each interim reporting period in consideration of facts and circumstances that may indicate a shortfall of the fair value of its investment in AllianceBernstein as compared to its carrying value and thereby require re-performance of its annual impairment testing.
	The Company primarily uses a discounted cash flow valuation technique to measure the fair value of its investment in AllianceBernstein for purpose of goodwill impairment testing. The cash flows used in this technique are sourced from AllianceBernstein's current business plan and projected thereafter over the estimated life of the goodwill asset by applying an annual growth rate assumption. The present value amount that results from discounting these expected cash flows is then adjusted to reflect the noncontrolling interest in AllianceBernstein as well as taxes incurred at the Company level in order to determine the fair value of its investment in AllianceBernstein. At December 31, 2013 and 2012, the Company determined that goodwill was not impaired as the fair value of its investment in AllianceBernstein exceeded its carrying value at each respective date. Similarly, no impairments resulted from the Company's interim assessments of goodwill recoverability during the periods then ended.
	The gross carrying amount of AllianceBernstein related intangible assets was $583 million and $561 million at December 31, 2013 and 2012, respectively and the accumulated amortization of these intangible assets was $384 million and $360 million at December 31, 2013 and 2012, respectively. Amortization expense related to the AllianceBernstein intangible assets totaled $24 million, $24 million and $23 million for 2013, 2012 and 2011, respectively, and estimated amortization expense for each of the next five years is expected to be approximately $25 million.
	At December 31, 2013 and 2012, respectively, net deferred sales commissions totaled $71 million and $95 million and are included within the Investment Management segment's Other assets. The estimated amortization expense of deferred sales commissions, based on the December 31, 2013 net asset balance for each of the next five years is $29 million, $20 million, $15 million, $5 million and $0 million. AllianceBernstein tests the deferred sales commission asset for impairment quarterly by comparing undiscounted future cash flows to the recorded value, net of accumulated amortization. Each quarter, significant assumptions used to estimate the future cash flows are updated to reflect management's consideration of current market conditions on expectations made with respect to future market levels and redemption rates. As of December 31, 2013, AllianceBernstein determined that the deferred sales commission asset was not impaired.
	On December 12, 2013, AllianceBernstein acquired W.P. Stewart & Co., Ltd. (“WPS”), an equity investment manager that, as of December 31, 2013, managed approximately $2,000 million in U.S., Global and EAFE concentrated growth equity strategies for clients, primarily in the U.S. and Europe. On the acquisition date, AllianceBernstein made a cash payment of $12 per share for the approximate 4.9 million WPS shares outstanding and issued to WPS shareholders transferable Contingent Value Rights (“CVRs”) entitling the holders to an additional $4 per share if the assets under management in the acquired WPS investment services reach $5 billion on or before the third anniversary of the acquisition date. The excess of the purchase price over the fair value of identifiable assets acquired resulted in the recognition of $32 million of goodwill. AllianceBernstein also recorded $8 million of indefinite-lived intangible assets relating to the acquired fund's investment contracts and $14 million of definite-lived intangible assets relating to separately managed account relationships. As of the acquisition date, AllianceBernstein recorded a contingent consideration payable of $17 million in regard to the CVRs.
	Capitalized Software
	Capitalized software, net of accumulated amortization, amounted to $163 million and $237 million at December 31, 2013 and 2012, respectively. Amortization of capitalized software in 2013 was $119 million including $45 million of accelerated amortization and in 2012 and 2011 amortization of capitalized software was $77 million and $81 million respectively..

CLOSED_BLOCKS

CLOSED BLOCKS	12 Months Ended
	Dec. 31, 2013
Closed Blocks [Abstract]	'
CLOSED BLOCKS	'
	5)       CLOSED BLOCK
	Summarized financial information for the AXA Equitable Closed Block is as follows:
					December 31,
					2013			2012
					(In Millions)
	CLOSED BLOCK LIABILITIES:
	Future policy benefits, policyholders’ account balances and other				$	7,716		$	7,942
	Policyholder dividend obligation					128			373
	Other liabilities					144			192
	Total Closed Block liabilities					7,988			8,507
	ASSETS DESIGNATED TO THE CLOSED BLOCK:
	Fixed maturities, available for sale, at fair value (amortized cost of
		$4,987 and $5,245)				5,232			5,741
	Mortgage loans on real estate					1,343			1,255
	Policy loans					949			1,026
	Cash and other invested assets					48			30
	Other assets					186			204
	Total assets designated to the Closed Block					7,758			8,256
	Excess of Closed Block liabilities over assets designated to the Closed Block					230			251
	Amounts included in accumulated other comprehensive income (loss):
		Net unrealized investment gains (losses), net of deferred income tax
			(expense) benefit of $(45) and $(47) and policyholder
			dividend obligation of $(128) and $(373)			83			87
	Maximum Future Earnings To Be Recognized From Closed Block
		Assets and Liabilities			$	313		$	338
	AXA Equitable's Closed Block revenues and expenses follow:
						2013			2012		2011
						(In Millions)
	REVENUES:
	Premiums and other income					$	286		$	316	$	354
	Investment income (loss)						402			420		438
	Net investment gains (losses)						-11			-9		-10
	Total revenues						677			727		782
	BENEFITS AND OTHER DEDUCTIONS:
	Policyholders’ benefits and dividends						637			724		757
	Other operating costs and expenses						1			0		2
	Total benefits and other deductions						638			724		759
	Net revenues, before income taxes						39			3		23
	Income tax (expense) benefit						-14			-1		-8
	Net Revenues (Losses)					$	25		$	2	$	15
	A reconciliation of AXA Equitable's policyholder dividend obligation follows:
				December 31,
			2013			2012
			(In Millions)
	Balances, beginning of year		$	373		$	260
	Unrealized investment gains (losses)			-245			113
	Balances, End of year		$	128		$	373

CONTRACTHOLDER_BONUS_INTEREST_

CONTRACTHOLDER BONUS INTEREST CREDITS	12 Months Ended
	Dec. 31, 2013
Contractholder Bonus Interest Credits [Abstract]	'
Contractholder Bonus Interest Credits	'
	6)       CONTRACTHOLDER BONUS INTEREST CREDITS
	Changes in the deferred asset for contractholder bonus interest credits are as follows:
		December 31,
		2013		2012
		(In Millions)
	Balance, beginning of year	$	621	$	718
	Contractholder bonus interest credits deferred		18		30
	Amortization charged to income		-121		-127
	Balance, End of Year	$	518	$	621

FAIR_VALUE_DISCLOSURES

FAIR VALUE DISCLOSURES	12 Months Ended
	Dec. 31, 2013																								Dec. 31, 2012
Fair Value Disclosures [Abstract]	'																								'
FAIR VALUE DISCLOSURES	'																								'
	7)              FAIR VALUE DISCLOSURES
																									Excludes GMAB and GIB liabilities.
	Assets and liabilities measured at fair value on a recurring basis are summarized below. Fair value measurements also are required on a non-recurring basis for certain assets, including goodwill, mortgage loans on real estate, equity real estate held for production of income, and equity real estate held for sale, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. At December 31, 2013 and 2012, no assets were required to be measured at fair value on a non-recurring basis.
	Fair Value Measurements at December 31, 2013
						Level 1			Level 2			Level 3			Total
						(In Millions)
	Assets
	Investments:
		Fixed maturities, available-for-sale:
			Corporate			$	0		$	22,400		$	291		$	22,691
			U.S. Treasury, government and agency				0			3,129			0			3,129
			States and political subdivisions				0			431			46			477
			Foreign governments				0			433			0			433
			Commercial mortgage-backed				0			16			700			716
			Residential mortgage-backed(1)				0			943			4			947
			Asset-backed(2)				0			56			83			139
			Redeemable preferred stock				216			656			15			887
				Subtotal			216			28,064			1,139			29,419
		Other equity investments					233			9			52			294
		Trading securities					529			3,692			0			4,221
		Other invested assets:
			Short-term investments				0			99			0			99
			Swaps				0			-45			0			-45
			Credit Default Swaps				0			9			0			9
			Futures				-2			0			0			-2
			Options				0			463			0			463
			Floors				0			193			0			193
			Swaptions				0			0			0			0
				Subtotal			-2			719			0			717
	Cash equivalents						1,310			0			0			1,310
	Segregated securities						0			981			0			981
	GMIB reinsurance contracts						0			0			6,747			6,747
	Separate Accounts' assets						105,579			2,948			237			108,764
			Total Assets			$	107,865		$	36,413		$	8,175		$	152,453
	Liabilities
	GWBL and other features' liability					$	0		$	0		$	0		$	0
	SCS, SIO, MSO and IUL indexed
	features' liability						0			346			0			346
			Total Liabilities			$	0		$	346		$	0		$	346
	Includes publicly traded agency pass-through securities and collateralized obligations.
	Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans..
	Fair Value Measurements at December 31, 2012
						Level 1			Level 2			Level 3			Total
						(In Millions)
	Assets
	Investments:
		Fixed maturities, available-for-sale:
			Corporate			$	6		$	22,837		$	355		$	23,198
			U.S. Treasury, government and agency				0			5,180			0			5,180
			States and political subdivisions				0			480			50			530
			Foreign governments				0			511			19			530
			Commercial mortgage-backed				0			0			900			900
			Residential mortgage-backed(1)				0			1,940			9			1,949
			Asset-backed(2)				0			69			113			182
			Redeemable preferred stock				242			881			15			1,138
				Subtotal			248			31,898			1,461			33,607
		Other equity investments					78			0			77			155
		Trading securities					446			1,863			0			2,309
		Other invested assets:
			Short-term investments				0			98			0			98
			Swaps				0			148			0			148
			Futures				-2			0			0			-2
			Options				0			224			0			224
		Floors				0			291			0			291
		Swaptions				0			502			0			502
			Subtotal			-2			1,263			0			1,261
Cash equivalents						2,289			0			0			2,289
Segregated securities						0			1,551			0			1,551
GMIB reinsurance contracts						0			0			11,044			11,044
Separate Accounts' assets						90,751			2,775			224			93,750
		Total Assets			$	93,810		$	39,350		$	12,806		$	145,966
Liabilities
GWBL and other features' liability					$	0		$	0		$	265		$	265
		Total Liabilities			$	0		$	0		$	265		$	265
At December 31, 2013 and 2012, respectively, the fair value of public fixed maturities is approximately $21,671 million and $25,591 million or approximately 15.0% and 19.2% of the Company's total assets measured at fair value on a recurring basis (excluding GMIB reinsurance contracts and segregated securities measured at fair value on a recurring basis). The fair values of the Company's public fixed maturity securities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturity securities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If, as a result, it is determined that the independent valuation service provider is able to reprice the security in a manner agreed as more consistent with current market observations, the security remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company's own assumptions about market-participant inputs would be used in pricing the security.
At December 31, 2013 and 2012, respectively, the fair value of private fixed maturities is approximately $7,748 million and $8,016 million or approximately 5.4% and 6.0% of the Company's total assets measured at fair value on a recurring basis. The fair values of the Company's private fixed maturities, which primarily are comprised of investments in private placement securities generally are determined using a discounted cash flow model. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model may also incorporate unobservable inputs, which reflect the Company's own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made.
As disclosed in Note 3, at December 31, 2013 and 2012, respectively, the net fair value of freestanding derivative positions is approximately $617 million and $1,163 million or approximately 86.1% and 92.2% of Other invested assets measured at fair value on a recurring basis. The fair values of the Company's derivative positions are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the Over-The-Counter (“OTC”) derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the derivative instrument in a manner agreed as more consistent with current market observations, the position remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company's own assumptions about market-participant inputs would be used in pricing the security.
The credit risk of the counterparty and of the Company are considered in determining the fair values of all OTC derivative asset and liability positions, respectively, after taking into account the effects of master netting agreements and collateral arrangements. Each reporting period, the Company values its derivative positions using the standard swap curve and evaluates whether to adjust the embedded credit spread to reflect changes in counterparty or its own credit standing. As a result, the Company reduced the fair value of its OTC derivative asset exposures by $0.4 million at December 31, 2013 to recognize incremental counterparty non-performance risk. The unadjusted swap curve was determined to be reflective of the non-performance risk of the Company for purpose of determining the fair value of its OTC liability positions at December 31, 2013.
At December 31, 2013 and 2012, respectively, investments classified as Level 1 comprise approximately 74.5% and 70.3% of assets measured at fair value on a recurring basis and primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less, and are carried at cost as a proxy for fair value measurement due to their short-term nature.
At December 31, 2013 and 2012, respectively, investments classified as Level 2 comprise approximately 24.5% and 28.4% of assets measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security's duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury Bills segregated by AllianceBernstein in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Exchange Act and for which fair values are based on quoted yields in secondary markets.
Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. At December 31, 2013 and 2012, respectively, approximately $970 million and $1,966 million of AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors.
The Company currently offers indexed investment options in the SCS and EQUI-VEST variable annuity products, the IUL product, and in the MSO investment option available in some life contracts. These investment options, which depending on the product and on the index selected can currently have 1, 3, or 5 year terms, provide for participation in the performance of specified indices up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g. holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on prices obtained from independent valuation service providers.
At December 31, 2013 and 2012, respectively, investments classified as Level 3 comprise approximately 1.0% and 1.3% of assets measured at fair value on a recurring basis and primarily include CMBS and corporate debt securities, such as private fixed maturities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification at December 31, 2013 and 2012, respectively, were approximately $150 million and $222 million of fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company applies various due-diligence procedures, as considered appropriate, to validate these non-binding broker quotes for reasonableness, based on its understanding of the markets, including use of internally-developed assumptions about inputs a market participant would use to price the security. In addition, approximately $787 million and $1,021 million of mortgage- and asset-backed securities, including commercial mortgage-backed securities (“CMBS”), are classified as Level 3 at December 31, 2013 and 2012, respectively. At June 30, 2013, the Company changed its methodology for measuring the fair value of CMBS securities below the senior AAA tranche from a risk-adjusted present value technique to pricing obtained from an independent valuation service vendor as returning liquidity in CMBS markets contributed to the availability of more reliable and representative measures of fair value. In applying the risk-adjusted present value technique in periods prior to June 30, 2013, the Company adjusted the projected cash flows of these securities for origination year, default metrics, and level of subordination, with the objective of maximizing observable inputs, and weighted the result with a 10% attribution to pricing sourced from a third party service whose process placed significant reliance on market trading activity.
The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract's benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract's benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base.
Level 3 also includes the GMIB reinsurance contract asset which is accounted for as derivative contracts. The GMIB reinsurance contract asset's fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while the GIB and GWBL and other features related liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins, attributable to the GIB and GWBL and other features over a range of market-consistent economic scenarios. The valuations of both the GMIB reinsurance contract asset and GIB and GWBL and other features' liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity Separate Account funds consistent with the S&P 500 Index. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GIB and GWBL and other features' liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the swap curve, adjusted for non-performance risk, is made to the resulting fair values of the GMIB reinsurance contract asset to reflect change in the claims-paying ratings of counterparties to the reinsurance treaties. After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $133 million and $447 million at December 31, 2013 and 2012, respectively, to recognize incremental counterparty non-performance risk. The unadjusted swap curve was determined to be reflective of the AA quality claims-paying rating of AXA Equitable, therefore, no incremental adjustment was made for non-performance risk for purpose of determining the fair value of the GIB and GWBL and other features' liability embedded derivative at December 31, 2013. Equity and fixed income volatilities are combined, with weighting based on the current fund distribution, to produce an overall volatility assumption. Scenarios are developed that value an at the money option at a price consistent with the overall volatility.
In 2013, AFS fixed maturities with fair values of $37 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $20 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.4% of total equity at December 31, 2013. In 2013, one of the Company's private securities went public and as a result, $20 million was transferred from a Level 3 classification to a Level 1 classification. In 2013, $9 million was transferred from a Level 3 to a Level 2 classification due to merger of one of the private securities with a public company that had a trading restriction period at December 31, 2013.
In 2012, AFS fixed maturities with fair values of $109 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $17 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.7% of total equity at December 31, 2012. In the first quarter of 2012, one of the Company's private securities went public and as a result, $14 million was transferred from a Level 3 classification to a Level 2 classification. In the third quarter of 2012, $6 million was transferred from a Level 2 classification to a Level 1 classification due to the lapse of the trading restriction period for one of the Company's public securities.
The table below presents a reconciliation for all Level 3 assets and liabilities at December 31, 2013 and 2012, respectively.
Level 3 Instruments
Fair Value Measurements
										State and
										Political						Commercial			Residential
										Sub-			Foreign			Mortgage-			Mortgage-			Asset-
							Corporate			divisions			Govts			backed			backed			backed
							(In Millions)
Balance, January 1, 2013							$	355		$	50		$	19		$	900		$	9		$	113
	Total gains (losses), realized and
		unrealized, included in:
			Earnings (loss) as:
				Net investment income (loss)				2			0			0			0			0			0
				Investment gains (losses), net				5			0			0			-68			0			0
					Subtotal			7			0			0			-68			0			0
			Other comprehensive income (loss)					-1			-3			-2			13			-1			3
Purchases								70			0			0			31			0			0
Issuances								0			0			0			0			0			0
Sales								-150			-1			-17			-160			-4			-22
Settlements								0			0			0			0			0			0
Transfers into Level 3(1)								20			0			0			0			0			0
Transfers out of Level 3(1)								-10			0			0			-16			0			-11
Balance, December 31, 2013							$	291		$	46		$	0		$	700		$	4		$	83
Balance, January 1, 2012							$	432		$	53		$	22		$	902		$	14		$	172
	Total gains (losses), realized and
		unrealized, included in:
			Earnings (loss) as:
				Net investment income (loss)				2			0			0			2			0			0
				Investment gains (losses), net				4			0			0			-105			0			0
					Subtotal		$	6		$	0		$	0		$	-103		$	0		$	0
			Other comprehensive income (loss)					15			-1			0			128			0			4
	Purchases							0			0			0			0			0			0
	Sales							-47			-2			0			-27			-5			-25
	Transfers into Level 3(1)							17			0			0			0			0			0
	Transfers out of Level 3(1)							-68			0			-3			0			0			-38
Balance, December 31, 2012							$	355		$	50		$	19		$	900		$	9		$	113
Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.
							Redeem-															GWBL
							able			Other			Other			GMIB			Separate			and Other
							Preferred			Equity			Invested			Reinsurance			Accounts			Features
							Stock			Investments(1)			Assets			Asset			Assets			Liability
							(In Millions)
Balance, January 1, 2013							$	15		$	77		$	0		$	11,044		$	224		$	265
	Total gains (losses), realized and
		unrealized, included in:
		Earnings (loss) as:
			Net investment income (loss)					0			0			0			0			0			0
			Investment gains (losses), net					0			10			0			0			10			0
				of reinsurance contracts				0			-7			0			-4,496			0			0
			Policyholders' benefits					0			0			0			0			0			-351
					Subtotal			0			3			0			-4,496			10			-351
		Other comprehensive income (loss)						0			0			0			0			-1			0
Purchases								0			4			0			237			6			86
Issuances								0			0			0			0			0			0
Sales								0			-3			0			-38			-3			0
Settlements								0			0			0			0			-2			0
Transfers into Level 3(2)								0			0			0			0			3			0
Transfers out of Level 3(2)								0			-29			0			0			0			0
Balance, December 31, 2013							$	15		$	52		$	0		$	6,747		$	237		$	0
Balance, January 1, 2012							$	14		$	77		$	-2		$	10,547		$	215		$	291
	Total gains (losses), realized and
		unrealized, included in:
		Earnings (loss) as:
			Net investment income (loss)					0			0			0			0			0			0
			Investment gains (losses), net					0			0			0			0			8			0
			Increase (decrease) in the fair value
				of reinsurance contracts				0			0			0			315			0			0
			Policyholders' benefits					0			0			0			0			0			-77
					Subtotal		$	0		$	0		$	0		$	315		$	8		$	-77
		Other comprehensive income (loss)						1			0			2			0			0			0
	Purchases							0			0			0			182			6			51
	Sales							0			0			0			0			-2			0
	Settlements							0			0			0			0			-3			0
	Transfers into Level 3(2)							0			0			0			0			0			0
Balance, December 31, 2012							$	15		$	77		$	0		$	11,044		$	224		$	265
Includes Trading securities' Level 3 amount.
Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.
The table below details changes in unrealized gains (losses) for 2013 and 2012 by category for Level 3 assets and liabilities still held at December 31, 2013 and 2012, respectively:
									Earnings (Loss)
															Increase
									Net			Investment			(Decrease) in the
									Investment			Gains			Fair Value of						Policy-
									Income			(Losses),			Reinsurance						holders'
									(Loss)			Net			Contracts			OCI			Benefits
									(In Millions)
Level 3 Instruments
Full Year 2013
Still Held at December 31, 2013:
	Change in unrealized gains (losses):
		Fixed maturities, available-for-sale:
			Corporate						$	0		$	0		$	0		$	-2		$	0
			State and political subdivisions							0			0			0			-4			0
			Foreign governments							0			0			0			0			0
			Commercial mortgage-backed							0			0			0			6			0
			Asset-backed							0			0			0			4			0
			Other fixed maturities, available-for-sale							0			0			0			0			0
				Subtotal					$	0		$	0		$	0		$	4		$	0
		GMIB reinsurance contracts								0			0			-4,297			0			0
		Separate Accounts’ assets								0			10			0			0			0
		GWBL and other features’ liability								0			0			0			0			-265
				Total					$	0		$	10		$	-4,297		$	4		$	-265
Level 3 Instruments
Full Year 2012
Still Held at December 31, 2012:
	Change in unrealized gains (losses):
		Fixed maturities, available-for-sale:
			Corporate						$	0		$	0		$	0		$	14		$	0
			State and political subdivisions							0			0			0			-1			0
			Foreign governments							0			0			0			1			0
			Commercial mortgage-backed							0			0			0			124			0
			Asset-backed							0			0			0			3			0
			Other fixed maturities, available-for-sale							0			0			0			0			0
				Subtotal					$	0		$	0		$	0		$	141		$	0
		GMIB reinsurance contracts								0			0			497			0			0
		Separate Accounts’ assets								0			8			0			0			0
		GWBL and other features’ liability								0			0			0			0			26
				Total					$	0		$	8		$	497		$	141		$	26
The following table discloses quantitative information about Level 3 fair value measurements by category for assets and liabilities as of December 31, 2013 and 2012, respectively.
Quantitative Information about Level 3 Fair Value Measurements
31-Dec-13
				Fair			Valuation			Significant
				Value			Technique			Unobservable Input			Range
Assets:				(In Millions)
Investments:
	Fixed maturities, available-for-sale:
		Corporate		$	54		Matrix pricing model			Spread over the industry-specific
										benchmark yield curve			125 bps - 550 bps
		Residential mortgage-backed			1		Matrix pricing model			Spread over U.S. Treasury curve			45 bps
		Asset-backed			7		Matrix pricing model			Spread over U.S. Treasury curve			30 bps - 687 bps
	Other equity investments				52		Market comparable			Revenue multiple			1.2x - 4.9x
								companies		R&D multiple			1.1x - 17.1x
										Discount rate			18.00%
										Discount years			1
										Discount for lack of marketability
											and risk factors		50% - 60%
Separate Accounts' assets					215		Third party appraisal			Capitalization rate			5.40%
										Exit capitalization rate			6.40%
										Discount rate			7.40%
					11		Discounted cash flow			Spread over U.S. Treasury curve			256 bps - 434 bps
										Inflation rate			0.0 % - 2.3 %
										Discount factor			3.3 % - 6.8 %
GMIB reinsurance contracts					6,747		Discounted Cash flow				Lapse Rates		1.0% - 8.0%
											Withdrawal rates		0.2% - 8.0%
											GMIB Utilization Rates		0.0% - 15.0%
											Non-performance risk		7 bps - 21 bps
											Volatility rates - Equity		20.0% - 33.0%
Liabilities:
GMWB/GWBL(1)					61		Discounted Cash flow				Lapse Rates		1.0% - 8.0%
											Withdrawal rates		0.0% -7.0%
											Volatility rates - Equity		20.0% - 33.0%
Quantitative Information about Level 3 Fair Value Measurements
31-Dec-12
				Fair			Valuation			Significant
				Value			Technique			Unobservable Input			Range
Assets:				(In Millions)
Investments:
	Fixed maturities, available-for-sale:
		Corporate		$	94		Matrix pricing model			Spread over the industry-specific
										benchmark yield curve			125 bps - 650 bps
		Commercial mortgage-backed			889		Discounted Cash flow			Constant default rate			3.0% - 25.0%
										Probability of default			55.00%
										Loss severity			49.00%
										Discount rate			3.72% - 13.42%
		Residential mortgage-backed			1		Matrix pricing model			Spread over U.S. Treasury curve			46 bps
		Asset-backed			8		Matrix pricing model			Spread over U.S. Treasury curve			30 bps - 695 bps
	Other equity investments				38		Market comparable			Revenue multiple			0.6x - 62.5x
								companies		R&D multiple			1.0x - 30.6x
										Discount rate			18.00%
										Discount years			2-Jan
										Discount for lack of marketability
											and risk factors		40.0% - 60.0%
Separate Accounts' assets					194		Third party appraisal			Capitalization rate			5.50%
										Exit capitalization rate			6.60%
										Discount rate			7.70%
					22		Discounted cash flow			Spread over U.S. Treasury curve			275 bps - 586 bps
										Inflation rate			2.0% - 3.0%
										Discount factor			1.0% - 2.0%
GMIB reinsurance contracts					11,044		Discounted cash flow				Lapse Rates		1.5% - 8.0%
											Withdrawal Rates		0.2% - 8.0%
											GMIB Utilization Rates		0.0% - 15.0%
											Non-performance risk		13 bps - 45 bps
											Volatility rates - Equity		24.0% - 36.0%
Liabilities:
GMWB/GWBL (1)					205		Discounted cash flow				Lapse Rates		1.0% - 8.0%
											Withdrawal Rates		0.0% - 7.0%
											Volatility rates - Equity		24.0% - 36.0%
Excludes GMAB and GIB liabilities.
Excluded from the tables above at December 31, 2013 and 2012, respectively, are approximately $1,088 million and $516 million Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not reasonably available. The fair value measurements of these Level 3 investments comprise approximately 76.2% and 29.3% of total assets classified as Level 3 and represent only 0.8% and 0.4% of total assets measured at fair value on a recurring basis. These investments primarily consist of certain privately placed debt securities with limited trading activity, including commercial mortgage-, residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company's reporting significantly higher or lower fair value measurements for these Level 3 investments.
Included in the table above at December 31, 2013 and 2012, respectively, are approximately $54 million and $94 million fair value of privately placed, available-for-sale corporate debt securities classified as Level 3 that is determined by application of a matrix pricing model, representing approximately 18.6% and 26.5% of the total fair value of Level 3 securities in the corporate fixed maturities asset class. The significant unobservable input to the matrix pricing model is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities.
At December 31, 2012, CMBS classified as Level 3 consist of holdings subordinate to the AAA-tranche position and for which the Company applies a discounted cash flow methodology to measure fair value. The process for determining fair value first adjusts the contractual principal and interest payments to reflect performance expectations and then discounts the securities' cash flows to reflect an appropriate risk-adjusted return. The significant unobservable inputs used in these fair value measurements are default rate and probability, loss severity, and the discount rate. An increase either in the cumulative default rate, probability of default, or loss severity would result in a decrease in the fair value of these securities; generally, those assumptions would change in a directionally similar manner. A decrease in the discount rate would result in directionally inverse movement in the fair value measurement of these securities. At December 31, 2013, all CMBS securities were valued using prices obtained from an independent valuation service vendor and therefore excluded from the quantitative disclosures discussed above.
Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above at December 31, 2013 and 2012, are approximately 25.0% and 11.1%, respectively, of the total fair value of these Level 3 securities that is determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities.
Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit tenant loans, and equipment financings. Included in the tables above at December 31, 2013 and 2012, are approximately 8.4% and 7.1%, respectively, of the total fair value of these Level 3 securities that is determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would result in significantly lower (higher) fair value measurements.
Other equity investments classified as Level 3 primarily consist of private venture capital fund investments of AllianceBernstein for which fair values are adjusted to reflect expected exit values as evidenced by financing and sale transactions with third parties or when consideration of other factors, such as current company performance and market conditions, is determined by management to require valuation adjustment. Significant increase (decrease) in isolation in the underlying enterprise value to revenue multiple and enterprise value to R&D investment multiple, if applicable, would result in significantly higher (lower) fair value measurement. Significant increase (decrease) in the discount rate would result in a significantly lower (higher) fair value measurement. Significant increase (decrease) in isolation in the discount factor ascribed for lack of marketability and various risk factors would result in significantly lower (higher) fair value measurement. Changes in the discount factor generally are not correlated to changes in the value multiples. Also classified as Level 3 at December 31, 2013 and 2012, respectively, are approximately $30 million and $30 million private venture capital fund-of-fund investments of AllianceBernstein for which fair value is estimated using the capital account balances provided by the partnerships. The interests in these partnerships cannot be redeemed. As of December 31, 2013 and 2012, AllianceBernstein's aggregate unfunded commitments to these investments were approximately $10 million and $12 million.
Separate Accounts' assets classified as Level 3 at December 31, 2013 and 2012, respectively, primarily consist of private equity investments with fair value of approximately $215 million and $198 million, including approximately $219 million and $194 million fair value investment in a private real estate fund, as well as mortgage loans with fair value of approximately $7 million and $18 million. Third party appraisal is used to measure the fair value of the private real estate investment fund, including consideration of observable replacement cost and sales comparisons for the underlying commercial properties, as well as the results from applying a discounted cash flow approach. Significant increase (decrease) in isolation in the capitalization rate and exit capitalization rate assumptions used in the discounted cash flow approach to appraisal value would result in a higher (lower) measure of fair value. A discounted cash flow approach also is applied to determine the approximately $4 million and $4 million fair value of the other private equity investment and for which the significant unobservable assumptions are an inflation rate formula and a discount factor that takes into account various risks, including the illiquid nature of the investment at December 31, 2013 and 2012, respectively. A significant increase (decrease) in the inflation rate would have directionally inverse effect on the fair value of the security. With respect to the fair value measurement of mortgage loans, a significant increase (decrease) in the assumed spread over US Treasuries would produce a lower (higher) fair value measurement. Changes in the discount rate or factor used in the valuation techniques to determine the fair values of these private equity investments and mortgage loans generally are not correlated to changes in the other significant unobservable inputs. Significant increase (decrease) in isolation in the discount rate or factor would result in significantly lower (higher) fair value measurements. The remaining Separate Accounts' investments classified as Level 3 at December 31, 2013 and 2012, respectively, consist of mortgage- and asset-backed securities with fair values of approximately $3 million, $7 million, $4 million and $4 million and for which those measurements are determined using substantially the same valuation techniques as earlier described above for the Company's General Account investments in these securities.
Significant unobservable inputs with respect to the fair value measurement of the Level 3 GMIB reinsurance contract asset and the Level 3 liabilities identified in the table above are developed using Company data. Validations of unobservable inputs are performed to the extent the Company has experience. When an input is changed the model is updated and the results of each step of the model are analyzed for reasonableness.
The significant unobservable inputs used in the fair value measurement of the Company's GMIB reinsurance contract asset are lapse rates, withdrawal rates and GMIB utilization rates. Significant increases in GMIB utilization rates or decreases in lapse or withdrawal rates in isolation would tend to increase the GMIB reinsurance contract asset.
Fair value measurement of the GMIB reinsurance contract asset includes dynamic lapse and GMIB utilization assumptions whereby projected contractual lapses and GMIB utilization reflect the projected net amount of risks of the contract. As the net amount of risk of a contract increases, the assumed lapse rate decreases and the GMIB utilization increases. Increases in volatility would increase the asset.
The significant unobservable inputs used in the fair value measurement of the Company's GMWB and GWBL liability are lapse rates and withdrawal rates. Significant increases in withdrawal rates or decreases in lapse rates in isolation would tend to increase these liabilities. Increases in volatility would increase these liabilities.
The carrying values and fair values at December 31, 2013 and 2012 for financial instruments not otherwise disclosed in Notes 3 and 12 are presented in the table below. Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts and pension and other postretirement obligations.
				Carrying			Fair Value
				Value			Level 1			Level 2			Level 3			Total
				(In Millions)
	December 31, 2013:
	Mortgage loans on real estate			$	5,684		$	0		$	0		$	5,716		$	5,716
	Other limited partnership interests				1,592			0			0			1,592			1,592
	Loans to affiliates				1,088			0			800			398			1,198
	Policyholders liabilities: Investment contracts				2,435			0			0			2,523			2,523
	Long-term debt				200			0			225			0			225
	Loans from affiliates				825			0			969			0			969
	December 31, 2012:
	Mortgage loans on real estate			$	5,059		$	0		$	0		$	5,249		$	5,249
	Other limited partnership interests				1,514			0			0			1,514			1,514
	Loans to affiliates				1,037			0			784			402			1,186
	Policyholders liabilities: Investment contracts				2,494			0			0			2,682			2,682
	Long-term debt				200			0			236			0			236
	Loans from affiliates				1,325			0			1,676			0			1,676
Fair values for commercial and agricultural mortgage loans on real estate are measured by discounting future contractual cash flows to be received on the mortgage loan using interest rates at which loans with similar characteristics and credit quality would be made. The discount rate is derived from taking the appropriate U.S. Treasury rate with a like term to the remaining term of the loan and adding a spread reflective of the risk premium associated with the specific loan. Fair values for mortgage loans anticipated to be foreclosed and problem mortgage loans are limited to the fair value of the underlying collateral, if lower.
Other limited partnership interests and other equity investments, including interests in investment companies, are accounted for under the equity method and for which the carrying value provides a reasonable estimate of fair value as the underlying investments of these partnerships are valued at estimated fair value.
Fair values for the Company's long-term debt are determined from quotations provided by brokers knowledgeable about these securities and internally assessed for reasonableness. The fair values of the Company's borrowing and lending arrangements with AXA affiliated entities are determined in the same manner as for such transactions with third parties, including matrix pricing models for debt securities and discounted cash flow analysis for mortgage loans.
The fair values for the Company's association plans contracts, supplementary contracts not involving life contingencies (“SCNILC”), deferred annuities and certain annuities, which are included in Policyholder's account balances are estimated using projected cash flows discounted at rates reflecting current market rates. Significant unobservable inputs reflected in the cash flows include lapse rates and withdrawal rates. Incremental adjustments may be made to the fair value to reflect non-performance risk. Certain other products such as Access Accounts are held at book value.

GMDB_GMIB_GWBL_AND_NO_LAPSE_GU

GMDB, GMIB, GWBL AND NO LAPSE GUARANTEE FEATURES	12 Months Ended
	Dec. 31, 2013
Gmdb Gmib Gwbl And No Lapse Guarantee Features [Abstract]	'
GMDB GMIB GWBL AND NO LAPSE GUARANTEE FEATURES	'
	8)       GMDB, GMIB, GIB, GWBL AND OTHER FEATURES AND NO LAPSE GUARANTEE FEATURES
	A) Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features
	The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following:
	Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals);
	Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals);
	Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages;
	Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include a five year or an annual reset; or
	Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life.
	The following table summarizes the GMDB and GMIB liabilities, before reinsurance ceded, reflected in the General Account in future policy benefits and other policyholders' liabilities:
				GMDB			GMIB			Total
				(In Millions)
	Balance at January 1, 2011			$	1,265		$	2,311		$	3,576
		Paid guarantee benefits			-203			-47			-250
		Other changes in reserve			531			1,866			2,397
	Balance at December 31, 2011				1,593			4,130			5,723
		Paid guarantee benefits			-288			-77			-365
		Other changes in reserve			467			508			975
	Balance at December 31, 2012				1,772			4,561			6,333
		Paid guarantee benefits			-237			-325			-562
		Other changes in reserve			91			-33			58
	Balance at December 31, 2013			$	1,626		$	4,203		$	5,829
	Related GMDB reinsurance ceded amounts were:
				GMDB
				(In Millions)
	Balance at January 1, 2011			$	533
		Paid guarantee benefits			-81
		Other changes in reserve			264
	Balance at December 31, 2011				716
		Paid guarantee benefits			-127
		Other changes in reserve			255
	Balance at December 31, 2012				844
		Paid guarantee benefits			-109
		Other changes in reserve			56
	Balance at December 31, 2013			$	791
	The GMIB reinsurance contracts are considered derivatives and are reported at fair value.
	The December 31, 2013 values for variable annuity contracts in force on such date with GMDB and GMIB features are presented in the following table. For contracts with the GMDB feature, the net amount at risk in the event of death is the amount by which the GMDB benefits exceed related account values. For contracts with the GMIB feature, the net amount at risk in the event of annuitization is the amount by which the present value of the GMIB benefits exceeds related account values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB guarantees may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive:
					Return
					of
					Premium			Ratchet			Roll-Up		Combo		Total
					(Dollars In Millions)
	GMDB:
		Account values invested in:
			General Account		$	13,121		$	228		$	92	$	393	$	13,834
			Separate Accounts		$	36,658		$	8,551		$	4,094	$	37,795	$	87,098
		Net amount at risk, gross			$	270		$	169		$	2,192	$	10,891	$	13,522
		Net amount at risk, net of
			amounts reinsured		$	270		$	111		$	1,451	$	4,152	$	5,984
		Average attained age of
			contractholders			50.8			64.5			70.2		65.2		54.6
		Percentage of contractholders
			over age 70			8.40%			32.20%			53.00%		33.70%		15.50%
		Range of contractually
			specified interest rates			N/A			N/A			3% - 6%		3% - 6.5%		3% - 6.5%
	GMIB:
		Account values invested in:
			General Account			N/A			N/A		$	37	$	428	$	465
			Separate Accounts			N/A			N/A		$	8,349	$	49,109	$	57,458
		Net amount at risk, gross				N/A			N/A		$	892	$	1,551	$	2,443
		Net amount at risk, net of
			amounts reinsured			N/A			N/A		$	268	$	369	$	637
		Weighted average years
			remaining until annuitization			N/A			N/A			0.7		3.5		3.3
		Range of contractually
		specified interest rates			N/A			N/A			3% - 6%		3% - 6.5%		3% - 6.5%
In the second quarter 2013, the approach for determining the above noted GMIB net amount at risk was updated to be more reflective of the economic exposure to the Company. Previously, the calculation used a current annuitization factor based on the retail pricing basis for single-premium individual annuities, including premium loads and interest margins. The updated approach excludes premium loads and interest margins.
The Company continues to proactively manage the risks associated with its in-force business, particularly variable annuities with guarantee features. For example, in third quarter 2013, the Company initiated a program to purchase from certain policyholders the GMDB and GMIB riders contained in their Accumulator® contracts. As a result of this program, the Company is assuming a change in the short term behavior of remaining policyholders, as those who do not accept are assumed to be less likely to surrender their contract over the short term.
Due to the difference in accounting recognition between the fair value of the reinsurance contract asset and the U.S. GAAP gross reserves and DAC the net impact is an after-tax loss of $20 million, which was recognized in 2013.
The liability for SCS, SIO, MSO, IUL, GIB and GWBL and other features, not included above, was $346 million at December 31, 2013 and the liability for GIB and GWBL and other features, not included above, was $265 million at December 31, 2012, which are accounted for as embedded derivatives. The liability for GIB, GWBL and other features reflects the present value of expected future payments (benefits) less the fees attributable to these features over a range of market consistent economic scenarios. The liability for SCS, SIO, MSO and IUL reflects the present value of expected future payments assuming the segments are held to maturity.
B) Separate Account Investments by Investment Category Underlying GMDB and GMIB Features
The total account values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB benefits and guarantees. The investment performance of the assets impacts the related account values and, consequently, the net amount of risk associated with the GMDB and GMIB benefits and guarantees. Since variable annuity contracts with GMDB benefits and guarantees may also offer GMIB benefits and guarantees in each contract, the GMDB and GMIB amounts listed are not mutually exclusive:
Investment in Variable Insurance Trust Mutual Funds
		December 31,
		2013				2012
		(In Millions)
GMDB:
Equity		$	64,035		$	52,633
Fixed income			3,330			3,748
Balanced			19,237			19,102
Other			496			543
Total		$	87,098		$	76,026
GMIB:
Equity		$	41,603		$	33,361
Fixed income			2,208			2,335
Balanced			13,401			12,906
Other			246			264
Total		$	57,458		$	48,866
C) Hedging Programs for GMDB, GMIB, GIB and GWBL and Other Features
Beginning in 2003, AXA Equitable established a program intended to hedge certain risks associated first with the GMDB feature and, beginning in 2004, with the GMIB feature of the Accumulator® series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program currently utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits' exposures attributable to movements in the equity and fixed income markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not reinsured. At December 31, 2013, the total account value and net amount at risk of the hedged variable annuity contracts were $40,319 million and $4,774 million, respectively, with the GMDB feature and $23,346 million and $370 million, respectively, with the GMIB feature.
These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in net investment income (loss) in the period in which they occur, and may contribute to earnings (loss) volatility.
D) Variable and Interest-Sensitive Life Insurance Policies - No Lapse Guarantee
The no lapse guarantee feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The no lapse guarantee remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements.
The following table summarizes the no lapse guarantee liabilities reflected in the General Account in Future policy benefits and other policyholders' liabilities, and the related reinsurance ceded.
						Reinsurance
			Direct Liability			Ceded			Net
			(In Millions)
Balance at January 1, 2011			$	375		$	-231		$	144
	Other changes in reserves			95			-31			64
Balance at December 31, 2011				470			-262			208
	Other changes in reserves			86			-48			38
Balance at December 31, 2012				556			-310			246
	Other changes in reserves			273			-131			142
Balance at December 31, 2013			$	829		$	-441		$	388

REINSURANCE_AGREEMENTS

REINSURANCE AGREEMENTS	12 Months Ended
	Dec. 31, 2013
Reinsurance Agreements [Abstract]	'
REINSURANCE AGREEMENTS	'
	9)       REINSURANCE AGREEMENTS
	The Company assumes and cedes reinsurance with other insurance companies. The Company evaluates the financial condition of its reinsurers to minimize its exposure to significant losses from reinsurer insolvencies. Ceded reinsurance does not relieve the originating insurer of liability.
	The Company reinsures most of its new variable life, UL and term life policies on an excess of retention basis. The Insurance Group maintains a maximum retention on each single-life policy of $25 million and on each second-to-die policy of $30 million with the excess 100% reinsured. The Company also reinsures the entire risk on certain substandard underwriting risks and in certain other cases.
	At December 31, 2013, the Company had reinsured with non-affiliates and affiliates in the aggregate approximately 5.6% and 50.2%, respectively, of its current exposure to the GMDB obligation on annuity contracts in-force and, subject to certain maximum amounts or caps in any one period, approximately 32.0% and 41.9%, respectively, of its current liability exposure resulting from the GMIB feature. See Note 8.
	Based on management's estimates of future contract cash flows and experience, the estimated fair values of the GMIB reinsurance contracts, considered derivatives at December 31, 2013 and 2012 were $6,747 million and $11,044 million, respectively. The increases (decreases) in estimated fair value were $(4,297) million, $497 million and $5,941 million for 2013, 2012 and 2011, respectively.
	At December 31, 2013 and 2012, respectively, third-party reinsurance recoverables related to insurance contracts amounted to $2,379 million and $2,465 million, of which $1,920 million and $1,964 million related to two specific reinsurers, which are rated A/AA- with the remainder of the reinsurers rated BBB and above or not rated. At December 31, 2013 and 2012, affiliated reinsurance recoverables related to insurance contracts amounted to $1,555 million and $1,383 million, respectively. A contingent liability exists with respect to reinsurance should the reinsurers be unable to meet their obligations.  The Insurance Group evaluates the financial condition of its reinsurers in an effort to minimize its exposure to significant losses from reinsurer insolvencies.
	Reinsurance payables related to insurance contracts totaling $70 million and $73 million are included in other liabilities in the consolidated balance sheets at December 31, 2013 and 2012, respectively.
	The Insurance Group cedes substantially all of its group life and health business to a third party insurer. Insurance liabilities ceded totaled $143 million and $160 million at December 31, 2013 and 2012, respectively.
	The Insurance Group also cedes a portion of its extended term insurance and paid-up life insurance and substantially all of its individual disability income business through various coinsurance agreements.
	The Insurance Group has also assumed accident, health, annuity, aviation and space risks by participating in or reinsuring various reinsurance pools and arrangements. In addition to the sale of insurance products, the Insurance Group currently acts as a professional retrocessionaire by assuming life reinsurance from professional reinsurers. Reinsurance assumed reserves at December 31, 2013 and 2012 were $709 million and $752 million, respectively.
	The following table summarizes the effect of reinsurance:
		2013		2012		2011
		(In Millions)
	Direct premiums	$	848	$	873	$	908
	Reinsurance assumed		213		219		210
	Reinsurance ceded		-565		-578		-585
	Premiums	$	496	$	514	$	533
	Universal Life and Investment-type Product Policy Fee Income Ceded	$	247	$	234	$	221
	Policyholders' Benefits Ceded	$	703	$	667	$	510
	Individual Disability Income and Major Medical
	Claim reserves and associated liabilities net of reinsurance ceded for individual DI and major medical policies were $79 million and $86 million at December 31, 2013 and 2012, respectively. At December 31, 2013 and 2012, respectively, $1,687 million and $1,704 million of DI reserves and associated liabilities were ceded through indemnity reinsurance agreements with a singular reinsurance group, rated AA-. Net incurred benefits (benefits paid plus changes in claim reserves) and benefits paid for individual DI and major medical policies are summarized below:
		2013		2012		2011
		(In Millions)
	Incurred benefits related to current year	$	15	$	16	$	24
	Incurred benefits related to prior years		10		14		18
	Total Incurred Benefits	$	25	$	30	$	42
	Benefits paid related to current year	$	19	$	21	$	15
	Benefits paid related to prior years		13		16		24
	Total Benefits Paid	$	32	$	37	$	39

SHORTTERM_AND_LONGTERM_DEBT

SHORT-TERM AND LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2013
Short Term And Long Term Debt [Abstract]	'
SHORT TERM AND LONG TERM DEBT	'
	10)       SHORT-TERM AND LONG-TERM DEBT
	Short-term and long-term debt consists of the following:
			December 31,
			2013		2012
			(In Millions)
	Short-term debt:
	AllianceBernstein commercial paper (with interest rates of 0.3% and 0.5%)		$	268	$	323
	Total short-term debt			268		323
	Long-term debt:
	AXA Equitable:
		Surplus Notes, 7.7%, due 2015		200		200
	Total long-term debt			200		200
	Total Short-term and Long-term Debt		$	468	$	523
	Short-term Debt
	AXA Equitable is a member of the Federal Home Loan Bank of New York (“FHLBNY”), which provides AXA Equitable with access to collateralized borrowings and other FHLBNY products. As membership requires the ownership of member stock, AXA Equitable purchased stock to meet its membership requirement ($13 million, as of December 31, 2013). Any borrowings from the FHLBNY require the purchase of FHLBNY activity based stock in an amount equal to 4.5% of the borrowings. AXA Equitable's borrowing capacity with FHLBNY is $1,000 million. As a member of FHLBNY, AXA Equitable can receive advances for which it would be required to pledge qualified mortgage-backed assets and government securities as collateral. At December 31, 2013, there were no outstanding borrowings from FHLBNY.
	In December 2010, AllianceBernstein entered into a committed, unsecured three-year senior revolving credit facility (the “AB Credit Facility”) with a group of commercial banks and other lenders in an original principal amount of $1,000 million with SCB LLC as an additional borrower.
	The AB Credit Facility is available for AllianceBernstein's and SCB LLC's business purposes, including the support of AllianceBernstein's $1,000 million commercial paper program. Both AllianceBernstein and SCB LLC can draw directly under the AB Credit Facility and management expects to draw on the AB Credit Facility from time to time.
	The AB Credit Facility contains affirmative, negative and financial covenants, which are customary for facilities of this type, including, among other things, restrictions on dispositions of assets, restrictions on liens, a minimum interest coverage ratio and a maximum leverage ratio. The AB Credit Facility also includes customary events of default (with customary grace periods, as applicable), including provisions under which, upon the occurrence of an event of default, all outstanding loans may be accelerated and/or lender's commitments may be terminated. Also, under such provisions, upon the occurrence of certain insolvency or bankruptcy related events of default, all amounts payable under the AB Credit Facility would automatically become immediately due and payable, and the lender's commitments would automatically terminate.
	The AB Credit Facility provides for possible increases in principal amount by up to an aggregate incremental amount of $250 million (“accordion feature”), any such increase being subject to the consent of the affected lenders. Amounts under the AB Credit Facility may be borrowed, repaid and re-borrowed by either company from time to time until the maturity of the facility. Voluntary prepayments and commitment reductions requested by AllianceBernstein are permitted at any time without fee (other than customary breakage costs relating to the prepayment of any drawn loans) upon proper notice and subject to a minimum dollar requirement. Borrowings under the AB Credit Facility bear interest at a rate per annum, which will be, at AllianceBernstein's option, a rate equal to an applicable margin, which is subject to adjustment based on the credit ratings of AllianceBernstein, plus one of the following indexes: London Interbank Offered Rate (“LIBOR”); a floating base rate; or the Federal Funds rate.
	On January 17, 2012, the AB Credit Facility was amended and restated. The principal amount was amended to $900 million from the original principal amount of $1,000 million. Also, the amendment increased the accordion feature from $250 million to $350 million. In addition, the maturity date of the AB Credit Facility has been extended from December 9, 2013 to January 17, 2017. There were no other significant changes in terms and conditions included in this amendment.
	As of December 31, 2013 and 2012, AllianceBernstein had no amounts outstanding under the AB Credit Facility or the previous revolving credit facilities, respectively.
	In addition, SCB LLC has five uncommitted lines of credit with four financial institutions. Two of these lines of credit permit AllianceBernstein to borrow up to an aggregate of approximately $200 million while three lines have no stated limit.
	Long-term Debt
	At December 31, 2013, the Company was not in breach of any long-term debt covenants.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	11)       RELATED PARTY TRANSACTIONS
	Loans to Affiliates
	In September 2007, AXA issued a $650 million 5.4% Senior Unsecured Note to AXA Equitable. The note pays interest semi-annually and was scheduled to mature on September 30, 2012. In March 2011, the maturity date of the note was extended to December 30, 2020 and the interest rate was increased to 5.7%.
	In June 2009, AXA Equitable sold a jointly owned real estate property valued at $1,100 million to a non-insurance subsidiary of AXA Financial in exchange for $700 million in cash and $400 million in 8.0% ten year term mortgage notes on the property reported in Loans to affiliates in the consolidated balance sheets. The $439 million after-tax excess of the property's fair value over its carrying value was accounted for as a capital contribution to AXA Equitable.
	In third quarter 2013, AXA Equitable purchased, at fair value, AXA Arizona's $50 million note receivable from AXA for $56 million. This note pays interest semi-annually at an interest rate of 5.4% and matures on December 15, 2020.
	Loans from Affiliates
	In 2005, AXA Equitable issued a surplus note to AXA Financial in the amount of $325 million with an interest rate of 6.0% and a maturity date of December 1, 2035. Interest on this note is payable semi-annually.
	In December 2008, AXA Equitable issued a $500 million callable 7.1% surplus note to AXA Financial. The note pays interest semi-annually and matures on December 1, 2018.
	In November 2008, AXA Equitable issued a $500 million callable 7.1% surplus note to AXA Financial. The note paid interest semi-annually and was scheduled to mature on December 1, 2018. In June 2013, AXA Equitable repaid this note at par value plus interest accrued to AXA Financial.
	Other Transactions
	In third quarter 2013, AXA Equitable purchased, at fair value, MONY Life Insurance Company's ("MONY Life") equity interest in limited partnerships for $53 million and MONY Life's CMBS portfolio for $31 million.
	In October 2012, AXA Equitable sold its 50% interest in a real estate joint venture supporting the Wind-up Annuities line of business to 1285 Holdings, LLC, a non-insurance subsidiary of AXA Financial in exchange for $402 million in cash. The $195 million after-tax excess of the real estate joint venture's fair value over its carrying value has been accounted for as a capital contribution to AXA Equitable. In connection with this sale, the Company recognized a $226 million pre-tax premium deficiency reserve related to the Wind-up Annuities line of business.
	In August 2012, the Company purchased agricultural mortgage loans from MONY Life and MONY Life Insurance Company of America (“MLOA”), for a purchase price of $109 million.
	The Company reimburses AXA Financial for expenses relating to the Excess Retirement Plan, Supplemental Executive Retirement Plan and certain other employee benefit plans that provide participants with medical, life insurance, and deferred compensation benefits. Such reimbursement was based on the cost to AXA Financial of the benefits provided which totaled $40 million, $37 million and $14 million, respectively, for 2013, 2012 and 2011.
	In 2013, 2012 and 2011, respectively, the Company paid AXA Distribution and its subsidiaries $621 million, $684 million and $641 million of commissions and fees for sales of insurance products. The Company charged AXA Distribution's subsidiaries $306 million, $348 million and $413 million, respectively, for their applicable share of operating expenses in 2013, 2012 and 2011, pursuant to the Agreements for Services.
	The Company currently reinsures to AXA RE Arizona Company (“AXA Arizona”) a 100% quota share of all liabilities for variable annuities with enhanced GMDB and GMIB riders issued on or after January 1, 2006 and in-force on September 30, 2008. AXA Arizona also reinsures a 90% quota share of level premium term insurance issued by AXA Equitable on or after March 1, 2003 through December 31, 2008 and lapse protection riders under UL insurance policies issued by AXA Equitable on or after June 1, 2003 through June 30, 2007. The reinsurance arrangements with AXA Arizona provide important capital management benefits to AXA Equitable. At December 31, 2013 and 2012, the Company's GMIB reinsurance asset with AXA Arizona had carrying values of $5,388 million and $8,888 million, respectively, and is reported in Guaranteed minimum income benefit reinsurance asset, at fair value in the consolidated balance sheets. Ceded premiums in 2013, 2012 and 2011 related to the UL and no lapse guarantee riders totaled approximately $474 million, $484 million and $484 million, respectively. Ceded claims paid in 2013, 2012 and 2011 were $70 million, $68 million and $31 million, respectively.
	Various AXA affiliates, including AXA Equitable, cede a portion of their life, health and catastrophe insurance business through reinsurance agreements to AXA Global Life beginning in 2010 (and AXA Cessions in 2009 and prior), AXA affiliated reinsurers. AXA Global Life, in turn, retrocedes a quota share portion of these risks prior to 2008 to AXA Equitable on a one-year term basis.
	AXA Life Insurance Company Ltd (Japan), an AXA subsidiary, cedes a portion of their annuity business to AXA Equitable.
	Various AXA Financial affiliates cede a portion of their life business through excess of retention treaties to AXA Equitable on a yearly renewal term basis.
	Premiums earned from the above mentioned affiliated reinsurance transactions in 2013, 2012 and 2011 totaled approximately $21 million, $21 million and $22 million, respectively. Claims and expenses paid in 2013, 2012 and 2011 were $10 million, $13 million and $14 million, respectively.
	Both AXA Equitable and AllianceBernstein, along with other AXA affiliates, participate in certain intercompany cost sharing and service agreements including technology and professional development arrangements. AXA Equitable and AllianceBernstein incurred expenses under such agreements of approximately $165 million, $161 million and $152 million in 2013, 2012 and 2011, respectively. Expense reimbursements by AXA and AXA affiliates to AXA Equitable under such agreements totaled approximately $24 million, $26 million and $22 million in 2013, 2012 and 2011, respectively. The net receivable (payable) related to these contracts was approximately $(8) million and $8 million at December 31, 2013 and 2012, respectively.
	Commissions, fees and other income includes certain revenues for services provided to mutual funds managed by AllianceBernstein. These revenues are described below:
		2013		2012		2011
		(In Millions)
	Investment advisory and services fees	$	1,010	$	879	$	831
	Distribution revenues		455		408		360
	Other revenues - shareholder servicing fees		91		89		92
	Other revenues - other		6		5		6

EMPLOYEE_BENEFIT_PLANS

EMPLOYEE BENEFIT PLANS	12 Months Ended
	Dec. 31, 2013
Employee Benefit Plans [Abstract]	'
EMPLOYEE BENEFIT PLANS	'
	12)       EMPLOYEE BENEFIT PLANS
	Pension Plans
	AXA Equitable sponsors a qualified defined benefit pension plan covering its eligible employees (including certain qualified part-time employees), managers and financial professionals. This pension plan is non-contributory and its benefits are generally based on a cash balance formula and/or, for certain participants, years of service and average earnings over a specified period in the plan. AXA Equitable also sponsors non-qualified defined benefit pension plans.
	AXA Equitable announced in the third quarter of 2013 that benefit accruals under its qualified and non-qualified defined benefit pension plans would be discontinued after December 31, 2013. This plan curtailment resulted in a decrease in the Projected Benefit Obligation (“PBO”) of approximately $29 million, which was offset against existing deferred losses in AOCI, and recognition of a $3 million curtailment loss from accelerated recognition of existing prior service costs accumulated in OCI. In addition, AXA Equitable announced that it will begin providing a company contribution to the AXA Equitable 401(k) Plan as of January 1, 2014. AXA Equitable will also provide an excess 401(k) contribution for eligible compensation over the qualified plan compensation limits under a nonqualified deferred compensation plan.
	AllianceBernstein maintains a qualified, non-contributory, defined benefit retirement plan covering current and former employees who were employed by AllianceBernstein in the United States prior to October 2, 2000. AllianceBernstein's benefits are based on years of credited service and average final base salary. The Company uses a December 31 measurement date for its pension plans.
	For 2013, no cash contributions were made by AXA Equitable to its qualified pension plan. AllianceBernstein made a $4 million cash contribution to its qualified pension plan in 2013. The funding policy of the Company for its qualified pension plans is to satisfy its funding obligations each year in an amount not less than the minimum required by the Employee Retirement Income Security Act of 1974 (“ERISA”), as amended by the Pension Protection Act of 2006 (the “Pension Act”), and not greater than the maximum it can deduct for Federal income tax purposes. Based on the funded status of the plans at December 31, 2013, no minimum contribution is required to be made in 2014 under ERISA, as amended by the Pension Act. AllianceBernstein currently estimates that it will contribute $6 million to its pension plan during 2014.
	Components of net periodic pension expense for the Company's qualified plans were as follows:
			2013			2012			2011
			(In Millions)
	Service cost		$	40		$	40		$	41
	Interest cost			99			109			122
	Expected return on assets			-155			-146			-120
	Actuarial (gain) loss			1			1			-
	Net amortization			155			164			145
	Curtailment			3			-			-
	Net Periodic Pension Expense		$	143		$	168		$	188
	Changes in the PBO of the Company's qualified plans were comprised of:
			December 31,
			2013			2012
			(In Millions)
	Projected benefit obligation, beginning of year		$	2,797		$	2,626
	Service cost			32			32
	Interest cost			99			109
	Actuarial (gains) losses			-260			219
	Benefits paid			-176			-187
	Plan amendments and curtailments			-29			-2
	Projected Benefit Obligation, End of Year		$	2,463		$	2,797
	The following table discloses the change in plan assets and the funded status of the Company's qualified pension plans:
			December 31,
			2013			2012
			(In Millions)
	Pension plan assets at fair value, beginning of year		$	2,396		$	2,093
	Actual return on plan assets			180			231
	Contributions			4			265
	Benefits paid and fees			-179			-193
	Pension plan assets at fair value, end of year			2,401			2,396
	PBO			2,463			2,797
	Excess of PBO Over Pension Plan Assets		$	-62		$	-401
	Amounts recognized in the accompanying consolidated balance sheets to reflect the funded status of these plans were accrued pension costs of $62 million and $401 million at December 31, 2013 and 2012, respectively. The aggregate PBO and fair value of pension plan assets for plans with PBOs in excess of those assets were $2,463 million and $2,401 million, respectively, at December 31, 2013 and $2,797 million and $2,396 million, respectively, at December 31, 2012. The aggregate accumulated benefit obligation and fair value of pension plan assets for pension plans with accumulated benefit obligations in excess of those assets were $2,463 million and $2,401 million, respectively, at December 31, 2013 and $2,761 million and $2,396 million, respectively, at December 31, 2012. The accumulated benefit obligation for all defined benefit pension plans was $2,463 million and $2,761 million at December 31, 2013 and 2012, respectively.
	The following table discloses the amounts included in AOCI at December 31, 2013 and 2012 that have not yet been recognized as components of net periodic pension cost:
				December 31,
				2013			2012
				(In Millions)
	Unrecognized net actuarial (gain) loss			$	1,181		$	1,650
	Unrecognized prior service cost (credit)				0			4
		Total		$	1,181		$	1,654
	The estimated net actuarial (gain) loss and prior service cost (credit) expected to be reclassified from AOCI and recognized as components of net periodic pension cost over the next year are $115 million and $0 million, respectively.
	The following table discloses the allocation of the fair value of total plan assets for the qualified pension plans of the Company at December 31, 2013 and 2012:
				December 31,
				2013			2012
				(In Millions)
	Fixed Maturities			49	%			52.8	%
	Equity Securities			39.1				36.5
	Equity real estate			9.3				8.4
	Cash and short-term investments			1.9				2.3
	Other			0.7				0
		Total		100	%			100	%
	The primary investment objective of the qualified pension plan of AXA Equitable is to maximize return on assets, giving consideration to prudent risk. Guidelines regarding the allocation of plan assets for AXA Equitable's qualified pension plan are formalized by the Investment Committee established by the funded benefit plans of AXA Equitable and are designed with a long-term investment horizon. During 2013, AXA Equitable continued to implement an investment allocation strategy of the qualified defined benefit pension plan targeting 30%-40% equities, 50%-60% high quality bonds, and 0%-15% equity real estate and other investments. Exposure to real estate investments offers diversity to the total portfolio and long-term inflation protection.
	In 2013, AXA Equitable's qualified pension plan continued to implement hedging strategies intended to minimize downside equity risk, principally using exchange-traded options contracts. As a result of a strategic asset allocation project conducted in the latter half of 2013, the existing equity-hedging program was discontinued in January 2014 at maturity of the underlying positions.
	The following tables disclose the fair values of plan assets and their level of observability within the fair value hierarchy for the qualified pension plans of the Company at December 31, 2013 and 2012, respectively.
	December 31, 2013:					Level 1			Level 2		Level 3		Total
	Asset Categories					(In Millions)
	Fixed Maturities:
	Corporate				$	0		$	801	$	0	$	801
	U.S. Treasury, government and agency					0			343		0		343
	States and political subdivisions					0			16		0		16
	Other structured debt					0			6		4		10
Common and preferred equity						716			191		0		907
Mutual funds						44			0		0		44
Private real estate investment funds						0			0		2		2
Private real estate investment trusts						0			11		220		231
Cash and cash equivalents						1			0		0		1
Short-term investments						23			23		0		46
	Total				$	784		$	1,391	$	226	$	2,401
December 31, 2012:					Level 1			Level 2		Level 3		Total
Asset Categories					(In Millions)
Fixed Maturities:
	Corporate				$	0		$	849	$	0	$	849
	U.S. Treasury, government and agency					0			410		0		410
	States and political subdivisions					0			18		0		18
	Other structured debt					0			0		5		5
Common and preferred equity						751			62		0		813
Mutual funds						35			0		0		35
Private real estate investment funds						0			0		3		3
Private real estate investment trusts						0			11		197		208
Cash and cash equivalents						25			0		0		25
Short-term investments						0			30		0		30
	Total				$	811		$	1,380	$	205	$	2,396
At December 31, 2013, assets classified as Level 1, Level 2, and Level 3 comprise approximately 32.7%, 57.9% and 9.4%, respectively, of qualified pension plan assets. At December 31, 2012, assets classified as Level 1, Level 2 and Level 3 comprised approximately 33.9%, 57.5% and 8.6%, respectively, of qualified pension plan assets. See Note 2 for a description of the fair value hierarchy. The fair values of qualified pension plan assets are measured and ascribed to levels within the fair value hierarchy in a manner consistent with the invested assets of the Company that are measured at fair value on a recurring basis. Except for an investment of approximately $2 million in a private REIT through a pooled separate account, there are no significant concentrations of credit risk arising within or across categories of qualified pension plan assets.
The tables below present a reconciliation for all Level 3 qualified pension plan assets at December 31, 2013 and 2012, respectively.
								Private
								Real Estate		Private
					Fixed			Investment		Investment		Common
					Maturities(1)			Funds		Trusts		Equity		Total
					(In Millions)
Balance at January 1, 2013					$	5		$	3	$	197	$	0	$	205
Actual return on plan assets:
	Relating to assets still held
		at December 31, 2013				0			0		23		0		23
	Purchases/issues					0			0		0		0		0
	Sales/settlements					0			0		0		0		0
	Transfers into/out of Level 3					-1			-1		0		0		-2
Balance at December 31, 2013					$	4		$	2	$	220	$	0	$	226
Balance at January 1, 2012					$	6		$	4	$	183	$	0	$	193
Actual return on plan assets:
	Relating to assets still held
		at December 31, 2012				0			0		14		0		14
	Sales/settlements					-1			-1		0		0		-2
	Transfers into/out of Level 3					0			0		0		0		0
Balance at December 31, 2012					$	5		$	3	$	197	$	0	$	205
(1)       Includes commercial mortgage- and asset-backed securities and other structured debt.
The discount rate assumptions used by the Company to measure the benefits obligations and related net periodic cost of its qualified pension plans reflect the rates at which those benefits could be effectively settled. Projected nominal cash outflows to fund expected annual benefits payments under each of the Company's qualified pension plans were discounted using a published high-quality bond yield curve. The discount rate used to measure each of the benefits' obligations at December 31, 2013 and 2012 represents the level equivalent spot discount rate that produces the same aggregate present value measure of the total benefits obligation as the aforementioned discounted cash flow analysis. The following table discloses the weighted-average assumptions used to measure the Company's pension benefit obligations and net periodic pension cost at and for the years ended December 31, 2013 and 2012.
			2013			2012
Discount rates:
	Benefit obligation		4.5	%		3.5	%
	Periodic cost		4.5	%		4.25	%
Rates of compensation increase:
	Benefit obligation and periodic cost		6	%		6	%
Expected long-term rates of return on pension plan assets (periodic cost)			6.75	%		6.75	%
The expected long-term rate of return assumption on plan assets is based upon the target asset allocation of the plan portfolio and is determined using forward-looking assumptions in the context of historical returns and volatilities for each asset class.  Based upon new plan asset allocation targets for 2014 intended to rebalance between the bond and equity portfolios under the long-term investment strategy, the expected long-term rate of return assumed on pension plan assets in the measurement of net periodic cost will be increased to 7.00%.
Prior to 1987, participants' benefits under AXA Equitable's qualified plan were funded through the purchase of non-participating annuity contracts from AXA Equitable. Benefit payments under these contracts were approximately $10 million, $12 million and $13 million for 2013, 2012 and 2011, respectively.
The following table provides an estimate of future benefits expected to be paid in each of the next five years, beginning January 1, 2014, and in the aggregate for the five years thereafter. These estimates are based on the same assumptions used to measure the respective benefit obligations at December 31, 2013 and include benefits attributable to estimated future employee service.
		Pension
		Benefits
		(In Millions)
2014		$	189
2015			196
2016			192
2017			188
2018			185
Years 2019-2023			853
Health Plans
The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the “Health Acts”), signed into law in March 2010, have both immediate and long-term financial reporting implications for many employers who sponsor health plans for active employees and retirees. While many of the provisions of the Health Acts do not take effect until future years and are intended to coincide with fundamental changes to the healthcare system, current-period measurement of the benefits obligation is required to reflect an estimate of the potential implications of presently enacted law changes absent consideration of potential future plan modifications. Management, in consultation with its actuarial advisors in respect of the Plan, has concluded the Health Acts have no material impact on the calculations on future benefit levels due to the caps on the Company subsidy for retirees. Any increases in plan cost, including those associated under the Excise Tax on high cost plans, are anticipated to be passed on to retirees.
Included among the major provisions of the Health Acts is a change in the tax treatment of the Medicare Part D subsidy. The subsidy came into existence with the enactment of the Medicare Modernization Act (“MMA”) in 2003 and is available to sponsors of retiree health benefit plans with a prescription drug benefit that is “actuarially equivalent” to the benefit provided by the Medicare Part D program. Prior to the Health Acts, sponsors were permitted to deduct the full cost of these retiree prescription drug plans without reduction for subsidies received. Although the Medicare Part D subsidy did not become taxable until years beginning after December 31, 2012, the effects of changes in tax law had to be recognized immediately in the income statement of the period of enactment. When MMA was enacted, the Company reduced its health benefits obligation to reflect the expected future subsidies from this program but did not establish a deferred tax asset for the value of the related future tax deductions. Consequently, passage of the Health Acts did not result in adjustment of the deferred tax accounts.
In 2011, AXA Equitable eliminated any subsidy for retiree medical and dental coverage for individuals retiring on or after May 1, 2012 as well as a $10,000 retiree life insurance benefit for individuals retiring on or after January 1, 2012. As a result, the Company recognized a one-time reduction in benefits expense of approximately $37 million in 2011.
AXA Financial Assumption
Since December 31, 1999, AXA Financial has legally assumed primary liability from AXA Equitable for all current and future liabilities of AXA Equitable under certain employee benefit plans that provide participants with medical, life insurance, and deferred compensation benefits; AXA Equitable remains secondarily liable. AXA Equitable reimburses AXA Financial, Inc. for costs associated with these plans, as described in Note 11.

SHAREBASED_AND_OTHER_COMPENSAT

SHARE-BASED AND OTHER COMPENSATION PROGRAMS	12 Months Ended
	Dec. 31, 2013
Shared Based And Other Compensation Programs [Abstract]	'
SHARE BASED AND OTHER COMPENSATION PROGRAMS	'
	13)       SHARE-BASED AND OTHER COMPENSATION PROGRAMS
	AXA and AXA Financial sponsor various share-based compensation plans for eligible employees and financial professionals of AXA Financial and its subsidiaries, including the Company. AllianceBernstein also sponsors its own unit option plans for certain of its employees.
	Compensations costs for 2013, 2012 and 2011 for share-based payment arrangements as further described herein are as follows:
			2013			2012			2011
			(In Millions)
	Performance Unit/Shares		$	43		$	24		$	2
	Stock Options			2			3			4
	AXA Shareplan			13			18			9
	AXA Miles			0			1			1
	AllianceBernstein Stock Options			-4			1			21
	AllianceBernstein Restricted Units			286			148			377
	Total Compensation Expenses		$	340		$	195		$	414
	U.S. employees are granted AXA ordinary share options under the Stock Option Plan for AXA Financial Employees and Associates (the “Stock Option Plan”) and are granted AXA performance units under the AXA Performance Unit Plan (the “Performance Unit Plan”). In 2013, they were granted performance shares under the AXA International Performance Share Plan 2013 (the “Performance Share Plan”).
	Performance Units and Performance Shares
	2013 Grant. On March 22, 2013, under the terms of the Performance Share Plan, AXA awarded approximately 2.2 million unearned performance shares to employees of AXA Equitable. The extent to which 2013-2014 cumulative performance targets measuring the performance of AXA and the insurance related businesses of AXA Financial Group are achieved will determine the number of performance shares earned, which may vary in linear formula between 0% and 130% of the number of performance shares at stake. The performance shares earned during this performance period will vest and be settled on the third anniversary of the award date. The plan will settle in shares to all participants. In 2013, the expense associated with the March 22, 2013 grant of performance shares was approximately $11 million.
	50% Settlement of 2010 Grant in 2013. On April 4, 2013, cash distributions of approximately $7 million and share distributions of approximately $49,000 were made to active and former AXA Equitable employees in settlement of 390,460 performance units, representing the remaining 50 percent of the number of performance units earned under the terms of the AXA Performance Unit Plan 2010. Cash distributions of approximately $9 million in settlement of approximately 539,000 performance units, representing the first 50 percent of the performance units earned under the terms of the AXA Performance Unit Plan 2010 were distributed in April 2012.
	2012 Grant. On March 16, 2012, under the terms of the AXA Performance Unit Plan 2012, AXA awarded approximately 2.3 million unearned performance units to employees of AXA Equitable. The extent to which 2012-2013 cumulative performance targets measuring the performance of AXA and the insurance related businesses of AXA Financial Group are achieved will determine the number of performance units earned, which may vary in linear formula between 0% and 130% of the number of performance units at stake. The performance units earned during this performance period will vest and be settled in cash on the third anniversary of the award date. The price used to value the performance units at settlement will be the average closing price of the AXA ordinary share for the last 20 trading days of the vesting period converted to U.S. dollars using the Euro to U.S. dollar exchange rate on March 15, 2015. In 2013 and 2012, the expense associated with the March 16, 2012 grant of performance units was approximately $26 million and $11 million, respectively.
	2011 Grant. On March 18, 2011, under the terms of the AXA Performance Unit Plan 2011, AXA awarded approximately 1.8 million unearned performance units to AXA Equitable employees. The extent to which 2011-2012 cumulative two-year targets measuring the performance of AXA and the insurance related businesses of AXA Financial Group are achieved will determine the number of performance units earned, which may vary in linear formula between 0% and 130% of the number of performance units at stake. The performance units earned during this performance period will vest and be settled on the third anniversary of the award date. The price used to value the performance units at settlement will be the average closing price of the AXA ordinary share for the last 20 trading days of the vesting period converted to U.S. dollars using the Euro to U.S. dollar exchange rate on March 17, 2014. For 2013, 2012 and 2011, the Company recognized expenses associated with the March 18, 2011 grant of performance units of approximately $6 million, $11 million and $2 million, respectively.
	Settlement of 2009 Grant in 2011. On March 20, 2011, approximately 831,000 performance units earned under the AXA Performance Unit Plan 2009 were fully vested for total value of approximately $17 million. Distributions to participants were made on April 14, 2011, resulting in cash settlements of approximately 80% of these performance units for aggregate value of approximately $14 million and equity settlements of the remainder with approximately 164,000 restricted AXA ordinary shares for aggregate value of approximately $3 million. The AXA ordinary shares were sourced from Treasury shares.
	For 2013, 2012 and 2011, the Company recognized compensation costs of $43 million, $24 million and $2 million, respectively, for performance shares and units earned to date. The change in fair value of these awards is measured by the closing price of the underlying AXA ordinary shares or AXA ADRs. The cost of performance unit and share awards, as adjusted for achievement of performance targets and pre-vesting forfeitures is attributed over the shorter of the cliff-vesting period or to the date at which retirement eligibility is achieved. The value of performance units and shares earned and reported in Other liabilities in the consolidated balance sheets at December 31, 2013 and 2012 was $108 million and $58 million, respectively. Approximately 5.3 million outstanding performance units and shares are at risk to achievement of 2013 performance criteria, primarily representing the performance shares grant of March 22, 2013 for which cumulative average 2013-2014 performance targets will determine the number of performance shares earned and including one-half of the performance unit award granted on March 16, 2012.
	Stock Options
	2013 Grant On March 22, 2013, approximately 457,000 options to purchase AXA ordinary shares were granted to employees of AXA Equitable under the terms of the Stock Option Plan at an exercise price of 13.81 euros. All of those options have a four-year graded vesting schedule, with one-third vesting on each of the second, third, and fourth anniversaries of the grant date. Approximately 246,000 of the total options awarded on March 22, 2013 are further subject to conditional vesting terms that require the AXA ordinary share price to outperform the Euro Stoxx Insurance Index over a specified period. All of the options granted on March 22, 2013 have a ten-year term. The weighted average grant date fair value per option award was estimated at $1.79 using a Black-Scholes options pricing model with modification to measure the value of the conditional vesting feature. Key assumptions used in the valuation included expected volatility of 31.27%, a weighted average expected term of 7.7 years, an expected dividend yield of 7.52% and a risk-free interest rate of 1.34%. The total fair value of these options (net of expected forfeitures) of $818,597 is charged to expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible. In 2013, the Company recognized expenses associated with the March 22, 2013 grant of options of approximately $357,000
	2012 Grant. On March 16, 2012, approximately 901,000 options to purchase AXA ordinary shares were granted to AXA Equitable employees under the terms of the Stock Option Plan at an exercise price of 12.22 euros. All of those options have a four-year graded vesting schedule, with one-third vesting on each of the second, third, and fourth anniversaries of the grant date. Approximately 370,000 of the total options awarded on March 16, 2012 are further subject to conditional vesting terms that require the AXA ordinary share price to outperform the Euro Stoxx Insurance Index over a specified period. All of the options granted on March 16, 2012 have a ten-year term. The weighted average grant date fair value per option award was estimated at $2.48 using a Black-Scholes options pricing model with modification to measure the value of the conditional vesting feature. Key assumptions used in the valuation included expected volatility of 39.89%, a weighted average expected term of 5.6 years, an expected dividend yield of 7.54% and a risk-free interest rate of 1.8%. The total fair value of these options (net of expected forfeitures) of approximately $2 million is charged to expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible. In 2013 and 2012, respectively, the expense associated with the March 16, 2012 grant of options was approximately $504,000 and $791,000,.
	2011 Grant. On March 18, 2011, approximately 2.4 million options to purchase AXA ordinary shares were granted under the terms of the Stock Option Plan at an exercise price of 14.73 euros. Approximately 2.3 million of those options have a four-year graded vesting schedule, with one-third vesting on each of the second, third, and fourth anniversaries of the grant date. In addition, approximately 483,000 of the total options awarded on March 18, 2011 are further subject to conditional vesting terms that require the AXA ordinary share price to outperform the Euro Stoxx Insurance Index over a specified period. All of the options granted on March 18, 2011 have a ten-year term. The weighted average grant date fair value per option award was estimated at $2.49 using a Black-Scholes options pricing model with modification to measure the value of the conditional vesting feature. Key assumptions used in the valuation included expected volatility of 33.9%, a weighted average expected term of 6.4 years, an expected dividend yield of 7.0% and a risk-free interest rate of 3.13%. The total fair value of these options (net of expected forfeitures) of approximately $6 million is charged to expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible. For 2013, 2012 and 2011, the Company recognized expenses associated with the March 18, 2011 grant of options of $573,000, $1 million and $2 million, respectively.
	The number of AXA ADRs or AXA ordinary shares authorized to be issued pursuant to option grants and, as further described below, restricted stock grants under The AXA Financial, Inc. 1997 Stock Incentive Plan (the “Stock Incentive Plan”) is approximately 124 million less the number of shares issued pursuant to option grants under The AXA Financial, Inc. 1991 Stock Incentive Plan (the predecessor plan to the Stock Incentive Plan).
	A summary of the activity in the AXA, AXA Financial and AllianceBernstein option plans during 2013 follows:
				Options Outstanding
				AXA Ordinary Shares							AXA ADRs(3)						AllianceBernstein Holding Units
							Weighted							Weighted					Weighted
				Number			Average				Number			Average			Number		Average
				Outstanding			Exercise				Outstanding			Exercise			Outstanding		Exercise
				(In 000's)			Price				(In 000's)			Price			(In 000's)		Price
	Options outstanding at
		1-Jan-13			18,101.70		€	21				4,990.00		$	20.01			8,553.30	$	39.77
	Options granted				486.2		€	13.81				0		$	0			37.7	$	25.47
	Options exercised				-527.8		€	12.15				-3,022.60		$	17.74			-887.6	$	17.05
	Options forfeited, net				-490.4		€	19.27				-145.5		$	22.01			-602.4	$	60.1
	Options expired				0			0				7.9			0			-26.9	$	36.5
	Options Outstanding at
		31-Dec-13			17,569.70		€	21				1,829.80		$	23.6			7,074.10	$	40.82
	Aggregate Intrinsic
		Value(1)					€	0	(2)					$	8,120.60				$	0	(2)
	Weighted Average
		Remaining
		Contractual Term
		(in years)			4.24							1.28						4.9
	Options Exercisable at
		31-Dec-13			13,599.80		€	23.12				1,820.10		$	23.66			4,684.50		34.97
	Aggregate Intrinsic
		Value(1)					€	0	(2)					$	7,967.90				$	0	(2)
	Weighted Average
		Remaining
		Contractual Term
		(in years)			3.35							1.26						4.8
	Intrinsic value, presented in millions, is calculated as the excess of the closing market price on December 31, 2013 of the respective underlying shares over the strike prices of the option awards.
	The aggregate intrinsic value on options outstanding, exercisable and expected to vest is negative and is therefore presented as zero in the table above.
	AXA ordinary shares will be delivered to participants in lieu of AXA ADRs at exercise or maturity.
	Cash proceeds received from employee exercises of stock options in 2013 was $54 million. The intrinsic value related to employee exercises of stock options during 2013, 2012 and 2011 were $14 million, $5 million and $3 million respectively, resulting in amounts currently deductible for tax purposes of $5 million, $2 million, and $1 million, respectively, for the periods then ended. In 2013, 2012 and 2011, windfall tax benefits of approximately $5 million, $2 million and $1 million, respectively, resulted from employee exercises of stock option awards.
	At December 31, 2013, AXA Financial held approximately 351,000 AXA ADRs and AXA ordinary shares in treasury at a weighted average cost of $24.73 per share, of which approximately 302,000 were designated to fund future exercises of outstanding stock options and approximately 49,000 were designated to fund restricted stock grants. The AXA ADRs were obtained primarily by exercise of call options that had been purchased by AXA Financial beginning in fourth quarter 2004 to mitigate the U.S. dollar price and foreign exchange risks associated with funding exercises of stock options. These call options expired on November 23, 2009. Outstanding employee options to purchase AXA ordinary shares began to become exercisable on March 29, 2007, coincident with the second anniversary of the first award made in 2005, and exercises of these awards are funded by newly issued AXA ordinary shares.
	For the purpose of estimating the fair value of stock option awards, the Company applies the Black-Scholes model and attributes the result over the requisite service period using the graded-vesting method. A Monte-Carlo simulation approach was used to model the fair value of the conditional vesting feature of the awards of options to purchase AXA ordinary shares. Shown below are the relevant input assumptions used to derive the fair values of options awarded in 2013, 2012 and 2011, respectively.
				AXA Ordinary Shares												AllianceBernstein Holding Units
				2013				2012				2011				2013			2012			2011
	Dividend yield				7.52	%			7.54	%			7	%		8.0-8.3		%	6.2		%	5.4		%
Expected volatility				31.27	%			39.89	%			33.9	%		49.7-49.8		%	49.2		%	47.3		%
Risk-free interest rates				1.34	%			1.8	%			3.13	%		0.8-1.7		%	0.7		%	1.9		%
Expected life in years				7.7				5.6				6.4				6			6			6
Weighted average fair value per
	option at grant date		$	1.79			$	2.48			$	2.49			$	5.44		$	3.67		$	5.98
For 2013, 2012 and 2011, the Company recognized compensation costs (credits) for employee stock options of $(2) million, $4 million and $25 million, respectively. As of December 31, 2013, approximately $1 million of unrecognized compensation cost related to unvested employee stock option awards, net of estimated pre-vesting forfeitures, is expected to be recognized by the Company over a weighted average period of 0.5 years.
Restricted Awards
Under the Stock Incentive Plan, AXA Financial grants restricted stock to employees and financial professionals of its subsidiaries. Generally, all outstanding restricted stock awards have vesting terms ranging from three to five years. Under The Equity Plan for Directors (the “Equity Plan”), AXA Financial grants non-officer directors of AXA Financial and certain subsidiaries (including AXA Equitable) restricted AXA ordinary shares (prior to 2011, AXA ADRs) and unrestricted AXA ordinary shares (prior to March 15, 2010, AXA ADRs) annually. Similarly, AllianceBernstein awards restricted AllianceBernstein Holding units to independent members of its General Partner. In addition, under its Century Club Plan, awards of restricted AllianceBernstein Holding units that vest ratably over three years are made to eligible AllianceBernstein employees whose primary responsibilities are to assist in the distribution of company-sponsored mutual funds.
For 2013, 2012 and 2011, respectively, the Company recognized compensation costs of $286 million, $148 million and $377 million for awards outstanding under these restricted stock and unit award plans. The fair values of awards made under these plans are measured at the date of grant by reference to the closing price of the unrestricted shares, and the result generally is attributed over the shorter of the requisite service period, the performance period, if any, or to the date at which retirement eligibility is achieved and subsequent service no longer is required for continued vesting of the award. At December 31, 2013, approximately 22.3 million restricted shares and Holding units remain unvested. At December 31, 2013, approximately $48 million of unrecognized compensation cost related to these unvested awards, net of estimated pre-vesting forfeitures, is expected to be recognized over a weighted average period of 4.2 years.
The following table summarizes unvested restricted stock activity for 2013.
					Weighted
		Shares of			Average
		Restricted			Grant Date
		Stock			Fair Value
Unvested as of January 1, 2013			177,001		$	27.23
Granted			11,613		$	13.97
Vested			117,235		$	33.91
Forfeited			0			0
Unvested as of December 31, 2013			71,379		$	14.09
Restricted stock vested in 2013, 2012 and 2011 had aggregate vesting date fair values of approximately $1 million, $1 million and $2 million, respectively.
AXA Shareplan
In 2013, eligible employees of participating AXA Financial subsidiaries were offered the opportunity to purchase newly issued AXA stock, subject to plan limits, under the terms of AXA Shareplan 2013. Eligible employees could have reserved a share purchase during the reservation period from September 2, 2013 through September 17, 2013 and could have canceled their reservation or elected to make a purchase for the first time during the retraction/subscription period from October 28, 2013 through October 31, 2013. The U.S. dollar purchase price was determined by applying the U.S. dollar/Euro forward exchange rate on October 24, 2013 to the discounted formula subscription price in Euros. “Investment Option A” permitted participants to purchase AXA ordinary shares at a 20% formula discounted price of $19.85 per share. “Investment Option B” permitted participants to purchase AXA ordinary shares at a 12.95% formula discounted price of $21.59 per share on a leveraged basis with a guaranteed return of initial investment plus a portion of any appreciation in the undiscounted value of the total shares purchased. For purposes of determining the amount of any appreciation, the AXA ordinary share price will be measured over a fifty-two week period preceding the scheduled end date of AXA Shareplan 2013 which is July 1, 2018. All subscriptions became binding and irrevocable at October 31, 2013.
The Company recognized compensation expense of $13 million in 2013, $18 million in 2012 and $9 million in 2011 in connection with each respective year's offering of AXA Shareplan, representing the aggregate discount provided to AXA Equitable participants for their purchase of AXA stock under each of those plans, as adjusted for the post-vesting, five-year holding period. AXA Equitable participants in AXA Shareplans 2013, 2012 and 2011 primarily invested under Investment Option B for the purchase of approximately 5 million, 8 million and 9 million AXA ordinary shares, respectively.
AXA Miles Program
AXA Miles Program 2012. On March 16, 2012, under the terms of the AXA Miles Program 2012, AXA granted 50 AXA ordinary shares (“AXA Miles”) to every employee and eligible financial professional of AXA Group for the purpose of enhancing long-term employee-shareholder engagement. Each AXA Mile represents a phantom share of AXA stock that will convert to an actual AXA ordinary share at the end of a four-year vesting period provided the employee or financial professional remains in the employ of the company or has retired from service.  Half of each AXA Miles grant, or 25 AXA Miles, were subject to an additional vesting condition that required improvement in at least one of two AXA performance metrics in 2012 as compared to 2011 and was confirmed to have been achieved. The total fair value of these AXA Miles awards of approximately $6 million, net of expected forfeitures, is charged to expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible and is updated to reflect changes in respect of the expectation for meeting the predefined performance conditions. In 2013 and 2012, respectively, the expense associated with the March 16, 2012 grant of AXA Miles was approximately $278,000 and $538,000,.
AXA Miles Program 2007. On July 1, 2007, under the terms of the AXA Miles Program 2007, AXA granted 50 AXA Miles to every employee and eligible financial professionals of AXA Group for the purpose of enhancing long-term employee-shareholder engagement. Each AXA Mile represented the right to receive one unrestricted AXA ordinary share on July 1, 2011, conditional only upon continued employment with AXA at the close of the four-year cliff-vesting period with exceptions for retirement, death, and disability. The grant date fair value of approximately 449,000 AXA Miles awarded to employees and financial professionals of AXA Financial's subsidiaries was approximately $19 million, measured as the market equivalent of a vested AXA ordinary share. Beginning on July 1, 2007, the total fair value of this award, net of expected forfeitures, has been expensed over the shorter of the vesting term or to the date at which the participant becomes retirement eligible. For 2011, the Company recognized compensation expense of approximately $1 million in respect of this grant of AXA Miles.
AllianceBernstein Long-term Incentive Compensation Plans
AllianceBernstein maintains several unfunded long-term incentive compensation plans for the benefit of certain eligible employees and executives. The AllianceBernstein Capital Accumulation Plan was frozen on December 31, 1987 and no additional awards have been made, however, ACMC, LLC (“ACMC”), an indirect wholly owned subsidiary of AXA Financial, is obligated to make capital contributions to AllianceBernstein in amounts equal to benefits paid under this plan as well as other assumed contractual unfunded deferred compensation arrangements covering certain executives. Prior to changes implemented by AllianceBernstein in fourth quarter 2011, as further described below, compensation expense for the remaining active plans was recognized on a straight-line basis over the applicable vesting period. Prior to 2009, participants in these plans designated the percentages of their awards to be allocated among notional investments in Holding units or certain investment products (primarily mutual funds) sponsored by AllianceBernstein. Beginning in 2009, annual awards granted under the Amended and Restated AllianceBernstein Incentive Compensation Award Program were in the form of restricted Holding units.
In fourth quarter 2011, AllianceBernstein implemented changes to AllianceBernstein's employee long-term incentive compensation award. AllianceBernstein amended all outstanding year-end deferred incentive compensation awards of active employees (i.e., those employees employed as of December 31, 2011), so that employees who terminate their employment or are terminated without cause may continue to vest, so long as the employees do not violate the agreements and covenants set forth in the applicable award agreement, including restrictions on competition, employee and client solicitation, and a claw-back for failing to follow existing risk management policies. This amendment resulted in the immediate recognition in the fourth quarter of the cost of all unamortized deferred incentive compensation on outstanding awards from prior years that would otherwise have been expensed in future periods.
As a result of this change, AllianceBernstein expensed in the fourth quarter all unamortized deferred incentive compensation awards from prior years and 100% of the expense associated with its 2011 deferred incentive compensation awards. The Company recorded a one-time, non-cash charge of $115 million, net of income taxes and noncontrolling interest in 2011.
In addition, awards granted in 2012 contain the same vesting provisions and, accordingly, AllianceBernstein's annual incentive compensation expense reflect 100% of the expense associated with the deferred incentive compensation awarded in each year. This approach to expense recognition closely matches the economic cost of awarding deferred incentive compensation to the period in which the related service is performed.
AllianceBernstein engages in open-market purchases of AllianceBernstein Holding L.P. (“AB Holding”) units (“Holding units”) to help fund anticipated obligations under its incentive compensation award program, for purchases of Holding units from employees and other corporate purposes. During 2013 and 2012, AllianceBernstein purchased 5.2 million and 15.7 million Holding units for $111 million and $239 million respectively. These amounts reflect open-market purchases of 1.9 million and 12.3 million Holding units for $39 million and $182 million, respectively, with the remainder relating to purchases of Holding units from employees to allow them to fulfill statutory tax requirements at the time of distribution of long-term incentive compensation awards, offset by Holding units purchased by employees as part of a distribution reinvestment election.
AllianceBernstein granted to employees and Eligible Directors 139. million (including 6.5 million restricted Holding units granted in December 2013 for 2013 year-end rewards and 6.5 million granted in January 2013 for 2012 year-end awards). During 2012, AllianceBernstein granted to employees and Eligible Directors 12.1 million restricted Holding awards (including 8.7 million granted in January 2012 for 2011 year-end awards). Prior to third quarter 2013, AllianceBernstein funded these awards by allocating previously repurchased Holding units that had been held in its consolidated rabbi trust. In December 2013, AB Holding newly issued 3.9 million Holding units to fund the restricted Holding units awards granted in December 2013.
Effective July 1, 2013, management of AllianceBernstein and AllianceBernstein Holding L.P. (“AB Holding”) retired all unallocated Holding units in AllianceBernstein's consolidated rabbi trust.  To retire such units, AllianceBernstein delivered the unallocated Holding units held in its consolidated rabbi trust to AB Holding in exchange for the same amount of AllianceBernstein units.  Each entity then retired its respective units.  As a result, on July 1, 2013, each of AllianceBernstein's and AB Holding's units outstanding decreased by approximately 13.1 million units.  AllianceBernstein and AB Holding intend to retire additional units as AllianceBernstein purchases Holding units on the open market or from employees to allow them to fulfill statutory tax withholding requirements at the time of distribution of long-term incentive compensation awards, if such units are not required to fund new employee awards in the near future.  If a sufficient number of Holding units is not available in the rabbi trust to fund new awards, AB Holding will issue new Holding units in exchange for newly-issued AllianceBernstein units, as was done in December 2013.
The 2012 long-term incentive compensation awards allowed most employees to allocate their award between restricted Holding units and deferred cash. As a result, 6.5 million restricted Holding unit awards for the December 2012 awards were awarded and allocated as such within the consolidated rabbi trust in January. There were approximately 17.9 million unallocated Holding units remaining in the consolidated rabbi trust as of December 31, 2012. The purchases and issuances of Holding units resulted in an increase of $60 million in Capital in excess of par value during 2012 with a corresponding decrease of $60 million in Noncontrolling interest.
The Company recorded compensation and benefit expenses in connection with these long-term incentive compensation plans of AllianceBernstein totaling $156 million, $147 million and $625 million (which includes the one-time, non-cash deferred compensation charge of $472 million) for 2013, 2012 and 2011, respectively. The cost of the 2013 awards made in the form of restricted Holding units was measured, recognized, and disclosed as a share-based compensation program.
On July 1, 2010, the AllianceBernstein 2010 Long Term Incentive Plan (“2010 Plan”), as amended, was established, under which various types of Holding unit-based awards have been available for grant to its employees and Eligible Directors, including restricted or phantom restricted Holding unit awards, Holding unit appreciation rights and performance awards, and options to buy Holding units. The 2010 Plan will expire on June 30, 2020 and no awards under the 2010 Plan will be made after that date. Under the 2010 Plan, the aggregate number of Holding units with respect to which awards may be granted is 60 million, including no more than 30 million newly issued Holding units. As of December 31, 2013, 248,281 options to buy Holding units had been granted and 38 million Holding units net of forfeitures, were subject to other Holding unit awards made under the 2010 Plan. Holding unit-based awards (including options) in respect of 22 million Holding units were available for grant as of December 31, 2013.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]	'
INCOME TAXES	'
	14)       INCOME TAXES
	A summary of the income tax (expense) benefit in the consolidated statements of earnings (loss) follows:
				2013			2012			2011
				(In Millions)
	Income tax (expense) benefit:
		Current (expense) benefit		$	197		$	-233		$	40
		Deferred (expense) benefit			1,876			391			-1,338
	Total			$	2,073		$	158		$	-1,298
	The Federal income taxes attributable to consolidated operations are different from the amounts determined by multiplying the earnings before income taxes and noncontrolling interest by the expected Federal income tax rate of 35%. The sources of the difference and their tax effects are as follows:
			2013			2012			2011
			(In Millions)
	Expected income tax (expense) benefit		$	1,858		$	-20		$	-1,443
	Noncontrolling interest			101			37			-36
	Separate Accounts investment activity			122			94			83
	Non-taxable investment income (loss)			20			24			8
	Adjustment of tax audit reserves			-14			-2			-7
	State income taxes			-6			7			7
	AllianceBernstein Federal and foreign taxes			2			10			-13
	Tax settlement			0			0			84
	Other			-10			8			19
	Income tax (expense) benefit		$	2,073		$	158		$	-1,298
	The Internal Revenue Service (“IRS”) completed its examination of the Company's 2004 and 2005 Federal corporate income tax returns and issued its Revenue Agent's Report during the third quarter of 2011. The impact of these completed audits on the Company's financial statements and unrecognized tax benefits in 2011 was a tax benefit of $84 million.
	The U.S. Department of the Treasury 2013-2014 Priority Guidance Plan includes an item for guidance in the form of a revenue ruling with respect to the calculation of the Separate Account dividends received deduction (“DRD”). The ultimate timing and substance of any such guidance is unknown. It is also possible that the calculation of the Separate Account DRD will be addressed in future legislation. Any such guidance or legislation could result in the elimination or reduction on either a retroactive or prospective basis of the Separate Account DRD tax benefit that the Company receives.
	The components of the net deferred income taxes are as follows:
			31-Dec-13						31-Dec-12
			Assets			Liabilities			Assets			Liabilities
			(In Millions)
	Compensation and related benefits		$	104		$	0		$	207		$	0
	Reserves and reinsurance			0			688			0			2,419
	DAC			0			1,016			0			960
	Unrealized investment gains or losses			0			85			0			739
	Investments			0			1,410			0			1,137
	Alternative minimum tax credits			0			0			157			0
	Net operating losses			492			0			0			0
	Other			7			0			0			57
	Total		$	603		$	3,199		$	364		$	5,312
	The Company does not provide income taxes on the undistributed earnings of non-U.S. corporate subsidiaries except to the extent that such earnings are not permanently invested outside the United States. As of December 31, 2013, $238 million of accumulated undistributed earnings of non-U.S. corporate subsidiaries were permanently invested. At existing applicable income tax rates, additional taxes of approximately $92 million would need to be provided if such earnings were remitted.
	At December 31, 2013, of the total amount of unrecognized tax benefits $568 million would affect the effective rate. At December 31, 2012, of the total amount of unrecognized tax benefits $522 million would affect the effective rate.
	The Company recognizes accrued interest and penalties related to unrecognized tax benefits in tax expense. Interest and penalties included in the amounts of unrecognized tax benefits at December 31, 2013 and 2012 were $120 million and $105 million, respectively. For 2013, 2012 and 2011, respectively, there were $15 million, $4 million and $14 million in interest expense related to unrecognized tax benefits.
	A reconciliation of unrecognized tax benefits (excluding interest and penalties) follows:
			2013			2012			2011
			(In Millions)
	Balance at January 1,		$	573		$	453		$	434
	Additions for tax positions of prior years			57			740			337
	Reductions for tax positions of prior years			-38			-620			-235
	Additions for tax positions of current year			0			0			1
	Settlements with tax authorities			0			0			-84
	Balance at December 31,		$	592		$	573		$	453
	In 2012, the Internal Revenue Service commenced the examination of the 2006 and 2007 tax years. An appeal of the 2004 and 2005 tax years is pending at the Appeals Office of the IRS. It is reasonably possible that the total amounts of unrecognized tax benefit will change within the next 12 months due to the conclusion of IRS proceedings and the addition of new issues for open tax years. The possible change in the amount of unrecognized tax benefits cannot be estimated at this time.

ACCUMULATED_OTHER_COMPREHENSIV

ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME	12 Months Ended
	Dec. 31, 2013
Accumulated Other Comprehensive Income Loss [Abstract]	'
ACCUMULATED OTHER COMPREHENSIVE INCOME LOSS	'
	15)       ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
	AOCI represents cumulative gains (losses) on items that are not reflected in earnings (loss). The balances for the past three years follow:
					December 31,
					2013			2012			2011
					(In Millions)
	Unrealized gains (losses) on investments				$	141		$	1,352		$	772
	Defined benefit pension plans					-757			-1,056			-1,082
	Total accumulated other comprehensive income (loss)					-616			296			-310
	Less: Accumulated other comprehensive (income) loss attributable
		to noncontrolling interest				13			21			13
	Accumulated Other Comprehensive Income (Loss) Attributable
		to AXA Equitable			$	-603		$	317		$	-297
	The components of OCI for the past three years, net of tax, follow:
				2013			2012			2011
				(In Millions)
	Change in net unrealized gains (losses) on investments:
		Net unrealized gains (losses) arising during the year		$	-1,550		$	658		$	571
		(Gains) losses reclassified into net earnings (loss) during the year(1)			49			59			18
	Net unrealized gains (losses) on investments				-1,501			717			589
	Adjustments for policyholders liabilities, DAC, insurance
		liability loss recognition and other			290			-137			-223
	Change in unrealized gains (losses), net of adjustments and (net of deferred
		income tax expense (benefit) of $654 million, $(318) million and $(193) million)			-1,211			580			366
	Change in defined benefit plans:
		Net gain (loss) arising during the year			198			-82			-169
		Prior service cost arising during the year			-			1			-
		Less: reclassification adjustments to net earnings (loss) for:(2)
			Amortization of net (gains) losses included in net periodic cost		101			106			94
			Amortization of net prior service credit included in net periodic cost		-			1			1
	Change in defined benefit plans (net of deferred income tax expense
		(benefit) of $161 million, $14 million and $(40) million)			299			26			-74
	Total other comprehensive income (loss), net of income taxes				-912			606			292
	Less: Other comprehensive (income) loss attributable
		to noncontrolling interest			-8			8			21
	Other Comprehensive Income (Loss) Attributable to AXA Equitable			$	-920		$	614		$	313
	See “Reclassification adjustments” in Note 3. Reclassification amounts presented net of income tax expense (benefit) of $(26) million, $(32) million and $(10) million for 2013, 2012 and 2011, respectively.
	These AOCI components are included in the computation of net periodic costs (see Note 12). Reclassification amounts presented net of income tax expense (benefit) of $(54) million, $(58) million and $(51) million for 2013, 2012 and 2011, respectively.
	Investment gains and losses reclassified from AOCI to net earnings (loss) primarily consist of realized gains (losses) on sales and OTTI of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of earnings (loss). Amounts reclassified from AOCI to net earnings (loss) as related to defined benefit plans primarily consist of amortizations of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefit expenses in the consolidated statements of earnings (loss). Amounts presented in the table above are net of tax.

COMMITMENTS_AND_CONTINGENT_LIA

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
	Dec. 31, 2013
Commitments And Contingent Liabilities [Abstract]	'
COMMITMENTS AND CONTINGENT LIABILITIES	'
	16)       COMMITMENTS AND CONTINGENT LIABILITIES
	Debt Maturities
	At December 31, 2013, aggregate maturities of the long-term debt, including any current portion of long-term debt, based on required principal payments at maturity, were $0 million for 2014, $200 million for 2015, $0 million for 2016 and thereafter.
	Leases
	The Company has entered into operating leases for office space and certain other assets, principally information technology equipment and office furniture and equipment. Future minimum payments under non-cancelable operating leases for 2014 and the four successive years are $217 million, $216 million, $209 million, $208 million, $192 million and $1,232 million thereafter. Minimum future sublease rental income on these non-cancelable operating leases for 2014 and the four successive years is $41 million, $48 million, $47 million, $48 million, $48 million and $316 million thereafter.
	Restructuring
	As part of the Company's on-going efforts to reduce costs and operate more efficiently, from time to time, management has approved and initiated plans to reduce headcount and relocate certain operations. In 2013, 2012 and 2011, respectively, AXA Equitable recorded $85 million, $30 million and $55 million pre-tax charges related to severance and lease costs. The amounts recorded in 2013 included a pre-tax charge of $52 million related to the reduction in office space in the Company's 1290 Avenue of the Americas, New York, NY headquarters. The restructuring costs and liabilities associated with the Company's initiatives were as follows:
		December 31,
		2013		2012		2011
		(In Millions)
	Balance, beginning of year	$	52	$	44	$	11
	Additions		140		54		79
	Cash payments		-66		-46		-43
	Other reductions		-4		0		-3
	Balance, End of Year	$	122	$	52	$	44
	As a result of AllianceBernstein's ongoing efforts to operate more efficiently during 2013 and 2012, respectively, AllianceBernstein recorded a $4 million and $21 million pre-tax charge related to severance costs. During 2013 and 2012, AllianceBernstein recorded $28 million and $223 million, respectively, of pre-tax real estate charges related to a global office space consolidation plan. The charges reflected the net present value of the difference between the amount of AllianceBernstein's on-going contractual operating lease obligations for this space and their estimate of current market rental rates, as well as the write-off of leasehold improvements, furniture and equipment related to this space offset by changes in estimates relating to previously recorded real estate charges. Included in the 2013 real estate charge was a charge of $17 million related to additional sublease losses resulting from the extension of sublease marketing periods. AllianceBernstein will compare current sublease market conditions to those assumed in their initial write-offs and record any adjustments if necessary.
	Guarantees and Other Commitments
	The Company provides certain guarantees or commitments to affiliates, investors and others. At December 31, 2013, these arrangements include commitments by the Company to provide equity financing of $504 million to certain limited partnerships under certain conditions. Management believes the Company will not incur material losses as a result of these commitments.
	AXA Equitable is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, AXA Equitable owns single premium annuities issued by previously wholly owned life insurance subsidiaries. AXA Equitable has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly owned subsidiaries be unable to meet their obligations. Management believes the need for AXA Equitable to satisfy those obligations is remote.
	The Company had $18 million of undrawn letters of credit related to reinsurance at December 31, 2013. The Company had $595 million of commitments under existing mortgage loan agreements at December 31, 2013.
	The Company has implemented capital management actions to mitigate statutory reserve strain for certain level term and UL policies with secondary guarantees and GMDB and GMIB riders on the Accumulator® products sold on or after January 1, 2006 and in-force at September 30, 2008 through reinsurance transactions with AXA Arizona, a wholly-owned subsidiary of AXA Financial.
	AXA Equitable receives statutory reserve credits for reinsurance treaties with AXA Arizona to the extent that AXA Arizona holds assets in an irrevocable trust (the “Trust”) ($6,805 million at December 31, 2013) and/or letters of credit ($3,251 million at December 31, 2013). These letters of credit are guaranteed by AXA. Under the reinsurance transactions, AXA Arizona is permitted to transfer assets from the Trust under certain circumstances. The level of statutory reserves held by AXA Arizona fluctuate based on market movements, mortality experience and policyholder behavior. Increasing reserve requirements may necessitate that additional assets be placed in trust and/or securing additional letters of credit, which could adversely impact AXA Arizona's liquidity.
	During 2009, AllianceBernstein entered into a subscription agreement under which it committed to invest up to $35 million, as amended in 2011, in a venture capital fund over a six-year period. As of December 31, 2013, AllianceBernstein had funded $25 million of this commitment.
	During 2010, as general partner of the AllianceBernstein U.S. Real Estate L.P. (the “Real Estate Fund”), AllianceBernstein committed to invest $25 million in the Real Estate Fund.  As of December 31, 2013, AllianceBernstein had funded $12 million of this commitment.
	During 2012, AllianceBernstein entered into an investment agreement under which it committed to invest up to $8 million in an oil and gas fund over a three-year period. As of December 31, 2013, AllianceBernstein had funded $8 million of this commitment.

LITIGATION

LITIGATION	12 Months Ended
	Dec. 31, 2013
Litigation [Abstract]	'
LITIGATION	'
	17)       LITIGATION
	Insurance Litigation
	A lawsuit was filed in the United States District Court of the District of New Jersey in July 2011, entitled Mary Ann Sivolella v. AXA Equitable Life Insurance Company and AXA Equitable Funds Management Group, LLC (“FMG LLC”) (“Sivolella Litigation”). The lawsuit was filed derivatively on behalf of eight funds. The lawsuit seeks recovery under Section 36(b) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), for alleged excessive fees paid to AXA Equitable and FMG LLC for investment management services. In November 2011, plaintiff filed an amended complaint, adding claims under Sections 47(b) and 26(f) of the Investment Company Act, as well as a claim for unjust enrichment. In addition, plaintiff purports to file the lawsuit as a class action in addition to a derivative action. In the amended complaint, plaintiff seeks recovery of the alleged overpayments, rescission of the contracts, restitution of all fees paid, interest, costs, attorney fees, fees for expert witnesses and reserves the right to seek punitive damages where applicable. In December 2011, AXA Equitable and FMG LLC filed a motion to dismiss the amended complaint. In May 2012, the Plaintiff voluntarily dismissed her claim under Section 26(f) seeking restitution and rescission under Section 47(b) of the 1940 Act. In September 2012, the Court denied the defendants' motion to dismiss as it related to the Section 36(b) claim and granted the defendants' motion as it related to the unjust enrichment claim.
	In January 2013, a second lawsuit was filed in the United States District Court of the District of New Jersey entitled Sanford et al. v. FMG LLC (“Sanford Litigation”). The lawsuit was filed derivatively on behalf of eight funds, four of which are named in the Sivolella lawsuit as well as four new funds, and seeks recovery under Section 36(b) of the Investment Company Act for alleged excessive fees paid to FMG LLC for investment management services. In light of the similarities of the allegations in the Sivolella and Sanford Litigations, the parties and the Court agreed to consolidate the two lawsuits.
	In April 2013, the plaintiffs in the Sivolella and Sanford Litigations amended the complaints to add additional claims under Section 36(b) of the Investment Company Act for recovery of alleged excessive fees paid to FMG LLC in its capacity as administrator of EQ Advisors Trust. The Plaintiffs seek recovery of the alleged overpayments, or alternatively, rescission of the contract and restitution of the excessive fees paid, interest, costs and fees.
	Insurance Regulatory Matters
	AXA Equitable is subject to various statutory and regulatory requirements concerning the payment of death benefits and the reporting and escheatment of unclaimed property, and is subject to audit and examination for compliance with these requirements. AXA Equitable, along with other life insurance industry companies, has been the subject of various inquiries regarding its death claim, escheatment, and unclaimed property procedures and is cooperating with these inquiries. For example, in June 2011, the New York State Attorney General's office issued a subpoena to AXA Equitable in connection with its investigation of industry escheatment and unclaimed property procedures. AXA Equitable is also under audit by a third party auditor acting on behalf of a number of U.S. state jurisdictions reviewing compliance with unclaimed property laws of those jurisdictions. In July 2011, AXA Equitable received a request from the New York State Department of Financial Services (the “NYSDFS”) to use data available on the U.S. Social Security Administration's Death Master File (“DMF”) or similar database to identify instances where death benefits under life insurance policies, annuities and retained asset accounts are payable, to locate and pay beneficiaries under such contracts, and to report the results of the use of the data. AXA Equitable filed a number of reports with the NYSDFS related to its request and has completed the process. A number of life insurance industry companies have received a multistate targeted market conduct examination notice issued on behalf of various U.S. state insurance departments reviewing use of the DMF, claims processing and payments to beneficiaries. In December 2012, AXA Equitable received an examination notice on behalf of at least six insurance departments. The audits and related inquiries have resulted in the payment of death benefits and changes to AXA Equitable's relevant procedures. AXA Equitable expects it will also result in the reporting and escheatment of unclaimed death benefits, including potential interest on such payments, and the payment of examination costs. In addition, AXA Equitable, along with other life insurance industry companies, is subject to lawsuits that may be filed by state regulatory agencies or other litigants.
	AXA Equitable is responding to requests for information and documents from the Consumer Protection Division of the NYDFS relating to the AXA Tactical Manager ("ATM") volatility management tool strategy. The inquiry relates to whether we failed to comply with certain provisions of New York Insurance law with respect to the implementation of the ATM strategy. The NYDFS has informed AXA Equitable that it intends to seek a penalty for what it considers a failure to comply with such provisions. AXA Equitable has responded to, and is actively discussing the issue with the NYDFS.
	AllianceBernstein Litigation
	During first quarter 2012, AllianceBernstein received a legal letter of claim (the “Letter of Claim”) sent on behalf of Philips Pension Trustees Limited and Philips Elecronics UK Limited (“Philips”), a former pension fund client, alleging that AllianceBernstein Limited (a wholly-owned subsidiary of AllianceBernstein organized in the United Kingdom) was negligent and failed to meet certain applicable standards of care with respect to AllianceBernstein's initial investment in and management of a £500 million portfolio of U.S. mortgage-backed securities. The alleged damages range between $177 million and $234 million plus compound interest on an alleged $125 million of realized losses in the portfolio. On January 2, 2014, Philips filed a claim form in the High Court of Justice in London, England regarding their alleged claim. AllianceBernstein believes that it has strong defenses to these claims, which were set forth in AllianceBernstein's October 12, 2012 response to the Letter of Claim, and will defend this matter vigorously.
	____________________________________________________________________________
	In addition to the matters described above, a number of lawsuits, claims and assessments have been filed against life and health insurers and asset managers in the jurisdictions in which AXA Equitable and its respective subsidiaries do business. These actions and proceedings involve, among other things, insurers' sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters. Some of the matters have resulted in the award of substantial judgments against other insurers and asset managers, including material amounts of punitive damages, or in substantial settlements. In some states, juries have substantial discretion in awarding punitive damages. AXA Equitable and its subsidiaries from time to time are involved in such actions and proceedings. Some of these actions and proceedings filed against AXA Equitable and its subsidiaries have been brought on behalf of various alleged classes of plaintiffs and certain of these plaintiffs seek damages of unspecified amounts. While the ultimate outcome of such matters cannot be predicted with certainty, in the opinion of management no such matter is likely to have a material adverse effect on AXA Equitable's consolidated financial position or results of operations. However, it should be noted that the frequency of large damage awards, including large punitive damage awards that bear little or no relation to actual economic damages incurred by plaintiffs in some jurisdictions, continues to create the potential for an unpredictable judgment in any given matter.
	Although the outcome of litigation and regulatory matters generally cannot be predicted with certainty, management intends to vigorously defend against the allegations made by the plaintiffs in the actions described above and believes that the ultimate resolution of the litigation and regulatory matters described therein involving AXA Equitable and/or its subsidiaries should not have a material adverse effect on the consolidated financial position of AXA Equitable. Management cannot make an estimate of loss, if any, or predict whether or not any of the litigations and regulatory matters described above will have a material adverse effect on AXA Equitable's consolidated results of operations in any particular period.

INSURANCE_GROUP_STATUTORY_FINA

INSURANCE GROUP STATUTORY FINANCIAL INFORMATION	12 Months Ended
	Dec. 31, 2013
Insurance Group Statutory Financial Information [Abstract]	'
INSURANCE GROUP STATUTORY FINANCIAL INFORMARMATION	'
	18)       INSURANCE GROUP STATUTORY FINANCIAL INFORMATION
	AXA Equitable is restricted as to the amounts it may pay as dividends to AXA Financial. Under New York insurance law, a domestic life insurer may, without prior approval of the Superintendent of the NYSDFS, pay a dividend to its shareholders not exceeding an amount calculated based on a statutory formula. This formula would permit AXA Equitable to pay shareholder dividends not greater than $382 million during 2014. Payment of dividends exceeding this amount requires the insurer to file notice of its intent to declare such dividends with the Superintendent of the NYSDFS who then has 30 days to disapprove the distribution. For 2013, 2012 and 2011, respectively, AXA Equitable's statutory net income (loss) totaled $(28) million, $602 million and $967 million. Statutory surplus, capital stock and Asset Valuation Reserve (“AVR”) totaled $4,358 million and $5,178 million at December 31, 2013 and 2012, respectively. In 2013, AXA Equitable paid $234 million in cash and transferred approximately 10.9 million in Units of AllianceBernstein (fair value of $234 million) in shareholder dividends to AXA Financial. In 2012 and 2011, respectively, AXA Equitable paid $362 million and $379 million in shareholder dividends.
	At December 31, 2013, AXA Equitable, in accordance with various government and state regulations, had $83 million of securities on deposit with such government or state agencies.
	At December 31, 2013 AXA Equitable had affiliated surplus notes of $825 million due to AXA Financial. The accrual and payment of interest expense and the payment of principal related to surplus notes require approval from the NYSDFS. Interest expense in 2013 will approximate $55 million. In second quarter 2013 AXA Equitable repaid a $500 million surplus note at par values plus interest accrued to AXA Financial.
	At December 31, 2013 and for the year then ended, there were no differences in net income (loss) and capital and surplus resulting from practices prescribed and permitted by NYSDFS and those prescribed by NAIC Accounting Practices and Procedures effective at December 31, 2013.
	Accounting practices used to prepare statutory financial statements for regulatory filings of stock life insurance companies differ in certain instances from U.S. GAAP. The differences between statutory surplus and capital stock determined in accordance with Statutory Accounting Principles (“SAP”) and total equity under U.S. GAAP are primarily: (a) the inclusion in SAP of an AVR intended to stabilize surplus from fluctuations in the value of the investment portfolio; (b) future policy benefits and policyholders' account balances under SAP differ from U.S. GAAP due to differences between actuarial assumptions and reserving methodologies; (c) certain policy acquisition costs are expensed under SAP but deferred under U.S. GAAP and amortized over future periods to achieve a matching of revenues and expenses; (d) under SAP, Federal income taxes are provided on the basis of amounts currently payable with limited recognition of deferred tax assets while under U.S. GAAP, deferred taxes are recorded for temporary differences between the financial statements and tax basis of assets and liabilities where the probability of realization is reasonably assured; (e) the valuation of assets under SAP and U.S. GAAP differ due to different investment valuation and depreciation methodologies, as well as the deferral of interest-related realized capital gains and losses on fixed income investments; (f) the valuation of the investment in AllianceBernstein and AllianceBernstein Holding under SAP reflects a portion of the market value appreciation rather than the equity in the underlying net assets as required under U.S. GAAP; (g) reporting the surplus notes as a component of surplus in SAP but as a liability in U.S. GAAP; (h) computer software development costs are capitalized under U.S. GAAP but expensed under SAP; (i) certain assets, primarily prepaid assets, are not admissible under SAP but are admissible under U.S. GAAP, (j) the fair valuing of all acquired assets and liabilities including intangible assets are required for U.S. GAAP purchase accounting and (k) cost of reinsurance which is recognized as expense under SAP and amortized over the life of the underlying reinsured policies under U.S. GAAP.
	The following tables reconcile AXA Equitable's statutory change in surplus and capital stock and statutory surplus and capital stock determined in accordance with accounting practices prescribed by NYSDFS laws and regulations with consolidated net earnings (loss) and equity attributable to AXA Equitable on a U.S. GAAP basis.
			December 31,
			2013		2012		2011
			(In Millions)
	Net change in statutory surplus and capital stock		$	-864	$	64	$	824
	Change in AVR			46		269		-211
	Net change in statutory surplus, capital stock and AVR			-818		333		613
	Adjustments:
		Future policy benefits and policyholders' account balances		-607		-508		-270
		DAC		75		142		-2,861
		Deferred income taxes		2,038		798		-1,272
		Valuation of investments		7		-377		16
		Valuation of investment subsidiary		-109		-306		590
		Increase (decrease) in the fair value of the reinsurance contract asset		-4,297		497		5,941
		Pension adjustment		-478		-41		111
		Amortization of deferred cost of insurance ceded to AXA Arizona		-280		-126		-156
		Shareholder dividends paid		468		362		379
		Changes in non-admitted assets		2		-489		-154
		Repayment of surplus Note		500		0		0
		Other, net		-74		-190		-10
	U.S. GAAP Net Earnings (Loss) Attributable to AXA Equitable		$	-3,573	$	95	$	2,927
			December 31,
			2013		2012		2011
			(In Millions)
	Statutory surplus and capital stock		$	3,825	$	4,689	$	4,625
	AVR			535		489		220
	Statutory surplus, capital stock and AVR			4,360		5,178		4,845
	Adjustments:
		Future policy benefits and policyholders' account balances		-3,884		-3,642		-2,456
		DAC		3,874		3,728		3,545
		Deferred income taxes		-2,672		-5,330		-5,357
		Valuation of investments		703		3,271		2,266
		Valuation of investment subsidiary		-515		-137		231
		Fair value of reinsurance contracts		6,747		11,044		10,547
		Deferred cost of insurance ceded to AXA Arizona		2,366		2,646		2,693
		Non-admitted assets		469		467		510
		Issuance of surplus notes		-1,025		-1,525		-1,525
		Other, net		115		-264		-459
	U.S. GAAP Total Equity Attributable to AXA Equitable		$	10,538	$	15,436	$	14,840

BUSINESS_SEGMENT_INFORMATION

BUSINESS SEGMENT INFORMATION	12 Months Ended
	Dec. 31, 2013
Business Segment Information [Abstract]	'
BUSINESS SEGMENT INFORMATION	'
	19)       BUSINESS SEGMENT INFORMATION
	The following tables reconcile segment revenues and earnings (loss) from continuing operations before income taxes to total revenues and earnings (loss) as reported on the consolidated statements of earnings (loss) and segment assets to total assets on the consolidated balance sheets, respectively.
		2013			2012				2011
		(In Millions)
	Segment revenues:
	Insurance	$	-54		$	6,443		$	15,140
	Investment Management(1)		2,915			2,738			2,750
	Consolidation/elimination		-21			-21			-18
	Total Revenues	$	2,840		$	9,160		$	17,872
	(1) Intersegment investment advisory and other fees of approximately $67 million, $58 million and $56 million for 2013, 2012 and 2011, respectively, are included in total revenues of the Investment Management segment.
			2013			2012			2011
			(In Millions)
	Segment earnings (loss) from continuing operations, before income taxes:
	Insurance		$	-5,872		$	-132		$	4,284
	Investment Management(2)			564			190			-164
	Consolidation/elimination			-1			0			4
	Total Earnings (Loss) from Continuing Operations, before Income Taxes		$	-5,309		$	58		$	4,124
	Net of interest expenses incurred on securities borrowed.
		December 31,
		2013			2012
		(In Millions)
	Segment assets:
	Insurance	$	171,532		$	164,201
	Investment Management		11,873			12,647
	Consolidation/elimination		-4			-5
	Total Assets	$	183,401		$	176,843
	In accordance with SEC regulations, securities with a fair value of $925 million and $1,509 million have been segregated in a special reserve bank custody account at December 31, 2013 and 2012, respectively, for the exclusive benefit of securities broker-dealer or brokerage customers under the Exchange Act.

QUARTERLY_RESULTS_OF_OPERATION

QUARTERLY RESULTS OF OPERATIONS (UNAUDITED)	12 Months Ended
	Dec. 31, 2013
Quarterly Result Of Operations Unaudited [Abstract]	'
QUARTERLY RESULTS OF OPERATIONS UNAUDITED	'
	20)       QUARTERLY RESULTS OF OPERATIONS (UNAUDITED)
	The quarterly results of operations for 2013 and 2012 are summarized below:
			Three Months Ended
			31-Mar		30-Jun		30-Sep		31-Dec
			(In Millions)
	2013
	Total Revenues		$	392	$	537	$	834	$	1,077
	Earnings (Loss) from Continuing Operations,
		Net of Income Taxes, Attributable to AXA Equitable	$	-1,004	$	-1,051	$	-878	$	-640
	Net Earnings (Loss), Attributable to AXA Equitable		$	-1,004	$	-1,051	$	-878	$	-640
	2012
	Total Revenues		$	-952	$	6,475	$	1,728	$	1,909
	Earnings (Loss) from Continuing Operations,
		Net of Income Taxes, Attributable to AXA Equitable	$	-1,635	$	2,421	$	-241	$	-450
	Net Earnings (Loss), Attributable to AXA Equitable		$	-1,635	$	2,421	$	-241	$	-450

SUMMARY_OF_INVESTMENTS_OTHER_T

SUMMARY OF INVESTMENTS- OTHER THAN INVESTMENTS IN RELATED PARTIES- SCHEDULE I	12 Months Ended
	Dec. 31, 2013
Summary Of Investments Other Than Those With Related Parties Schedule I [Abstract]	'
Summary of Investments, Other than Investments in Related Parties [Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE I
	SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES
	31-Dec-13
								Carrying
	Type of Investment			Cost(A)		Fair Value		Value
				(In Millions)
	Fixed Maturities:
		U.S. government, agencies and authorities		$	3,584	$	3,129	$	3,129
		State, municipalities and political subdivisions			444		477		477
		Foreign governments			359		393		393
		Public utilities			3,853		4,086		4,086
		All other corporate bonds			19,747		20,479		20,479
		Redeemable preferred stocks			849		855		855
	Total fixed maturities				28,836		29,419		29,419
	Equity securities:
		Common stocks:
			Industrial, miscellaneous and all other		37		34		34
	Mortgage loans on real estate				5,684		5,716		5,684
	Real estate joint ventures				3		N/A		3
	Policy loans				3,434		3,097		3,434
	Other limited partnership interests and equity investments				1,829		1,829		1,829
	Trading securities				4,225		4,221		4,221
	Other invested assets				1,353		1,353		1,353
	Total Investments			$	45,401	$	45,669	$	45,977
	Cost for fixed maturities represents original cost, reduced by repayments and writedowns and adjusted for amortization of premiums or accretion of discount; cost for equity securities represents original cost reduced by writedowns; cost for other limited partnership interests represents original cost adjusted for equity in earnings and reduced by distributions.

PARENT_COMPANY_SCHEDULES_II

PARENT COMPANY SCHEDULES II	12 Months Ended
	Dec. 31, 2013
Parent Company Schedules [Abstract]	'
Condensed Financial Information of Parent Company Only Disclosure [Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE II
	BALANCE SHEETS (PARENT COMPANY)
	DECEMBER 31, 2013 AND 2012
				2013		2012
				(In Millions)
	ASSETS
	Investment:
		Fixed maturities available-for-sale, at fair value (amortized cost of
			$28,785 and $30,656 respectively)	$	29,365	$	33,538
		Mortgage loans on real estate			5,684		5,059
		Equity real estate, held for the production of income			3		4
		Policy loans			3,434		3,512
		Investments in and loans to affiliates			2,190		2,328
		Trading securities			3,647		1,834
		Other equity investments			1,666		1,403
		Other invested assets			1,348		1,826
			Total investments		47,337		49,504
	Cash and cash equivalents				1,704		2,450
	Deferred policy acquisition costs				3,874		3,728
	Amounts due from reinsurers				3,934		3,847
	Guaranteed minimum income benefit reinsurance asset, at fair value				6,747		11,044
	Other assets				3,941		4,576
	Separate Accounts' assets				108,857		94,139
	Total Assets			$	176,394	$	169,288
	LIABILITIES
	Policyholders' account balances			$	30,340	$	28,263
	Future policy benefits and other policyholders liabilities				21,666		22,655
	Broker-dealer related payables				29		213
	Short-term and long-term debt				200		200
	Current and deferred income taxes				2,073		4,479
	Loans from affiliates				825		1,325
	Other liabilities				1,866		2,578
	Separate Accounts' liabilities				108,857		94,139
			Total liabilities		165,856		153,852
	SHAREHOLDER'S EQUITY
	Common stock, $1.25 par value, 2.0 million shares authorized, issued and outstanding				2		2
	Capital in excess of par value				5,934		5,992
	Retained earnings				5,205		9,125
	Accumulated other comprehensive income (loss)				-603		317
			Total AXA Equitable's equity		10,538		15,436
	Total Liabilities and AXA Equitable's Equity			$	176,394	$	169,288
	The financial information of AXA Equitable Life Insurance Company (“Parent Company”) should be read in conjunction with the Consolidated Financial Statements and Notes thereto.
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE II
	STATEMENTS OF EARNINGS (PARENT COMPANY)
	YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
				2013		2012		2011
				(In Millions)
	REVENUES
	Universal life and investment-type product policy fee income			$	3,546	$	3,334	$	3,312
	Premiums				496		514		533
	Net investment income (loss):
		Investment income (loss) from derivative instruments			-2,846		-943		2,369
		Other investment income (loss)			2,146		2,208		2,186
			Total net investment income (loss)		-700		1,265		4,555
	Investment gains (losses), net:
		Total other-than-temporary impairment losses			-81		-96		-36
		Portion of loss recognized in other comprehensive income (loss)			15		2		4
			Net impairment losses recognized		-66		-94		-32
		Other investment gains (losses), net			-25		14		-10
			Total investment gains (losses), net		-91		-80		-42
	Equity in earnings (loss) of subsidiaries				788		483		55
Commissions, fees and other income				219		201		338
Increase (decrease) in the fair value of the reinsurance contract asset				-4,297		497		5,941
		Total revenues		-39		6,214		14,692
BENEFITS AND OTHER DEDUCTIONS
Policyholders' benefits				1,689		2,986		4,357
Interest credited to policyholders' account balances				1,373		1,166		999
Compensation and benefits				432		399		372
Commissions				1,173		1,265		1,212
Interest expense				87		106		106
Amortization of deferred policy acquisition costs				580		576		3,620
Capitalization of deferred policy acquisition costs				-654		-718		-759
Rent expense				35		34		47
Premium taxes				36		42		43
Other operating costs and expenses				789		472		651
		Total benefits and other deductions		5,540		6,328		10,648
Earnings (loss) from continuing operations, before income taxes				-5,579		-114		4,044
Income tax (expense) benefit				2,343		330		-1,218
Net Earnings (Loss)				-3,236		216		2,826
	Less: net (earnings) loss attributable to the noncontrolling interest			-337		-121		101
Net Earnings (Loss) Attributable to AXA Equitable				-3,573		95		2,927
Total other comprehensive income (loss), net of income taxes
	Attributable to AXA Equitable			-920		614		313
Comprehensive Income (Loss) Attributable to AXA Equitable			$	-4,493	$	709	$	3,240
AXA EQUITABLE LIFE INSURANCE COMPANY
SCHEDULE II
STATEMENTS OF CASH FLOWS (PARENT COMPANY)
YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
			2013		2012		2011
			(In Millions)
Net earnings (loss)			$	-3,236	$	216	$	2,826
Adjustments to reconcile net earnings (loss) to net cash provided
	by (used in) operating activities:
	Interest credited to policyholders' account balances			1,373		1,166		999
	Universal life and investment-type policy fee income			-3,546		-3,334		-3,312
	Investment gains (losses), net			91		80		42
	Equity in net earnings of subsidiaries			-788		-483		-55
	Dividends from subsidiaries			467		323		332
	Change in deferred policy acquisition costs			-74		-142		2,861
	Change in future policy benefits and other policyholder funds			-432		876		2,229
	(Income) loss related to derivative instruments			2,846		943		-2,369
	Change in reinsurance recoverable with affiliate			-175		-207		-242
	Change in the fair value of the reinsurance contract asset			4,297		-497		-5,941
	Change in current and deferred income taxes			-1,753		-224		1,250
	Amortization of reinsurance cost			280		47		211
	Amortization and depreciation			103		62		83
	Real estate asset write-off charge			52		0		0
	Other, net			363		-182		-190
Net cash provided by (used in) operating activities				-132		-1,356		-1,276
Cash flows from investing activities:
	Maturities and repayments of fixed maturities and mortgage loans
		on real estate		3,681		3,547		3,427
	Sales of investments			4,978		1,566		626
	Purchases of investments			-9,583		-7,563		-7,462
	Cash settlements related to derivative instruments			-2,479		-287		1,429
	Additional loans to affiliates			-56		0		0
	Decrease in loans to affiliates			5		4		0
	Change in short-term investments			0		34		16
	Change in policy loans			78		31		38
	Other, net			-103		-37		-44
Net cash provided by (used in) investing activities				-3,479		-2,705		-1,970
AXA EQUITABLE LIFE INSURANCE COMPANY
SCHEDULE II
STATEMENTS OF CASH FLOWS (PARENT COMPANY)
YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011 - CONTINUED
			2013		2012		2011
			(In Millions)
Cash flows from financing activities:
	Policyholders' account balances:
		Deposits	$	5,469	$	5,437	$	4,461
		Withdrawals and transfers to Separate Accounts		-1,188		-982		-821
	Shareholder dividends paid			-234		-362		-379
	Capital contribution			0		195		0
	Change in collateralized pledged liabilities			-663		-288		989
	Change in collateralized pledged assets			-19		-5		99
	Decrease in loans from affiliates			-500		0		0
Net cash provided by (used in) financing activities				2,865		3,995		4,349
Change in cash and cash equivalents				-746		-66		1,103
Cash and cash equivalents, beginning of year				2,450		2,516		1,413
Cash and Cash Equivalents, End of Year			$	1,704	$	2,450	$	2,516
Supplemental cash flow information:
	Interest Paid		$	91	$	107	$	106
	Income Taxes (Refunded) Paid		$	-227	$	261	$	15

SUPPLEMENTAL_INSURANCE_INFORMA

SUPPLEMENTAL INSURANCE INFORMATION SCHEDULE III	12 Months Ended
	Dec. 31, 2013
Supplemental Insurance Information [Abstract]	'
Supplementary Insurance Information, for Insurance Companies Disclosure [Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE III
	SUPPLEMENTARY INSURANCE INFORMATION
	AT AND FOR THE YEAR ENDED DECEMBER 31, 2013
							Future Policy		Policy						Amortization
			Deferred				Benefits		Charges		Net		Policyholders'		of Deferred
			Policy		Policyholders'		and other		And		Investment		Benefits and		Policy		Other
			Acquisition		Account		Policyholders'		Premium		Income		Interest		Acquisition		Operating
	Segment		Costs		Balances		Funds		Revenue		(Loss)(1)		Credited		Costs		Expense(2)
			(In Millions)
	Insurance		$	3,874	$	30,340	$	21,697	$	4,042	$	-724	$	3,064	$	580	$	2,174
	Investment
		Management		0		0		0		0		58		0		0		2,351
	Consolidation/
		Elimination		0		0		0		0		37		0		0		-20
	Total		$	3,874	$	30,340	$	21,697	$	4,042	$	-629	$	3,064	$	580	$	4,505
	Net investment income (loss) is based upon specific identification of portfolios within segments.
	Operating expenses are principally incurred directly by a segment.
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE III
	SUPPLEMENTARY INSURANCE INFORMATION
	AT AND FOR THE YEAR ENDED DECEMBER 31, 2012
							Future Policy		Policy						Amortization
			Deferred				Benefits		Charges		Net		Policyholders'		of Deferred
			Policy		Policyholders'		and other		And		Investment		Benefits and		Policy		Other
			Acquisition		Account		Policyholders'		Premium		Income		Interest		Acquisition		Operating
	Segment		Costs		Balances		Funds		Revenue		(Loss)(1)		Credited		Costs		Expense(2)
			(In Millions)
	Insurance		$	3,728	$	28,263	$	22,687	$	3,848	$	1,242	$	4,155	$	576	$	1,844
	Investment
		Management		0		0		0		0		65		0		0		2,548
	Consolidation/
		Elimination		0		0		0		0		31		0		0		-21
	Total		$	3,728	$	28,263	$	22,687	$	3,848	$	1,338	$	4,155	$	576	$	4,371
	Net investment income (loss) is based upon specific identification of portfolios within segments.
	Operating expenses are principally incurred directly by a segment.
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE III
	SUPPLEMENTARY INSURANCE INFORMATION
	AT AND FOR THE YEAR ENDED DECEMBER 31, 2011
			Policy						Amortization
			Charges		Net		Policyholders'		of Deferred
			And		Investment		Benefits and		Policy		Other
			Premium		Income		Interest		Acquisition		Operating
	Segment		Revenue		(Loss)(1)		Credited		Costs		Expense(2)
	Insurance		$	3,845	$	4,526	$	5,359	$	3,620	$	1,877
	Investment
		Management		0		-58		0		0		2,914
	Consolidation/
		Elimination		0		34		0		0		-22
	Total		$	3,845	$	4,502	$	5,359	$	3,620	$	4,769
	Net investment income (loss) is based upon specific identification of portfolios within segments.
	Operating expenses are principally incurred directly by a segment.

REINSURANCE_SCHEDULE_IV

REINSURANCE SCHEDULE IV	12 Months Ended
	Dec. 31, 2013
Reinsurance Schedule [Abstract]	'
Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE IV
	REINSURANCE(A)
	AT OR FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
						Assumed				Percentage
				Ceded to		from				of Amount
		Gross		Other		Other		Net		Assumed
		Amount		Companies		Companies		Amount		to Net
		(Dollars In Millions)
	2013
	Life Insurance In-Force	$	414,362	$	92,252	$	33,494	$	355,604	9.4	%
	Premiums:
	Life insurance and annuities	$	770	$	511	$	201	$	460	43.7	%
	Accident and health		78		54		12		36	33.3	%
	Total Premiums	$	848	$	565	$	213	$	496	42.9	%
	2012
	Life Insurance In-Force	$	409,488	$	96,869	$	34,361	$	346,980	9.9	%
	Premiums:
	Life insurance and annuities	$	785	$	518	$	206	$	473	43.5	%
	Accident and health		88		60		13		41	31.7	%
	Total Premiums	$	873	$	578	$	219	$	514	42.6	%
	2011
	Life Insurance In-Force	$	396,304	$	101,926	$	34,738	$	329,116	10.6	%
	Premiums:
	Life insurance and annuities	$	815	$	521	$	195	$	489	39.9	%
	Accident and health		93		64		15		44	34.1	%
	Total Premiums	$	908	$	585	$	210	$	533	39.4	%
	Includes amounts related to the discontinued group life and health business.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (POLICY)	12 Months Ended
	Dec. 31, 2013
Significant Accounting Policies [Abstract]	'
Basis Of Presentation And Principles Of Consolidation [Policy Text Block]	'
	Basis of Presentation and Principles of Consolidation
	The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions (including normal, recurring accruals) that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. The accompanying consolidated financial statements reflect all adjustments necessary in the opinion of management for a fair presentation of the consolidated financial position of the Company and its consolidated results of operations and cash flows for the periods presented.
	The accompanying consolidated financial statements include the accounts of AXA Equitable and its subsidiary engaged in insurance related businesses (collectively, the “Insurance Group”); other subsidiaries, principally AllianceBernstein; and those investment companies, partnerships and joint ventures in which AXA Equitable or its subsidiaries has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation.
Accounting for Variable Annuities With Guarantee Features [Policy Text Block]	'
	Accounting for Variable Annuities with GMDB and GMIB Features
	Future claims exposure on products with guaranteed minimum death benefit (“GMDB”) and guaranteed minimum income benefit (“GMIB”) features are sensitive to movements in the equity markets and interest rates. The Company has in place various hedging programs utilizing derivatives that are designed to mitigate the impact of movements in equity markets and interest rates. Under U.S. GAAP, the accounting for these various hedging programs do not qualify for hedge accounting treatment. As a result, changes in the value of the derivatives will be recognized in the period in which they occur while offsetting changes in reserves and deferred policy acquisition costs (“DAC”) will be recognized over time in accordance with policies described below under “Policyholders' Account Balances and Future Policy Benefits” and “DAC”. These differences in recognition contribute to earnings volatility.
	GMIB reinsurance contracts are used to cede to affiliated and non-affiliated reinsurers a portion of the exposure on variable annuity products that offer the GMIB feature. Under U.S. GAAP, the GMIB reinsurance contracts are accounted for as derivatives and are reported at fair value. Under U.S. GAAP, gross reserves for GMIB are calculated on the basis of assumptions related to projected benefits and related contract charges over the lives of the contracts and therefore will not immediately reflect the offsetting impact on future claims exposure resulting from the same capital market and/or interest rate fluctuations that cause gains or losses on the fair value of the GMIB reinsurance contracts. The changes in the fair value of the GMIB reinsurance contracts are recorded in the period in which they occur while offsetting changes in gross reserves and DAC for GMIB are recognized over time in accordance with policies described below under “Policyholders' Account Balances and Future Policy Benefits” and “DAC”. These differences in recognition contribute to earnings volatility.
Accounting And Consolidation Of Variable Interest Entities [Policy Text Block]	'
	Accounting and Consolidation of VIE's
	At December 31, 2013 and 2012, respectively, the Insurance Group's General Account held $3 million and $1 million of investment assets issued by VIEs and determined to be significant variable interests under Financial Accounting Standards Board (“FASB”) guidance Consolidation of Variable Interest Entities – Revised. At December 31, 2013 and 2012, respectively, as reported in the consolidated balance sheet, these investments included $3 million and $1 million of other equity investments (principally investment limited partnership interests) and are subject to ongoing review for impairment in value. These VIEs do not require consolidation because management has determined that the Insurance Group is not the primary beneficiary. These variable interests at December 31, 2013 represent the Insurance Group's maximum exposure to loss from its direct involvement with the VIEs. The Insurance Group has no further economic interest in these VIEs in the form of related guarantees, commitments, derivatives, credit enhancements or similar instruments and obligations.
	For all new investment products and entities developed by AllianceBernstein (other than Collaterized Debt Obligations (“CDOs”), AllianceBernstein first determines whether the entity is a VIE, which involves determining an entity's variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, AllianceBernstein then identifies the primary beneficiary of the VIE. If AllianceBernstein is deemed to be the primary beneficiary of the VIE, then AllianceBernstein and the Company consolidate the entity.
	AllianceBernstein provides seed capital to its investment teams to develop new products and services for their clients. AllianceBernstein's original seed investment typically represents all or a majority of the equity investment in the new product is temporary in nature. AllianceBernstein evaluates its seed investments on a quarterly basis and consolidates such investments as required pursuant to U.S. GAAP.
	Management of AllianceBernstein reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client assets under management (“AUM”) to determine the entities that AllianceBernstein is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships.
	AllianceBernstein earned investment management fees on client AUM of these entities but derived no other benefit from those assets and cannot utilize those assets in its operations.
	At December 31, 2013, AllianceBernstein had significant variable interests in certain other structured products and hedge funds with approximately $26 million in client AUM. However, these VIEs do not require consolidation because management has determined that AllianceBernstein is not the primary beneficiary of the expected losses or expected residual returns of these entities. AllianceBernstein's maximum exposure to loss in these entities is limited to its investments of $200,000 in and prospective investment management fees earned from these entities.
Adoption of New Accounting Pronouncements, Policy [Policy Text Block]	'
	Adoption of New Accounting Pronouncements
	In February 2013, the FASB issued new guidance to improve the reporting of reclassifications out of accumulated other comprehensive income (“AOCI”). The amendments in this guidance require an entity to report the effect of significant reclassifications out of AOCI on the respective line items in the statement of earnings (loss) if the amount being reclassified is required to be reclassified in its entirety to net earnings (loss). For other amounts that are not required to be reclassified in their entirety to net earnings in the same reporting period, an entity is required to cross-reference other disclosures that provide additional detail about those amounts. The guidance requires disclosure of reclassification information either in the notes or the face of the financial statements provided the information is presented in one location. This guidance was effective for interim and annual periods beginning after December 31, 2012. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
	In July 2012, the FASB issued new guidance on testing indefinite-lived intangible assets for impairment.  The guidance is intended to reduce the cost and complexity of the annual indefinite-lived intangible assets impairment test by providing entities with the option of performing a "qualitative" assessment to determine whether further impairment testing is necessary. The guidance was effective for annual and interim indefinite-lived intangible assets impairment tests performed for fiscal years beginning after September 15, 2012. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements.
	In December 2011, the FASB issued new and enhanced disclosures about offsetting (netting) of financial instruments and derivatives, including repurchase/reverse repurchase agreements and securities lending/borrowing arrangements, to converge with those required by International Financial Reporting Standards (“IFRS”). The disclosures require presentation in tabular format of gross and net information about assets and liabilities that either are offset (presented net) on the balance sheet or are subject to master netting agreements or similar arrangements providing rights of setoff, such as global master repurchase, securities lending, and derivative clearing agreements, irrespective of whether the assets and liabilities are offset. Financial instruments subject only to collateral agreements are excluded from the scope of these requirements, however, the tabular disclosures are required to include the fair values of financial collateral, including cash, related to master netting agreements or similar arrangements. In January 2013, the FASB issued new guidance limiting the scope of the new balance sheet offsetting disclosures to derivatives, repurchase agreements, and securities lending transactions to the extent that they are (1) offset in the financial statements or (2) subject to an enforceable master netting arrangement or similar agreement. This guidance was effective for interim and annual periods beginning after January 1, 2013 and was applied retrospectively to all comparative prior periods presented. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
	In September 2011, the FASB issued new guidance on testing goodwill for impairment.  The guidance is intended to reduce the cost and complexity of the annual goodwill impairment test by providing entities with the option of performing a "qualitative" assessment to determine whether further impairment testing is necessary. The guidance was effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements.
	In June 2011, the FASB issued new guidance to amend the existing alternatives for presenting Other comprehensive income (loss) (“OCI”) and its components in financial statements. The amendments eliminate the current option to report OCI and its components in the statement of changes in equity. An entity can elect to present items of net earnings (loss) and OCI in one continuous statement or in two separate, but consecutive statements. This guidance will not change the items that constitute net earnings (loss) and OCI, when an item of OCI must be reclassified to net earnings (loss). This guidance was effective for interim and annual periods beginning after December 15, 2011. Consistent with this guidance, the Company currently presents items of net earnings (loss) and OCI in two consecutive statements.
	In May 2011, the FASB amended its guidance on fair value measurements and disclosure requirements to enhance comparability between U.S. GAAP and IFRS. The changes to the existing guidance include how and when the valuation premise of highest and best use applies, the application of premiums and discounts, as well as new required disclosures. This guidance was effective for reporting periods beginning after December 15, 2011. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
	In April 2011, the FASB issued new guidance for a creditor's determination of whether a restructuring is a troubled debt restructuring (“TDR”). The new guidance provided additional guidance to creditors for evaluating whether a modification or restructuring of a receivable is a TDR. The new guidance required creditors to evaluate modifications and restructurings of receivables using a more principles-based approach, which may result in more modifications and restructurings being considered TDR. The financial reporting implications of being classified as a TDR are that the creditor is required to:
	Consider the receivable impaired when calculating the allowance for credit losses; and
	Provide additional disclosures about its troubled debt restructuring activities in accordance with the requirements of recently issued guidance on disclosures about the credit quality of financing receivables and the allowance for credit losses.
	The new guidance was effective for the first interim or annual period beginning on or after June 15, 2011. Implementation of this guidance did not have a material impact on the Company's consolidated financial statements. These new disclosures have been included in the Notes to the Company's consolidated financial statements, as appropriate.
Consolidations [Policy Text Block]	'
	Consolidations
	All significant intercompany transactions and balances have been eliminated in consolidation. The years “2013”, “2012” and “2011” refer to the years ended December 31, 2013, 2012 and 2011, respectively.
Future Adoption Of New Accounting Pronouncements [Policy Text Block]	'
	Future Adoption of New Accounting Pronouncements
	The FASB issued new guidance that allows investors to elect to use the proportional amortization method to account for investments in qualified affordable housing projects if certain conditions are met. Under this method, which replaces the effective yield method, an investor amortizes the cost of its investment, in proportion to the tax credits and other tax benefits it receives, to income tax expense. The guidance also introduces disclosure requirements for all investments in qualified affordable housing projects, regardless of the accounting method used for those investments. The guidance is effective for annual periods beginning after December 15, 2014. Management does not expect implementation of this guidance will have a material impact on the Company's consolidated financial statements.
	In July 2013, the FASB issued new guidance on the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The amendments in this guidance state that an unrecognized tax benefit, or a portion thereof, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. An exception to this guidance would be where a net operating loss carryforward or similar tax loss or credit carryforward would not be available under the tax law to settle any additional income taxes that would result from the disallowance of a tax position, or the tax law does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose. In such a case, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. This guidance is effective for interim and annual periods beginning after December 15, 2013. Management does not expect implementation of this guidance will have a material impact on the Company's consolidated financial statements.
Closed Block [Policy Text Block]	'
	Closed Block
	As a result of demutualization, the Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders.
	Assets allocated to the Closed Block inure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of AXA Equitable. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of AXA Equitable's General Account, any of its Separate Accounts or any affiliate of AXA Equitable without the approval of the Superintendent of The New York State Department of Financial Services, (the “NYSDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account.
	The excess of Closed Block liabilities over Closed Block assets (adjusted to exclude the impact of related amounts in AOCI) represents the expected maximum future post-tax earnings from the Closed Block that would be recognized in income from continuing operations over the period the policies and contracts in the Closed Block remain in force. As of January 1, 2001, the Company has developed an actuarial calculation of the expected timing of the Closed Block's earnings.
	If the actual cumulative earnings from the Closed Block are greater than the expected cumulative earnings, only the expected earnings will be recognized in net income. Actual cumulative earnings in excess of expected cumulative earnings at any point in time are recorded as a policyholder dividend obligation because they will ultimately be paid to Closed Block policyholders as an additional policyholder dividend unless offset by future performance that is less favorable than originally expected. If a policyholder dividend obligation has been previously established and the actual Closed Block earnings in a subsequent period are less than the expected earnings for that period, the policyholder dividend obligation would be reduced (but not below zero). If, over the period the policies and contracts in the Closed Block remain in force, the actual cumulative earnings of the Closed Block are less than the expected cumulative earnings, only actual earnings would be recognized in income from continuing operations. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside the Closed Block.
	Many expenses related to Closed Block operations, including amortization of DAC, are charged to operations outside of the Closed Block; accordingly, net revenues of the Closed Block do not represent the actual profitability of the Closed Block operations. Operating costs and expenses outside of the Closed Block are, therefore, disproportionate to the business outside of the Closed Block.
Investment [Policy Text Block]	'
	Investments
	The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in OCI. The amortized cost of fixed maturities is adjusted for impairments in value deemed to be other than temporary which are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock, and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer.
	The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment.
	The Company's management, with the assistance of its investment advisors, monitors the investment performance of its portfolio and reviews AFS securities with unrealized losses for other-than-temporary impairments (“OTTI”). Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company's Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security is expected to recover. This assessment includes, but is not limited to, consideration of the duration and severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity, and continued viability of the issuer and, for equity securities only, the intent and ability to hold the investment until recovery, and results in identification of specific securities for which OTTI is recognized.
	If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting OTTI is recognized in earnings (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management's best estimate of projected future cash flows at the effective interest rate implicit in the debt security prior to impairment. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. For mortgage- and asset-backed securities, projected future cash flows also include assumptions regarding prepayments and underlying collateral value.
	Real estate held for the production of income, including real estate acquired in satisfaction of debt, is stated at depreciated cost less valuation allowances. At the date of foreclosure (including in-substance foreclosure), real estate acquired in satisfaction of debt is valued at estimated fair value. Impaired real estate is written down to fair value with the impairment loss being included in Investment gains (losses), net.
	Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years.
	Policy loans are stated at unpaid principal balances.
	Partnerships, investment companies and joint venture interests that the Company has control of and has a majority economic interest in (that is, greater than 50% of the economic return generated by the entity) or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity basis of accounting and are reported either with equity real estate or other equity investments, as appropriate. The Company records its interests in certain of these partnerships on a one quarter lag.
	Equity securities, which include common stock, and non-redeemable preferred stock classified as AFS securities, are carried at fair value and are included in other equity investments with changes in fair value reported in OCI.
	Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with unrealized gains (losses) reported in Net earnings (loss).
	Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At December 31, 2013 and 2012, the carrying value of COLI was $770 million and $715 million, respectively, and is reported in Other invested assets in the consolidated balance sheets.
	Short-term investments are reported at amortized cost that approximates fair value and are included in Other invested assets.
	Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value.
	All securities owned, including United States government and agency securities, mortgage-backed securities and futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis.
Valuation Allowances for Mortgage Loans [Policy Text Block]	'
	Valuation Allowances for Mortgage Loans:
	For commercial and agricultural loans, an allowance for credit loss is typically recommended when management believes it is probable that principal and interest will not be collected according to the contractual terms. Factors that influence management's judgment in determining allowance for credit losses include the following:
	Loan-to-value ratio – Derived from current loan balance divided by the fair market value of the property.  An allowance for credit loss is typically recommended when the loan-to-value ratio is in excess of 100%.   In the case where the loan-to-value is in excess of 100%, the allowance for credit loss is derived by taking the difference between the fair market value (less cost of sale) and the current loan balance.
	Debt service coverage ratio – Derived from actual net operating income divided by annual debt service.  If the ratio is below 1.0x, then the income from the property does not support the debt.
	Occupancy – Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance.
	Lease expirations – The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio.  In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor.
	Maturity – Loans that are not fully amortizing and have upcoming maturities within the next 12 to 24 months are monitored in conjunction with the capital markets to determine the borrower's ability to refinance the debt and/or pay off the balloon balance.
	Borrower/tenant related issues – Financial concerns, potential bankruptcy, or words or actions that indicate imminent default or abandonment of property.
	Payment status – current vs. delinquent – A history of delinquent payments may be a cause for concern.
	Property condition – Significant deferred maintenance observed during Lender's annual site inspections.
	Other – Any other factors such as current economic conditions may call into question the performance of the loan.
	Mortgage loans on real estate are stated at unpaid principal balances, net of unamortized discounts and valuation allowances. Valuation allowances are based on the present value of expected future cash flows discounted at the loan's original effective interest rate or on its collateral value if the loan is collateral dependent. However, if foreclosure is or becomes probable, the collateral value measurement method is used.
	Mortgage loans also are individually evaluated quarterly by the IUS Committee for impairment, including an assessment of related collateral value. Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problems but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being restructured. The decision whether to classify a performing mortgage loan as a potential problem involves significant subjective judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property.
	For problem mortgage loans a valuation allowance is established to provide for the risk of credit losses inherent in the lending process. The allowance includes loan specific reserves for loans determined to be non-performing as a result of the loan review process. A non-performing loan is defined as a loan for which it is probable that amounts due according to the contractual terms of the loan agreement will not be collected. The loan specific portion of the loss allowance is based on the Company's assessment as to ultimate collectability of loan principal and interest. Valuation allowances for a non-performing loan are recorded based on the present value of expected future cash flows discounted at the loan's effective interest rate or based on the fair value of the collateral if the loan is collateral dependent. The valuation allowance for mortgage loans can increase or decrease from period to period based on such factors.
	Impaired mortgage loans without provision for losses are loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Changes in the present value attributable to changes in the amount or timing of expected cash flows are reported as investment gains or losses.
	Mortgage loans on real estate are placed on nonaccrual status once management believes the collection of accrued interest is doubtful. Once mortgage loans on real estate are classified as nonaccrual loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan on real estate has been restructured to where the collection of interest is considered likely. At December 31, 2013 and 2012, the carrying values of commercial and agricultural mortgage loans on real estate that had been classified as nonaccrual loans were $93 million and $0 million for commercial and $0 million and $2 million for agricultural, respectively.
Derivatives [Policy Text Block]	'
	Derivatives
	Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter market. All derivative positions are carried in the consolidated balance sheets at fair value, generally by obtaining quoted market prices or through the use of valuation models.
	Freestanding derivative contracts are reported in the consolidated balance sheets either as assets within “Other invested assets” or as liabilities within “Other liabilities.” The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. The Company uses derivatives to manage asset/liability risk but has not designated those economic relationships under the criteria to qualify for hedge accounting treatment. All changes in the fair value of the Company's freestanding derivative positions, including net receipts and payments, are included in “Investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities.
	The Company is a party to financial instruments and other contracts that contain “embedded” derivative instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are “clearly and closely related” to the economic characteristics of the remaining component of the “host contract” and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When those criteria are satisfied, the resulting embedded derivative is bifurcated from the host contract, carried in the consolidated balance sheets at fair value, and changes in its fair value are recognized immediately and captioned in the consolidated statements of earnings (loss) according to the nature of the related host contract. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company instead may elect to carry the entire instrument at fair value.
Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses) [Policy Text Block]	'
	Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses)
	Net investment income (loss) and realized investment gains (losses), net (together “investment results”) related to certain participating group annuity contracts which are passed through to the contractholders are offset by amounts reflected as interest credited to policyholders' account balances.
	Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the valuation allowances are included in Investment gains (losses), net.
	Realized and unrealized holding gains (losses) on trading securities are reflected in Net investment income (loss).
	Unrealized investment gains (losses) on fixed maturities and equity securities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, amounts attributable to certain pension operations, Closed Blocks' policyholders dividend obligation, insurance liability loss recognition and DAC related to universal life (“UL”) policies, investment-type products and participating traditional life policies.
	Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities and equity securities classified as AFS and do not reflect any change in fair value of policyholders' account balances and future policy benefits.
Fair Value of Other Financial Instruments [Policy Text Block]	'
	Fair Value of Financial Instruments
	Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance established a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
	Level 1       Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
	Level 2       Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.
	Level 3       Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity's own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.
	The Company defines fair value as the unadjusted quoted market prices for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company's entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.
	Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.
Recognition of Insurance Income and Related Expenses [Policy Text Block]	'
	Recognition of Insurance Income and Related Expenses
	Premiums from UL and investment-type contracts are reported as deposits to policyholders' account balances. Revenues from these contracts consist of fees assessed during the period against policyholders' account balances for mortality charges, policy administration charges and surrender charges. Policy benefits and claims that are charged to expense include benefit claims incurred in the period in excess of related policyholders' account balances.
	Premiums from participating and non-participating traditional life and annuity policies with life contingencies generally are recognized in income when due. Benefits and expenses are matched with such income so as to result in the recognition of profits over the life of the contracts. This match is accomplished by means of the provision for liabilities for future policy benefits and the deferral and subsequent amortization of policy acquisition costs.
	For contracts with a single premium or a limited number of premium payments due over a significantly shorter period than the total period over which benefits are provided, premiums are recorded as revenue when due with any excess profit deferred and recognized in income in a constant relationship to insurance in-force or, for annuities, the amount of expected future benefit payments.
	Premiums from individual health contracts are recognized as income over the period to which the premiums relate in proportion to the amount of insurance protection provided.
DAC [Policy Text Block]	'
	DAC
	Acquisition costs that vary with and are primarily related to the acquisition of new and renewal insurance business, reflecting incremental direct costs of contract acquisition with independent third parties or employees that are essential to the contract transaction, as well as the portion of employee compensation, including payroll fringe benefits and other costs directly related to underwriting, policy issuance and processing, medical inspection, and contract selling for successfully negotiated contracts including commissions, underwriting, agency and policy issue expenses, are deferred. DAC is subject to recoverability testing at the time of policy issue and loss recognition testing at the end of each accounting period.
	After the initial establishment of reserves, premium deficiency and loss recognition tests are performed each period end using best estimate assumptions as of the testing date without provisions for adverse deviation. When the liabilities for future policy benefits plus the present value of expected future gross premiums for the aggregate product group are insufficient to provide for expected future policy benefits and expenses for that line of business (i.e., reserves net of any DAC asset), DAC would first be written off and thereafter, if required, a premium deficiency reserve would be established by a charge to earnings.
	In accordance with the guidance for the accounting and reporting by insurance enterprises for certain long-duration contracts and participating contracts and for realized gains and losses from the sale of investments, current and expected future profit margins for products covered by this guidance are examined regularly in determining the amortization of DAC. Due primarily to the significant decline in Separate Accounts balances during 2008 and a change in the estimate of average gross short-term annual return on Separate Accounts balances to 9.0%, future estimated gross profits at December 31, 2008 for certain issue years for the Accumulator® products were expected to be negative as the increases in the fair values of derivatives used to hedge certain risks related to these products would be recognized in current earnings while the related reserves do not fully and immediately reflect the impact of equity and interest market fluctuations. As required under U.S. GAAP, for those issue years with future estimated negative gross profits, the DAC amortization method was permanently changed in fourth quarter 2008 from one based on estimated gross profits to one based on estimated assessments for the Accumulator® products, subject to loss recognition testing. In second quarter 2011, the DAC amortization method was changed to one based on estimated assessments for all issue years for the Accumulator® products due to continued volatility of margins and the continued emergence of periods of negative margins.
	DAC associated with UL and investment-type products, other than Accumulator® products is amortized over the expected total life of the contract group as a constant percentage of estimated gross profits arising principally from investment results, Separate Account fees, mortality and expense margins and surrender charges based on historical and anticipated future experience, updated at the end of each accounting period. When estimated gross profits are expected to be negative for multiple years of a contract life, DAC is amortized using the present value of estimated assessments. The effect on the amortization of DAC of revisions to estimated gross profits or assessments is reflected in earnings (loss) in the period such estimated gross profits or assessments are revised. A decrease in expected gross profits or assessments would accelerate DAC amortization. Conversely, an increase in expected gross profits or assessments would slow DAC amortization. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date.
	A significant assumption in the amortization of DAC on variable annuities and variable and interest-sensitive life insurance relates to projected future Separate Account performance. Management sets estimated future gross profit or assessment assumptions related to Separate Account performance using a long-term view of expected average market returns by applying a reversion to the mean approach, a commonly used industry practice. This future return approach influences the projection of fees earned, as well as other sources of estimated gross profits. Returns that are higher than expectations for a given period produce higher than expected account balances, increase the fees earned resulting in higher expected future gross profits and lower DAC amortization for the period. The opposite occurs when returns are lower than expected.
	In applying this approach to develop estimates of future returns, it is assumed that the market will return to an average gross long-term return estimate, developed with reference to historical long-term equity market performance. Currently, the average gross long-term return estimate is measured from December 31, 2008. Management has set limitations as to maximum and minimum future rate of return assumptions, as well as a limitation on the duration of use of these maximum or minimum rates of return. At December 31, 2013, the average gross short-term and long-term annual return estimate on variable and interest-sensitive life insurance and variable annuities was 9.0% (6.68)% net of product weighted average Separate Account fees), and the gross maximum and minimum short-term annual rate of return limitations were 15.0% (12.68)% net of product weighted average Separate Account fees) and 0.0% (-2.32% net of product weighted average Separate Account fees), respectively. The maximum duration over which these rate limitations may be applied is 5 years. This approach will continue to be applied in future periods. These assumptions of long-term growth are subject to assessment of the reasonableness of resulting estimates of future return assumptions.
	If actual market returns continue at levels that would result in assuming future market returns of 15.0% for more than 5 years in order to reach the average gross long-term return estimate, the application of the 5 year maximum duration limitation would result in an acceleration of DAC amortization. Conversely, actual market returns resulting in assumed future market returns of 0.0% for more than 5 years would result in a required deceleration of DAC amortization. At December 31, 2013, current projections of future average gross market returns assume a 0.0% annualized return for the next seven quarters, which is the minimum limitations grading to a reversion to the mean of 9.0% in fifteen quarters.
	In addition, projections of future mortality assumptions related to variable and interest-sensitive life products are based on a long-term average of actual experience. This assumption is updated quarterly to reflect recent experience as it emerges. Improvement of life mortality in future periods from that currently projected would result in future deceleration of DAC amortization. Conversely, deterioration of life mortality in future periods from that currently projected would result in future acceleration of DAC amortization.
	Other significant assumptions underlying gross profit estimates for UL and investment type products relate to contract persistency and General Account investment spread.
	For participating traditional life policies (substantially all of which are in the Closed Block), DAC is amortized over the expected total life of the contract group as a constant percentage based on the present value of the estimated gross margin amounts expected to be realized over the life of the contracts using the expected investment yield. At December 31, 2013, the average rate of assumed investment yields, excluding policy loans, was 5.3% grading to 5.0% over 10 years. Estimated gross margins include anticipated premiums and investment results less claims and administrative expenses, changes in the net level premium reserve and expected annual policyholder dividends. The effect on the accumulated amortization of DAC of revisions to estimated gross margins is reflected in earnings in the period such estimated gross margins are revised. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date. Many of the factors that affect gross margins are included in the determination of the Company's dividends to these policyholders. DAC adjustments related to participating traditional life policies do not create significant volatility in results of operations as the Closed Block recognizes a cumulative policyholder dividend obligation expense in “Policyholders' dividends,” for the excess of actual cumulative earnings over expected cumulative earnings as determined at the time of demutualization.
	DAC associated with non-participating traditional life policies is amortized in proportion to anticipated premiums. Assumptions as to anticipated premiums are estimated at the date of policy issue and are consistently applied during the life of the contracts. Deviations from estimated experience are reflected in earnings (loss) in the period such deviations occur. For these contracts, the amortization periods generally are for the total life of the policy. DAC related to these policies is subject to recoverability testing as part of AXA Financial Group's premium deficiency testing. If a premium deficiency exists, DAC is reduced by the amount of the deficiency or to zero through a charge to current period earnings (loss). If the deficiency exceeds the DAC balance, the reserve for future policy benefits is increased by the excess, reflected in earnings (loss) in the period such deficiency occurs.
Contractholder Bonus Interest Credits [Policy Text Block]	'
	Contractholder Bonus Interest Credits
	Contractholder bonus interest credits are offered on certain deferred annuity products in the form of either immediate bonus interest credited or enhanced interest crediting rates for a period of time. The interest crediting expense associated with these contractholder bonus interest credits is deferred and amortized over the lives of the underlying contracts in a manner consistent with the amortization of DAC. Unamortized balances are included in Other assets.
Policyholders Account Balances and Future Policy Benefits [Policy Text Block]	'
	Policyholders' Account Balances and Future Policy Benefits
	Policyholders' account balances for UL and investment-type contracts are equal to the policy account values. The policy account values represent an accumulation of gross premium payments plus credited interest less expense and mortality charges and withdrawals.
	The Company has issued and continues to offer certain variable annuity products with GMDB and Guaranteed income benefit (“GIB”) features. The Company previously issued certain variable annuity products with Guaranteed withdrawal benefit for life (“GWBL”) and other features. The Company also issues certain variable annuity products that contain a GMIB feature which, if elected by the policyholder after a stipulated waiting period from contract issuance, guarantees a minimum lifetime annuity based on predetermined annuity purchase rates that may be in excess of what the contract account value can purchase at then-current annuity purchase rates. This minimum lifetime annuity is based on predetermined annuity purchase rates applied to a GMIB base. Reserves for GMDB and GMIB obligations are calculated on the basis of actuarial assumptions related to projected benefits and related contract charges generally over the lives of the contracts using assumptions consistent with those used in estimating gross profits for purposes of amortizing DAC. The determination of this estimated liability is based on models that involve numerous estimates and subjective judgments, including those regarding expected market rates of return and volatility, contract surrender and withdrawal rates, mortality experience, and, for contracts with the GMIB feature, GMIB election rates. Assumptions regarding Separate Account performance used for purposes of this calculation are set using a long-term view of expected average market returns by applying a reversion to the mean approach, consistent with that used for DAC amortization. There can be no assurance that actual experience will be consistent with management's estimates.
	For reinsurance contracts other than those covering GMIB exposure, reinsurance recoverable balances are calculated using methodologies and assumptions that are consistent with those used to calculate the direct liabilities.
	For participating traditional life policies, future policy benefit liabilities are calculated using a net level premium method on the basis of actuarial assumptions equal to guaranteed mortality and dividend fund interest rates. The liability for annual dividends represents the accrual of annual dividends earned. Terminal dividends are accrued in proportion to gross margins over the life of the contract.
	For non-participating traditional life insurance policies, future policy benefit liabilities are estimated using a net level premium method on the basis of actuarial assumptions as to mortality, persistency and interest established at policy issue. Assumptions established at policy issue as to mortality and persistency are based on the Insurance Group's experience that, together with interest and expense assumptions, includes a margin for adverse deviation. Benefit liabilities for traditional annuities during the accumulation period are equal to accumulated contractholders' fund balances and, after annuitization, are equal to the present value of expected future payments. Interest rates used in establishing such liabilities range from 2.25% to 10.9% for life insurance liabilities and from 1.57% to 11.25% for annuity liabilities.
	Individual health benefit liabilities for active lives are estimated using the net level premium method and assumptions as to future morbidity, withdrawals and interest. Benefit liabilities for disabled lives are estimated using the present value of benefits method and experience assumptions as to claim terminations, expenses and interest. While management believes its disability income (“DI”) reserves have been calculated on a reasonable basis and are adequate, there can be no assurance reserves will be sufficient to provide for future liabilities.
	When the liabilities for future policy benefits plus the present value of expected future gross premiums for a product are insufficient to provide for expected future policy benefits and expenses for that product, DAC is written off and thereafter, if required, a premium deficiency reserve is established by a charge to earnings.
Policyholders Dividends [Policy Text Block]	'
	Policyholders' Dividends
	The amount of policyholders' dividends to be paid (including dividends on policies included in the Closed Block) is determined annually by AXA Equitable's board of directors. The aggregate amount of policyholders' dividends is related to actual interest, mortality, morbidity and expense experience for the year and judgment as to the appropriate level of statutory surplus to be retained by AXA Equitable.
	At December 31, 2013, participating policies, including those in the Closed Block, represent approximately 5.2% ($21,194 million) of directly written life insurance in-force, net of amounts ceded.
Separate Accounts [Policy Text Block]	'
	Separate Accounts
	Generally, Separate Accounts established under New York State Insurance Law are not chargeable with liabilities that arise from any other business of the Insurance Group. Separate Accounts assets are subject to General Account claims only to the extent Separate Accounts assets exceed Separate Accounts liabilities. Assets and liabilities of the Separate Accounts represent the net deposits and accumulated net investment earnings (loss) less fees, held primarily for the benefit of contractholders, and for which the Insurance Group does not bear the investment risk. Separate Accounts' assets and liabilities are shown on separate lines in the consolidated balance sheets. Assets held in Separate Accounts are reported at quoted market values or, where quoted values are not readily available or accessible for these securities, their fair value measures most often are determined through the use of model pricing that effectively discounts prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security's duration, also taking into consideration issuer-specific credit quality and liquidity. The assets and liabilities of six Separate Accounts are presented and accounted for as General Account assets and liabilities due to the fact that not all of the investment performance in those Separate Accounts is passed through to policyholders. Investment assets in these Separate Accounts principally consist of fixed maturities that are classified as AFS in the accompanying consolidated financial statements.
	The investment results of Separate Accounts, including unrealized gains (losses), on which the Insurance Group does not bear the investment risk are reflected directly in Separate Accounts liabilities and are not reported in revenues in the consolidated statements of earnings (loss). For 2013, 2012 and 2011, investment results of such Separate Accounts were gains (losses) of $19,022 million, $10,110 million and $(2,928) million, respectively.
	Deposits to Separate Accounts are reported as increases in Separate Accounts liabilities and are not reported in revenues. Mortality, policy administration and surrender charges on all policies including those funded by Separate Accounts are included in revenues.
	The Company reports the General Account's interests in Separate Accounts as Other equity investments in the consolidated balance sheets.
Recognition of Investment Management Revenues and Related Expenses [Policy Text Block]	'
	Recognition of Investment Management Revenues and Related Expenses
	Commissions, fees and other income principally include the Investment Management segment's investment advisory and service fees, distribution revenues and institutional research services revenue. Investment advisory and service base fees, generally calculated as a percentage, referred to as basis points (“BPs”), of assets under management, are recorded as revenue as the related services are performed; they include brokerage transactions charges received by Sanford C. Bernstein & Co. LLC (“SCB LLC”) for certain retail, private client and institutional investment client transactions. Certain investment advisory contracts, including those associated with hedge funds, provide for a performance-based fee, in addition to or in lieu of a base fee which is calculated as either a percentage of absolute investment results or a percentage of the investment results in excess of a stated benchmark over a specified period of time. Performance-based fees are recorded as a component of revenue at the end of each contract's measurement period. Institutional research services revenue consists of brokerage transaction charges received by SCB LLC and Sanford C. Bernstein Limited (“SCBL”) for independent research and brokerage-related services provided to institutional investors. Brokerage transaction charges earned and related expenses are recorded on a trade date basis. Distribution revenues and shareholder servicing fees are accrued as earned.
	Commissions paid to financial intermediaries in connection with the sale of shares of open-end AllianceBernstein sponsored mutual funds sold without a front-end sales charge (“back-end load shares”) are capitalized as deferred sales commissions and amortized over periods not exceeding five and one-half years for U.S. fund shares and four years for non-U.S. fund shares, the periods of time during which the deferred sales commissions are generally recovered. These commissions are recovered from distribution services fees received from those funds and from contingent deferred sales commissions (“CDSC”) received from shareholders of those funds upon the redemption of their shares. CDSC cash recoveries are recorded as reductions of unamortized deferred sales commissions when received. Effective January 31, 2009, back-end load shares are no longer offered to new investors by AllianceBernstein's U.S. funds. Management tests the deferred sales commission asset for recoverability quarterly and determined that the balance as of December 31, 2013 was not impaired.
	AllianceBernstein's management determines recoverability by estimating undiscounted future cash flows to be realized from this asset, as compared to its recorded amount, as well as the estimated remaining life of the deferred sales commission asset over which undiscounted future cash flows are expected to be received. Undiscounted future cash flows consist of ongoing distribution services fees and CDSC. Distribution services fees are calculated as a percentage of average assets under management related to back-end load shares. CDSC are based on the lower of cost or current value, at the time of redemption, of back-end load shares redeemed and the point at which redeemed during the applicable minimum holding period under the mutual fund distribution system.
	Significant assumptions utilized to estimate future average assets under management and undiscounted future cash flows from back-end load shares include expected future market levels and redemption rates. Market assumptions are selected using a long-term view of expected average market returns based on historical returns of broad market indices. Future redemption rate assumptions are determined by reference to actual redemption experience over the five-year, three-year and one-year periods and current quarterly periods ended December 31, 2013. These assumptions are updated periodically. Estimates of undiscounted future cash flows and the remaining life of the deferred sales commission asset are made from these assumptions and the aggregate undiscounted cash flows are compared to the recorded value of the deferred sales commission asset. If AllianceBernstein's management determines in the future that the deferred sales commission asset is not recoverable, an impairment condition would exist and a loss would be measured as the amount by which the recorded amount of the asset exceeds its estimated fair value. Estimated fair value is determined using AllianceBernstein's management's best estimate of future cash flows discounted to a present value amount.
Goodwill and Other Intangible Assets [Policy Text Block]	'
	Goodwill and Other Intangible Assets
	Goodwill represents the excess of the purchase price over the fair value of identifiable net assets of acquired companies, and relates principally to the Bernstein Acquisition and purchases of AllianceBernstein units. In accordance with the guidance for Goodwill and Other Intangible Assets, goodwill is tested annually for impairment and at interim periods if events or circumstances indicate an impairment could have occurred.
	Intangible assets related to the Bernstein Acquisition and purchases of AllianceBernstein Units include values assigned to contracts of businesses acquired based on their estimated fair value at the time of acquisition, less accumulated amortization. These intangible assets are generally amortized on a straight-line basis over their estimated useful life of approximately 20 years. All intangible assets are periodically reviewed for impairment as events or changes in circumstances indicate that the carrying value may not be recoverable. If the carrying value exceeds fair value, additional impairment tests are performed to measure the amount of the impairment loss, if any.
Other Accounting Policies [Policy Text Block]	'
	Other Accounting Policies
	Capitalized internal-use software, included in Other assets in the consolidated balance sheets, is amortized on a straight-line basis over the estimated useful life of the software that ranges between three and five years. If an impairment is determined to have occurred, software capitalization is accelerated for the remaining balance deemed to be impaired.
	AXA Financial and certain of its consolidated subsidiaries and affiliates, including the Company, file a consolidated Federal income tax return. Current Federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. Deferred income tax assets and liabilities are recognized based on the difference between financial statement carrying amounts and income tax bases of assets and liabilities using enacted income tax rates and laws.
Troubled Debt Restructuring [Policy Text Block]	'
	Troubled Debt Restructuring
	When a loan modification is determined to be a troubled debt restructuring, the impairment of the loan is re-measured by discounting the expected cash flows to be received based on the modified terms using the loan's original effective yield, and the allowance for loss is adjusted accordingly. Subsequent to the modification, income is recognized prospectively based on the modified terms of the loans. Additionally, the loan continues to be subject to the credit review process noted above.

INVESTMENTS_TABLES

INVESTMENTS (TABLES)	12 Months Ended
	Dec. 31, 2013
Investments Tables [Abstract]	'
Available For Sale Securities [ Table Text Block]	'
	Available-for-Sale Securities by Classification
								Gross			Gross
					Amortized			Unrealized			Unrealized			Fair			OTTI
					Cost			Gains			Losses			Value			in AOCI(3)
					(In Millions)
	December 31, 2013:
	Fixed Maturity Securities:
		Corporate			$	21,516		$	1,387		$	213		$	22,690		$	0
		U.S. Treasury, government
			and agency			3,584			22			477			3,129			0
		States and political subdivisions				444			35			2			477			0
		Foreign governments				392			46			5			433			0
		Commercial mortgage-backed				971			10			265			716			23
		Residential mortgage-backed(1)				914			34			1			947			0
		Asset-backed(2)				132			11			3			140			4
		Redeemable preferred stock				883			55			51			887			0
			Total Fixed Maturities			28,836			1,600			1,017			29,419			27
	Equity securities					37			0			3			34			0
	Total at December 31, 2013				$	28,873		$	1,600		$	1,020		$	29,453		$	27
	December 31, 2012:
	Fixed Maturity Securities:
		Corporate			$	20,854		$	2,364		$	20		$	23,198		$	0
		U.S. Treasury, government
			and agency			4,664			517			1			5,180			0
		States and political subdivisions				445			85			0			530			0
		Foreign governments				454			76			0			530			0
		Commercial mortgage-backed				1,175			16			291			900			13
		Residential mortgage-backed(1)				1,864			85			0			1,949			0
		Asset-backed(2)				175			12			5			182			5
		Redeemable preferred stock				1,089			60			11			1,138			0
			Total Fixed Maturities			30,720			3,215			328			33,607			18
	Equity securities					23			1			0			24			0
	Total at December 31, 2012				$	30,743		$	3,216		$	328		$	33,631		$	18
Investments Classified By Contractual Maturity Date [Table Text Block]	'
	Available-for-Sale Fixed Maturities
	Contractual Maturities at December 31, 2013
				Amortized Cost			Fair Value
				(In Millions)
	Due in one year or less			$	953		$	969
	Due in years two through five				7,786			8,387
	Due in years six through ten				10,232			10,561
	Due after ten years				6,965			6,812
		Subtotal			25,936			26,729
	Commercial mortgage-backed securities				971			716
	Residential mortgage-backed securities				914			947
	Asset-backed securities				132			140
	Total			$	27,953		$	28,532
Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Table Text Block]	'
					December 31,
					2013			2012			2011
					(In Millions)
	Proceeds from sales				$	3,220		$	139		$	340
	Gross gains on sales				$	71		$	13		$	6
	Gross losses on sales				$	-88		$	-12		$	-9
	Total OTTI				$	-81		$	-96		$	-36
	Non-credit losses recognized in OCI					15			2			4
	Credit losses recognized in earnings (loss)				$	-66		$	-94		$	-32
Fixed Maturities Credit LossImpairments [Table Text Block]	'
	Fixed Maturities - Credit Loss Impairments
			2013			2012
			(In Millions)
	Balances at January 1,		$	-372		$	-332
	Previously recognized impairments on securities that matured, paid, prepaid or sold			67			54
	Recognized impairments on securities impaired to fair value this period(1)			0			0
	Impairments recognized this period on securities not previously impaired			-59			-62
	Additional impairments this period on securities previously impaired			-6			-32
	Increases due to passage of time on previously recorded credit losses			0			0
	Accretion of previously recognized impairments due to increases in expected cash flows			0			0
	Balances at December 31,		$	-370		$	-372
Unrealized Gain Loss On Investments [Table Text Block]	'
					December 31,
					2013			2012
					(In Millions)
	AFS Securities:
		Fixed maturities:
			With OTTI loss		$	-28		$	-12
			All other			610			2,899
		Equity securities				-3			1
	Net Unrealized Gains (Losses)				$	579		$	2,888
Unrealized Gain Loss On Investments With Other Than Temporary Impairment [Table Text Block]	'
	Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses
																		AOCI Gain
						Net												(Loss) Related
						Unrealized									Deferred			to Net
						Gains									Income			Unrealized
						(Losses) on						Policyholders			Tax Asset			Investment
						Investments			DAC			Liabilities			(Liability)			Gains (Losses)
						(In Millions)
	Balance, January 1, 2013					$	-12		$	1		$	4		$	2		$	-5
	Net investment gains (losses) arising
		during the period					-14			0			0			0			-14
	Reclassification adjustment for OTTI losses:
			Included in Net earnings (loss)				13			0			0			0			13
			Excluded from Net earnings (loss)(1)				-15			0			0			0			-15
	Impact of net unrealized investment
		gains (losses) on:
			DAC				0			1			0			0			1
			Deferred income taxes				0			0			0			3			3
			Policyholders liabilities				0			0			6			0			6
	Balance, December 31, 2013					$	-28		$	2		$	10		$	5		$	-11
	Balance, January 1, 2012					$	-47		$	5		$	6		$	12		$	-24
	Net investment gains (losses) arising
		during the period					5			0			0			0			5
	Reclassification adjustment for OTTI losses:
			Included in Net earnings (loss)				32			0			0			0			32
			Excluded from Net earnings (loss)(1)				-2			0			0			0			-2
	Impact of net unrealized investment
		gains (losses) on:
			DAC				0			-4			0			0			-4
			Deferred income taxes				0			0			0			-10			-10
			Policyholders liabilities				0			0			-2			0			-2
	Balance, December 31, 2012					$	-12		$	1		$	4		$	2		$	-5
Other Net Unrealized Investment Gains Losses In Accumulated Other Comprehensive Income [Table Text Block]	'2,900
	All Other Net Unrealized Investment Gains (Losses) in AOCI
																		AOCI Gain
						Net												(Loss) Related
						Unrealized									Deferred			to Net
						Gains									Income			Unrealized
						(Losses) on						Policyholders			Tax Asset			Investment
						Investments			DAC			Liabilities			(Liability)			Gains (Losses)
						(In Millions)
	Balance, January 1, 2013					$	2,900		$	-179		$	-603		$	-741		$	1,377
	Net investment gains (losses) arising
		during the period					-2,370			0			0			0			-2,370
	Reclassification adjustment for OTTI losses:
			Included in Net earnings (loss)				62			0			0			0			62
			Excluded from Net earnings (loss)(1)				15			0			0			0			15
	Impact of net unrealized investment
		gains (losses) on:
			DAC				0			72			0			0			72
			Deferred income taxes				0			0			0			651			651
			Policyholders liabilities				0			0			358			0			358
	Balance, December 31, 2013					$	607		$	-107		$	-245		$	-90		$	165
	Balance, January 1, 2012					$	1,831		$	-207		$	-385		$	-433		$	806
	Net investment gains (losses) arising
		during the period					1,008			0			0			0			1,008
	Reclassification adjustment for OTTI losses:
			Included in Net earnings (loss)				59			0			0			0			59
			Excluded from Net earnings (loss)(1)				2			0			0			0			2
	Impact of net unrealized investment
		gains (losses) on:
			DAC				0			28			0			0			28
			Deferred income taxes				0			0			0			-308			-308
			Policyholders liabilities				0			0			-218			0			-218
	Balance, December 31, 2012					$	2,900		$	-179		$	-603		$	-741		$	1,377
Schedule Of Unrealized Loss On Investments [Table Text Block]	'
					Less Than 12 Months						12 Months or Longer						Total
								Gross						Gross						Gross
								Unrealized						Unrealized						Unrealized
					Fair Value			Losses			Fair Value			Losses			Fair Value			Losses
					(In Millions)
	December 31, 2013:
	Fixed Maturity Securities:
		Corporate			$	4,381		$	-187		$	248		$	-26		$	4,629		$	-213
		U.S. Treasury, government
			and agency			2,645			-477			0			0			2,645			-477
		States and political subdivisions				36			-2			0			0			36			-2
		Foreign governments				68			-4			7			-1			75			-5
		Commercial mortgage-backed				30			-5			529			-260			559			-265
		Residential mortgage-backed				260			-1			1			0			261			-1
		Asset-backed				2			0			28			-3			30			-3
		Redeemable preferred stock				232			-49			79			-2			311			-51
	Total				$	7,654		$	-725		$	892		$	-292		$	8,546		$	-1,017
	December 31, 2012:
	Fixed Maturity Securities:
		Corporate			$	562		$	-5		$	208		$	-15		$	770		$	-20
		U.S. Treasury, government
			and agency			513			-1			0			0			513			-1
		States and political subdivisions				20			0			0			0			20			0
		Foreign governments				6			0			2			0			8			0
		Commercial mortgage-backed				7			-3			805			-288			812			-291
		Residential mortgage-backed				27			0			1			0			28			0
		Asset-backed				8			0			36			-5			44			-5
		Redeemable preferred stock				143			-1			327			-10			470			-11
	Total				$	1,286		$	-10		$	1,379		$	-318		$	2,665		$	-328
Troubled Debt Restructurings on Financing Receivables [Table Text Block]	'
	Troubled Debt Restructuring - Modifications
	31-Dec-13
				Number			Outstanding Recorded Investment
				of Loans			Pre-Modification			Post - Modification
							(Dollars In Millions)
		Commercial mortgage loans			2			126			135
Allowance For Credit Losses On Financing Receivables [Table Text Block]	'
				Commercial Mortgage Loans
				2013			2012			2011
	Allowance for credit losses:			(In Millions)
	Beginning Balance, January 1,			$	34		$	32		$	18
		Charge-offs			0			0			0
		Recoveries			-2			-24			-8
		Provision			10			26			22
	Ending Balance, December 31,			$	42		$	34		$	32
	Ending Balance, December 31,:
		Individually Evaluated for Impairment		$	42		$	34		$	32
Debt Service Coverage Ratio [Table Text Block]	'
	Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
	31-Dec-13
						Debt Service Coverage Ratio
																					Less		Total
						Greater			1.8x to			1.5x to			1.2x to			1.0x to			than		Mortgage
	Loan-to-Value Ratio:(2)					than 2.0x			2.0x			1.8x			1.5x			1.2x			1.0x		Loans
						(In Millions)
	Commercial Mortgage Loans(1)
	0% - 50%					$	285		$	0		$	0		$	0		$	36		$	0	$	321
	50% - 70%						360			573			671			533			135			0		2,272
	70% - 90%						116			0			313			240			105			219		993
	90% plus						135			0			0			60			27			48		270
	Total Commercial
		Mortgage Loans				$	896		$	573		$	984		$	833		$	303		$	267	$	3,856
	Agricultural Mortgage Loans(1)
	0% - 50%					$	185		$	82		$	214		$	410		$	208		$	49	$	1,148
	50% - 70%						127			50			193			164			149			39		722
	70% - 90%						0			0			0			0			0			0		0
	90% plus						0			0			0			0			0			0		0
	Total Agricultural
		Mortgage Loans				$	312		$	132		$	407		$	574		$	357		$	88	$	1,870
	Total Mortgage Loans(1)
	0% - 50%					$	470		$	82		$	214		$	410		$	244		$	49	$	1,469
	50% - 70%						487			623			864			697			284			39		2,994
	70% - 90%						116			0			313			240			105			219		993
	90% plus						135			0			0			60			27			48		270
	Total Mortgage Loans					$	1,208		$	705		$	1,391		$	1,407		$	660		$	355	$	5,726
	Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
	31-Dec-12
						Debt Service Coverage Ratio
																					Less		Total
						Greater			1.8x to			1.5x to			1.2x to			1.0x to			than		Mortgage
	Loan-to-Value Ratio:(2)					than 2.0x			2.0x			1.8x			1.5x			1.2x			1.0x		Loans
						(In Millions)
	Commercial Mortgage Loans(1)
	0% - 50%					$	269		$	21		$	0		$	0		$	27		$	0	$	317
	50% - 70%						370			75			619			655			0			0		1,719
	70% - 90%						61			102			235			445			131			15		989
	90% plus						0			0			0			156			89			165		410
	Total Commercial
		Mortgage Loans				$	700		$	198		$	854		$	1,256		$	247		$	180	$	3,435
	Agricultural Mortgage Loans(1)
	0% - 50%					$	179		$	84		$	211		$	308		$	177		$	49	$	1,008
	50% - 70%						122			29			136			188			116			50		641
	70% - 90%						0			0			0			1			0			8		9
	90% plus						0			0			0			0			0			0		0
	Total Agricultural
		Mortgage Loans				$	301		$	113		$	347		$	497		$	293		$	107	$	1,658
	Total Mortgage Loans(1)
	0% - 50%					$	448		$	105		$	211		$	308		$	204		$	49	$	1,325
	50% - 70%						492			104			755			843			116			50		2,360
	70% - 90%						61			102			235			446			131			23		998
	90% plus						0			0			0			156			89			165		410
	Total Mortgage Loans					$	1,001		$	311		$	1,201		$	1,753		$	540		$	287	$	5,093
Age Analysis Of Past Due Mortgage Loans [Table Text Block]	'
	Age Analysis of Past Due Mortgage Loans
																							Recorded
																							Investment
												90									Total		> 90 Days
						30-59			60-89			Days									Financing		and
						Days			Days			Or >			Total			Current			Receivables		Accruing
						(In Millions)
	31-Dec-13
		Commercial				$	0		$	0		$	0		$	0		$	3,856		$	3,856	$	0
		Agricultural					5			4			14			23			1,847			1,870		14
	Total Mortgage Loans					$	5		$	4		$	14		$	23		$	5,703		$	5,726	$	14
	31-Dec-12
		Commercial				$	0		$	0		$	0		$	0		$	3,435		$	3,435	$	0
		Agricultural					6			1			10			17			1,641			1,658		9
	Total Mortgage Loans					$	6		$	1		$	10		$	17		$	5,076		$	5,093	$	9
Impaired Mortgage Loans [Table Text Block]	'
									Impaired Mortgage Loans
									Unpaid						Average			Interest
						Recorded			Principal			Related			Recorded			Income
						Investment			Balance			Allowance			Investment(1)			Recognized
						(In Millions)
	December 31, 2013:
	With no related allowance recorded:
		Commercial mortgage loans - other				$	0		$	0		$	0		$	0		$	0
		Agricultural mortgage loans					0			0			0			1			0
	Total					$	0		$	0		$	0		$	1		$	0
	With related allowance recorded:
		Commercial mortgage loans - other				$	135		$	135		$	-42		$	139		$	2
		Agricultural mortgage loans					0			0			0			0			0
	Total					$	135		$	135		$	-42		$	139		$	2
	December 31, 2012:
	With no related allowance recorded:
		Commercial mortgage loans - other				$	0		$	0		$	0		$	0		$	0
		Agricultural mortgage loans					2			2			0			3			0
	Total					$	2		$	2		$	0		$	3		$	0
	With related allowance recorded:
		Commercial mortgage loans - other				$	170		$	170		$	-34		$	178		$	10
		Agricultural mortgage loans					0			0			0			0			0
	Total					$	170		$	170		$	-34		$	178		$	10
Real Estate Investment Financial Statements Disclosure [Table Text Block]	'
				December 31,
				2013			2012
				(In Millions)
	BALANCE SHEETS
	Investments in real estate, at depreciated cost			$	231		$	233
	Investments in securities, generally at fair value				482			54
	Cash and cash equivalents				7			8
	Other assets				14			14
	Total Assets			$	734		$	309
	Borrowed funds - third party			$	159		$	162
	Other liabilities				10			11
	Total liabilities				169			173
	Partners’ capital				565			136
	Total Liabilities and Partners’ Capital			$	734		$	309
	The Company’s Carrying Value in These Entities Included Above			$	216		$	63
				2013			2012			2011
				(In Millions)
	STATEMENTS OF EARNINGS (LOSS)
	Revenues of real estate joint ventures			$	25		$	26		$	111
	Net revenues of other limited partnership interests				11			3			6
	Interest expense - third party				0			0			-21
	Other expenses				-22			-19			-61
	Net Earnings (Loss)			$	14		$	10		$	35
	The Company's Equity in Net Earnings (Loss) of These
		Entities Included Above		$	9		$	18		$	20
Schedule Of Derivative Instruments [Table Text Block]	'
	Derivative Instruments by Category
		At or For the Year Ended December 31, 2013
							Fair Value
													Gains (Losses)
				Notional			Asset			Liability			Reported In
				Amount			Derivatives			Derivatives			Earnings (Loss)
				(In Millions)
	Freestanding derivatives:
	Equity contracts:(1)
		Futures		$	4,935		$	0		$	3		$	-1,434
		Swaps			1,293			0			51			-316
		Options			7,506			1,056			593			366
	Interest rate contracts:(1)
		Floors			2,400			193			0			-5
		Swaps			9,823			216			212			-1,010
		Futures			10,763			0			0			-314
		Swaptions			0			0			0			-154
	Credit contracts:(1)
		Credit default swaps			342			10			1			4
	Other freestanding contracts:(1)
		Foreign currency Contracts			112			1			1			-3
		Net investment income (loss)												-2,866
	Embedded derivatives:
	GMIB reinsurance contracts				0			6,746			0			-4,297
	GIB and GWBL and other features(2)				0			0			0			265
	SCS, SIO, MSO and IUL indexed features(3)				0			0			346			-429
	Balances, December 31, 2013			$	37,174		$	8,222		$	1,207		$	-7,327
	Derivative Instruments by Category
		At or For the Year Ended December 31, 2012
							Fair Value
													Gains (Losses)
				Notional			Asset			Liability			Reported In
				Amount			Derivatives			Derivatives			Earnings (Loss)
				(In Millions)
	Freestanding derivatives:
	Equity contracts:(1)
		Futures		$	6,189		$	0		$	2		$	-1,058
		Swaps			965			2			56			-320
		Options			3,492			443			219			66
	Interest rate contracts:(1)
		Floors			2,700			291			0			68
		Swaps			18,239			554			353			402
		Futures			14,033			0			0			84
		Swaptions			7,608			502			0			-220
	Other freestanding contracts:(1)
		Foreign currency contracts			81			1			0			0
		Net investment income (loss)												-978
	Embedded derivatives:
		GMIB reinsurance contracts			0			11,044			0			497
		GIB and GWBL and other features (2)			0			0			265			26
	Balances, December 31, 2012			$	53,307		$	12,837		$	895		$	-455
Offsetting ssets And Liabilities [Table Text Block]	'
	Offsetting of Financial Assets and Liabilities and Derivative Instruments
	At December 31, 2013
								Gross
					Gross			Amounts			Net Amounts
					Amounts			Offset in the			Presented in the
					Recognized			Balance Sheets			Balance Sheets
					(In Millions)
	ASSETS(1)
	Description
	Derivatives:
	Equity contracts				$	1,056		$	642		$	414
	Interest rate contracts					344			211			133
	Credit contracts					9			0			9
			Total Derivatives, subject to an ISDA Master Agreement			1,409			853			556
	Total Derivatives, not subject to an ISDA Master Agreement					64			0			64
			Total Derivatives			1,473			853			620
	Other financial instruments					733			0			733
			Other invested assets		$	2,206		$	853		$	1,353
	LIABILITIES(2)
	Description
	Derivatives:
	Equity contracts				$	642		$	642		$	0
	Interest rate contracts					211			211			0
	Credit contracts					0			0			0
			Total Derivatives, subject to an ISDA Master Agreement			853			853			0
	Total Derivatives, not subject to an ISDA Master Agreement					0			0			0
			Total Derivatives			853			853			0
	Other financial liabilities					2,653			0			2,653
			Other liabilities		$	3,506		$	853		$	2,653
	Offsetting of Financial Assets and Liabilities and Derivative Instruments
	At December 31, 2012
								Gross
					Gross			Amounts			Net Amounts
					Amounts			Offset in the			Presented in the
					Recognized			Balance Sheets			Balance Sheets
					(In Millions)
	ASSETS(1)
	Description
	Derivatives:
	Equity contracts				$	444		$	272		$	172
	Interest rate contracts					1,251			351			900
			Total Derivatives, subject to an ISDA Master Agreement			1,695			623			1,072
	Total Derivatives, not subject to an ISDA Master Agreement					96			0			96
			Total Derivatives			1,791			623			1,168
	Other financial instruments					660			0			660
			Other invested assets		$	2,451		$	623		$	1,828
	LIABILITIES(2)
	Description
	Derivatives:
	Equity contracts				$	272		$	272		$	0
	Interest rate contracts					351			351			0
			Total Derivatives, subject to an ISDA Master Agreement			623			623			0
	Total Derivatives, not subject to an ISDA Master Agreement					0			0			0
			Total Derivatives			623			623			0
	Other financial liabilities					3,503			0			3,503
			Other liabilities		$	4,126		$	623		$	3,503
Collateral Arrangements By Counterparty Not Offset In Consolidated Balancesheets [Table Text Block]	'
	Gross Collateral Amounts Not Offset in the Consolidated Balance Sheets
	At December 31, 2013
					Net Amounts		Collateral (Received)/Held
					Presented in the			Financial						Net
					Balance Sheets			Instruments			Cash			Amounts
					(In Millions)
	Counterparty A				$	46		$	0		$	-46		$	0
	Counterparty B					17			0			-17			0
	Counterparty C					28			0			-28			0
	Counterparty D					175			0			-175			0
	Counterparty E					47			0			-47			0
	Counterparty F					-28			0			28			0
	Counterparty G					134			-134			0			0
	Counterparty H					4			0			-4			0
	Counterparty I					-2			0			2			0
	Counterparty J					-12			0			12			0
	Counterparty K					41			0			-38			3
	Counterparty L					72			0			-69			3
	Counterparty M					30			0			-30			0
	Counterparty N					64			0			0			64
	Counterparty Q					4			0			-4			0
			Total Derivatives		$	620		$	-134		$	-416		$	70
	Other financial instruments					733			0			0			733
			Other invested assets		$	1,353		$	-134		$	-416		$	803
	Gross Collateral Amounts Not Offset in the Consolidated Balance Sheets
	At December 31, 2012
					Net Amounts		Collateral (Received)/Held
					Presented in the			Financial						Net
					Balance Sheets			Instruments			Cash			Amounts
					(In Millions)
	Counterparty A				$	30		$	0		$	-30		$	0
	Counterparty B					32			0			-29			3
	Counterparty C					55			0			-55			0
	Counterparty D					310			0			-310			0
	Counterparty E					38			0			-38			0
	Counterparty F					326			0			-326			0
	Counterparty G					55			0			-55			0
	Counterparty H					-5			0			5			0
	Counterparty I					98			0			-98			0
	Counterparty J					19			0			-19			0
	Counterparty K					15			0			-3			12
	Counterparty L					48			-46			0			2
	Counterparty M					51			0			-51			0
	Counterparty N					96			0			0			96
			Total Derivatives		$	1,168		$	-46		$	-1,009		$	113
	Other financial instruments					660			0			0			660
			Other invested assets		$	1,828		$	-46		$	-1,009		$	773
Investment Income [Table Text Block]	'
				2013			2012			2011
				(In Millions)
	Fixed maturities			$	1,462		$	1,529		$	1,555
	Mortgage loans on real estate				284			264			241
	Equity real estate				1			14			19
	Other equity investments				234			189			116
	Policy loans				219			226			229
	Short-term investments				1			15			5
	Derivative investments				-2,866			-978			2,374
	Broker-dealer related receivables				14			14			13
	Trading securities				48			85			-29
	Other investment income				34			33			37
		Gross investment income (loss)			-569			1,391			4,560
	Investment expenses				-57			-50			-55
	Interest expense				-3			-3			-3
	Net Investment Income (Loss)			$	-629		$	1,338		$	4,502
Investment Gains Losses Net Including Changes In Valuation Allowances [Table Text Block]	'
			2013			2012			2011
			(In Millions)
	Fixed maturities		$	-75		$	-89		$	-29
	Mortgage loans on real estate			-7			-7			-14
	Other equity investments			-17			-13			-4
	Other			0			12			0
	Investment Gains (Losses), Net		$	-99		$	-97		$	-47

CLOSED_BLOCKS_TABLES

CLOSED BLOCKS (TABLES)	12 Months Ended
	Dec. 31, 2013
Closed Block Operations Net Results [Abstract]	'
Schedule of Closed Block Assets and Liabilities [Table Text Block]	'
					December 31,
					2013			2012
					(In Millions)
	CLOSED BLOCK LIABILITIES:
	Future policy benefits, policyholders’ account balances and other				$	7,716		$	7,942
	Policyholder dividend obligation					128			373
	Other liabilities					144			192
	Total Closed Block liabilities					7,988			8,507
	ASSETS DESIGNATED TO THE CLOSED BLOCK:
	Fixed maturities, available for sale, at fair value (amortized cost of
		$4,987 and $5,245)				5,232			5,741
	Mortgage loans on real estate					1,343			1,255
	Policy loans					949			1,026
	Cash and other invested assets					48			30
	Other assets					186			204
	Total assets designated to the Closed Block					7,758			8,256
	Excess of Closed Block liabilities over assets designated to the Closed Block					230			251
	Amounts included in accumulated other comprehensive income (loss):
		Net unrealized investment gains (losses), net of deferred income tax
			(expense) benefit of $(45) and $(47) and policyholder
			dividend obligation of $(128) and $(373)			83			87
	Maximum Future Earnings To Be Recognized From Closed Block
		Assets and Liabilities			$	313		$	338
Closed Block Operations, Net Results [Table Text Block]	'
						2013			2012		2011
						(In Millions)
	REVENUES:
	Premiums and other income					$	286		$	316	$	354
	Investment income (loss)						402			420		438
	Net investment gains (losses)						-11			-9		-10
	Total revenues						677			727		782
	BENEFITS AND OTHER DEDUCTIONS:
	Policyholders’ benefits and dividends						637			724		757
	Other operating costs and expenses						1			0		2
	Total benefits and other deductions						638			724		759
	Net revenues, before income taxes						39			3		23
	Income tax (expense) benefit						-14			-1		-8
	Net Revenues (Losses)					$	25		$	2	$	15
Closed Block Dividend Obligation [Table Text Block]	'
				December 31,
			2013			2012
			(In Millions)
	Balances, beginning of year		$	373		$	260
	Unrealized investment gains (losses)			-245			113
	Balances, End of year		$	128		$	373

CONTRACTHOLDER_BONUS_INTEREST_1

CONTRACTHOLDER BONUS INTEREST CREDITS (TABLES)	12 Months Ended
	Dec. 31, 2013
Contractholder Bonus Interest Credits Tables [Abstract]	'
Contractholder Bonus Interest Credits [Table Text Block]	'
		December 31,
		2013		2012
		(In Millions)
	Balance, beginning of year	$	621	$	718
	Contractholder bonus interest credits deferred		18		30
	Amortization charged to income		-121		-127
	Balance, End of Year	$	518	$	621

FAIR_VALUE_DISCLOSURES_TABLES

FAIR VALUE DISCLOSURES (TABLES)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures Tables [Abstract]	'
Fair Value, by Balance Sheet Grouping [Table Text Block]	'
	Fair Value Measurements at December 31, 2013
						Level 1			Level 2			Level 3			Total
						(In Millions)
	Assets
	Investments:
		Fixed maturities, available-for-sale:
			Corporate			$	0		$	22,400		$	291		$	22,691
			U.S. Treasury, government and agency				0			3,129			0			3,129
			States and political subdivisions				0			431			46			477
			Foreign governments				0			433			0			433
			Commercial mortgage-backed				0			16			700			716
			Residential mortgage-backed(1)				0			943			4			947
			Asset-backed(2)				0			56			83			139
			Redeemable preferred stock				216			656			15			887
				Subtotal			216			28,064			1,139			29,419
		Other equity investments					233			9			52			294
		Trading securities					529			3,692			0			4,221
		Other invested assets:
			Short-term investments				0			99			0			99
			Swaps				0			-45			0			-45
			Credit Default Swaps				0			9			0			9
			Futures				-2			0			0			-2
			Options				0			463			0			463
			Floors				0			193			0			193
			Swaptions				0			0			0			0
				Subtotal			-2			719			0			717
	Cash equivalents						1,310			0			0			1,310
	Segregated securities						0			981			0			981
	GMIB reinsurance contracts						0			0			6,747			6,747
	Separate Accounts' assets						105,579			2,948			237			108,764
			Total Assets			$	107,865		$	36,413		$	8,175		$	152,453
	Liabilities
	GWBL and other features' liability					$	0		$	0		$	0		$	0
	SCS, SIO, MSO and IUL indexed
	features' liability						0			346			0			346
			Total Liabilities			$	0		$	346		$	0		$	346
	Fair Value Measurements at December 31, 2012
						Level 1			Level 2			Level 3			Total
						(In Millions)
	Assets
	Investments:
		Fixed maturities, available-for-sale:
			Corporate			$	6		$	22,837		$	355		$	23,198
			U.S. Treasury, government and agency				0			5,180			0			5,180
			States and political subdivisions				0			480			50			530
			Foreign governments				0			511			19			530
			Commercial mortgage-backed				0			0			900			900
			Residential mortgage-backed(1)				0			1,940			9			1,949
			Asset-backed(2)				0			69			113			182
			Redeemable preferred stock				242			881			15			1,138
				Subtotal			248			31,898			1,461			33,607
		Other equity investments					78			0			77			155
		Trading securities					446			1,863			0			2,309
		Other invested assets:
			Short-term investments				0			98			0			98
			Swaps				0			148			0			148
			Futures				-2			0			0			-2
			Options				0			224			0			224
			Floors				0			291			0			291
			Swaptions				0			502			0			502
				Subtotal			-2			1,263			0			1,261
	Cash equivalents						2,289			0			0			2,289
	Segregated securities						0			1,551			0			1,551
GMIB reinsurance contracts						0			0			11,044			11,044
Separate Accounts' assets						90,751			2,775			224			93,750
		Total Assets			$	93,810		$	39,350		$	12,806		$	145,966
Liabilities
GWBL and other features' liability					$	0		$	0		$	265		$	265
		Total Liabilities			$	0		$	0		$	265		$	265
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	Level 3 Instruments
	Fair Value Measurements
											State and
											Political						Commercial			Residential
											Sub-			Foreign			Mortgage-			Mortgage-			Asset-
								Corporate			divisions			Govts			backed			backed			backed
								(In Millions)
	Balance, January 1, 2013							$	355		$	50		$	19		$	900		$	9		$	113
		Total gains (losses), realized and
			unrealized, included in:
				Earnings (loss) as:
					Net investment income (loss)				2			0			0			0			0			0
					Investment gains (losses), net				5			0			0			-68			0			0
						Subtotal			7			0			0			-68			0			0
				Other comprehensive income (loss)					-1			-3			-2			13			-1			3
	Purchases								70			0			0			31			0			0
	Issuances								0			0			0			0			0			0
	Sales								-150			-1			-17			-160			-4			-22
	Settlements								0			0			0			0			0			0
	Transfers into Level 3(1)								20			0			0			0			0			0
	Transfers out of Level 3(1)								-10			0			0			-16			0			-11
	Balance, December 31, 2013							$	291		$	46		$	0		$	700		$	4		$	83
	Balance, January 1, 2012							$	432		$	53		$	22		$	902		$	14		$	172
		Total gains (losses), realized and
			unrealized, included in:
				Earnings (loss) as:
					Net investment income (loss)				2			0			0			2			0			0
					Investment gains (losses), net				4			0			0			-105			0			0
						Subtotal		$	6		$	0		$	0		$	-103		$	0		$	0
				Other comprehensive income (loss)					15			-1			0			128			0			4
		Purchases							0			0			0			0			0			0
		Sales							-47			-2			0			-27			-5			-25
		Transfers into Level 3(1)							17			0			0			0			0			0
		Transfers out of Level 3(1)							-68			0			-3			0			0			-38
	Balance, December 31, 2012							$	355		$	50		$	19		$	900		$	9		$	113
								Redeem-															GWBL
								able			Other			Other			GMIB			Separate			and Other
								Preferred			Equity			Invested			Reinsurance			Accounts			Features
								Stock			Investments(1)			Assets			Asset			Assets			Liability
								(In Millions)
	Balance, January 1, 2013							$	15		$	77		$	0		$	11,044		$	224		$	265
		Total gains (losses), realized and
			unrealized, included in:
			Earnings (loss) as:
				Net investment income (loss)					0			0			0			0			0			0
				Investment gains (losses), net					0			10			0			0			10			0
					of reinsurance contracts				0			-7			0			-4,496			0			0
				Policyholders' benefits					0			0			0			0			0			-351
						Subtotal			0			3			0			-4,496			10			-351
			Other comprehensive income (loss)						0			0			0			0			-1			0
	Purchases								0			4			0			237			6			86
	Issuances								0			0			0			0			0			0
	Sales								0			-3			0			-38			-3			0
	Settlements								0			0			0			0			-2			0
	Transfers into Level 3(2)								0			0			0			0			3			0
	Transfers out of Level 3(2)								0			-29			0			0			0			0
	Balance, December 31, 2013							$	15		$	52		$	0		$	6,747		$	237		$	0
	Balance, January 1, 2012							$	14		$	77		$	-2		$	10,547		$	215		$	291
		Total gains (losses), realized and
			unrealized, included in:
			Earnings (loss) as:
				Net investment income (loss)					0			0			0			0			0			0
				Investment gains (losses), net					0			0			0			0			8			0
			Increase (decrease) in the fair value
				of reinsurance contracts				0			0			0			315			0			0
			Policyholders' benefits					0			0			0			0			0			-77
					Subtotal		$	0		$	0		$	0		$	315		$	8		$	-77
		Other comprehensive income (loss)						1			0			2			0			0			0
	Purchases							0			0			0			182			6			51
	Sales							0			0			0			0			-2			0
	Settlements							0			0			0			0			-3			0
	Transfers into Level 3(2)							0			0			0			0			0			0
Balance, December 31, 2012							$	15		$	77		$	0		$	11,044		$	224		$	265
Fair Value Assets Unrealized Gains Losses By Category For Level 3 Assets And Liabilities Still Held [Table Text Block]	'
										Earnings (Loss)
																Increase
										Net			Investment			(Decrease) in the
										Investment			Gains			Fair Value of						Policy-
										Income			(Losses),			Reinsurance						holders'
										(Loss)			Net			Contracts			OCI			Benefits
										(In Millions)
	Level 3 Instruments
	Full Year 2013
	Still Held at December 31, 2013:
		Change in unrealized gains (losses):
			Fixed maturities, available-for-sale:
				Corporate						$	0		$	0		$	0		$	-2		$	0
				State and political subdivisions							0			0			0			-4			0
				Foreign governments							0			0			0			0			0
				Commercial mortgage-backed							0			0			0			6			0
				Asset-backed							0			0			0			4			0
				Other fixed maturities, available-for-sale							0			0			0			0			0
					Subtotal					$	0		$	0		$	0		$	4		$	0
			GMIB reinsurance contracts								0			0			-4,297			0			0
			Separate Accounts’ assets								0			10			0			0			0
			GWBL and other features’ liability								0			0			0			0			-265
					Total					$	0		$	10		$	-4,297		$	4		$	-265
	Level 3 Instruments
	Full Year 2012
	Still Held at December 31, 2012:
		Change in unrealized gains (losses):
			Fixed maturities, available-for-sale:
				Corporate						$	0		$	0		$	0		$	14		$	0
				State and political subdivisions							0			0			0			-1			0
				Foreign governments							0			0			0			1			0
				Commercial mortgage-backed							0			0			0			124			0
				Asset-backed							0			0			0			3			0
				Other fixed maturities, available-for-sale							0			0			0			0			0
					Subtotal					$	0		$	0		$	0		$	141		$	0
			GMIB reinsurance contracts								0			0			497			0			0
			Separate Accounts’ assets								0			8			0			0			0
			GWBL and other features’ liability								0			0			0			0			26
					Total					$	0		$	8		$	497		$	141		$	26
Fair Value Inputs Quantitative Information [Table Text Block]	'
	Quantitative Information about Level 3 Fair Value Measurements
	31-Dec-13
					Fair			Valuation			Significant
					Value			Technique			Unobservable Input			Range
	Assets:				(In Millions)
	Investments:
		Fixed maturities, available-for-sale:
			Corporate		$	54		Matrix pricing model			Spread over the industry-specific
											benchmark yield curve			125 bps - 550 bps
			Residential mortgage-backed			1		Matrix pricing model			Spread over U.S. Treasury curve			45 bps
			Asset-backed			7		Matrix pricing model			Spread over U.S. Treasury curve			30 bps - 687 bps
		Other equity investments				52		Market comparable			Revenue multiple			1.2x - 4.9x
									companies		R&D multiple			1.1x - 17.1x
											Discount rate			18.00%
											Discount years			1
											Discount for lack of marketability
												and risk factors		50% - 60%
	Separate Accounts' assets					215		Third party appraisal			Capitalization rate			5.40%
											Exit capitalization rate			6.40%
											Discount rate			7.40%
						11		Discounted cash flow			Spread over U.S. Treasury curve			256 bps - 434 bps
											Inflation rate			0.0 % - 2.3 %
											Discount factor			3.3 % - 6.8 %
	GMIB reinsurance contracts					6,747		Discounted Cash flow				Lapse Rates		1.0% - 8.0%
												Withdrawal rates		0.2% - 8.0%
												GMIB Utilization Rates		0.0% - 15.0%
												Non-performance risk		7 bps - 21 bps
												Volatility rates - Equity		20.0% - 33.0%
	Liabilities:
	GMWB/GWBL(1)					61		Discounted Cash flow				Lapse Rates		1.0% - 8.0%
												Withdrawal rates		0.0% -7.0%
												Volatility rates - Equity		20.0% - 33.0%
	Quantitative Information about Level 3 Fair Value Measurements
	31-Dec-12
					Fair			Valuation			Significant
					Value			Technique			Unobservable Input			Range
	Assets:				(In Millions)
	Investments:
		Fixed maturities, available-for-sale:
			Corporate		$	94		Matrix pricing model			Spread over the industry-specific
											benchmark yield curve			125 bps - 650 bps
			Commercial mortgage-backed			889		Discounted Cash flow			Constant default rate			3.0% - 25.0%
											Probability of default			55.00%
											Loss severity			49.00%
											Discount rate			3.72% - 13.42%
			Residential mortgage-backed			1		Matrix pricing model			Spread over U.S. Treasury curve			46 bps
			Asset-backed			8		Matrix pricing model			Spread over U.S. Treasury curve			30 bps - 695 bps
		Other equity investments				38		Market comparable			Revenue multiple			0.6x - 62.5x
									companies		R&D multiple			1.0x - 30.6x
											Discount rate			18.00%
											Discount years			2-Jan
											Discount for lack of marketability
												and risk factors		40.0% - 60.0%
	Separate Accounts' assets					194		Third party appraisal			Capitalization rate			5.50%
											Exit capitalization rate			6.60%
											Discount rate			7.70%
						22		Discounted cash flow			Spread over U.S. Treasury curve			275 bps - 586 bps
											Inflation rate			2.0% - 3.0%
											Discount factor			1.0% - 2.0%
	GMIB reinsurance contracts					11,044		Discounted cash flow				Lapse Rates		1.5% - 8.0%
												Withdrawal Rates		0.2% - 8.0%
												GMIB Utilization Rates		0.0% - 15.0%
												Non-performance risk		13 bps - 45 bps
											Volatility rates - Equity		24.0% - 36.0%
Liabilities:
GMWB/GWBL (1)					205		Discounted cash flow				Lapse Rates		1.0% - 8.0%
											Withdrawal Rates		0.0% - 7.0%
											Volatility rates - Equity		24.0% - 36.0%
Fair Value Disclosure Financial Instruments Not Carried At Fair Value [Table Text Block]	'
					Carrying			Fair Value
					Value			Level 1			Level 2			Level 3			Total
					(In Millions)
		December 31, 2013:
		Mortgage loans on real estate			$	5,684		$	0		$	0		$	5,716		$	5,716
		Other limited partnership interests				1,592			0			0			1,592			1,592
		Loans to affiliates				1,088			0			800			398			1,198
		Policyholders liabilities: Investment contracts				2,435			0			0			2,523			2,523
		Long-term debt				200			0			225			0			225
		Loans from affiliates				825			0			969			0			969
		December 31, 2012:
		Mortgage loans on real estate			$	5,059		$	0		$	0		$	5,249		$	5,249
		Other limited partnership interests				1,514			0			0			1,514			1,514
		Loans to affiliates				1,037			0			784			402			1,186
		Policyholders liabilities: Investment contracts				2,494			0			0			2,682			2,682
		Long-term debt				200			0			236			0			236
		Loans from affiliates				1,325			0			1,676			0			1,676

GMDB_GMIB_GWBL_AND_NO_LAPSE_GU1

GMDB, GMIB, GWBL AND NO LAPSE GUARANTEE FEATURES (TABLES)	12 Months Ended
	Dec. 31, 2013
Variable Annuity Contracts GMDB GMIB And GWBL Tables [Abstract]	'
Variable Annuity Contracts- GMDB GMIB [Table Text Block]	'
				GMDB			GMIB			Total
				(In Millions)
	Balance at January 1, 2011			$	1,265		$	2,311		$	3,576
		Paid guarantee benefits			-203			-47			-250
		Other changes in reserve			531			1,866			2,397
	Balance at December 31, 2011				1,593			4,130			5,723
		Paid guarantee benefits			-288			-77			-365
		Other changes in reserve			467			508			975
	Balance at December 31, 2012				1,772			4,561			6,333
		Paid guarantee benefits			-237			-325			-562
		Other changes in reserve			91			-33			58
	Balance at December 31, 2013			$	1,626		$	4,203		$	5,829
Guaranteed Minimum Death Benefit Reinsurance Ceded [Table Text Block]	'
				GMDB
				(In Millions)
	Balance at January 1, 2011			$	533
		Paid guarantee benefits			-81
		Other changes in reserve			264
	Balance at December 31, 2011				716
		Paid guarantee benefits			-127
		Other changes in reserve			255
	Balance at December 31, 2012				844
		Paid guarantee benefits			-109
		Other changes in reserve			56
	Balance at December 31, 2013			$	791
Schedule of Net Amount of Risk by Product and Guarantee [Table Text Block]	'
					Return
					of
					Premium			Ratchet			Roll-Up		Combo		Total
					(Dollars In Millions)
	GMDB:
		Account values invested in:
			General Account		$	13,121		$	228		$	92	$	393	$	13,834
			Separate Accounts		$	36,658		$	8,551		$	4,094	$	37,795	$	87,098
		Net amount at risk, gross			$	270		$	169		$	2,192	$	10,891	$	13,522
		Net amount at risk, net of
			amounts reinsured		$	270		$	111		$	1,451	$	4,152	$	5,984
		Average attained age of
			contractholders			50.8			64.5			70.2		65.2		54.6
		Percentage of contractholders
			over age 70			8.40%			32.20%			53.00%		33.70%		15.50%
		Range of contractually
			specified interest rates			N/A			N/A			3% - 6%		3% - 6.5%		3% - 6.5%
	GMIB:
		Account values invested in:
			General Account			N/A			N/A		$	37	$	428	$	465
			Separate Accounts			N/A			N/A		$	8,349	$	49,109	$	57,458
		Net amount at risk, gross				N/A			N/A		$	892	$	1,551	$	2,443
		Net amount at risk, net of
			amounts reinsured			N/A			N/A		$	268	$	369	$	637
		Weighted average years
			remaining until annuitization			N/A			N/A			0.7		3.5		3.3
		Range of contractually
			specified interest rates			N/A			N/A			3% - 6%		3% - 6.5%		3% - 6.5%
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Table Text Block]	'
	Investment in Variable Insurance Trust Mutual Funds
			December 31,
			2013				2012
			(In Millions)
	GMDB:
	Equity		$	64,035		$	52,633
	Fixed income			3,330			3,748
	Balanced			19,237			19,102
	Other			496			543
	Total		$	87,098		$	76,026
	GMIB:
	Equity		$	41,603		$	33,361
	Fixed income			2,208			2,335
	Balanced			13,401			12,906
	Other			246			264
	Total		$	57,458		$	48,866
No Lapse Guarantee Liabilities [Table Text Block]	'
							Reinsurance
				Direct Liability			Ceded			Net
				(In Millions)
	Balance at January 1, 2011			$	375		$	-231		$	144
		Other changes in reserves			95			-31			64
	Balance at December 31, 2011				470			-262			208
		Other changes in reserves			86			-48			38
	Balance at December 31, 2012				556			-310			246
		Other changes in reserves			273			-131			142
	Balance at December 31, 2013			$	829		$	-441		$	388

REINSURANCE_AGREEMENTS_TABLES

REINSURANCE AGREEMENTS (TABLES)	12 Months Ended
	Dec. 31, 2013
Reinsurance Disclosures Tables [Abstract]	'
Schedule Of Effect Of Reinsurance [Table Text Block]	'
		2013		2012		2011
		(In Millions)
	Direct premiums	$	848	$	873	$	908
	Reinsurance assumed		213		219		210
	Reinsurance ceded		-565		-578		-585
	Premiums	$	496	$	514	$	533
	Universal Life and Investment-type Product Policy Fee Income Ceded	$	247	$	234	$	221
	Policyholders' Benefits Ceded	$	703	$	667	$	510
Schedule Of Net Incurred Benefits And Benefits Paid For Individual DI And Major Medical Policies [Table Text Block ]	'
		2013		2012		2011
		(In Millions)
	Incurred benefits related to current year	$	15	$	16	$	24
	Incurred benefits related to prior years		10		14		18
	Total Incurred Benefits	$	25	$	30	$	42
	Benefits paid related to current year	$	19	$	21	$	15
	Benefits paid related to prior years		13		16		24
	Total Benefits Paid	$	32	$	37	$	39

SHORT_TERM_AND_LONG_TERM_DEBT_

SHORT- TERM AND LONG- TERM DEBT (TABLES)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure Tables [Abstract]	'
Short Term And Long Term Debt [Table Text Block]	'
			December 31,
			2013		2012
			(In Millions)
	Short-term debt:
	AllianceBernstein commercial paper (with interest rates of 0.3% and 0.5%)		$	268	$	323
	Total short-term debt			268		323
	Long-term debt:
	AXA Equitable:
		Surplus Notes, 7.7%, due 2015		200		200
	Total long-term debt			200		200
	Total Short-term and Long-term Debt		$	468	$	523

RELATED_PARTY_TRANSACTIONS_TAB

RELATED PARTY TRANSACTIONS (TABLES)	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Table Text Block]	'
		2013		2012		2011
		(In Millions)
	Investment advisory and services fees	$	1,010	$	879	$	831
	Distribution revenues		455		408		360
	Other revenues - shareholder servicing fees		91		89		92
	Other revenues - other		6		5		6

EMPLOYEE_BENEFIT_PLANS_TABLES

EMPLOYEE BENEFIT PLANS (TABLES)	12 Months Ended
	Dec. 31, 2013
Employee Benefit Plans [Abstract]	'
Employee Benefit Plans Net Periodic Pension Expense [Table Text Block]	'
			2013			2012			2011
			(In Millions)
	Service cost		$	40		$	40		$	41
	Interest cost			99			109			122
	Expected return on assets			-155			-146			-120
	Actuarial (gain) loss			1			1			-
	Net amortization			155			164			145
	Curtailment			3			-			-
	Net Periodic Pension Expense		$	143		$	168		$	188
Schedule Of Accumulated And Projected Benefit Obligations [Table Text Block]	'
			December 31,
			2013			2012
			(In Millions)
	Projected benefit obligation, beginning of year		$	2,797		$	2,626
	Service cost			32			32
	Interest cost			99			109
	Actuarial (gains) losses			-260			219
	Benefits paid			-176			-187
	Plan amendments and curtailments			-29			-2
	Projected Benefit Obligation, End of Year		$	2,463		$	2,797
Schedule Of Net Funded Status [Table Text Block]	'
			December 31,
			2013			2012
			(In Millions)
	Pension plan assets at fair value, beginning of year		$	2,396		$	2,093
	Actual return on plan assets			180			231
	Contributions			4			265
	Benefits paid and fees			-179			-193
	Pension plan assets at fair value, end of year			2,401			2,396
	PBO			2,463			2,797
	Excess of PBO Over Pension Plan Assets		$	-62		$	-401
Schedule Of Net Periodic Benefit Cost Not Yet Recognized [Table Text Block]	'
				December 31,
				2013			2012
				(In Millions)
	Unrecognized net actuarial (gain) loss			$	1,181		$	1,650
	Unrecognized prior service cost (credit)				0			4
		Total		$	1,181		$	1,654
Schedule Of Allocation Of Plan Assets [Table Text Block]	'
				December 31,
				2013			2012
				(In Millions)
	Fixed Maturities			49	%			52.8	%
	Equity Securities			39.1				36.5
	Equity real estate			9.3				8.4
	Cash and short-term investments			1.9				2.3
	Other			0.7				0
		Total		100	%			100	%
Schedule Of Fair Values Of Plan Assets Within Fair Value Hierarchy [Table Text Block]	'
	December 31, 2013:					Level 1			Level 2		Level 3		Total
	Asset Categories					(In Millions)
	Fixed Maturities:
		Corporate				$	0		$	801	$	0	$	801
		U.S. Treasury, government and agency					0			343		0		343
		States and political subdivisions					0			16		0		16
		Other structured debt					0			6		4		10
	Common and preferred equity						716			191		0		907
	Mutual funds						44			0		0		44
	Private real estate investment funds						0			0		2		2
	Private real estate investment trusts						0			11		220		231
	Cash and cash equivalents						1			0		0		1
	Short-term investments						23			23		0		46
		Total				$	784		$	1,391	$	226	$	2,401
	December 31, 2012:					Level 1			Level 2		Level 3		Total
	Asset Categories					(In Millions)
	Fixed Maturities:
		Corporate				$	0		$	849	$	0	$	849
		U.S. Treasury, government and agency					0			410		0		410
		States and political subdivisions					0			18		0		18
		Other structured debt					0			0		5		5
	Common and preferred equity						751			62		0		813
	Mutual funds						35			0		0		35
	Private real estate investment funds						0			0		3		3
	Private real estate investment trusts						0			11		197		208
	Cash and cash equivalents						25			0		0		25
	Short-term investments						0			30		0		30
		Total				$	811		$	1,380	$	205	$	2,396
Schedule Of Reconciliation For All Level 3 Qualified Pension Plan Assets [Table Text Block]	'
									Private
									Real Estate		Private
						Fixed			Investment		Investment		Common
						Maturities(1)			Funds		Trusts		Equity		Total
						(In Millions)
	Balance at January 1, 2013					$	5		$	3	$	197	$	0	$	205
	Actual return on plan assets:
		Relating to assets still held
			at December 31, 2013				0			0		23		0		23
		Purchases/issues					0			0		0		0		0
		Sales/settlements					0			0		0		0		0
		Transfers into/out of Level 3					-1			-1		0		0		-2
	Balance at December 31, 2013					$	4		$	2	$	220	$	0	$	226
	Balance at January 1, 2012					$	6		$	4	$	183	$	0	$	193
	Actual return on plan assets:
		Relating to assets still held
			at December 31, 2012				0			0		14		0		14
		Sales/settlements					-1			-1		0		0		-2
		Transfers into/out of Level 3					0			0		0		0		0
	Balance at December 31, 2012					$	5		$	3	$	197	$	0	$	205
Schedule or Description of Weighted Average Discount Rate [Table Text Block]	'
				2013			2012
	Discount rates:
		Benefit obligation		4.5	%		3.5	%
		Periodic cost		4.5	%		4.25	%
	Rates of compensation increase:
		Benefit obligation and periodic cost		6	%		6	%
	Expected long-term rates of return on pension plan assets (periodic cost)			6.75	%		6.75	%
Schedule Of Expected Benefit Payments [Table Text Block]	'
			Pension
			Benefits
			(In Millions)
	2014		$	189
	2015			196
	2016			192
	2017			188
	2018			185
	Years 2019-2023			853

SHARE_BASED_AND_OTHER_COMPENSA

SHARE- BASED AND OTHER COMPENSATION PROGRAMS (TABLES)	12 Months Ended
	Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Schedule of Share-based Compensation, expenses [Table Text Block]	'
			2013			2012			2011
			(In Millions)
	Performance Unit/Shares		$	43		$	24		$	2
	Stock Options			2			3			4
	AXA Shareplan			13			18			9
	AXA Miles			0			1			1
	AllianceBernstein Stock Options			-4			1			21
	AllianceBernstein Restricted Units			286			148			377
	Total Compensation Expenses		$	340		$	195		$	414
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
				Options Outstanding
				AXA Ordinary Shares							AXA ADRs(3)						AllianceBernstein Holding Units
							Weighted							Weighted					Weighted
				Number			Average				Number			Average			Number		Average
				Outstanding			Exercise				Outstanding			Exercise			Outstanding		Exercise
				(In 000's)			Price				(In 000's)			Price			(In 000's)		Price
	Options outstanding at
		1-Jan-13			18,101.70		€	21				4,990.00		$	20.01			8,553.30	$	39.77
	Options granted				486.2		€	13.81				0		$	0			37.7	$	25.47
	Options exercised				-527.8		€	12.15				-3,022.60		$	17.74			-887.6	$	17.05
	Options forfeited, net				-490.4		€	19.27				-145.5		$	22.01			-602.4	$	60.1
	Options expired				0			0				7.9			0			-26.9	$	36.5
	Options Outstanding at
		31-Dec-13			17,569.70		€	21				1,829.80		$	23.6			7,074.10	$	40.82
	Aggregate Intrinsic
		Value(1)					€	0	(2)					$	8,120.60				$	0	(2)
	Weighted Average
		Remaining
		Contractual Term
		(in years)			4.24							1.28						4.9
	Options Exercisable at
		31-Dec-13			13,599.80		€	23.12				1,820.10		$	23.66			4,684.50		34.97
	Aggregate Intrinsic
		Value(1)					€	0	(2)					$	7,967.90				$	0	(2)
	Weighted Average
		Remaining
		Contractual Term
		(in years)			3.35							1.26						4.8
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions [Table Text Block]	'
				AXA Ordinary Shares												AllianceBernstein Holding Units
				2013				2012				2011				2013			2012			2011
	Dividend yield				7.52	%			7.54	%			7	%		8.0-8.3		%	6.2		%	5.4		%
	Expected volatility				31.27	%			39.89	%			33.9	%		49.7-49.8		%	49.2		%	47.3		%
	Risk-free interest rates				1.34	%			1.8	%			3.13	%		0.8-1.7		%	0.7		%	1.9		%
	Expected life in years				7.7				5.6				6.4				6			6			6
	Weighted average fair value per
		option at grant date		$	1.79			$	2.48			$	2.49			$	5.44		$	3.67		$	5.98
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	'
						Weighted
			Shares of			Average
			Restricted			Grant Date
			Stock			Fair Value
	Unvested as of January 1, 2013			177,001		$	27.23
	Granted			11,613		$	13.97
	Vested			117,235		$	33.91
	Forfeited			0			0
	Unvested as of December 31, 2013			71,379		$	14.09

INCOME_TAXES_TABLES

INCOME TAXES (TABLES)	12 Months Ended
	Dec. 31, 2013
Income Tax Tables [Abstract]	'
Summary Of Income Tax Eexpense Benefit [Table Text Block]	'
				2013			2012			2011
				(In Millions)
	Income tax (expense) benefit:
		Current (expense) benefit		$	197		$	-233		$	40
		Deferred (expense) benefit			1,876			391			-1,338
	Total			$	2,073		$	158		$	-1,298
Schedule Of Components Of Income Tax Expense Benefit [Table Text Block]	'
			2013			2012			2011
			(In Millions)
	Expected income tax (expense) benefit		$	1,858		$	-20		$	-1,443
	Noncontrolling interest			101			37			-36
	Separate Accounts investment activity			122			94			83
	Non-taxable investment income (loss)			20			24			8
	Adjustment of tax audit reserves			-14			-2			-7
	State income taxes			-6			7			7
	AllianceBernstein Federal and foreign taxes			2			10			-13
	Tax settlement			0			0			84
	Other			-10			8			19
	Income tax (expense) benefit		$	2,073		$	158		$	-1,298
Schedule Of Deferred Tax Assets And Liabilities [Table Text Block]	'
			31-Dec-13						31-Dec-12
			Assets			Liabilities			Assets			Liabilities
			(In Millions)
	Compensation and related benefits		$	104		$	0		$	207		$	0
	Reserves and reinsurance			0			688			0			2,419
	DAC			0			1,016			0			960
	Unrealized investment gains or losses			0			85			0			739
	Investments			0			1,410			0			1,137
	Alternative minimum tax credits			0			0			157			0
	Net operating losses			492			0			0			0
	Other			7			0			0			57
	Total		$	603		$	3,199		$	364		$	5,312
Unrecognized Tax Benefits Reconciliation [Table Text Block]	'
			2013			2012			2011
			(In Millions)
	Balance at January 1,		$	573		$	453		$	434
	Additions for tax positions of prior years			57			740			337
	Reductions for tax positions of prior years			-38			-620			-235
	Additions for tax positions of current year			0			0			1
	Settlements with tax authorities			0			0			-84
	Balance at December 31,		$	592		$	573		$	453

ACCUMULATED_OTHER_COMPREHENSIV1

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (TABLES)	12 Months Ended
	Dec. 31, 2013
Comprehensive Income Note Tables [Abstract]	'
Schedule Of Accumulated Other Comprehensive Income Loss [Table Text Block]	'
					December 31,
					2013			2012			2011
					(In Millions)
	Unrealized gains (losses) on investments				$	141		$	1,352		$	772
	Defined benefit pension plans					-757			-1,056			-1,082
	Total accumulated other comprehensive income (loss)					-616			296			-310
	Less: Accumulated other comprehensive (income) loss attributable
		to noncontrolling interest				13			21			13
	Accumulated Other Comprehensive Income (Loss) Attributable
		to AXA Equitable			$	-603		$	317		$	-297
				2013			2012			2011
				(In Millions)
	Change in net unrealized gains (losses) on investments:
		Net unrealized gains (losses) arising during the year		$	-1,550		$	658		$	571
		(Gains) losses reclassified into net earnings (loss) during the year(1)			49			59			18
	Net unrealized gains (losses) on investments				-1,501			717			589
	Adjustments for policyholders liabilities, DAC, insurance
		liability loss recognition and other			290			-137			-223
	Change in unrealized gains (losses), net of adjustments and (net of deferred
		income tax expense (benefit) of $654 million, $(318) million and $(193) million)			-1,211			580			366
	Change in defined benefit plans:
		Net gain (loss) arising during the year			198			-82			-169
		Prior service cost arising during the year			-			1			-
		Less: reclassification adjustments to net earnings (loss) for:(2)
			Amortization of net (gains) losses included in net periodic cost		101			106			94
			Amortization of net prior service credit included in net periodic cost		-			1			1
	Change in defined benefit plans (net of deferred income tax expense
		(benefit) of $161 million, $14 million and $(40) million)			299			26			-74
	Total other comprehensive income (loss), net of income taxes				-912			606			292
	Less: Other comprehensive (income) loss attributable
		to noncontrolling interest			-8			8			21
	Other Comprehensive Income (Loss) Attributable to AXA Equitable			$	-920		$	614		$	313

COMMITMENTS_AND_CONTINGENT_LIA1

COMMITMENTS AND CONTINGENT LIABILITIES (TABLES)	12 Months Ended
	Dec. 31, 2013
Commitments And Contingent Liabilites Tables [Abstract]	'
Schedule of Restructuring and Related Costs [Table Text Block]	'
		December 31,
		2013		2012		2011
		(In Millions)
	Balance, beginning of year	$	52	$	44	$	11
	Additions		140		54		79
	Cash payments		-66		-46		-43
	Other reductions		-4		0		-3
	Balance, End of Year	$	122	$	52	$	44

INSURANCE_GROUP_STATUTORY_FINA1

INSURANCE GROUP STATUTORY FINANCIAL INFORMATION (TABLES)	12 Months Ended
	Dec. 31, 2013
Statutory Financial Information Tables [Abstract]	'
Statutory Accounting Practices Disclosure [Table Text Block]	'
			December 31,
			2013		2012		2011
			(In Millions)
	Net change in statutory surplus and capital stock		$	-864	$	64	$	824
	Change in AVR			46		269		-211
	Net change in statutory surplus, capital stock and AVR			-818		333		613
	Adjustments:
		Future policy benefits and policyholders' account balances		-607		-508		-270
		DAC		75		142		-2,861
		Deferred income taxes		2,038		798		-1,272
		Valuation of investments		7		-377		16
		Valuation of investment subsidiary		-109		-306		590
		Increase (decrease) in the fair value of the reinsurance contract asset		-4,297		497		5,941
		Pension adjustment		-478		-41		111
		Amortization of deferred cost of insurance ceded to AXA Arizona		-280		-126		-156
		Shareholder dividends paid		468		362		379
		Changes in non-admitted assets		2		-489		-154
		Repayment of surplus Note		500		0		0
		Other, net		-74		-190		-10
	U.S. GAAP Net Earnings (Loss) Attributable to AXA Equitable		$	-3,573	$	95	$	2,927
			December 31,
			2013		2012		2011
			(In Millions)
	Statutory surplus and capital stock		$	3,825	$	4,689	$	4,625
	AVR			535		489		220
	Statutory surplus, capital stock and AVR			4,360		5,178		4,845
	Adjustments:
		Future policy benefits and policyholders' account balances		-3,884		-3,642		-2,456
		DAC		3,874		3,728		3,545
		Deferred income taxes		-2,672		-5,330		-5,357
		Valuation of investments		703		3,271		2,266
		Valuation of investment subsidiary		-515		-137		231
		Fair value of reinsurance contracts		6,747		11,044		10,547
		Deferred cost of insurance ceded to AXA Arizona		2,366		2,646		2,693
		Non-admitted assets		469		467		510
		Issuance of surplus notes		-1,025		-1,525		-1,525
		Other, net		115		-264		-459
	U.S. GAAP Total Equity Attributable to AXA Equitable		$	10,538	$	15,436	$	14,840

BUSINESS_SEGMENT_INFORMATION_T

BUSINESS SEGMENT INFORMATION (TABLES)	12 Months Ended
	Dec. 31, 2013
Business Segment Information Tables [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
		2013			2012				2011
		(In Millions)
	Segment revenues:
	Insurance	$	-54		$	6,443		$	15,140
	Investment Management(1)		2,915			2,738			2,750
	Consolidation/elimination		-21			-21			-18
	Total Revenues	$	2,840		$	9,160		$	17,872
			2013			2012			2011
			(In Millions)
	Segment earnings (loss) from continuing operations, before income taxes:
	Insurance		$	-5,872		$	-132		$	4,284
	Investment Management(2)			564			190			-164
	Consolidation/elimination			-1			0			4
	Total Earnings (Loss) from Continuing Operations, before Income Taxes		$	-5,309		$	58		$	4,124
		December 31,
		2013			2012
		(In Millions)
	Segment assets:
	Insurance	$	171,532		$	164,201
	Investment Management		11,873			12,647
	Consolidation/elimination		-4			-5
	Total Assets	$	183,401		$	176,843

QUARTERLY_RESULTS_OF_OPERATION1

QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) (TABLES)	12 Months Ended
	Dec. 31, 2013
Quarterly Results Of Operations Tables [Abstract]	'
Schedule Of Quarterly Financial Information [Table Text Block]	'
			Three Months Ended
			31-Mar		30-Jun		30-Sep		31-Dec
			(In Millions)
	2013
	Total Revenues		$	392	$	537	$	834	$	1,077
	Earnings (Loss) from Continuing Operations,
		Net of Income Taxes, Attributable to AXA Equitable	$	-1,004	$	-1,051	$	-878	$	-640
	Net Earnings (Loss), Attributable to AXA Equitable		$	-1,004	$	-1,051	$	-878	$	-640
	2012
	Total Revenues		$	-952	$	6,475	$	1,728	$	1,909
	Earnings (Loss) from Continuing Operations,
		Net of Income Taxes, Attributable to AXA Equitable	$	-1,635	$	2,421	$	-241	$	-450
	Net Earnings (Loss), Attributable to AXA Equitable		$	-1,635	$	2,421	$	-241	$	-450

SUMMARY_OF_INVESTMENTS_OTHER_T1

SUMMARY OF INVESTMENTS- OTHER THAN INVESTMENTS IN RELATED PARTIES- SCHEDULE I (TABLES)	12 Months Ended
	Dec. 31, 2013
Summary Of Investments OtherThan Investments In Related Parties Tables [Abstract]	'
Summary Of Investments Other Than Investments In Related Parties [Table Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE I
	SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES
	31-Dec-13
								Carrying
	Type of Investment			Cost(A)		Fair Value		Value
				(In Millions)
	Fixed Maturities:
		U.S. government, agencies and authorities		$	3,584	$	3,129	$	3,129
		State, municipalities and political subdivisions			444		477		477
		Foreign governments			359		393		393
		Public utilities			3,853		4,086		4,086
		All other corporate bonds			19,747		20,479		20,479
		Redeemable preferred stocks			849		855		855
	Total fixed maturities				28,836		29,419		29,419
	Equity securities:
		Common stocks:
			Industrial, miscellaneous and all other		37		34		34
	Mortgage loans on real estate				5,684		5,716		5,684
	Real estate joint ventures				3		N/A		3
	Policy loans				3,434		3,097		3,434
	Other limited partnership interests and equity investments				1,829		1,829		1,829
	Trading securities				4,225		4,221		4,221
	Other invested assets				1,353		1,353		1,353
	Total Investments			$	45,401	$	45,669	$	45,977

BALANCE_SHEETS_PARENT_COMPANY_

BALANCE SHEETS (PARENT COMPANY)- SCHEDULE II (TABLES)	12 Months Ended
	Dec. 31, 2013
Condensed Financial Information Of Parent Company Only Disclosure Tables [Abstract]	'
Schedule Of Condensed Financial Information Of Parent Company Only [Table Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE II
	BALANCE SHEETS (PARENT COMPANY)
	DECEMBER 31, 2013 AND 2012
				2013		2012
				(In Millions)
	ASSETS
	Investment:
		Fixed maturities available-for-sale, at fair value (amortized cost of
			$28,785 and $30,656 respectively)	$	29,365	$	33,538
		Mortgage loans on real estate			5,684		5,059
		Equity real estate, held for the production of income			3		4
		Policy loans			3,434		3,512
		Investments in and loans to affiliates			2,190		2,328
		Trading securities			3,647		1,834
		Other equity investments			1,666		1,403
		Other invested assets			1,348		1,826
			Total investments		47,337		49,504
	Cash and cash equivalents				1,704		2,450
	Deferred policy acquisition costs				3,874		3,728
	Amounts due from reinsurers				3,934		3,847
	Guaranteed minimum income benefit reinsurance asset, at fair value				6,747		11,044
	Other assets				3,941		4,576
	Separate Accounts' assets				108,857		94,139
	Total Assets			$	176,394	$	169,288
	LIABILITIES
	Policyholders' account balances			$	30,340	$	28,263
	Future policy benefits and other policyholders liabilities				21,666		22,655
	Broker-dealer related payables				29		213
	Short-term and long-term debt				200		200
	Current and deferred income taxes				2,073		4,479
	Loans from affiliates				825		1,325
	Other liabilities				1,866		2,578
	Separate Accounts' liabilities				108,857		94,139
			Total liabilities		165,856		153,852
	SHAREHOLDER'S EQUITY
	Common stock, $1.25 par value, 2.0 million shares authorized, issued and outstanding				2		2
	Capital in excess of par value				5,934		5,992
	Retained earnings				5,205		9,125
	Accumulated other comprehensive income (loss)				-603		317
			Total AXA Equitable's equity		10,538		15,436
	Total Liabilities and AXA Equitable's Equity			$	176,394	$	169,288

STATEMENTS_OF_EARNINGS_PARENT_

STATEMENTS OF EARNINGS (PARENT COMPANY)- SCHEDULE II (TABLES)	12 Months Ended
	Dec. 31, 2013
STATEMENTS OF EARNINGS (LOSS) (Details) [Abstract]	'
Income Statement [Table Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE II
	STATEMENTS OF EARNINGS (PARENT COMPANY)
	YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
				2013		2012		2011
				(In Millions)
	REVENUES
	Universal life and investment-type product policy fee income			$	3,546	$	3,334	$	3,312
	Premiums				496		514		533
	Net investment income (loss):
		Investment income (loss) from derivative instruments			-2,846		-943		2,369
		Other investment income (loss)			2,146		2,208		2,186
			Total net investment income (loss)		-700		1,265		4,555
	Investment gains (losses), net:
		Total other-than-temporary impairment losses			-81		-96		-36
		Portion of loss recognized in other comprehensive income (loss)			15		2		4
			Net impairment losses recognized		-66		-94		-32
		Other investment gains (losses), net			-25		14		-10
			Total investment gains (losses), net		-91		-80		-42
	Equity in earnings (loss) of subsidiaries				788		483		55
	Commissions, fees and other income				219		201		338
	Increase (decrease) in the fair value of the reinsurance contract asset				-4,297		497		5,941
			Total revenues		-39		6,214		14,692
	BENEFITS AND OTHER DEDUCTIONS
	Policyholders' benefits				1,689		2,986		4,357
	Interest credited to policyholders' account balances				1,373		1,166		999
	Compensation and benefits				432		399		372
	Commissions				1,173		1,265		1,212
	Interest expense				87		106		106
	Amortization of deferred policy acquisition costs				580		576		3,620
	Capitalization of deferred policy acquisition costs				-654		-718		-759
	Rent expense				35		34		47
	Premium taxes				36		42		43
	Other operating costs and expenses				789		472		651
			Total benefits and other deductions		5,540		6,328		10,648
	Earnings (loss) from continuing operations, before income taxes				-5,579		-114		4,044
	Income tax (expense) benefit				2,343		330		-1,218
	Net Earnings (Loss)				-3,236		216		2,826
		Less: net (earnings) loss attributable to the noncontrolling interest			-337		-121		101
	Net Earnings (Loss) Attributable to AXA Equitable				-3,573		95		2,927
	Total other comprehensive income (loss), net of income taxes
		Attributable to AXA Equitable			-920		614		313
	Comprehensive Income (Loss) Attributable to AXA Equitable			$	-4,493	$	709	$	3,240

STATEMENTS_OF_CASH_FLOWS_PAREN

STATEMENTS OF CASH FLOWS (PARENT COMPANY)- SCHEDULE II (TABLES)	12 Months Ended
	Dec. 31, 2013
STATEMENTS OF CASH FLOWS [Abstract]	'
Statement Of Cash Flows [Table Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE II
	STATEMENTS OF CASH FLOWS (PARENT COMPANY)
	YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
				2013		2012		2011
				(In Millions)
	Net earnings (loss)			$	-3,236	$	216	$	2,826
	Adjustments to reconcile net earnings (loss) to net cash provided
		by (used in) operating activities:
		Interest credited to policyholders' account balances			1,373		1,166		999
		Universal life and investment-type policy fee income			-3,546		-3,334		-3,312
		Investment gains (losses), net			91		80		42
		Equity in net earnings of subsidiaries			-788		-483		-55
		Dividends from subsidiaries			467		323		332
		Change in deferred policy acquisition costs			-74		-142		2,861
		Change in future policy benefits and other policyholder funds			-432		876		2,229
		(Income) loss related to derivative instruments			2,846		943		-2,369
		Change in reinsurance recoverable with affiliate			-175		-207		-242
		Change in the fair value of the reinsurance contract asset			4,297		-497		-5,941
		Change in current and deferred income taxes			-1,753		-224		1,250
		Amortization of reinsurance cost			280		47		211
		Amortization and depreciation			103		62		83
		Real estate asset write-off charge			52		0		0
		Other, net			363		-182		-190
	Net cash provided by (used in) operating activities				-132		-1,356		-1,276
	Cash flows from investing activities:
		Maturities and repayments of fixed maturities and mortgage loans
			on real estate		3,681		3,547		3,427
		Sales of investments			4,978		1,566		626
		Purchases of investments			-9,583		-7,563		-7,462
		Cash settlements related to derivative instruments			-2,479		-287		1,429
		Additional loans to affiliates			-56		0		0
		Decrease in loans to affiliates			5		4		0
		Change in short-term investments			0		34		16
		Change in policy loans			78		31		38
		Other, net			-103		-37		-44
	Net cash provided by (used in) investing activities				-3,479		-2,705		-1,970
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE II
	STATEMENTS OF CASH FLOWS (PARENT COMPANY)
	YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011 - CONTINUED
				2013		2012		2011
				(In Millions)
	Cash flows from financing activities:
		Policyholders' account balances:
			Deposits	$	5,469	$	5,437	$	4,461
			Withdrawals and transfers to Separate Accounts		-1,188		-982		-821
		Shareholder dividends paid			-234		-362		-379
		Capital contribution			0		195		0
		Change in collateralized pledged liabilities			-663		-288		989
		Change in collateralized pledged assets			-19		-5		99
		Decrease in loans from affiliates			-500		0		0
	Net cash provided by (used in) financing activities				2,865		3,995		4,349
	Change in cash and cash equivalents				-746		-66		1,103
	Cash and cash equivalents, beginning of year				2,450		2,516		1,413
	Cash and Cash Equivalents, End of Year			$	1,704	$	2,450	$	2,516
	Supplemental cash flow information:
		Interest Paid		$	91	$	107	$	106
		Income Taxes (Refunded) Paid		$	-227	$	261	$	15

SUPPLEMENTARY_INSURANCE_INFORM

SUPPLEMENTARY INSURANCE INFORMATION- SCHEDULE III (TABLES)	12 Months Ended
	Dec. 31, 2013
Supplementary Insurance Information [Abstract]	'
Supplementary Insurance Information For Insurance Companies [Table Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE III
	SUPPLEMENTARY INSURANCE INFORMATION
	AT AND FOR THE YEAR ENDED DECEMBER 31, 2013
							Future Policy		Policy						Amortization
			Deferred				Benefits		Charges		Net		Policyholders'		of Deferred
			Policy		Policyholders'		and other		And		Investment		Benefits and		Policy		Other
			Acquisition		Account		Policyholders'		Premium		Income		Interest		Acquisition		Operating
	Segment		Costs		Balances		Funds		Revenue		(Loss)(1)		Credited		Costs		Expense(2)
			(In Millions)
	Insurance		$	3,874	$	30,340	$	21,697	$	4,042	$	-724	$	3,064	$	580	$	2,174
	Investment
		Management		0		0		0		0		58		0		0		2,351
	Consolidation/
		Elimination		0		0		0		0		37		0		0		-20
	Total		$	3,874	$	30,340	$	21,697	$	4,042	$	-629	$	3,064	$	580	$	4,505
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE III
	SUPPLEMENTARY INSURANCE INFORMATION
	AT AND FOR THE YEAR ENDED DECEMBER 31, 2012
							Future Policy		Policy						Amortization
			Deferred				Benefits		Charges		Net		Policyholders'		of Deferred
			Policy		Policyholders'		and other		And		Investment		Benefits and		Policy		Other
			Acquisition		Account		Policyholders'		Premium		Income		Interest		Acquisition		Operating
	Segment		Costs		Balances		Funds		Revenue		(Loss)(1)		Credited		Costs		Expense(2)
			(In Millions)
	Insurance		$	3,728	$	28,263	$	22,687	$	3,848	$	1,242	$	4,155	$	576	$	1,844
	Investment
		Management		0		0		0		0		65		0		0		2,548
	Consolidation/
		Elimination		0		0		0		0		31		0		0		-21
	Total		$	3,728	$	28,263	$	22,687	$	3,848	$	1,338	$	4,155	$	576	$	4,371
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE III
	SUPPLEMENTARY INSURANCE INFORMATION
	AT AND FOR THE YEAR ENDED DECEMBER 31, 2011
			Policy						Amortization
			Charges		Net		Policyholders'		of Deferred
			And		Investment		Benefits and		Policy		Other
			Premium		Income		Interest		Acquisition		Operating
	Segment		Revenue		(Loss)(1)		Credited		Costs		Expense(2)
	Insurance		$	3,845	$	4,526	$	5,359	$	3,620	$	1,877
	Investment
		Management		0		-58		0		0		2,914
	Consolidation/
		Elimination		0		34		0		0		-22
	Total		$	3,845	$	4,502	$	5,359	$	3,620	$	4,769

REINSURANCE_SCHEDULE_IV_TABLES

REINSURANCE- SCHEDULE IV (TABLES)	12 Months Ended
	Dec. 31, 2013
Supplemental Schedule Of Reinsurance Premiums For Insurance Companies [Abstract]	'
Reinsurance Premiums For Insurance Companies By Product Segment [Table Text Block]	'
	AXA EQUITABLE LIFE INSURANCE COMPANY
	SCHEDULE IV
	REINSURANCE(A)
	AT OR FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
						Assumed				Percentage
				Ceded to		from				of Amount
		Gross		Other		Other		Net		Assumed
		Amount		Companies		Companies		Amount		to Net
		(Dollars In Millions)
	2013
	Life Insurance In-Force	$	414,362	$	92,252	$	33,494	$	355,604	9.4	%
	Premiums:
	Life insurance and annuities	$	770	$	511	$	201	$	460	43.7	%
	Accident and health		78		54		12		36	33.3	%
	Total Premiums	$	848	$	565	$	213	$	496	42.9	%
	2012
	Life Insurance In-Force	$	409,488	$	96,869	$	34,361	$	346,980	9.9	%
	Premiums:
	Life insurance and annuities	$	785	$	518	$	206	$	473	43.5	%
	Accident and health		88		60		13		41	31.7	%
	Total Premiums	$	873	$	578	$	219	$	514	42.6	%
	2011
	Life Insurance In-Force	$	396,304	$	101,926	$	34,738	$	329,116	10.6	%
	Premiums:
	Life insurance and annuities	$	815	$	521	$	195	$	489	39.9	%
	Accident and health		93		64		15		44	34.1	%
	Total Premiums	$	908	$	585	$	210	$	533	39.4	%

ORGANIZATIONS_DETAILS

ORGANIZATIONS (DETAILS) (USD $)	3 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
	Alliance Bernstein [Member]	Alliance Bernstein [Member]	AXA Equitable [Member]	AXA Equitable [Member]	Parent Company [Member]	Parent Company [Member]
Organization Basis Of Presentation [Line Items]	'	'	'	'	'	'
Economic Interest In AllianceBernstein	50.00%	'	32.70%	39.50%	63.70%	65.50%
Purchase of interest in subsidiary	50.00%	'	'	'	'	'
Increase in Equity	$6	'	'	'	'	'
Purchase price of this acquisition	21	'	'	'	'	'
Noncontrolling Interest, Period Increase (Decrease)	($27)	($60)	'	'	'	'

SIGNIFICANT_ACCOUNTING_POLICIE1

SIGNIFICANT ACCOUNTING POLICIES - VIEs (DETAILS) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Investments [Abstract]	'	'
Real Estate Held for Production of Income, Useful Life, Minimum (in years)	'40 years 0 months 0 days	'
Real Estate And Accumulated Depreciation Life Used For Depreciation Maximum	'50 years 0 months 0 days	'
Carrying value of COLI	$770,000,000	$715,000,000
Insurance Group [Member]	'	'
Consolidation Policy [Line Items]	'	'
Investment assets issued by VIEs	3,000,000	1,000,000
Variable Interest Entity Nonconsolidated Carrying Amount Assets	3,000,000	1,000,000
Alliance Bernstein [Member]	'	'
Consolidation Policy [Line Items]	'	'
Variable Interest Entity Nonconsolidated Carrying Amount Assets	26,000,000	'
Variable Interest Entity Entity Maximum Loss Exposure Amount	$200,000	'

SIGNIFICANT_ACCOUNTING_POLICIE2

SIGNIFICANT ACCOUNTING POLICIES - MORTGAGES REAL ESTATE (DETAILS) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Commercial Real Estate Portfolio Segment [Member]	'	'
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]	'	'
Nonaccrual Mortgage Loans on Real Estate, Net	$93	$0
Agricultural Real Estate Portfolio Segment [Member]	'	'
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]	'	'
Nonaccrual Mortgage Loans on Real Estate, Net	$0	$2

SIGNIFICANT_ACCOUNTING_POLICIE3

SIGNIFICANT ACCOUNTING POLICIES - DAC (DETAILS)	12 Months Ended
	Dec. 31, 2013
DAC [Abstract]	'
Estimated Average Annual Rate of Return, Gross	9.00%
Estimated Average Annual Rate of Return, Net	6.68%
Future Annual Rate of Return, Gross, Maximum	15.00%
Future Annual Rate of Return, Net, Maximum	12.68%
Future Annual Rate of Return, Gross, Minimum	0.00%
Future Annual Rate of Return, Net, Minimum	-2.32%
Future Annual Rate of Return, Assumption, Duration, Maximum (in years)	'5 years 0 months 0 days
Future Rate of Return, Gross, Annualized Rate	0.00%
Future Rate of Return, Gross, Annualized Period (in quarters)	'7
Future Rate of Return, Gross, Mean Rate	9.00%
Future Rate of Return, Gross, Period for Mean Rate (in quarters)	'15
Assumed Average Investment Yield Excluding Policy Loans, High End	5.30%
Assumed Average Investment Yield Excluding Policy Loans, Low End	5.00%
Period Used in Assumed Average Investment Yield Excluding Policy Loans (in years)	'10 years 0 months 0 days

SIGNIFICANT_ACCOUNTING_POLICIE4

SIGNIFICANT ACCOUNTING POLICIES - OTHER (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Policyholders Dividend Policy [Abstract]	'	'	'
Carrying Amount of Dividend Paying Policy as Percentage of Directly Written Life Insurance In-Force	5.20%	'	'
Carrying Amount Of Dividend Paying Policies	$21,194	'	'
Separate Accounts Disclosure [Abstract]	'	'	'
Gain (Loss) Recognized on Assets Transferred to Separate Account	$19,022	$10,110	($2,928)
Goodwill And Intangible Asset Impairment [Abstract]	'	'	'
Finite Lived Intangible Asset Useful Life	'20 years 0 months 0 days	'	'
Life Insurance Liabilities [Member]	'	'	'
Liability For Future Policy Benefits Assumptions [Line Items]	'	'	'
Traditional Life Interest Rate High End	10.90%	'	'
Traditional Life Interest Rate Low End	2.25%	'	'
Annuity Liabilities [Member]	'	'	'
Liability For Future Policy Benefits Assumptions [Line Items]	'	'	'
Liability for Policyholder Contract Deposits, Interest Rate, Deferred Annuity, Low End	1.57%	'	'
Liability for Policyholder Contract Deposits, Interest Rate, Deferred Annuity, High End	11.25%	'	'

INVESTMENTS_AVAILABLE_FOR_SALE

INVESTMENTS (AVAILABLE FOR SALE SECURITIES) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	$28,873	$30,743	'
Gross Unrealized Gains	1,600	3,216	'
Gross Unrealized Losses	1,020	328	'
Fair Value	29,453	33,631	'
OTTI in AOCI	27	18	'
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]	'	'	'
Subtotal, Fair Value	29,419	33,607	'
Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Abstract]	'	'	'
Proceeds from sales	3,220	139	340
Gross gains on sales	71	13	6
Gross losses on sales	-88	-12	-9
Total other-than-temporary impairment losses	-81	-96	-36
Non-credit losses recognized in OCI	-15	-2	-4
Net impairment losses recognized	-66	-94	-32
Corporate Debt Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	21,516	20,854	'
Gross Unrealized Gains	1,387	2,364	'
Gross Unrealized Losses	213	20	'
Fair Value	22,690	23,198	'
OTTI in AOCI	0	0	'
US Government Agencies Debt Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	3,584	4,664	'
Gross Unrealized Gains	22	517	'
Gross Unrealized Losses	477	1	'
Fair Value	3,129	5,180	'
OTTI in AOCI	0	0	'
US States and Political Subdivisions Debt Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	444	445	'
Gross Unrealized Gains	35	85	'
Gross Unrealized Losses	2	0	'
Fair Value	477	530	'
OTTI in AOCI	0	0	'
Foreign Government Debt Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	392	454	'
Gross Unrealized Gains	46	76	'
Gross Unrealized Losses	5	0	'
Fair Value	433	530	'
OTTI in AOCI	0	0	'
Commercial Mortgage Backed Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	971	1,175	'
Gross Unrealized Gains	10	16	'
Gross Unrealized Losses	265	291	'
Fair Value	716	900	'
OTTI in AOCI	23	13	'
Available For Sale Securities Debt Maturities Amortized Cost [Abstract]	'	'	'
Amortized Cost Basis, without Single Maturity Date	971	'	'
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]	'	'	'
Fair Value, without Single Maturity Date	716	'	'
Residential Mortgage Backed Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	914	1,864	'
Gross Unrealized Gains	34	85	'
Gross Unrealized Losses	1	0	'
Fair Value	947	1,949	'
OTTI in AOCI	0	0	'
Available For Sale Securities Debt Maturities Amortized Cost [Abstract]	'	'	'
Amortized Cost Basis, without Single Maturity Date	914	'	'
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]	'	'	'
Fair Value, without Single Maturity Date	947	'	'
Asset-backed Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	132	175	'
Gross Unrealized Gains	11	12	'
Gross Unrealized Losses	3	5	'
Fair Value	140	182	'
OTTI in AOCI	4	5	'
Available For Sale Securities Debt Maturities Amortized Cost [Abstract]	'	'	'
Amortized Cost Basis, without Single Maturity Date	132	'	'
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]	'	'	'
Fair Value, without Single Maturity Date	140	'	'
Redeemable Preferred Stock [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	883	1,089	'
Gross Unrealized Gains	55	60	'
Gross Unrealized Losses	51	11	'
Fair Value	887	1,138	'
OTTI in AOCI	0	0	'
Fixed Maturities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	28,836	30,720	'
Gross Unrealized Gains	1,600	3,215	'
Gross Unrealized Losses	1,017	328	'
Fair Value	29,419	33,607	'
OTTI in AOCI	27	18	'
Available For Sale Securities Debt Maturities Amortized Cost [Abstract]	'	'	'
Due in one year or less, Amortized Cost	953	'	'
Due in years two through five, Amortized Cost	7,786	'	'
Due in years six through ten, Amortized Cost	10,232	'	'
Due after ten years, Amortized Cost	6,965	'	'
Subtotal, Amortized Cost Basis	25,936	'	'
Amortized Cost Basis, without Single Maturity Date	27,953	'	'
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]	'	'	'
Due in one year or less, Fair Value	969	'	'
Due in years two through five, Fair Value	8,387	'	'
Due in years six through ten, Fair Value	10,561	'	'
Due after ten years, Fair Value	6,812	'	'
Subtotal, Fair Value	26,729	'	'
Available For Sale Securities, Debt Maturities, Fair Value	28,532	'	'
Fixed Maturities - Credit Loss Impairments	'	'	'
Balance beginning of period	-372	-332	'
Previously recognized impairments on securities that matured, paid, prepaid or sold	-67	-54	'
Impairments recognized this period on securities not previously impaired	-59	-62	'
Additional impairments this period on securities previously impaired	-6	-32	'
Balances at December 31,	-370	-372	'
Equity Securities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	37	23	'
Gross Unrealized Gains	0	1	'
Gross Unrealized Losses	3	0	'
Fair Value	34	24	'
OTTI in AOCI	0	0	'
Trading Fixed Maturities [Member]	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Amortized Cost Basis	243	194	'
Gross Unrealized Gains	2	12	'
Gross Unrealized Losses	7	4	'
Fair Value	$238	$202	'

INVESTMENTS_NET_UNREALIZED_INV

INVESTMENTS (NET UNREALIZED INVESTMENTS) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Net unrealized gains (losses) arising during the year	($1,550)	$658	$571
Fixed Maturities [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, Attributable to AXA Equitable, End of Year	579	2,888	'
Fixed Maturities [Member] | Unrealized Investment Gains Losses With Otti Losses [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, Attributable to AXA Equitable, End of Year	-28	-12	'
Fixed Maturities [Member] | Unrealized Investment Gains Losses All Other [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, Attributable to AXA Equitable, End of Year	610	2,899	'
Fixed Maturities [Member] | Net Unrealized Gains (Losses) On Investmetns [Member] | Unrealized Investment Gains Losses With Otti Losses [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	-12	-47	'
Net unrealized gains (losses) arising during the year	-14	5	'
Reclassification adjustment for OTTI losses Included in Net earnings (loss)	13	32	'
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	-15	-2	'
Balance, Attributable to AXA Equitable, End of Year	-28	-12	'
Fixed Maturities [Member] | Net Unrealized Gains (Losses) On Investmetns [Member] | Unrealized Investment Gains Losses All Other [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	2,900	1,831	'
Net unrealized gains (losses) arising during the year	-2,370	1,008	'
Reclassification adjustment for OTTI losses Included in Net earnings (loss)	62	59	'
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	15	2	'
Balance, Attributable to AXA Equitable, End of Year	607	2,900	'
Fixed Maturities [Member] | DAC [Member] | Unrealized Investment Gains Losses With Otti Losses [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	1	5	'
Impact of net unrealized investment gains (losses) on DAC	1	-4	'
Balance, Attributable to AXA Equitable, End of Year	2	1	'
Fixed Maturities [Member] | DAC [Member] | Unrealized Investment Gains Losses All Other [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	-179	-207	'
Impact of net unrealized investment gains (losses) on DAC	72	28	'
Balance, Attributable to AXA Equitable, End of Year	-107	-179	'
Fixed Maturities [Member] | Policyholders Liabilities [Member] | Unrealized Investment Gains Losses With Otti Losses [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	4	6	'
Impact of net unrealized investment gains (losses) on Policyholders liabilities	6	-2	'
Balance, Attributable to AXA Equitable, End of Year	10	4	'
Fixed Maturities [Member] | Policyholders Liabilities [Member] | Unrealized Investment Gains Losses All Other [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	-603	-385	'
Impact of net unrealized investment gains (losses) on Policyholders liabilities	358	-218	'
Balance, Attributable to AXA Equitable, End of Year	-245	-603	'
Fixed Maturities [Member] | Deferred Income Tax Asset Liability [Member] | Unrealized Investment Gains Losses With Otti Losses [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	2	12	'
Impact of net unrealized investment gains (losses) on Deferred income taxes	3	-10	'
Balance, Attributable to AXA Equitable, End of Year	5	2	'
Fixed Maturities [Member] | Deferred Income Tax Asset Liability [Member] | Unrealized Investment Gains Losses All Other [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	-741	-433	'
Impact of net unrealized investment gains (losses) on Deferred income taxes	651	-308	'
Balance, Attributable to AXA Equitable, End of Year	-90	-741	'
Fixed Maturities [Member] | AOCI Gain Losses Related to Net Unrealized Investment Gains Losses [Member] | Unrealized Investment Gains Losses With Otti Losses [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	-5	-24	'
Net unrealized gains (losses) arising during the year	-14	5	'
Reclassification adjustment for OTTI losses Included in Net earnings (loss)	13	32	'
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	-15	-2	'
Impact of net unrealized investment gains (losses) on DAC	1	-4	'
Impact of net unrealized investment gains (losses) on Deferred income taxes	3	-10	'
Impact of net unrealized investment gains (losses) on Policyholders liabilities	6	-2	'
Balance, Attributable to AXA Equitable, End of Year	-11	-5	'
Fixed Maturities [Member] | AOCI Gain Losses Related to Net Unrealized Investment Gains Losses [Member] | Unrealized Investment Gains Losses All Other [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, attributable to AXA Equitable, beginning of year	1,377	806	'
Net unrealized gains (losses) arising during the year	-2,370	1,008	'
Reclassification adjustment for OTTI losses Included in Net earnings (loss)	62	59	'
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	15	2	'
Impact of net unrealized investment gains (losses) on DAC	72	28	'
Impact of net unrealized investment gains (losses) on Deferred income taxes	651	-308	'
Impact of net unrealized investment gains (losses) on Policyholders liabilities	358	-218	'
Balance, Attributable to AXA Equitable, End of Year	165	1,377	'
Equity Securities [Member] | Unrealized Investment Gains Losses All Other [Member]	'	'	'
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]	'	'	'
Balance, Attributable to AXA Equitable, End of Year	($3)	$1	'

INVESTMENTS_FIXED_MATURITIES_A

INVESTMENTS (FIXED MATURITIES AVAILABLE FOR SALE) (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	$7,654	$1,286	'
Less than 12 Months, Gross unrealized Losses	-725	-10	'
12 Months or Longer, Fair Value	892	1,379	'
12 Months or Longer, Gross unrealized Losses	-292	-318	'
Total Fair Value	8,546	2,665	'
Total Gross unrealized losses	-1,017	-328	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	28,873	30,743	'
Investment Income Investment Expense	-57	-50	-55
Trading Securities, Cost	4,225	2,265	'
Trading securities	4,221	2,309	'
Separate Account Equity Investment Carrying Value	192	58	'
Separate Account Equity Investment Cost	183	57	'
Equity Securities, Carrying Value	34	24	'
Equity Securities, Amortized Cost	37	23	'
Net Realized and Unrealized Gain (Loss) on Trading Securities	48	69	-42
Subprime residential mortgage loans [Member]	'	'	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Other Investments and Securities, at Cost	10	17	'
Alt residential mortgage loans [Member]	'	'	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Other Investments and Securities, at Cost	8	11	'
Corporate Debt Securities [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	4,381	562	'
Less than 12 Months, Gross unrealized Losses	-187	-5	'
12 Months or Longer, Fair Value	248	208	'
12 Months or Longer, Gross unrealized Losses	-26	-15	'
Total Fair Value	4,629	770	'
Total Gross unrealized losses	-213	-20	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Debt Securities Exposure In Single Issuer Of Total Investments	158	138	'
Available-for-sale Securities, Amortized Cost Basis	21,516	20,854	'
US Government Agencies Debt Securities [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	2,645	513	'
Less than 12 Months, Gross unrealized Losses	-477	-1	'
Total Fair Value	2,645	513	'
Total Gross unrealized losses	-477	-1	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	3,584	4,664	'
US States and Political Subdivisions Debt Securities [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	36	20	'
Less than 12 Months, Gross unrealized Losses	-2	'	'
Total Fair Value	36	20	'
Total Gross unrealized losses	-2	'	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	444	445	'
Foreign Government Debt Securities [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	68	6	'
Less than 12 Months, Gross unrealized Losses	-4	'	'
12 Months or Longer, Fair Value	7	2	'
12 Months or Longer, Gross unrealized Losses	-1	'	'
Total Fair Value	75	8	'
Total Gross unrealized losses	-5	'	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	392	454	'
Commercial Mortgage Backed Securities [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	30	7	'
Less than 12 Months, Gross unrealized Losses	-5	-3	'
12 Months or Longer, Fair Value	529	805	'
12 Months or Longer, Gross unrealized Losses	-260	-288	'
Total Fair Value	559	812	'
Total Gross unrealized losses	-265	-291	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	971	1,175	'
Residential Mortgage Backed Securities [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	260	27	'
Less than 12 Months, Gross unrealized Losses	-1	'	'
12 Months or Longer, Fair Value	1	1	'
Total Fair Value	261	28	'
Total Gross unrealized losses	-1	'	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	914	1,864	'
Asset-backed Securities [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	2	8	'
12 Months or Longer, Fair Value	28	36	'
12 Months or Longer, Gross unrealized Losses	-3	-5	'
Total Fair Value	30	44	'
Total Gross unrealized losses	-3	-5	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	132	175	'
Redeemable Preferred Stock [Member]	'	'	'
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]	'	'	'
Less than Twelve Months, Fair Value	232	143	'
Less than 12 Months, Gross unrealized Losses	-49	-1	'
12 Months or Longer, Fair Value	79	327	'
12 Months or Longer, Gross unrealized Losses	-2	-10	'
Total Fair Value	311	470	'
Total Gross unrealized losses	-51	-11	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis	883	1,089	'
Fixed Maturities [Member]	'	'	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Debt Securities Exposure In Single Issuer Greater Than Stated Percentage Of Total Investments	0.30%	'	'
Available-for-sale Securities, Amortized Cost Basis	28,836	30,720	'
Accumulated Other Comprehensive Income Unrealized Gain Loss On Available For Sale Securities	579	2,888	'
The carrying value of fixed maturities non-income producing	17	'	'
Fixed Maturities [Member] | Other Than Investment Grade [Member] | External Credit Rating, Non Investment Grade [Member]	'	'	'
Investments In Fixed Maturity Securities Other Disclosure [Abstract]	'	'	'
Available-for-sale Securities, Amortized Cost Basis Other Than Investment Grade	1,913	2,095	'
Percentage Of Available For Sale Securities	6.60%	6.80%	'
Accumulated Other Comprehensive Income Unrealized Gain Loss On Available For Sale Securities	$215	$224	'

INVESTMENTS_Troubled_Debt_Rest

INVESTMENTS (Troubled Debt Restructuring) (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Financing Receivable, Modifications [Line Items]	'	'	'
Gross Interest Income Recognized In Investment Income Restructured Mortgage Loans	$2	$7	$7
Gross Interest Income Restructured Mortgage Loans Pre Modification	7	8	7
Commercial Real Estate Portfolio Segment [Member]	'	'	'
Financing Receivable, Modifications [Line Items]	'	'	'
Number of loans	2	'	'
Outstanding Recorded Investment Pre Modification	126	'	'
Outstanding Recorded Investment Post Modification	$135	$126	'

INVESTMENTS_M_Loans_DETAILS

INVESTMENTS (M Loans) (DETAILS) (Commercial Real Estate Portfolio Segment [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Commercial Real Estate Portfolio Segment [Member]	'	'	'
Allowance for Credit Losses [Roll Forward]	'	'	'
Beginning balance	$34	$32	$18
Charge-offs	0	0	0
Recoveries	2	24	8
Provisions	10	26	22
Ending balance	42	34	32
Ending Balance [Abstract]:	'	'	'
Financing Receivable, Allowance for Credit Losses, Individually Evaluated for Impairment	$42	$34	$32

INVESTMENTS_Loans_DETAILS

INVESTMENTS ( Loans) (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Impaired Mortgage Loans [Abstract]	'	'
Unpaid principal balance	'	$170
Interest Income recognized	0	'
Commercial Real Estate Portfolio Segment [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	3,856	3,435
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
30 to 59 Days Past Due	0	0
60 to 89 Days Past Due	0	0
Greater than 90 Days Past Due	0	0
Total Past Due	0	0
Current	3,856	3,435
Total financing receivables	3,856	3,435
Recorded Investment 90 Days Past Due and Still Accruing	0	0
Commercial Real Estate Portfolio Segment [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	896	700
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	896	700
Commercial Real Estate Portfolio Segment [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	573	198
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	573	198
Commercial Real Estate Portfolio Segment [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	984	854
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	984	854
Commercial Real Estate Portfolio Segment [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	833	1,256
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	833	1,256
Commercial Real Estate Portfolio Segment [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	303	247
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	303	247
Commercial Real Estate Portfolio Segment [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	267	180
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	267	180
Commercial Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	321	317
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	321	317
Commercial Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	285	269
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	285	269
Commercial Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	21
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	21
Commercial Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	36	27
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	36	27
Commercial Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	2,272	1,719
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	2,272	1,719
Commercial Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	360	370
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	360	370
Commercial Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	573	75
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	573	75
Commercial Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	671	619
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	671	619
Commercial Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	533	655
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	533	655
Commercial Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	135	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	135	0
Commercial Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	993	989
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	993	989
Commercial Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	116	61
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	116	61
Commercial Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	102
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	102
Commercial Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	313	235
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	313	235
Commercial Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	240	445
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	240	445
Commercial Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	105	131
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	105	131
Commercial Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	219	15
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	219	15
Commercial Real Estate Portfolio Segment [Member] | More than ninty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	270	'
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	270	'
Commercial Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	135	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	135	0
Commercial Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	60	156
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	60	156
Commercial Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	27	89
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	27	89
Commercial Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	48	165
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	48	165
Commercial Real Estate Portfolio Segment [Member] | With No Related Allowance Recorded [Member]	'	'
Impaired Mortgage Loans [Abstract]	'	'
Recorded Investment	0	0
Unpaid principal balance	0	0
Related allowance	0	0
Average Record investments	0	0
Interest Income recognized	'	0
Commercial Real Estate Portfolio Segment [Member] | With Related Allowance Recorded [Member]	'	'
Impaired Mortgage Loans [Abstract]	'	'
Recorded Investment	135	170
Unpaid principal balance	135	'
Related allowance	-42	-34
Average Record investments	139	178
Interest Income recognized	2	10
Agricultural Real Estate Portfolio Segment [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	1,870	1,658
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
30 to 59 Days Past Due	5	6
60 to 89 Days Past Due	4	1
Greater than 90 Days Past Due	14	10
Total Past Due	23	17
Current	1,847	1,641
Total financing receivables	1,870	1,658
Recorded Investment 90 Days Past Due and Still Accruing	14	9
Agricultural Real Estate Portfolio Segment [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	312	301
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	312	301
Agricultural Real Estate Portfolio Segment [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	132	113
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	132	113
Agricultural Real Estate Portfolio Segment [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	407	347
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	407	347
Agricultural Real Estate Portfolio Segment [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	574	497
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	574	497
Agricultural Real Estate Portfolio Segment [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	357	293
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	357	293
Agricultural Real Estate Portfolio Segment [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	88	107
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	88	107
Agricultural Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	1,148	1,008
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	1,148	1,008
Agricultural Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	185	179
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	185	179
Agricultural Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	82	84
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	82	84
Agricultural Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	214	211
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	214	211
Agricultural Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	410	308
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	410	308
Agricultural Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	208	177
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	208	177
Agricultural Real Estate Portfolio Segment [Member] | Zero to fifty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	49	49
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	49	49
Agricultural Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	722	641
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	722	641
Agricultural Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	127	122
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	127	122
Agricultural Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	50	29
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	50	29
Agricultural Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	193	136
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	193	136
Agricultural Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	164	188
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	164	188
Agricultural Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	149	116
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	149	116
Agricultural Real Estate Portfolio Segment [Member] | Fifty to seventy percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	39	50
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	39	50
Agricultural Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	9
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	9
Agricultural Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	1
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	1
Agricultural Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | Seventy to ninty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	8
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	8
Agricultural Real Estate Portfolio Segment [Member] | More than ninty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | More than ninty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment [Member] | With No Related Allowance Recorded [Member]	'	'
Impaired Mortgage Loans [Abstract]	'	'
Recorded Investment	0	2
Unpaid principal balance	0	2
Related allowance	0	0
Average Record investments	1	3
Interest Income recognized	0	0
Agricultural Real Estate Portfolio Segment [Member] | With Related Allowance Recorded [Member]	'	'
Impaired Mortgage Loans [Abstract]	'	'
Recorded Investment	0	0
Unpaid principal balance	0	0
Related allowance	0	0
Average Record investments	0	0
Interest Income recognized	0	0
Total Mortgages Loan [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	5,726	5,093
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
30 to 59 Days Past Due	5	6
60 to 89 Days Past Due	4	1
Greater than 90 Days Past Due	14	10
Total Past Due	23	17
Current	5,703	5,076
Total financing receivables	5,726	5,093
Recorded Investment 90 Days Past Due and Still Accruing	14	9
Total Mortgages Loan [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	1,208	1,001
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	1,208	1,001
Total Mortgages Loan [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	705	311
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	705	311
Total Mortgages Loan [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	1,391	1,201
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	1,391	1,201
Total Mortgages Loan [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	1,407	1,753
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	1,407	1,753
Total Mortgages Loan [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	660	540
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	660	540
Total Mortgages Loan [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	355	287
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	355	287
Total Mortgages Loan [Member] | Zero to fifty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	1,469	1,325
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	1,469	1,325
Total Mortgages Loan [Member] | Zero to fifty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	470	448
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	470	448
Total Mortgages Loan [Member] | Zero to fifty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	82	105
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	82	105
Total Mortgages Loan [Member] | Zero to fifty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	214	211
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	214	211
Total Mortgages Loan [Member] | Zero to fifty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	410	308
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	410	308
Total Mortgages Loan [Member] | Zero to fifty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	244	204
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	244	204
Total Mortgages Loan [Member] | Zero to fifty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	49	49
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	49	49
Total Mortgages Loan [Member] | Fifty to seventy percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	2,994	2,360
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	2,994	2,360
Total Mortgages Loan [Member] | Fifty to seventy percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	487	492
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	487	492
Total Mortgages Loan [Member] | Fifty to seventy percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	623	104
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	623	104
Total Mortgages Loan [Member] | Fifty to seventy percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	864	755
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	864	755
Total Mortgages Loan [Member] | Fifty to seventy percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	697	843
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	697	843
Total Mortgages Loan [Member] | Fifty to seventy percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	284	116
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	284	116
Total Mortgages Loan [Member] | Fifty to seventy percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	39	50
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	39	50
Total Mortgages Loan [Member] | Seventy to ninty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	993	998
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	993	998
Total Mortgages Loan [Member] | Seventy to ninty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	116	61
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	116	61
Total Mortgages Loan [Member] | Seventy to ninty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	102
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	102
Total Mortgages Loan [Member] | Seventy to ninty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	313	235
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	313	235
Total Mortgages Loan [Member] | Seventy to ninty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	240	446
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	240	446
Total Mortgages Loan [Member] | Seventy to ninty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	105	131
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	105	131
Total Mortgages Loan [Member] | Seventy to ninty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	219	23
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	219	23
Total Mortgages Loan [Member] | More than ninty percent [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	270	410
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	270	410
Total Mortgages Loan [Member] | More than ninty percent [Member] | Ratio greater than 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	135	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	135	0
Total Mortgages Loan [Member] | More than ninty percent [Member] | Ratio between 1.8 to 2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Total Mortgages Loan [Member] | More than ninty percent [Member] | Ratio between 1.5 to 1.8 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	0	0
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	0	0
Total Mortgages Loan [Member] | More than ninty percent [Member] | Ratio between 1.2 to 1.5 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	60	156
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	60	156
Total Mortgages Loan [Member] | More than ninty percent [Member] | Ratio between 1 to 1.2 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	27	89
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	27	89
Total Mortgages Loan [Member] | More than ninty percent [Member] | Ratio less than 1 times [Member]	'	'
Mortgage Loans by Loan-to-Value & Debt Service Coverage Ratios [Line Items]	'	'
Mortgage Loans on Real Estate, Face Amount of Mortgages	48	165
Age Analysis of Past Due Mortgage Loans [Abstract]	'	'
Total financing receivables	48	165
Total Mortgages Loan [Member] | With No Related Allowance Recorded [Member]	'	'
Impaired Mortgage Loans [Abstract]	'	'
Recorded Investment	0	2
Unpaid principal balance	0	2
Related allowance	0	0
Average Record investments	1	3
Interest Income recognized	0	0
Total Mortgages Loan [Member] | With Related Allowance Recorded [Member]	'	'
Impaired Mortgage Loans [Abstract]	'	'
Recorded Investment	135	170
Unpaid principal balance	135	170
Related allowance	-42	-34
Average Record investments	139	178
Interest Income recognized	$2	$10

INVESTMENTS_Equity_DETAILS

INVESTMENTS (Equity) (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity Method Investments [Line Items]	'	'	'
Equity investments limited partnership carrying value	$1,596	$1,520	'
Total equity in net earnings (losses)	206	170	179
Equity Method Investment [Member]	'	'	'
Equity Method Investments [Line Items]	'	'	'
Equity investment real estate joint ventures	3	0	'
Investment 10 million or greater and equity interest of 10% Or greater [Member]	'	'	'
Balance sheet equity method [Abstract]	'	'	'
Total Assets	734	309	'
Total liabilities	169	173	'
Partners' capital	565	136	'
Total Liabilities and Partners' Capital	734	309	'
The Company's Carrying Value in investements	216	63	'
Statement of earnings and loss [Abstract]	'	'	'
Net Earnings (Loss)	14	10	35
The Company's Equity in Net Earnings (Loss)	9	18	20
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Revenues of real estate joint ventures [Member]	'	'	'
Statement of earnings and loss [Abstract]	'	'	'
Net Earnings (Loss)	25	26	111
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Net revenues of other limited partnership interests [Member]	'	'	'
Statement of earnings and loss [Abstract]	'	'	'
Net Earnings (Loss)	11	3	6
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Interest expense - third party [Member]	'	'	'
Statement of earnings and loss [Abstract]	'	'	'
Net Earnings (Loss)	0	0	-21
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Other Expenses [Member]	'	'	'
Statement of earnings and loss [Abstract]	'	'	'
Net Earnings (Loss)	-22	-19	-61
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Investments in real estate, at depreciated cost [Member]	'	'	'
Balance sheet equity method [Abstract]	'	'	'
Total Assets	231	233	'
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Investments in securities, generally at fair value [Member]	'	'	'
Balance sheet equity method [Abstract]	'	'	'
Total Assets	482	54	'
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Cash and Cash Equivalents [Member]	'	'	'
Balance sheet equity method [Abstract]	'	'	'
Total Assets	7	8	'
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Other assets [Member]	'	'	'
Balance sheet equity method [Abstract]	'	'	'
Total Assets	14	14	'
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Borrowed funds - third party [Member]	'	'	'
Balance sheet equity method [Abstract]	'	'	'
Total liabilities	159	162	'
Investment 10 million or greater and equity interest of 10% Or greater [Member] | Other liabilities [Member]	'	'	'
Balance sheet equity method [Abstract]	'	'	'
Total liabilities	$10	$11	'

INVESTMENTS_Derivatives_DETAIL

INVESTMENTS (Derivatives) (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	$37,174	$53,307
Fair Value Assets Derivatives	8,222	12,837
Fair Value Liabilities Derivatives	1,207	895
Gain (losses) reported in net earnings (losses)	-7,327	-455
Equity Contracts Futures [Member]	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	4,935	6,189
Fair Value Liabilities Derivatives	3	2
Gain (losses) reported in net earnings (losses)	-1,434	-1,058
Equity Contracts Swaps [Member] Member	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	1,293	965
Fair Value Assets Derivatives	'	2
Fair Value Liabilities Derivatives	51	56
Gain (losses) reported in net earnings (losses)	-316	-320
Equity Contracts Options [Member] Member	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	7,506	3,492
Fair Value Assets Derivatives	1,056	443
Fair Value Liabilities Derivatives	593	219
Gain (losses) reported in net earnings (losses)	366	66
Interest Rate Floor [Member]	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	2,400	2,700
Fair Value Assets Derivatives	193	291
Fair Value Liabilities Derivatives	0	'
Gain (losses) reported in net earnings (losses)	-5	68
Interest rate contracts Swaps [Member] Member	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	9,823	18,239
Fair Value Assets Derivatives	216	554
Fair Value Liabilities Derivatives	212	353
Gain (losses) reported in net earnings (losses)	-1,010	402
Interest rate contracts Futures [Member]	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	10,763	14,033
Gain (losses) reported in net earnings (losses)	-314	84
Interest rate contracts Swaptions [Member] Member	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	'	7,608
Fair Value Assets Derivatives	'	502
Gain (losses) reported in net earnings (losses)	-154	-220
Credit Default Swap [Member]	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	342	'
Fair Value Assets Derivatives	10	'
Fair Value Liabilities Derivatives	1	'
Gain (losses) reported in net earnings (losses)	4	'
Foreign currency Contracts [Member] Member	'	'
Derivative Instruments by Category [Line Items]	'	'
Derivative, Notional Amount	112	81
Fair Value Assets Derivatives	1	1
Fair Value Liabilities Derivatives	1	'
Gain (losses) reported in net earnings (losses)	-3	'
Net investment Income (loss) [Member] Member	'	'
Derivative Instruments by Category [Line Items]	'	'
Gain (losses) reported in net earnings (losses)	-2,866	-978
Gmib Reinsurance [Member]	'	'
Derivative Instruments by Category [Line Items]	'	'
Fair Value Assets Derivatives	6,746	11,044
Gain (losses) reported in net earnings (losses)	-4,297	497
GIB and GWBL and Other Features [Member]	'	'
Derivative Instruments by Category [Line Items]	'	'
Fair Value Liabilities Derivatives	'	265
Gain (losses) reported in net earnings (losses)	265	26
SCS, SIO, MSO and IUL indexed features	'	'
Derivative Instruments by Category [Line Items]	'	'
Fair Value Liabilities Derivatives	346	'
Gain (losses) reported in net earnings (losses)	($429)	'

INVESTMENTS_Derivatives_DETAIL1

INVESTMENTS (Derivatives) (DETAILS1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Accounting Policies [Abstract]	'	'
Cash And Securities Collateral For Derivative Contract	$607	$1,165
Collateralized derivative transactions	42	5
Cash and securities collateral	35	5
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices [Member]	'	'
Exchange Traded Future Contract [Line Items]	'	'
Exchange-Traded Future Contract, Initial Margin Requirement	194	'
Us Treasury Notes Ultra Long Bonds And Euro Dollar [Member]	'	'
Exchange Traded Future Contract [Line Items]	'	'
Exchange-Traded Future Contract, Initial Margin Requirement	58	'
Euro Stoxx, FTSE100, EAFE And Topix Indices [Member]	'	'
Exchange Traded Future Contract [Line Items]	'	'
Exchange-Traded Future Contract, Initial Margin Requirement	$6	'

INVESTMENTS_offsetting_Details

INVESTMENTS (offsetting) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Offsetting Assets [Line Items]	'	'
Fair Value Assets Derivatives	$8,222	$12,837
Investment Management [Member]	'	'
Offsetting Assets [Line Items]	'	'
Fair Value Assets Derivatives	3	2
Securities Borrowed	84	106
Equity Contract [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	1,056	444
Gross amounts offset in the balance sheets	642	272
Net amounts presented in the balance sheets	414	172
Interest Rate Contract [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	344	1,251
Gross amounts offset in the balance sheets	211	351
Net amounts presented in the balance sheets	133	900
Credit Default Swap [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	9	'
Net amounts presented in the balance sheets	9	'
Fair Value Assets Derivatives	10	'
Derivatives Subject to an ISDA Master Agreements [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	1,409	1,695
Gross amounts offset in the balance sheets	853	623
Net amounts presented in the balance sheets	556	1,072
Derivatives not subject to an ISDA Master Agreements [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	64	96
Net amounts presented in the balance sheets	64	96
Total Derivatives [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	1,473	1,791
Gross amounts offset in the balance sheets	853	623
Net amounts presented in the balance sheets	620	1,168
Other Financial Instruments [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	733	660
Net amounts presented in the balance sheets	733	660
Other Invested Assets [Member]	'	'
Offsetting Assets [Line Items]	'	'
Gross amounts recognized	2,206	2,451
Gross amounts offset in the balance sheets	853	623
Net amounts presented in the balance sheets	$1,353	$1,828

INVESTMENTS_offsetting_Details1

INVESTMENTS (offsetting) (Details1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Offsetting Liabilities [Line Items]	'	'
Fair Value Liabilities Derivatives	$1,207	$895
Investment Management [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Fair Value Liabilities Derivatives	8	7
Securities Loaned	65	13
Equity Contract [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Gross amount recognized	642	272
Gross amounts offset in the balance sheets	642	272
Interest Rate Contract [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Gross amount recognized	211	351
Gross amounts offset in the balance sheets	211	351
Credit Default Swap [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Fair Value Liabilities Derivatives	1	'
Derivatives Subject to an ISDA Master Agreements [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Gross amount recognized	853	623
Gross amounts offset in the balance sheets	853	623
Derivative [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Gross amount recognized	853	623
Gross amounts offset in the balance sheets	853	623
Other Financial Liabilities [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Gross amount recognized	2,653	3,503
Net amounts presented in the balance sheets	2,653	3,503
Other liabilities [Member]	'	'
Offsetting Liabilities [Line Items]	'	'
Gross amount recognized	3,506	4,126
Gross amounts offset in the balance sheets	853	623
Net amounts presented in the balance sheets	$2,653	$3,503

INVESTMENTS_offsetting_Details2

INVESTMENTS (offsetting) (Details2) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Counterparty A [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	$46	$30
Collateral Cash (Received)	-46	-30
Counterparty B [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	17	32
Collateral Cash (Received)	-17	-29
Net Amounts	'	3
Counterparty C [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	28	55
Collateral Cash (Received)	-28	-55
Counterparty D [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	175	310
Collateral Cash (Received)	-175	-310
Counterparty E [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	47	38
Collateral Cash (Received)	-47	-38
Counterparty F [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	-28	326
Collateral Cash (Received)	'	-326
Collateral Cash Held	28	'
Counterparty G [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	134	55
Colleteral Securities (Received)	-134	'
Collateral Cash (Received)	'	-55
Counterparty H [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	4	-5
Collateral Cash (Received)	-4	'
Collateral Cash Held	'	5
Counterparty I [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	-2	98
Collateral Cash (Received)	'	-98
Collateral Cash Held	2	'
Counterparty J [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	-12	19
Collateral Cash (Received)	'	-19
Collateral Cash Held	12	'
Counterparty K[Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	41	15
Collateral Cash (Received)	-38	-3
Net Amounts	3	12
Counterparty L [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	72	48
Colleteral Securities (Received)	'	-46
Collateral Cash (Received)	-69	'
Net Amounts	3	2
Counterparty M [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	30	51
Collateral Cash (Received)	-30	-51
Counterparty N [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	64	96
Net Amounts	64	96
Counterparty Q [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	4	'
Collateral Cash (Received)	-4	'
Derivative [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	620	1,168
Colleteral Securities (Received)	-134	-46
Collateral Cash (Received)	-416	-1,009
Net Amounts	70	113
Other Financial Instruments [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	733	660
Net Amounts	733	660
Other Investments [Member]	'	'
Offsetting Assets [Line Items]	'	'
Net amounts presented in the balance sheets	1,353	1,828
Colleteral Securities (Received)	-134	-46
Collateral Cash (Received)	-416	-1,009
Net Amounts	$803	$773

INVESTMENTS_Net_Investment_Inc

INVESTMENTS (Net Investment Income) (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	($569)	$1,391	$4,560
Investment Income Investment Expense	-57	-50	-55
Investment Income Interest Expense	-3	-3	-3
Total net investment income (loss)	-629	1,338	4,502
Realized Investment Gains Losses	-99	-97	-47
Unrealized Gain Loss On Derivatives	-37	-746	1,071
Schedule Of Gain Loss On Investments Including Marketable Securities And Investments Held At Cost Income Statement Reported Amounts Summary [Abstract]	'	'	'
Investment (gains) losses, net	-99	-97	-47
Fixed Maturities [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	1,462	1,529	1,555
Realized Investment Gains Losses	-75	-89	-29
Mortgage Loans On Real Estate [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	284	264	241
Realized Investment Gains Losses	-7	-7	-14
Real Estate Investment [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	1	14	19
Equity Method Investments [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	234	189	116
Realized Investment Gains Losses	-17	-13	-4
Policy Loans [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	219	226	229
Short Term Investments [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	1	15	5
Derivative [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	-2,866	-978	2,374
Realized Investment Gains Losses	-2,829	-232	1,303
Broker Dealer Related Receivables [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	14	14	13
Trading Assets Excluding Debt And Equity Securities [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	48	85	-29
Other Investments [Member]	'	'	'
Schedule Of Investment Income Reported Amounts By Category [Line Items]	'	'	'
Interest and Dividend Income Operating	34	33	37
Realized Investment Gains Losses	$0	$12	$0

GOODWILL_AND_OTHER_INTANGIBLE_1

GOODWILL AND OTHER INTANGIBLE ASSETS (DETAILS) (USD $)	12 Months Ended
Share data in Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Goodwill And Intangible Asset Impairment [Line Items]	'	'	'
Amortization expense related to the AllianceBernstein intangible assets	$24,000,000	$24,000,000	$24,000,000
AllianceBernstein acquired W P Stewart [Abstract]	'	'	'
Goodwill And Other Intangible Assets Net	3,703,000,000	3,673,000,000	'
Capitalized Software, Net [Abstract]	'	'	'
Capitalize software costs, net of accumulated amortization	163,000,000	237,000,000	'
Capitalize software costs, amortization	119,000,000	45,000,000	'
Capitalize software costs, accelerated amortization	77,000,000	81,000,000	'
Alliance Bernstein [Member]	'	'	'
Goodwill And Intangible Asset Impairment [Line Items]	'	'	'
Carrying value of goodwill related to AllianceBernstein	3,504,000,000	3,472,000,000	'
Alliance Bernstein [Member] | Investment Management [Member]	'	'	'
Goodwill And Intangible Asset Impairment [Line Items]	'	'	'
Gross carrying amount of AllianceBernstein related intangible assets	583,000,000	561,000,000	'
Accumulated amortization of these intangible assets	384,000,000	360,000,000	'
Amortization expense related to the AllianceBernstein intangible assets	24,000,000	24,000,000	23,000,000
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	25,000,000	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Two	25,000,000	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Three	25,000,000	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Four	25,000,000	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Five	25,000,000	'	'
Investment Management segments Other assets [Abstract]	'	'	'
Net deferred sales commissions	71,000,000	95,000,000	'
Estimated amortization expense of deferred sales commissions for year 1	29,000,000	'	'
Estimated amortization expense of deferred sales commissions for year 2	20,000,000	'	'
Estimated amortization expense of deferred sales commissions for year 3	15,000,000	'	'
Estimated amortization expense of deferred sales commissions for year 4	5,000,000	'	'
Estimated amortization expense of deferred sales commissions for year 5	0	'	'
Alliance Bernstein [Member] | W P Stewart [Member]	'	'	'
AllianceBernstein acquired W P Stewart [Abstract]	'	'	'
Business Acquisition Additional Cash Payment Per Share	$4	'	'
Alliance Bernstein [Member] | W P Stewart [Member] | Investment Management [Member]	'	'	'
AllianceBernstein acquired W P Stewart [Abstract]	'	'	'
Business Acquisition, Effective Date of Acquisition	12-Dec-13	'	'
Assets Under Management	2,000,000,000	'	'
Cash Payment per Share on Date of Acquisitions	$12	'	'
Business Acquisition Shares Outstanding And Issued To Shareholders Transferable Contingent Value Rights	4.9	'	'
Business Acquisition Maximum Amount Equity Investment Manage By Acquiree	5,000,000,000	'	'
Goodwill And Other Intangible Assets Net	32,000,000	'	'
Finite-lived Intangible Assets Acquired	14,000,000	'	'
Indefinite-lived Intangible Assets Acquired	8,000,000	'	'
Contingent Consideration Payable	$17,000,000	'	'

CLOSED_BLOCKS_DETAILS

CLOSED BLOCKS (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Closed Block Liabilities [Abstract]	'	'	'
Closed Block Liabilities, Future Policy Benefits and Policyholder Account Balances	$7,716	$7,942	'
Policyholder dividend obligation	128	373	260
Other liabilities	144	192	'
Total Closed Block liabilities	7,988	8,507	'
Assets Designated To Closed Block [Abstract]	'	'	'
Fixed maturities, available for sale, at fair value (amortized cost of $5,416 and $5,575)	5,232	5,741	'
Mortgage loans on real estate	1,343	1,255	'
Policy loans	949	1,026	'
Assets Designated To Closed Block Cash And Cash Equivalents	48	30	'
Assets Designated To Closed Block Other Closed Block Assets	186	204	'
Total assets designated to the Closed Block	7,758	8,256	'
Excess of Closed Block liabilities over assets designated to the Closed Block	230	251	'
Amounts included in accumulated other comprehensive income (loss) [Abstract]	'	'	'
Net unrealized investment gains (losses) net of deferred income tax (expense) benefit of $(28) and $(23) and policyholder dividend obligation of $(119) and $0	83	87	'
Maximum Future Earnings To Be Recognized From Closed Block Assets and Liabilities	313	338	'
Closed Block Operations Revenue [Abstract]	'	'	'
Premiums and other income	286	316	354
Investment income (loss)	402	420	438
Net investment gains (losses)	-11	-9	-10
Total Revenues	677	727	782
Closed Block Operations Benefits And Expense [Abstract]	'	'	'
Policyholders benefits and dividends	637	724	757
Other operating costs and expenses	1	0	2
Total benefits and other deductions	638	724	759
Net revenues, before income taxes	39	3	23
Income tax (expense) benefit	-14	-1	-8
Net Revenues	25	2	15
Movement In Closed Block Dividend Obligation [Roll Forward]	'	'	'
Balances, beginning of year	373	260	'
Unrealized investment gains (losses)	-245	113	'
Balances, End of year	128	373	260
Closed Block Investments Fixed Maturity Available For Sale Amortized Cost	4,987	5,245	'
Closed Block Operations, Income Taxes	$45	$47	'

CONTRACTHOLDER_BONUS_INTEREST_2

CONTRACTHOLDER BONUS INTEREST CREDITS (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Changes in the deferred asset for contractholder bonus interest credits	'	'
Balance, beginning of year	$621	$718
Contractholder bonus interest credits deferred	18	30
Amortization Charged To Income	121	127
Balance, End of Year	$518	$621

FAIR_VALUE_DISCLOSURES_DETAILS

FAIR VALUE DISCLOSURES (DETAILS) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	$29,453	$33,631
Trading securities	4,221	2,309
Fair Value, Measurements, Recurring [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	29,419	33,607
Other equity investments	294	155
Trading securities	4,221	2,309
Other invested assets:	717	1,261
Cash equivalents	1,310	2,289
Segregated securities	981	1,551
GMIB reinsurance contracts	6,747	11,044
Separate Accounts assets	108,764	93,750
Total Assets	152,453	145,966
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	'	265
Total Liabilities	346	265
Fair Value, Measurements, Recurring [Member] | Corporate Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	22,691	23,198
Fair Value, Measurements, Recurring [Member] | US Government Agencies Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	3,129	5,180
Fair Value, Measurements, Recurring [Member] | US States and Political Subdivisions Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	477	530
Fair Value, Measurements, Recurring [Member] | Foreign Government Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	433	530
Fair Value, Measurements, Recurring [Member] | Commercial Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	716	900
Fair Value, Measurements, Recurring [Member] | Residential Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	947	1,949
Fair Value, Measurements, Recurring [Member] | Asset-backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	139	182
Fair Value, Measurements, Recurring [Member] | Redeemable Preferred Stock [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	887	1,138
Fair Value, Measurements, Recurring [Member] | Short Term Investments [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	99	98
Fair Value, Measurements, Recurring [Member] | Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	-45	148
Fair Value, Measurements, Recurring [Member] | Credit Default Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	9	'
Fair Value, Measurements, Recurring [Member] | Future [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	-2	-2
Fair Value, Measurements, Recurring [Member] | Options Held [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	463	224
Fair Value, Measurements, Recurring [Member] | Interest Rate Floor [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	193	291
Fair Value, Measurements, Recurring [Member] | Swaptions [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	502
Fair Value, Measurements, Recurring [Member] | GWBL and other features' liability	'	'
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	0	'
Fair Value, Measurements, Recurring [Member] | SCS, SIO, MSO and IUL indexed features	'	'
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	346	'
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	216	248
Other equity investments	233	78
Trading securities	529	446
Other invested assets:	-2	-2
Cash equivalents	1,310	2,289
Segregated securities	0	0
GMIB reinsurance contracts	0	0
Separate Accounts assets	105,579	90,751
Total Assets	107,865	93,810
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	'	0
Total Liabilities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Corporate Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	6
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | US Government Agencies Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | US States and Political Subdivisions Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Foreign Government Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Commercial Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Residential Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Asset-backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Redeemable Preferred Stock [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	216	242
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Short Term Investments [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Credit Default Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	'
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Future [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	-2	-2
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Options Held [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Interest Rate Floor [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | Swaptions [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 1 [Member] | GWBL and other features' liability	'	'
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	0	'
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	28,064	31,898
Other equity investments	9	0
Trading securities	3,692	1,863
Other invested assets:	719	1,263
Cash equivalents	0	0
Segregated securities	981	1,551
GMIB reinsurance contracts	0	0
Separate Accounts assets	2,948	2,775
Total Assets	36,413	39,350
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	'	0
Total Liabilities	346	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Corporate Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	22,400	22,837
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | US Government Agencies Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	3,129	5,180
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | US States and Political Subdivisions Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	431	480
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Foreign Government Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	433	511
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Commercial Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	16	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Residential Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	943	1,940
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Asset-backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	56	69
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Redeemable Preferred Stock [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	656	881
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Short Term Investments [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	99	98
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	-45	148
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Credit Default Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	9	'
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Future [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Options Held [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	463	224
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Interest Rate Floor [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	193	291
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | Swaptions [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	502
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | GWBL and other features' liability	'	'
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	0	'
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 2 [Member] | SCS, SIO, MSO and IUL indexed features	'	'
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	346	'
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	1,139	1,461
Other equity investments	52	77
Trading securities	0	0
Other invested assets:	0	0
Cash equivalents	0	0
Segregated securities	0	0
GMIB reinsurance contracts	6,747	11,044
Separate Accounts assets	237	224
Total Assets	8,175	12,806
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	'	265
Total Liabilities	0	265
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Corporate Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	291	355
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | US Government Agencies Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | US States and Political Subdivisions Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	46	50
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Foreign Government Debt Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	0	19
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Commercial Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	700	900
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Residential Mortgage Backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	4	9
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Asset-backed Securities [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	83	113
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Redeemable Preferred Stock [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Available-for-sale Securities, Fair Value Disclosure	15	15
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Short Term Investments [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Credit Default Swap [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	'
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Future [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Options Held [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Interest Rate Floor [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | Swaptions [Member]	'	'
Investment Fair Value Disclosure [Abstract]	'	'
Other invested assets:	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value Inputs Level 3 [Member] | GWBL and other features' liability	'	'
Liabilities Fair Value Disclosure [Abstract]	'	'
Guarantees, Fair Value Disclosure	$0	'

FAIR_VALUE_DISCLOSURES_DETAILS1

FAIR VALUE DISCLOSURES (DETAILS 1) (USD $)	3 Months Ended			12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2012
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]	'	'	'	'	'	'
Available-for-sale Securities, Fair Value Disclosure	$29,453	'	'	$29,453	$33,631	'
Fair Value, Freestanding Contract	617	'	'	617	1,163	'
Freestanding Contract As Percentage Of Other Invested Assets Measured At Fair Value On Recurring Basis	'	'	'	86.10%	92.20%	'
Fair Value Adjustments On Over Counter Derivative Assets	'	'	'	0.4	'	'
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]	'	'	'	'	'	'
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3	9	20	14	37	109	'
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount	'	'	'	'	'	6
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	'	'	'	20	17	'
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Percentage	'	'	'	0.40%	0.70%	'
Fair Value Inputs Level 1 [Member]	'	'	'	'	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]	'	'	'	'	'	'
Percentage Of Assets Measured At Fair Value On Recurring Basis By Inputs Level	'	'	'	74.50%	70.30%	'
Fair Value Inputs Level 2 [Member]	'	'	'	'	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]	'	'	'	'	'	'
Percentage Of Assets Measured At Fair Value On Recurring Basis By Inputs Level	'	'	'	24.50%	28.40%	'
Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value	970	'	'	970	1,966	'
Fair Value Inputs Level 3 [Member]	'	'	'	'	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]	'	'	'	'	'	'
Percentage Of Assets Measured At Fair Value On Recurring Basis By Inputs Level	'	'	'	1.00%	1.30%	'
Fair Value Disclosures Broker Priced	150	'	'	150	222	'
Financial Instruments, Owned, Mortgages, Mortgage-backed and Asset-backed Securities, at Fair Value	787	'	'	787	1,021	'
Public Fixed Maturities [Member]	'	'	'	'	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]	'	'	'	'	'	'
Available-for-sale Securities, Fair Value Disclosure	21,671	'	'	21,671	25,591	'
Percentage Of Available For Sale Fixed Maturity Assets Measured At Fair Value On Recurring Basis	'	'	'	15.00%	19.20%	'
Private Fixed Maturities [Member]	'	'	'	'	'	'
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]	'	'	'	'	'	'
Available-for-sale Securities, Fair Value Disclosure	$7,748	'	'	$7,748	$8,016	'
Percentage Of Available For Sale Fixed Maturity Assets Measured At Fair Value On Recurring Basis	'	'	'	5.40%	6.00%	'

FAIR_VALUE_DISCLOSURES_DETAILS2

FAIR VALUE DISCLOSURES (DETAILS 2) (USD $)	3 Months Ended			12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Investment (gains) losses, net	'	'	'	($99)	($97)	($47)
Transfers into level 3	'	'	'	20	17	'
Transfers out of Level 3	9	20	14	37	109	'
Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	4	141	'
Corporate Debt Securities [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	432	355	432	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	2	2	'
Investment (gains) losses, net	'	'	'	5	4	'
Subtotal	'	'	'	7	6	'
Other comprehensive income (loss)	'	'	'	-1	15	'
Purchases	'	'	'	70	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	150	47	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	20	17	'
Transfers out of Level 3	'	'	'	-10	-68	'
Closing Balance	291	'	'	291	355	'
Corporate Debt Securities [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	-2	14	'
US States and Political Subdivisions Debt Securities [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	53	50	53	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Subtotal	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	-3	-1	'
Purchases	'	'	'	0	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	1	2	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	0	0	'
Closing Balance	46	'	'	46	50	'
US States and Political Subdivisions Debt Securities [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	-4	-1	'
Foreign Government Debt Securities [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	22	19	22	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Subtotal	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	-2	0	'
Purchases	'	'	'	0	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	17	0	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	0	-3	'
Closing Balance	0	'	'	0	19	'
Foreign Government Debt Securities [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	0	1	'
Commercial Mortgage Backed Securities [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	902	900	902	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	2	'
Investment (gains) losses, net	'	'	'	-68	-105	'
Subtotal	'	'	'	-68	-103	'
Other comprehensive income (loss)	'	'	'	13	128	'
Purchases	'	'	'	31	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	160	27	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	-16	0	'
Closing Balance	700	'	'	700	900	'
Commercial Mortgage Backed Securities [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	6	124	'
Residential Mortgage Backed Securities [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	14	9	14	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Subtotal	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	-1	0	'
Purchases	'	'	'	0	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	4	5	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	0	0	'
Closing Balance	4	'	'	4	9	'
Asset-backed Securities [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	172	113	172	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Subtotal	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	3	4	'
Purchases	'	'	'	0	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	22	25	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	-11	-38	'
Closing Balance	83	'	'	83	113	'
Asset-backed Securities [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	4	3	'
Redeemable Preferred Stock [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	14	15	14	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Subtotal	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	0	1	'
Purchases	'	'	'	0	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	0	0	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	0	0	'
Closing Balance	15	'	'	15	15	'
Equity Method Investments [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	77	77	77	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	10	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	-7	0	'
Policyholders' benefits	'	'	'	0	0	'
Subtotal	'	'	'	3	0	'
Other comprehensive income (loss)	'	'	'	0	0	'
Purchases	'	'	'	4	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	-3	0	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	-29	0	'
Closing Balance	52	'	'	52	77	'
Gmib Reinsurance [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	10,547	11,044	10,547	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	-4,496	315	'
Policyholders' benefits	'	'	'	0	0	'
Subtotal	'	'	'	-4,496	315	'
Other comprehensive income (loss)	'	'	'	0	0	'
Purchases	'	'	'	237	182	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	-38	0	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	0	0	'
Closing Balance	6,747	'	'	6,747	11,044	'
Gmib Reinsurance [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	-4,297	497	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	0	0	'
Separate Accounts [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	215	224	215	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	10	8	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Subtotal	'	'	'	10	8	'
Other comprehensive income (loss)	'	'	'	-1	0	'
Purchases	'	'	'	6	6	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	-3	-2	'
Settlements	'	'	'	-2	-3	'
Transfers into level 3	'	'	'	3	0	'
Transfers out of Level 3	'	'	'	0	0	'
Closing Balance	237	'	'	237	224	'
Separate Accounts [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	10	8	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	0	0	'
GIB and GWBL and Other Features [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	291	265	291	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	-351	-77	'
Subtotal	'	'	'	-351	-77	'
Other comprehensive income (loss)	'	'	'	0	0	'
Purchases	'	'	'	86	51	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	0	0	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	0	0	'
Closing Balance	0	'	'	0	265	'
GIB and GWBL and Other Features [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	265	-26	'
Other comprehensive income (loss)	'	'	'	0	0	'
Other Invested Assets [Member]	'	'	'	'	'	'
Fair Value Assets Measured on Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'	'	'	'	'
Opening Balance	'	'	-2	0	-2	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Subtotal	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	0	2	'
Purchases	'	'	'	0	0	'
Issuances	'	'	'	0	0	'
Sales	'	'	'	0	0	'
Settlements	'	'	'	0	0	'
Transfers into level 3	'	'	'	0	0	'
Transfers out of Level 3	'	'	'	0	0	'
Closing Balance	0	'	'	0	0	'
Other Fixed Maturities Available For Sale [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	0	0	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	0	0	'
Policyholders' benefits	'	'	'	0	0	'
Other comprehensive income (loss)	'	'	'	0	0	'
Total Debt Maturities Available For Sale [Member] | Level 3 Assets And Liabilities Still Held [Member]	'	'	'	'	'	'
Total Gains Losses Realized Unrealized Included In [Abstract]	'	'	'	'	'	'
Net investment income (loss)	'	'	'	0	0	'
Investment (gains) losses, net	'	'	'	10	8	'
Increase (decrease) in the fair value of the reinsurance contracts	'	'	'	-4,297	497	'
Policyholders' benefits	'	'	'	265	-26	'
Other comprehensive income (loss)	'	'	'	$4	$141	'

FAIR_VALUE_DISCLOSURES_DETAILS3

FAIR VALUE DISCLOSURES (DETAILS 3) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

In Millions, unless otherwise specified

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

Corporate Debt Securities [Member]

US States and Political Subdivisions Debt Securities [Member]

US States and Political Subdivisions Debt Securities [Member]

US States and Political Subdivisions Debt Securities [Member]

Foreign Government Debt Securities [Member]

Foreign Government Debt Securities [Member]

Foreign Government Debt Securities [Member]

Commercial Mortgage Backed Securities [Member]

Commercial Mortgage Backed Securities [Member]

Commercial Mortgage Backed Securities [Member]

Commercial Mortgage Backed Securities [Member]

Commercial Mortgage Backed Securities [Member]

Commercial Mortgage Backed Securities [Member]

Commercial Mortgage Backed Securities [Member]

Commercial Mortgage Backed Securities [Member]

Residential Mortgage Backed Securities [Member]

Residential Mortgage Backed Securities [Member]

Residential Mortgage Backed Securities [Member]

Residential Mortgage Backed Securities [Member]

Residential Mortgage Backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Asset-backed Securities [Member]

Redeemable Preferred Stock [Member]

Redeemable Preferred Stock [Member]

Redeemable Preferred Stock [Member]

Equity Method Investments [Member]

Equity Method Investments [Member]

Equity Method Investments [Member]

Equity Method Investments [Member]

Equity Method Investments [Member]

Equity Method Investments [Member]

Equity Method Investments [Member]

Equity Method Investments [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

Other Invested Assets [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

GMIB Reinsurance Contract Asset [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

Separate Accounts [Member]

GMIB and GWBL [Member]

GMIB and GWBL [Member]

GMIB and GWBL [Member]

GMIB and GWBL [Member]

GMIB and GWBL [Member]

GMIB and GWBL [Member]

Minimum [Member]

Maximum [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Minimum [Member]

Maximum [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Matrix Pricing Model Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Market Comparable Companies Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Third Party Appraisal Valuation Technique [Member]

Third Party Appraisal Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Discounted Cash Flow Valuation Technique [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Fair Value Inputs [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Spread Over Industry Yield Curve BPS

'

'

'

125

650

'

'

125

550

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

45

'

'

'

'

'

'

30

'

687

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

256

'

434

'

'

'

'

'

'

'

'

'

Constant Default Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Probability Of Default

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

55.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Severity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

49.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Discount Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.72%

13.42%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18.00%

18.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.30%

1.00%

6.80%

2.00%

7.40%

7.70%

'

'

'

'

'

'

Spread Over US Treasury Curve BPS

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

46

'

'

'

'

'

'

30

'

695

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

275

'

586

'

'

'

'

'

'

'

'

Revenue Multiple

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.2

0.6

4.9

62.5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Research And Development Multiple

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.1

1

17.1

30.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Discount Years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year 0 months 0 days

'1 year 0 months 0 days

'

'2 years 0 months 0 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Discount For Lack Of Marketability Risk Factors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

40.00%

60.00%

60.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Capitalization Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.40%

5.50%

'

'

'

'

'

'

Exit Capitalization Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.40%

6.60%

'

'

'

'

'

'

Inflation Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.00%

2.00%

2.30%

3.00%

'

'

'

'

'

'

'

'

Lapse Rates

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

1.50%

8.00%

8.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

1.00%

8.00%

8.00%

Withdrawal Rates

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.20%

0.20%

8.00%

8.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

0.00%

0.00%

7.00%

7.00%

GMIB Utilization Rates

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.00%

0.00%

15.00%

15.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non Performance Risk

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7

13

21

45

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Volatility Rates- Equity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20.00%

24.00%

33.00%

36.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

20.00%

24.00%

33.00%

36.00%

Fair Value Unabsorvable Inputs

$291

$355

$432

'

'

$54

$94

'

'

$46

$50

$53

$0

$19

$22

$700

$900

$902

'

'

$889

'

'

$4

$9

$14

$1

$1

$83

$113

$172

$7

$8

'

'

'

'

$15

$15

$14

$52

$77

$77

$38

'

'

'

'

$0

$0

($2)

$52

'

'

'

'

'

$6,747

$11,044

$10,547

$6,747

$11,044

'

'

'

'

$237

$224

$215

$11

$22

'

'

'

'

$215

$194

$61

$205

'

'

'

'

FAIR_VALUE_DISCLOSURES_DETAILS4

FAIR VALUE DISCLOSURES (DETAILS 4) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Measurements Not Included In Quantitative Information About Level 3 Fair Value Measurements	$1,088	$516
Fair Value Measurements Not Included In Quantitative Information Percentage Of Total Assets Classified As Level 3	76.20%	29.30%
Fair Value Measurements Not Included In Quantitative Information Percentage Of Total Assets Measured At Fair Value On Recurring Basis	0.80%	0.40%
Corporate Debt Securities [Member] | Matrix Pricing Model Valuation Technique [Member] | Private Available For Sale Corporate Securities [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Percentage Of Level 3 Asset Fair Value	18.60%	26.50%
Fair Value Unabsorvable Inputs	54	94
Residential Mortgage Backed Securities [Member] | Matrix Pricing Model Valuation Technique [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Percentage Of Level 3 Asset Fair Value	25.00%	11.10%
Asset-backed Securities [Member] | Matrix Pricing Model Valuation Technique [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Percentage Of Level 3 Asset Fair Value	8.40%	7.10%
Equity Method Investments [Member] | Private Venture Capital Fund Of Fund [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Unabsorvable Inputs	30	30
Partnership Unfunded Committments	10	12
Separate Accounts [Member] | Private Real Estate Fund [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Unabsorvable Inputs	219	194
Separate Accounts [Member] | Collateralized Mortgage Backed Securities [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Unabsorvable Inputs	3	4
Separate Accounts [Member] | Asset-backed Securities [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Unabsorvable Inputs	7	4
Separate Accounts [Member] | Discounted Cash Flow Valuation Technique [Member] | Other Private Equity Investment [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Unabsorvable Inputs	4	4
Separate Accounts [Member] | Third Party Appraisal And Discounted Cash Flow Valuation Technique [Member] | Private Equity Funds [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Unabsorvable Inputs	215	198
Separate Accounts [Member] | Third Party Appraisal Valuation Technique [Member] | Mortgage Loans On Real Estate [Member]	'	'
Fair Value Inputs Assets Quantitative Information 1 [Line Items]	'	'
Fair Value Unabsorvable Inputs	$7	$18

FAIR_VALUE_DISCLOSURES_DETAILS5

FAIR VALUE DISCLOSURES (DETAILS 5) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Consolidated Amounts [Abstract]	'	'
Mortgage Loans On Real Estate	$5,684	$5,059
Investment contracts	30,340	28,263
Long-term debt	200	200
Loans to affiliates	1,088	1,037
Loans from affiliates	825	1,325
Carrying (Reported) Amount, Fair Value Disclosure [Member]	'	'
Consolidated Amounts [Abstract]	'	'
Mortgage Loans On Real Estate	5,684	5,059
Other limited partnership interests	1,592	1,514
Investment contracts	2,435	2,494
Long-term debt	200	200
Loans to affiliates	1,088	1,037
Loans from affiliates	825	1,325
Portion at Fair Value, Fair Value Disclosure [Member]	'	'
Consolidated Amounts [Abstract]	'	'
Mortgage Loans On Real Estate	5,716	5,249
Other limited partnership interests	1,592	1,514
Investment contracts	2,523	2,682
Long-term debt	225	236
Loans to affiliates	1,198	1,186
Loans from affiliates	969	1,676
Portion at Fair Value, Fair Value Disclosure [Member] | Fair Value Inputs Level 2 [Member]	'	'
Consolidated Amounts [Abstract]	'	'
Long-term debt	225	236
Loans to affiliates	800	784
Loans from affiliates	969	1,676
Portion at Fair Value, Fair Value Disclosure [Member] | Fair Value Inputs Level 3 [Member]	'	'
Consolidated Amounts [Abstract]	'	'
Mortgage Loans On Real Estate	5,716	5,249
Other limited partnership interests	1,592	1,514
Investment contracts	2,523	2,682
Loans to affiliates	$398	$402

GMDB_GMIB_GWBL_AND_NO_LAPSE_GU2

GMDB, GMIB, GWBL AND NO LAPSE GUARANTEE FEATURES (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Movement In Guaranteed Benefit Liability Gross [Line Items]	'	'	'
Opening Balance	$6,333	$5,723	$3,576
Paid guarantee benefits	562	365	250
Other changes in reserve	58	975	2,397
Closing Balance	5,829	6,333	5,723
Guaranteed Minimum Death Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross [Line Items]	'	'	'
Opening Balance	1,772	1,593	1,265
Paid guarantee benefits	237	288	203
Other changes in reserve	91	467	531
Closing Balance	1,626	1,772	1,593
Guaranteed Minimum Death Benefit Reinsurance Ceded [Abstract]	'	'	'
Opening Balance	844	716	533
Paid guarantee benefits	109	127	81
Other changes in reserve	56	255	264
Closing Balance	791	844	716
Guaranteed Minimum Income Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross [Line Items]	'	'	'
Opening Balance	4,561	4,130	2,311
Paid guarantee benefits	325	77	47
Other changes in reserve	-33	508	1,866
Closing Balance	$4,203	$4,561	$4,130

GMDB_GMIB_GWBL_AND_NO_LAPSE_GU3

GMDB, GMIB, GWBL AND NO LAPSE GUARANTEE FEATURES 2 (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
The GIB and GWBL and other guaranteed benefits related liability	'	$265
Impact On Earnings From Offer To Purchase Guaranteed Benefits Rider From Policyholders	20	'
SCS, SIO, MSO, IUL, GIB and GWBL and other Features	346	'
Guaranteed Minimum Death Benefit [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	13,834	'
Separate Accounts	87,098	76,026
Net amount at risk, gross	13,522	'
Net amount at risk, net of amounts reinsured	5,984	'
Average attained age of contractholders	'54 years 7 months 6 days	'
Percentage of contractholders over age 70	15.50%	'
Guaranteed Minimum Death Benefit [Member] | Minimum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'3.0	'
Guaranteed Minimum Death Benefit [Member] | Maximum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'6.5	'
Guaranteed Minimum Death Benefit [Member] | Return Of Premium [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	13,121	'
Separate Accounts	36,658	'
Net amount at risk, gross	270	'
Net amount at risk, net of amounts reinsured	270	'
Average attained age of contractholders	'50 years 9 months 18 days	'
Percentage of contractholders over age 70	8.40%	'
Guaranteed Minimum Death Benefit [Member] | Ratchet [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	228	'
Separate Accounts	8,551	'
Net amount at risk, gross	169	'
Net amount at risk, net of amounts reinsured	111	'
Average attained age of contractholders	'64 years 6 months 0 days	'
Percentage of contractholders over age 70	32.20%	'
Guaranteed Minimum Death Benefit [Member] | Roll Up [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	92	'
Separate Accounts	4,094	'
Net amount at risk, gross	2,192	'
Net amount at risk, net of amounts reinsured	1,451	'
Average attained age of contractholders	'70 years 2 months 12 days	'
Percentage of contractholders over age 70	53.00%	'
Guaranteed Minimum Death Benefit [Member] | Roll Up [Member] | Minimum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'3.0	'
Guaranteed Minimum Death Benefit [Member] | Roll Up [Member] | Maximum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'6.0	'
Guaranteed Minimum Death Benefit [Member] | Combo [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	393	'
Separate Accounts	37,795	'
Net amount at risk, gross	10,891	'
Net amount at risk, net of amounts reinsured	4,152	'
Average attained age of contractholders	'65 years 2 months 12 days	'
Percentage of contractholders over age 70	33.70%	'
Guaranteed Minimum Death Benefit [Member] | Combo [Member] | Minimum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'3.0	'
Guaranteed Minimum Death Benefit [Member] | Combo [Member] | Maximum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'6.5	'
Guaranteed Minimum Income Benefit [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	465	'
Separate Accounts	57,458	48,866
Net amount at risk, gross	2,443	'
Net amount at risk, net of amounts reinsured	637	'
Weighted average years remaining until annuitization	'3 years 3 months 18 days	'
Guaranteed Minimum Income Benefit [Member] | Minimum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'3.0	'
Guaranteed Minimum Income Benefit [Member] | Maximum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'6.5	'
Guaranteed Minimum Income Benefit [Member] | Roll Up [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	37	'
Separate Accounts	8,349	'
Net amount at risk, gross	892	'
Net amount at risk, net of amounts reinsured	268	'
Weighted average years remaining until annuitization	'0 years 8 months 12 days	'
Guaranteed Minimum Income Benefit [Member] | Roll Up [Member] | Minimum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'3.0	'
Guaranteed Minimum Income Benefit [Member] | Roll Up [Member] | Maximum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'6.0	'
Guaranteed Minimum Income Benefit [Member] | Combo [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
General Account	428	'
Separate Accounts	49,109	'
Net amount at risk, gross	1,551	'
Net amount at risk, net of amounts reinsured	$369	'
Weighted average years remaining until annuitization	'3 years 6 months 0 days	'
Guaranteed Minimum Income Benefit [Member] | Combo [Member] | Minimum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'3.0	'
Guaranteed Minimum Income Benefit [Member] | Combo [Member] | Maximum [Member]	'	'
Net Amount At Risk By Product And Guarantee [Line Items]	'	'
Range of contractually specified interest rates	'6.5	'

GMDB_GMIB_GWBL_AND_NO_LAPSE_GU4

GMDB, GMIB, GWBL AND NO LAPSE GUARANTEE FEATURES 3 (DETAILS) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

In Millions, unless otherwise specified

Direct Liabilities For Guarantees [Member]

Direct Liabilities For Guarantees [Member]

Direct Liabilities For Guarantees [Member]

Ceded Liabilities For Guarantees [Member]

Ceded Liabilities For Guarantees [Member]

Ceded Liabilities For Guarantees [Member]

Net Liabilities For Guarantees [Member]

Net Liabilities For Guarantees [Member]

Net Liabilities For Guarantees [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Fixed Income Investments [Member]

Fixed Income Investments [Member]

Fixed Income Investments [Member]

Fixed Income Investments [Member]

Balanced [Member]

Balanced [Member]

Balanced [Member]

Balanced [Member]

Other Investments [Member]

Other Investments [Member]

Other Investments [Member]

Other Investments [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Death Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Guaranteed Minimum Income Benefit [Member]

Schedule Of Fair Value Of Separate Accounts By Major Category Of Investment [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Separate Account Investments by Investment Category

'

'

'

'

'

'

'

'

'

'

'

'

'

$87,098

$76,026

'

'

$57,458

$48,866

'

'

$64,035

$52,633

$41,603

$33,361

$3,330

$3,748

$2,208

$2,335

$19,237

$19,102

$13,401

$12,906

$496

$543

$246

$264

Price Risk Fair Value Hedge Derivative On Balance Sheet [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net Amount At Risk By Product And Guaranteel Account Value Hedged

'

'

'

'

'

'

'

'

'

'

'

'

'

40,319

'

'

'

23,346

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net Amount At Risk Hedged of Variable Annuity Contracts

'

'

'

'

'

'

'

'

'

'

'

'

'

4,774

'

'

'

370

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Liabilities For Guarantees On Long Duration Contracts [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Opening Balance

5,829

6,333

5,723

3,576

556

470

375

-310

-262

-231

246

208

144

1,626

1,772

1,593

1,265

4,203

4,561

4,130

2,311

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other changes in reserves

'

'

'

'

273

86

95

-131

-48

-31

142

38

64

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Closing Balance

$5,829

$6,333

$5,723

$3,576

$829

$556

$470

($441)

($310)

($262)

$388

$246

$208

$1,626

$1,772

$1,593

$1,265

$4,203

$4,561

$4,130

$2,311

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

REINSURANCE_AGREEMENTS_DETAILS

REINSURANCE AGREEMENTS (DETAILS1) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Reinsurance Retention Policy, Excess Retention, Percentage	100.00%	'	'
Guaranteed minimum income benefit reinsurance contract asset, at fair value	$6,747	$11,044	'
Increase (decrease) in the fair value of the reinsurance contract asset	-4,297	497	5,941
Amounts due to reinsurers	71	75	'
Affiliated Entity [Member] | Ceded Credit Risk, Not Concentrated Credit Risk [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Reinsurance Recoverables	1,555	1,383	'
Non Affiliated Entity [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Reinsurance Recoverables	2,379	2,465	'
Amounts due to reinsurers	70	73	'
Non Affiliated Entity [Member] | Ceded Credit Risk, Concentrated Credit Risk [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Reinsurance Recoverables	1,920	1,964	'
Guaranteed Minimum Death Benefit [Member] | Affiliated Entity [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Exposure Reinsured Percentage	50.20%	'	'
Guaranteed Minimum Death Benefit [Member] | Non Affiliated Entity [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Exposure Reinsured Percentage	5.60%	'	'
Guaranteed Minimum Income Benefit [Member] | Affiliated Entity [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Exposure Reinsured Percentage	41.90%	'	'
Guaranteed Minimum Income Benefit [Member] | Non Affiliated Entity [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Exposure Reinsured Percentage	32.00%	'	'
Variable Universal Term Life Insurance Single Life [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Reinsurance Retention Policy, Amount Retained	25	'	'
Variable Universal Term Life Insurance Second To Die Life [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Reinsurance Retention Policy, Amount Retained	30	'	'
Group Life And Health Insurance [Member] | Non Affiliated Entity [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Assumed Liability for Unpaid Claims and Claims Adjustment Expense	709	752	'
Ceded Liability For Unpaid Claims And Claims Adjustment Expense	$143	$160	'

REINSURANCE_AGREEMENTS_Premium

REINSURANCE AGREEMENTS - Premiums (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Premiums Earned, Net [Abstract]	'	'	'
Direct premiums	$848	$873	$908
Reinsurance assumed	213	219	210
Reinsurance ceded	-565	-578	-585
Premiums	496	514	533
Universal Life and Investment-type Product Policy Fee Income Ceded	247	234	221
Policyholders' Benefits Ceded	$703	$667	$510

REINSURANCE_AGREEMENTS_Liabili

REINSURANCE AGREEMENTS - Liability for unpaid claims (DETAILS) (Individual Disability Income And Major Medical [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Individual Disability Income And Major Medical [Member]	'	'	'
Reinsurance Premiums For Insurance Companies By Product Segment [Line Items]	'	'	'
Claim Reserves And Other Liabilities	$79	$86	'
Ceded Claim Reserves And Other Liabilities	1,687	1,704	'
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]	'	'	'
Incurred benefits related to current year	15	16	24
Incurred benefits related to prior years	10	14	18
Total Incurred Benefits	25	30	42
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]	'	'	'
Benefits paid related to current year	19	21	15
Benefits paid related to prior years	13	16	24
Total Benefits Paid	$32	$37	$39

SHORT_TERM_AND_LONG_TERM_DEBT_1

SHORT- TERM AND LONG- TERM DEBT (DETAILS) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Jan. 17, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified			AXA Equitable [Member]	AXA Equitable [Member]	AB Credit Facility 2010 [Member]	AB Credit Facility 2010 [Member]	AB Credit Facility 2010 [Member]	Scb Llc Credit Facility [Member]	Federal Home Loan Bank of Ny [Member]	Commercial Paper [Member]	Commercial Paper [Member]
					Alliance Bernstein [Member]	Alliance Bernstein [Member]	AXA Equitable [Member]	Alliance Bernstein [Member]	AXA Equitable [Member]	Alliance Bernstein [Member]	Alliance Bernstein [Member]
Short-term Debt [Abstract]	'	'	'	'	'	'	'	'	'	'	'
AllianceBernstein commercial paper	'	'	'	'	'	'	'	'	'	$268	$323
Total short-term debt	268	323	'	'	'	'	'	'	'	'	'
Long Term Debt [Abstract]	'	'	'	'	'	'	'	'	'	'	'
AXA Equitable: Surplus Notes	825	'	200	200	'	'	'	'	'	'	'
Total long-term debt	200	200	'	'	'	'	'	'	'	'	'
Total Short-term and Long-term Debt	468	523	'	'	'	'	'	'	'	'	'
Commercial paper interest rates	'	'	'	'	'	'	'	'	'	0.30%	0.50%
Notes Surplus Rate	'	'	7.70%	7.70%	'	'	'	'	'	'	'
Purchased stock to meet their membership requirement	'	'	'	'	'	'	'	'	13	'	'
Required purchase of FHLBNY activity based stock in an amount equal to borrowings	'	'	'	'	'	'	'	'	4.50%	'	'
Credit Facility Original Principal	'	'	'	'	1,000	900	1,000	'	1,000	'	'
Line Of Credit Facility Incremental Amount In Principal Allowed	'	'	'	'	$350	$250	'	$200	'	'	'

RELATED_PARTY_TRANSACTIONS_DET

RELATED PARTY TRANSACTIONS (DETAILS) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

In Millions, unless otherwise specified

Aug. 30, 2012

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2007

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2005

Nov. 30, 2008

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jun. 30, 2009

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Oct. 31, 2012

AXA [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Equitable [Member]

AXA Equitable [Member]

AXA Equitable [Member]

AXA Equitable [Member]

AXA Distribution [Member]

AXA Distribution [Member]

AXA Distribution [Member]

AXA Arizona [Member]

AXA Arizona [Member]

AXA Arizona [Member]

AXA Arizona [Member]

AXA Arizona [Member]

AXA Arizona [Member]

AXA Equitable And Alliance Bernstein [Member]

AXA Equitable And Alliance Bernstein [Member]

AXA Equitable And Alliance Bernstein [Member]

1285 Holding LLC [Member]

Senior Unsecured Notes [Member]

Surplus Notes 2005 [Member]

Surplus Notes November 2008 [Member]

Surplus Notes December 2008 [Member]

Mortgage Note [Member]

Universal Life And No Lapse Guarantee Riders [Member]

Universal Life And No Lapse Guarantee Riders [Member]

Universal Life And No Lapse Guarantee Riders [Member]

Senior Unsecured Notes [Member]

Note Maturity 2035 [Member]

Note Maturity 2018 [Member]

Note Maturity 2018 [Member]

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related Party Transaction Original Rate

'

'

'

'

'

5.40%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related Party Transaction, Rate

'

'

'

'

'

5.70%

'

'

'

6.00%

7.10%

7.10%

'

'

'

8.00%

'

'

'

'

'

'

'

'

5.40%

'

'

'

'

Mortgage Loans on Real Estate, Carrying Amount of Mortgages

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,100

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Sale of Real Estate Held-for-investment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

700

'

'

'

'

'

'

'

'

'

'

'

'

'

After Tax Excess Of Propertys Fair Value Over Carrying Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

439

'

'

'

'

'

'

'

'

'

'

'

'

'

Due from Related Parties, Unclassified [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due From Affiliates

'

'

1,088

1,037

'

650

'

'

'

'

'

'

'

'

'

400

'

'

'

'

'

'

'

'

50

'

'

'

'

Purchase of loans to affiliates

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

56

'

'

'

'

Due to Related Parties [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Due to Affiliate

'

'

'

'

'

'

'

'

'

325

500

500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of loans from affiliates

'

'

500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related Party Transactions Other [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of limited partnerships

'

53

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of CMBS portfolio

'

31

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Real Estate Joint Venture Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

Proceeds from Real Estate and Real Estate Joint Ventures

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

402

After Tax Excess Of Real Estate Joint Venture Fair Value Over Carrying Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

195

Premium Deficiency Reserve

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

226

Payments to Acquire Real Estate and Real Estate Joint Ventures

109

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expenses from Related Party Transactions

'

'

'

'

'

'

40

37

14

'

'

'

'

'

'

'

621

684

641

'

'

'

'

'

'

165

161

152

'

Revenue from Related Party Transactions

'

'

'

'

'

'

'

'

'

'

'

'

24

26

22

'

306

348

413

'

'

'

'

'

'

'

'

'

'

Guaranteed minimum income benefit reinsurance contract asset, at fair value

'

'

6,747

11,044

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,388

8,888

'

'

'

'

'

'

'

'

Ceded Premiums Earned Affiliated

'

'

21

21

22

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

474

484

484

'

'

'

'

'

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded To Affiliates

'

'

10

13

14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

70

68

31

'

'

'

'

'

Intercompany cost sharing and service agreements expenses

'

'

'

'

'

'

40

37

14

'

'

'

'

'

'

'

621

684

641

'

'

'

'

'

'

165

161

152

'

Accounts Receivable, Related Parties, Current

'

'

'

'

'

'

'

'

'

'

'

'

-8

8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Intercompany cost sharing and service agreements revenues

'

'

'

'

'

'

'

'

'

'

'

'

24

26

22

'

306

348

413

'

'

'

'

'

'

'

'

'

'

Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment advisory and services fees

'

'

1,010

879

831

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Distribution revenues

'

'

455

408

360

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other revenues - shareholder servicing fees

'

'

91

89

92

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other revenues - other

'

'

$6

$5

$6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

EMPLOYEE_BENEFIT_PLANS_Net_Per

EMPLOYEE BENEFIT PLANS - Net Periodic Benefit Cost, Change in Benefit Obligation (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Employer Contributions	$4	$265	'
Curtailment impact on PBO	29	'	'
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]	'	'	'
Service Cost	40	40	41
Interest Cost	99	109	122
Expected Return On Plan Assets	-155	-146	-120
Actuarial (gain) loss	1	1	0
Net amortization	155	164	145
Curtailment	3	0	0
Net Periodic Pension Expense	$143	$168	$188

EMPLOYEE_BENEFIT_PLANS_Change_

EMPLOYEE BENEFIT PLANS - Change in Benefit Obligation (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]	'	'	'
Projected benefit obligation, beginning of year	$2,797	$2,626	'
Service Costs (excluding service fees)	32	32	'
Interest Cost	99	109	122
Actuarial (gains) losses	-260	219	'
Benefits Paid	-176	-187	'
Plan amendments and curtailments	-29	-2	'
Projected Benefit Obligation, End of Year	2,463	2,797	2,626
Defined Benefit Plan, Funded Status of Plan [Abstract]	'	'	'
Fair value of plan, beginning of year	2,396	2,093	'
Actual return on plan assets	180	231	'
Employer Contributions	4	265	'
Benefits Paid And Fees	179	193	'
Fair value of plan, end of year	2,401	2,396	2,093
Defined Benefit Plan, Benefit Obligation	2,463	2,797	2,626
Excess of PBO Over Pension Plan Assets	-62	-401	'
Amounts included in AOCI not yet recognized as components of net periodic pension costs	'	'	'
Unrecognized net actuarial (gain) loss	1,181	1,650	'
Unrecognized prior service cost (credit)	0	4	'
Total	1,181	1,654	'
Estimated net actuarial gain (loss)	115	'	'
Estimated prior service cost (credit)	$0	'	'

EMPLOYEE_BENEFIT_PLANS_Allocat

EMPLOYEE BENEFIT PLANS - Allocations, Change In Fair Value of Plan Assets (DETAILS) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

In Millions, unless otherwise specified

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 3 [Member]

Corporate [Member]

Corporate [Member]

Corporate [Member]

Corporate [Member]

U.S.Treasury, Govt and Agency [Member]

U.S.Treasury, Govt and Agency [Member]

U.S.Treasury, Govt and Agency [Member]

U.S.Treasury, Govt and Agency [Member]

State and Political Sub-divisions [Member]

State and Political Sub-divisions [Member]

State and Political Sub-divisions [Member]

State and Political Sub-divisions [Member]

Other Debt Securities [Member]

Other Debt Securities [Member]

Other Debt Securities [Member]

Other Debt Securities [Member]

Other Debt Securities [Member]

Fixed Maturities [Member]

Fixed Maturities [Member]

Fixed Maturities [Member]

Fixed Maturities [Member]

Common and Preferred Equity [Member]

Common and Preferred Equity [Member]

Common and Preferred Equity [Member]

Common and Preferred Equity [Member]

Common and Preferred Equity [Member]

Common and Preferred Equity [Member]

Common and Preferred Equity [Member]

Real Estate [Member]

Real Estate [Member]

Mutual Funds [Member]

Mutual Funds [Member]

Mutual Funds [Member]

Mutual Funds [Member]

Private Real Estate Investment Funds [Member]

Private Real Estate Investment Funds [Member]

Private Real Estate Investment Funds [Member]

Private Real Estate Investment Funds [Member]

Private Real Estate Investment Trust [Member]

Private Real Estate Investment Trust [Member]

Private Real Estate Investment Trust [Member]

Private Real Estate Investment Trust [Member]

Private Real Estate Investment Trust [Member]

Private Real Estate Investment Trust [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Short Term Investments [Member]

Short Term Investments [Member]

Short Term Investments [Member]

Short Term Investments [Member]

Short Term Investments [Member]

Short Term Investments [Member]

Cash And Short Term Investments [Member]

Cash And Short Term Investments [Member]

High Quality Bonds [Member]

Equity Real Estate And Other Investments [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 3 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 1 [Member]

Fair Value Inputs Level 2 [Member]

Fair Value Inputs Level 2 [Member]

Defined Benefit Plan, Assets, Target Allocations [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Asset Allocations Total

100.00%

100.00%

'

32.70%

33.90%

57.90%

57.50%

9.40%

8.60%

'

'

'

'

'

'

'

'

'

'

'

'

0.70%

0.00%

'

'

'

49.00%

52.80%

'

'

39.10%

36.50%

'

'

'

'

'

9.30%

8.40%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.90%

2.30%

'

'

Defined Benefit Plan, Target Plan Asset Allocations Range Maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

15.00%

Defined Benefit Plan, Target Plan Asset Allocations Range Minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

0.00%

Defined Benefit Plan, Fair Value of Plan Assets

$2,401

$2,396

$2,093

$784

$811

$1,391

$1,380

$226

$205

$801

$849

$801

$849

$343

$410

$343

$410

$16

$18

$16

$18

$10

$5

$6

$4

$5

'

'

$4

$5

$907

'

$716

$751

$191

$62

$0

'

'

$44

$35

$44

$35

$2

$3

$2

$3

$231

$208

$11

$11

$220

$197

$1

$25

$1

$25

$0

$46

$30

$23

$0

$23

$30

'

'

'

'

Real Estate Investment Trust Investment

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of plan, beginning of year

2,401

2,396

2,093

784

811

1,391

1,380

205

193

801

849

801

849

343

410

343

410

16

18

16

18

10

5

6

4

5

'

'

5

6

813

'

716

751

191

62

'

'

'

44

35

44

35

2

3

3

4

231

208

11

11

197

183

1

25

1

25

0

46

30

23

0

23

30

'

'

'

'

Plan Assets Still Held

'

'

'

'

'

'

'

23

14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

23

14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchases and Issues

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sales and Settlements

'

'

'

'

'

'

'

0

-2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

-1

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

0

-1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Transfers Between Measurement Levels

'

'

'

'

'

'

'

-2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of plan, end of year

$2,401

$2,396

$2,093

$784

$811

$1,391

$1,380

$226

$205

$801

$849

$801

$849

$343

$410

$343

$410

$16

$18

$16

$18

$10

$5

$6

$4

$5

'

'

$4

$5

$907

'

$716

$751

$191

$62

$0

'

'

$44

$35

$44

$35

$2

$3

$2

$3

$231

$208

$11

$11

$220

$197

$1

$25

$1

$25

$0

$46

$30

$23

$0

$23

$30

'

'

'

'

EMPLOYEE_BENEFIT_PLANS_Assumpt

EMPLOYEE BENEFIT PLANS - Assumptions, Estimated Future Benefit Payments (DETAILS) (USD $)	12 Months Ended			12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
				Parent [Member]	Parent [Member]	Parent [Member]
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]	'	'	'	'	'	'
Benefit Obligation Discount Rate	4.50%	3.50%	7.00%	'	'	'
Net Periodic Benefit Cost Discount Rate	4.50%	4.25%	'	'	'	'
Benefit Obligation And Net Periodic Benefit Cost Rate Of Compensation Increase	6.00%	6.00%	'	'	'	'
Net Periodic Benefit Cost Expected Long Term Return On Assets	6.75%	6.75%	'	'	'	'
Benefit Payments Under Non Participating Annuity Contracts	'	'	'	$10	$12	$13
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]	'	'	'	'	'	'
2014	189	'	'	'	'	'
2015	196	'	'	'	'	'
2016	192	'	'	'	'	'
2017	188	'	'	'	'	'
2018	185	'	'	'	'	'
Years 2019-2023	$853	'	'	'	'	'

EMPLOYEE_BENEFIT_PLANS_Deferre

EMPLOYEE BENEFIT PLANS - Deferred Compensation Arrangements (DETAILS) (USD $)	12 Months Ended
	Dec. 31, 2011
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]	'
Retiree Life Insurance Benefit	$10,000
Reduction in benefit expense	$37,000,000

SHAREBASED_AND_OTHER_COMPENSAT1

SHARE-BASED AND OTHER COMPENSATION PROGRAMS (DETAILS) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	$340,000,000	$195,000,000	$414,000,000
Performance Unit Plans Combined [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	43,000,000	24,000,000	2,000,000
Stock Option Plan [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	2,000,000	3,000,000	4,000,000
AXA Shareplan	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	13,000,000	18,000,000	9,000,000
Axa Miles [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	0	1,000,000	1,000,000
Alliance Bernstein Stock Options [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	-4,000,000	1,000,000	21,000,000
Alliance Bernstein Restricted Units [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	$286,000,000	$148,000,000	$377,000,000

SHAREBASED_AND_OTHER_COMPENSAT2

SHARE-BASED AND OTHER COMPENSATION PROGRAMS PERFORMANCE UNITS (DETAILS) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Mar. 22, 2013

Mar. 16, 2012

Dec. 31, 2013

Dec. 31, 2012

Mar. 22, 2013

Mar. 16, 2012

Mar. 22, 2013

Mar. 16, 2012

Mar. 18, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 18, 2011

Mar. 18, 2011

Apr. 04, 2013

Apr. 30, 2012

Apr. 14, 2011

Mar. 20, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Performance Unit Plan 2013 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2012 [Member]

Performance Unit Plan 2011 [Member]

Performance Unit Plan 2011 [Member]

Performance Unit Plan 2011 [Member]

Performance Unit Plan 2011 [Member]

Performance Unit Plan 2011 [Member]

Performance Unit Plan 2011 [Member]

Performance Unit Plan 2010 [Member]

Performance Unit Plan 2010 [Member]

Performance Unit Plan 2009 [Member]

Performance Unit Plan 2009 [Member]

Performance Unit Plans Combined [Member]

Performance Unit Plans Combined [Member]

Performance Unit Plans Combined [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Expense

$340,000,000

$195,000,000

$414,000,000

$11,000,000

'

'

$26,000,000

$11,000,000

'

'

'

'

'

$6,000,000

$11,000,000

$2,000,000

'

'

'

'

'

'

$43,000,000

$24,000,000

$2,000,000

Expense recognized associated with grant of performance units

43,000,000

24,000,000

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Range of performance units at stake percentage

'

'

'

'

'

'

'

'

130.00%

130.00%

0.00%

0.00%

'

'

'

'

130.00%

0.00%

'

'

'

'

'

'

'

Stock Options Granted Shares

'

'

'

'

2,200,000

2,300,000

'

'

'

'

'

'

1,800,000

'

'

'

'

'

'

539,000

'

831,000

'

'

'

Cash Settlement Of Vested Units

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,000,000

9,000,000

14,000,000

17,000,000

'

'

'

Fair Value of Awards Vested

108,000,000

58,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage Of Vested Units Settled For Cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

50.00%

'

80.00%

'

'

'

Equity Settlement Of Vested Units With Ordinary Shares Number

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

390,460

'

164,000

'

'

'

'

Equity Settlement Of Vested Units With Ordinary Shares Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$49,000

'

'

$3,000,000

'

'

'

Outstanding Performance Units At Risk To Achievement Of Performance Criteria

5,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

SHAREBASED_AND_OTHER_COMPENSAT3

SHARE-BASED AND OTHER COMPENSATION PROGRAMS OPTIONS (DETAILS)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Mar. 22, 2013

Mar. 22, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Mar. 16, 2012

Mar. 16, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 18, 2011

Mar. 18, 2011

Mar. 18, 2011

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jul. 01, 2010

Dec. 31, 2013

USD ($)

USD ($)

USD ($)

Stock Option Plan [Member]

Stock Option Plan [Member]

Stock Option Plan [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Alliance Bernstein [Member]

Alliance Bernstein [Member]

Alliance Bernstein [Member]

Alliance Bernstein [Member]

AXA Financial [Member]

USD ($)

USD ($)

USD ($)

Axa Ordinary Shares [Member]

Axa Ordinary Shares [Member]

Axa Ordinary Shares [Member]

Axa Ordinary Shares [Member]

AXA ADR [Member]

Alliance Bernstein Holding Units [Member]

Alliance Bernstein Holding Units [Member]

Alliance Bernstein Holding Units [Member]

Alliance Bernstein Holding Units [Member]

Alliance Bernstein Holding Units [Member]

Stock Option Plan 2013 [Member]

Stock Option Plan 2013 [Member]

Stock Option Plan 2013 [Member]

Stock Option Plan 2013 [Member]

Stock Option Plan 2012 [Member]

Stock Option Plan 2012 [Member]

Stock Option Plan 2012 [Member]

Stock Option Plan 2012 [Member]

Stock Option Plan 2012 [Member]

Stock Option Plan 2011 [Member]

Stock Option Plan 2011 [Member]

Stock Option Plan 2011 [Member]

Stock Option Plan 2011 [Member]

Stock Option Plan 2011 [Member]

Stock Option Plan 2011 [Member]

Stock Option Plan 2011 [Member]

Stock Option Plan [Member]

Stock Option Plan [Member]

Stock Option Plan [Member]

USD ($)

USD ($)

USD ($)

Axa Ordinary Shares [Member]

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

Four-year graded vesting schedule [Member]

Conditional Vesting Term [Member]

Conditional Vesting Term [Member]

USD ($)

USD ($)

Four-year graded vesting schedule [Member]

Conditional Vesting Term [Member]

Conditional Vesting Term [Member]

USD ($)

USD ($)

USD ($)

Four-year graded vesting schedule [Member]

Conditional Vesting Term [Member]

Conditional Vesting Term [Member]

USD ($)

USD ($)

USD ($)

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

Summary of Plan Activity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Outstanding Weighted Average Exercise Price Beginning of Period

'

'

'

'

'

'

'

€ 21

'

'

$20.01

$39.77

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

'

'

'

'

'

'

'

€ 13.81

'

'

$0

$25.47

'

'

'

'

'

€ 13.81

'

'

'

'

€ 12.22

'

'

'

'

'

'

€ 14.73

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

'

'

'

'

'

'

'

€ 12.15

'

'

$17.74

$17.05

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

'

'

'

'

'

'

'

€ 19.27

'

'

$22.01

$60.10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price

'

'

'

'

'

'

'

€ 0

'

'

$0

$36.50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Outstanding Weighted Average Exercise Price End of Period

'

'

'

'

'

'

'

€ 21

'

'

$23.60

$40.82

$39.77

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Outstanding Number Beginning Balance

'

'

'

'

'

'

18,101,700,000

18,101,700,000

'

'

4,990,000,000

8,553,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Granted Shares

'

'

'

'

'

'

486,200,000

486,200,000

'

'

0

37,700,000

'

'

'

'

'

'

246,000

'

'

'

'

370,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Exercised Shares

'

'

'

'

'

'

-527,800,000

-527,800,000

'

'

-3,022,600,000

-887,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Cancelled Shares

'

'

'

'

'

'

-490,400,000

-490,400,000

'

'

-145,500,000

-602,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Expired Shares

'

'

'

'

'

'

0

0

'

'

7,900,000

-26,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Outstanding Number Ending Balance

'

'

'

'

'

'

17,569,700,000

17,569,700,000

'

'

1,829,800,000

7,074,100,000

8,553,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Outstanding Aggregate Intrinsic Value

'

'

'

'

'

'

'

'

'

'

$8,120,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term

'

'

'

'

'

'

'4 years 2 months 26 days

'4 years 2 months 26 days

'

'

'1 year 3 months 11 days

'4 years 10 months 24 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options Excercisable Shares

'

'

'

'

'

'

13,599,800,000

13,599,800,000

'

'

1,820,100,000

4,684,500,000

'

'

'

'

'

457,000

'

'

'

'

901,000

'

'

'

'

'

2,400,000

2,300,000

483,000

'

'

'

'

'

'

'

'

'

Options Excercisable Weighted Average Exercise Price

'

'

'

'

'

'

'

€ 23.12

'

'

$23.66

$34.97

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options Excercisable Aggregate Intrinsic Value

'

'

'

'

'

'

'

'

'

'

7,967,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term

'

'

'

'

'

'

'3 years 4 months 6 days

'3 years 4 months 6 days

'

'

'1 year 3 months 4 days

'4 years 9 months 18 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash Proceeds From Exercise Of Stock Options

54,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Options Excercises In Period Intrinsic Value

14,000,000

5,000,000

3,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Tax Benefits From Exercise Of Stock Options

5,000,000

2,000,000

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions Risk Expected Dividend Yield

'

'

'

'

'

'

7.52%

7.52%

7.54%

7.00%

'

5.40%

6.20%

5.40%

8.00%

8.30%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions Expected Volatility Rate

'

'

'

'

'

'

31.27%

31.27%

39.89%

33.90%

'

47.30%

49.20%

47.30%

49.70%

49.80%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions Risk Free Interest Rate

'

'

'

'

'

'

1.34%

1.34%

1.80%

3.13%

'

0.00%

0.70%

190.00%

0.80%

1.70%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

'

'

'

'

'

'

'7 years 8 months 12 days

'7 years 8 months 12 days

'5 years 7 months 6 days

'6 years 4 months 24 days

'

'6 years 0 months 0 days

'6 years 0 months 0 days

'6 years 0 months 0 days

'

'

'

'

'

'6 years 4 months 24 days

'

'

'

'

'0 years 0 months 0 days

'

'

'

'

'

'

'5 years 7 months 6 days

'

'

'

'

'

'

'

'

Weighted Average Grant Date Fair Value

'

'

'

'

'

'

$1.79

'

$2.48

$2.49

'

$5.44

$3.67

$5.98

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total Fair Value of Options, Net of Forfeitures

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

818,597

'

'

'

'

2,000,000

'

'

'

'

'

'

6,000,000

'

'

'

'

'

'

'

'

'

Share Based Compensation Expense

340,000,000

195,000,000

414,000,000

2,000,000

3,000,000

4,000,000

'

'

'

'

'

'

'

'

'

'

357,000

'

'

'

504,000

791,000

'

'

'

573,000

1,000,000

2,000,000

'

'

'

'

-2,000,000

4,000,000

25,000,000

156,000,000

147,000,000

625,000,000

'

'

Compensation Cost Not Yet Recognized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,000,000

'

'

'

'

'

'

'

Compensation Cost Recognition Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'0 years 6 months 0 days

'

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

351,000

Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$24.73

Common Stock Capital Shares Reserved For Funding Future Exercises Outstanding Stock Options

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

302,000

Common Stock Capital Shares Reserved For Funding Restricted Stock Grants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

49,000

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

'

'

'

'

'

'

124,000,000

124,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

22,000,000

'

'

60,000,000

'

SHAREBASED_AND_OTHER_COMPENSAT4

SHARE-BASED AND OTHER COMPENSATION PROGRAMS RESTRICTED AWARDS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restricted Awards Plan [Line Items]	'	'	'
Share Based Compensation Expense	$340,000,000	$195,000,000	$414,000,000
Share Based Compensation Equity Instruments Other Than Options Plan Activity [Abstract]	'	'	'
Fair Value of Awards Vested	108,000,000	58,000,000	'
Alliance Bernstein [Member]	'	'	'
Restricted Awards Plan [Line Items]	'	'	'
Share Based Compensation Expense	156,000,000	147,000,000	625,000,000
Unvested restricted shares and holding units	'	6,500,000	'
Restricted Stock Units (RSUs) [Member] | Parent [Member]	'	'	'
Restricted Awards Plan [Line Items]	'	'	'
Share Based Compensation Expense	286,000,000	148,000,000	377,000,000
Unvested restricted shares and holding units	22,300,000	'	'
Compensation Cost Not Yet Recognized	48,000,000	'	'
Compensation Cost Recognition Period	'4 years 2 months 12 days	'	'
Share Based Compensation Equity Instruments Other Than Options Plan Activity [Abstract]	'	'	'
Restricted Stock Nonvested Weighted Average Grant Date Fair Value Beginning of Period	$27.23	'	'
Units Granted Weighted Average Grant Date Fair Value	$13.97	'	'
Awards Vested Weighted Average Grant Date Fair Value	$33.91	'	'
Units Cancelled Weighted Average Grant Date Fair Value	$0	'	'
Restricted Stock Nonvested Weighted Average Grant Date Fair Value End of Period	$14.09	$27.23	'
Restricted Stock Nonvested Number Begining Balance	177,001	'	'
Award Units Granted In Period	11,613	'	'
Units Vested	117,235	'	'
Forfeited Units	0	'	'
Restricted Stock Nonvested Number Ending Balance	71,379	177,001	'
Fair Value of Awards Vested	$1,000,000	$1,000,000	$2,000,000

SHAREBASED_AND_OTHER_COMPENSAT5

SHARE-BASED AND OTHER COMPENSATION PROGRAMS SARs (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share Based Compensation Expense	$340,000,000	$195,000,000	$414,000,000
Stock Appreciation Rights (SARs) [Member] | AXA Financial [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Awards Outstanding Weighted Average Remaining Contractual Term	'7 years 0 months 0 days	'	'

SHAREBASED_AND_OTHER_COMPENSAT6

SHARE-BASED AND OTHER COMPENSATION PROGRAMS EMPLOYEE OPTION PLANS (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Mar. 16, 2012

Dec. 31, 2012

Mar. 16, 2012

Jul. 01, 2007

Dec. 31, 2011

Jul. 01, 2007

AXA Shareplan 2013 [Member]

AXA Shareplan 2012 [Member]

AXA Shareplan 2012 [Member]

AXA Shareplan 2011 [Member]

AXA Shareplan Option A 2013 [Member]

AXA Shareplan Option B 2013 [Member]

AXA Shareplan Option B 2013 [Member]

AXA Shareplan Option B 2013 [Member]

AXA Miles Program 2012 [Member]

AXA Miles Program 2012 [Member]

AXA Miles Program 2012 [Member]

AXA Miles Program 2012 [Member]

AXA Miles Program 2007 [Member]

AXA Miles Program 2007 [Member]

AXA Miles Program 2007 [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

Parent [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

AXA Financial [Member]

Four Year Cliff Vesting Term [Member]

Four Year Cliff Vesting Term [Member]

Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Discount on AXA Ordinary Shares

'

'

'

'

'

12.95%

'

'

'

'

'

'

'

'

'

Discounted Price of AXA Shares

'

'

'

'

$19.85

$21.59

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Employee Stock Ownership Plan

'

'

'

'

'

5,000,000

8,000,000

9,000,000

'

'

'

'

449,000

'

'

Employee Stock Ownership Plan (ESOP), Compensation Expense

$13,000,000

'

$18,000,000

$9,000,000

'

'

'

'

$278,000

'

$538,000

'

'

$1,000,000

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

19,000,000

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee

'

'

'

'

'

'

'

'

'

50

'

25

'

'

50

Total Fair Value of Options, Net of Forfeitures

'

$6,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

SHAREBASED_AND_OTHER_COMPENSAT7

SHARE-BASED AND OTHER COMPENSATION PROGRAMS ALLIANCE BERNSTEIN (DETAILS) (USD $)	1 Months Ended		3 Months Ended	12 Months Ended
	Jan. 31, 2012	Jan. 31, 2011	Mar. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Jul. 01, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'
Share Based Compensation Expense	'	'	'	$340,000,000	$195,000,000	$414,000,000	'
Unallocated Holding units remaining in the consolidated rabbi trust	'	'	'	'	17,900,000	'	'
Deferred compensation expense	'	'	'	'	'	10,000	'
Non cash deferred compensation charge	'	'	'	'	'	115,000,000	'
Alliance Bernstein [Member]	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'
Share Based Compensation Expense	'	'	'	156,000,000	147,000,000	625,000,000	'
Economic Interest In Subsidiary	'	'	50.00%	'	'	'	'
Adjustments to Additional Paid in Capital, Reallocation of Noncontrolling Interest	'	'	'	'	60,000,000	'	'
Noncontrolling Interest, Period Increase (Decrease)	'	'	-27,000,000	'	-60,000,000	'	'
Units purchased during the period (in Units)	'	'	'	5,200,000	15,700,000	'	'
Dollar amount paid for Holding Units acquired	'	'	'	111,000,000	239,000,000	'	'
Open Market Purchases Shares	'	'	'	1,900,000	12,300,000	'	'
Open Market Purchase Value	'	'	'	39,000,000	182,000,000	'	'
Restricted Holding Unit Awards Granted to Employees	6,500,000	8,700,000	'	'	'	'	'
Unvested restricted shares and holding units	'	'	'	'	6,500,000	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	'	'	'	22,000,000	'	'	60,000,000
Additional holding units	'	'	'	248,281	'	'	'
Grant of holding units net of forfeitures	'	'	'	38,000,000	'	'	'
Decrease in AllianceBernstein and AB Holding units	'	'	'	13,100,000	'	'	'
Newly issued holding units available for grant	'	'	'	3,900,000	'	'	30,000,000
Non cash deferred compensation charge	'	'	'	$472,000,000	'	'	'

INCOME_TAXES_DETAILS

INCOME TAXES (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Expense Benefit Abstract	'	'	'
Current (expense) benefit	$197	($233)	$40
Deferred (expense) benefit	1,876	391	-1,338
Income Tax Expense (Benefit)	2,073	158	-1,298
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate	35.00%	'	'
Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract]	'	'	'
Expected income tax (expense) benefit	1,858	-20	-1,443
Noncontrolling interest	101	37	-36
Tax Credits, Investment	122	94	83
Tax Exempt Income	20	24	8
Tax Contingencies	-14	-2	-7
State and Local Income Taxes	-6	7	7
Subsidiaries Income Tax Reconciliation Foreign Income Tax Rate Differential	2	10	-13
Tax Settlements	0	0	84
Conversion From Corporation To Limited Liability	0	0	0
Other Adjustments	-10	8	19
Income tax (expense) benefit	$2,073	$158	($1,298)

INCOME_TAXES_DETAILS_1

INCOME TAXES (DETAILS 1) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Contingency [Line Items]	'	'	'
Income Tax Reconciliation Tax Settlements	$0	$0	$84
Components Of Deferred Tax Assets [Abstract]	'	'	'
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits	104	207	'
Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax	'	157	'
Deferred Tax Assets, Net Operating Loss	492	'	'
Deferred Tax Assets, Other	7	'	'
Deferred Tax Assets, Total	603	364	'
Components Of Deferred Tax Liabilities [Abstract]	'	'	'
Deferred Tax Liabilities, Reserves and Reinsurance	688	2,419	'
Deferred Tax Liabilities, Deferred Policy Acquisition Cost	1,016	960	'
Deferred Tax Liabilities, Unrealized Investment Gains or Losses	85	739	'
Deferred Tax Liabilities Investments	1,410	1,137	'
Deferred Tax Liabilities, Other	0	57	'
Deferred Tax Liabilities, Total	3,199	5,312	'
Income Tax Uncertainties [Abstract]	'	'	'
Exclusion Of Deferred Tax Non US Affiliates	238	'	'
Foreign Earnings Repatriated Additional Taxes Remitted	92	'	'
Unrecognized Tax Benefits That Would Impact Effective Tax Rate	568	522	'
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued	120	105	'
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense	15	4	14
Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns [Roll Forward]	'	'	'
Unrecognized Tax Benefits, Beginning Balance	573	453	434
Additions for tax positions of prior years	57	740	337
Reductions for tax positions of prior years	38	620	235
Additions for tax positions of current year	0	0	1
Unrecognized Tax Benefits, Decreases Resulting from Current Period Tax Positions	0	0	0
Settlements with tax authorities	0	0	84
Unrecognized Tax Benefits, Ending Balance	$592	$573	$453

ACCUMULATED_OTHER_COMPREHENSIV2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accumulated Other Comprehensive Income Loss [Abstract]	'	'	'
Unrealized Gain (Loss) on Investments	$141	$1,352	$772
Defined benefit pension plans	-757	-1,056	-1,082
Total accumulated other comprehensive income (loss)	-616	296	-310
Less: Accumulated other comprehensive (income) loss attributable to noncontrolling interest	13	21	13
Accumulated Other Comprehensive Income (Loss) Attributable to AXA Equitable	-603	317	-297
Unrealized Gain Loss On Investments [Abstract]	'	'	'
Net unrealized gains (losses) arising during the year	-1,550	658	571
(Gains) losses reclassified into net earnings (loss) during the year	49	59	18
Net unrealized gains (losses) on investments	-1,501	717	589
Adjustments for policyholders liabilities, DAC, Insurance Liability Loss Recognition And Other	290	-137	-223
Change in unrealized gains (losses), net of adjustments	-1,211	580	366
Defined benefit plans:	'	'	'
Net gain (loss) arising during year	198	-82	-169
Prior service cost arising during year	0	1	0
Less: Reclassification Adjustments for:	'	'	'
Amortization of net (gains) losses included in net periodic cost	101	106	94
Amortization of net prior service credit included in net periodic cost	0	1	1
Other comprehensive income (loss) defined benefit plans	299	26	-74
Total other comprehensive income (loss), net of income taxes	-912	606	292
Less: Other comprehensive (income) loss attributable to noncontrolling interest	8	-8	-21
Other Comprehensive Income (Loss) Attributable to AXA Equitable	-920	614	313
Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]	'	'	'
Other Comprehensive Income (Loss), Available-for-sale Securities, Tax	654	-318	-193
Other Comprehensive (Income) Loss, Benefit Plans, Tax	161	14	-40
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Available for sale securities, Tax	-26	-32	-10
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Benefit Plans, Tax	($54)	($58)	($51)

COMMITMENTS_AND_CONTINGENT_LIA2

COMMITMENTS AND CONTINGENT LIABILITIES (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Long Term Debt By Maturity [Abstract]	'	'	'
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months	$0	'	'
Long-term Debt, Maturities, Repayments of Principal in Year Two	200	'	'
Long Term Debt Maturities Repayments Of Principal In Year Three	0	'	'
Long Term Debt Maturities Repayments Of Principal In Year Four	0	'	'
Long Term Debt Maturities Repayments Of Principal In Year Five	0	'	'
Long Term Debt Maturities Repayments Of Principal After Year Five	0	'	'
Operating Leases Future Minimum Payments Due [Abstract]	'	'	'
Operating Leases Future Minimum Payments Due Current	217	'	'
Operating Leases Future Minimum Payments Due In Two Years	216	'	'
Operating Leases Future Minimum Payments Due In Three Years	209	'	'
Operating Leases Future Minimum Payments Due In Four Years	208	'	'
Operating Leases Future Minimum Payments Due In Five Years	192	'	'
Operating Leases Future Minimum Payments Due Thereafter	1,232	'	'
Future Minimum Sublease Rentals Sale Leaseback Transactions [Abstract]	'	'	'
Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year	41	'	'
Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years	48	'	'
Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years	47	'	'
Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years	48	'	'
Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years	48	'	'
Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter	316	'	'
Restructuring And Related Cost [Line Items]	'	'	'
Balance, beginning of year	52	44	'
Additions	140	54	'
Cash payments	66	46	'
Other reductions	4	0	'
Balance, End of Year	122	52	'
Venture Capital Funds [Member]	'	'	'
Loss Contingencies [Line Items]	'	'	'
Investment in a venture capital	35	'	'
Commitment funded net of sale proceeds	25	'	'
Real Estate Funds [Member]	'	'	'
Loss Contingencies [Line Items]	'	'	'
Investment in a venture capital	25	'	'
Commitment funded net of sale proceeds	12	'	'
Oil And Gas Fund [Member]	'	'	'
Loss Contingencies [Line Items]	'	'	'
Investment in a venture capital	8	'	'
Commitment funded net of sale proceeds	8	'	'
AXA [Member]	'	'	'
Restructuring And Related Cost [Line Items]	'	'	'
Balance, beginning of year	'	44	11
Additions	'	'	79
Cash payments	'	'	43
Other reductions	'	'	3
Balance, End of Year	'	'	44
Pre-tax charge related to severance costs	85	30	55
Pre tax real estate charge	52	'	'
Commitments by the Company to provide equity financing	504	'	'
Letters Of Credit	18	'	'
Commitments under existing mortgage loan agreements	595	'	'
Alliance Bernstein [Member]	'	'	'
Restructuring And Related Cost [Line Items]	'	'	'
Pre-tax charge related to severance costs	4	21	'
Pre tax real estate charge	28	223	'
AXA Arizona [Member]	'	'	'
Restructuring And Related Cost [Line Items]	'	'	'
Letters Of Credit	3,251	'	'
Holds assets in an irrevocable trust	$6,805	'	'

INSURANCE_GROUP_STATUTORY_FINA2

INSURANCE GROUP STATUTORY FINANCIAL INFORMATION (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statutory Accounting Practices [Abstract]	'	'	'
Amount Available For Dividend Distribution Without Prior Approval From Regulatory Agency	$382	'	'
Insurance Groups statutory net income (loss)	-28	602	967
Statutory surplus, capital stock and Asset Valuation Reserve	4,358	5,178	'
Transfer of Units to Parent	10.9	'	'
Fair Value of Units Transferred	234	'	'
Shareholder dividends	234	362	379
Securities on deposit with such government or state agencies	83	'	'
Purchased callable surplus note	825	'	'
Interest Expense on surplus notes	55	'	'
Repayments of surplus notes	$500	'	'

INSURANCE_GROUP_STATUTORY_FINA3

INSURANCE GROUP STATUTORY FINANCIAL INFORMATION 1 (DETAILS) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Net change in statutory surplus and capital stock	'	'	'	'	'	'	'	'	($864)	$64	$824
Change in AVR	'	'	'	'	'	'	'	'	46	269	-211
Net change in statutory surplus, capital stock and AVR	'	'	'	'	'	'	'	'	-818	333	613
US GAAP Net Earnings (Loss), Attributable to AXA Equitable	-640	-878	-1,051	-1,004	-450	-241	2,421	-1,635	-3,573	95	2,927
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory surplus and capital stock	3,825	'	'	'	4,689	'	'	'	3,825	4,689	4,625
AVR	535	'	'	'	489	'	'	'	535	489	220
tatutory surplus, capital stock and Asset Valuation Reserve	4,358	'	'	'	5,178	'	'	'	4,358	5,178	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	4,360	'	'	'	5,178	'	'	'	4,360	5,178	4,845
U.S. GAAP Total Equity Attributable to AXA Equitable	10,538	'	'	'	15,436	'	'	'	10,538	15,436	14,840
Future Policy Benefits And Policyholders Account Balances [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	-607	-508	-270
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	-3,884	'	'	'	-3,642	'	'	'	-3,884	-3,642	-2,456
DAC [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	75	142	-2,861
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	3,874	'	'	'	3,728	'	'	'	3,874	3,728	3,545
Deferred Income Tax Asset Liability [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	2,038	798	-1,272
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	-2,672	'	'	'	-5,330	'	'	'	-2,672	-5,330	-5,357
Valuation Investments [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	7	-377	16
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	703	'	'	'	3,271	'	'	'	703	3,271	2,266
Valuation Investments In Subsidiary [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	-109	-306	590
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	-515	'	'	'	-137	'	'	'	-515	-137	231
Increase Decrease In Fair Value Of Reinsurance Contract Asset [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	-4,297	497	5,941
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	6,747	'	'	'	11,044	'	'	'	6,747	11,044	10,547
Pension Adjustment [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	-478	-41	111
Amortization Of Deferred Cost Of Insurance Ceded To Affiliates [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	-280	-126	-156
Deferred Cost Of Insurance Ceded To Affiliates [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	2,366	'	'	'	2,646	'	'	'	2,366	2,646	2,693
Shareholder Dividends Paid [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	468	362	379
Non Admitted Assets [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	2	-489	-154
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	469	'	'	'	467	'	'	'	469	467	510
Surplus Notes [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	500	'	'
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	-1,025	'	'	'	-1,525	'	'	'	-1,025	-1,525	-1,525
Other Statutory [Member]	'	'	'	'	'	'	'	'	'	'	'
Reconciliation Of Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices Statutory To Gaap Income Amount Of Reconciling Item	'	'	'	'	'	'	'	'	-74	-190	-10
Reconciliation Of Changes In Statutory Surplus And Capital Stock [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Statutory Accounting Practices, Statutory to GAAP, Amount of Reconciling Item	$115	'	'	'	($264)	'	'	'	$115	($264)	($459)

BUSINESS_SEGMENT_INFORMATION_D

BUSINESS SEGMENT INFORMATION (DETAILS) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Segment revenues	$1,077	$834	$537	$392	$1,909	$1,728	$6,475	($952)	$2,840	$9,160	$17,872
Intersegment investment advisory and other fees	'	'	'	'	'	'	'	'	1,010	879	831
Segment earnings (loss) from continuing operations, before income taxes	'	'	'	'	'	'	'	'	-5,309	58	4,124
Total Assets	183,401	'	'	'	176,843	'	'	'	183,401	176,843	'
Securties segregated in a special reserve bank custody, fair value	981	'	'	'	1,551	'	'	'	981	1,551	'
Consolidation Eliminations [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Segment revenues	'	'	'	'	'	'	'	'	-21	-21	-18
Segment earnings (loss) from continuing operations, before income taxes	'	'	'	'	'	'	'	'	-1	0	4
Total Assets	-4	'	'	'	-5	'	'	'	-4	-5	'
Intersegment Eliminations [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Intersegment investment advisory and other fees	'	'	'	'	'	'	'	'	67	58	56
Insurance [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Segment revenues	'	'	'	'	'	'	'	'	-54	6,443	15,140
Segment earnings (loss) from continuing operations, before income taxes	'	'	'	'	'	'	'	'	-5,872	-132	4,284
Total Assets	171,532	'	'	'	164,201	'	'	'	171,532	164,201	'
Investment Management [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Segment revenues	'	'	'	'	'	'	'	'	2,915	2,738	2,750
Segment earnings (loss) from continuing operations, before income taxes	'	'	'	'	'	'	'	'	564	190	-164
Total Assets	11,873	'	'	'	12,647	'	'	'	11,873	12,647	'
Securties segregated in a special reserve bank custody, fair value	$925	'	'	'	$1,509	'	'	'	$925	$1,509	'

QUARTERLY_RESULTS_OF_OPERATION2

QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) (DETAILS) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Quarterly Financial Data [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Total Revenues	$1,077	$834	$537	$392	$1,909	$1,728	$6,475	($952)	$2,840	$9,160	$17,872
Earnings (Loss) from Continuing Operations, Net of Income Taxes	-640	-878	-1,051	-1,004	-450	-241	2,421	-1,635	'	'	'
US GAAP Net Earnings (Loss), Attributable to AXA Equitable	($640)	($878)	($1,051)	($1,004)	($450)	($241)	$2,421	($1,635)	($3,573)	$95	$2,927

SUMMARY_OF_INVESTMENTS_OTHER_T2

SUMMARY OF INVESTMENTS- OTHER THAN INVESTMENTS IN RELATED PARTIES- SCHEDULE I (DETAILS) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	$45,401
Summary of Investments, Other than Investments in Related Parties, Fair Value	45,669
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	45,977
U.S. Government and Agencies and Authorities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	3,584
Summary of Investments, Other than Investments in Related Parties, Fair Value	3,129
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	3,129
State, Municipalities and Political Subdivisions [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	444
Summary of Investments, Other than Investments in Related Parties, Fair Value	477
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	477
Foreign Governments [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	359
Summary of Investments, Other than Investments in Related Parties, Fair Value	393
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	393
Public Utilities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	3,853
Summary of Investments, Other than Investments in Related Parties, Fair Value	4,086
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	4,086
All Other Corporate Bonds [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	19,747
Summary of Investments, Other than Investments in Related Parties, Fair Value	20,479
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	20,479
Redeemable Preferred Stock [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	849
Summary of Investments, Other than Investments in Related Parties, Fair Value	855
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	855
Fixed Maturities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	28,836
Summary of Investments, Other than Investments in Related Parties, Fair Value	29,419
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	29,419
Industrial, Miscellaneous, and All Others [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	37
Summary of Investments, Other than Investments in Related Parties, Fair Value	34
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	34
Mortgage Loans On Real Estate [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	5,684
Summary of Investments, Other than Investments in Related Parties, Fair Value	5,716
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	5,684
Real Estate Joint Venture [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	3
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	3
Policy Loans [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	3,434
Summary of Investments, Other than Investments in Related Parties, Fair Value	3,097
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	3,434
Other Limited Partnership Interests And Equity Investments [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	1,829
Summary of Investments, Other than Investments in Related Parties, Fair Value	1,829
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	1,829
Trading Securities	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	4,225
Summary of Investments, Other than Investments in Related Parties, Fair Value	4,221
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	4,221
Other Invested Assets [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Summary of Investments, Other than Investments in Related Parties, Cost	1,353
Summary of Investments, Other than Investments in Related Parties, Fair Value	1,353
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	$1,353

STATEMENT_OF_FINANCIAL_POSITIO

STATEMENT OF FINANCIAL POSITION (PARENT COMPANY)- SCHEDULE II (DETAILS) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified
Investments [Abstract]	'	'	'	'
Fixed maturities available for sale, at fair value	$29,419	$33,607	'	'
Mortgage Loans On Real Estate	5,684	5,059	'	'
Equity real estate, held for the production of income	3	4	'	'
Policy Loans	3,434	3,512	'	'
Trading securities	4,221	2,309	'	'
Other equity investments	1,863	1,643	'	'
Other invested assets	1,353	1,828	'	'
Total Investments	45,977	47,962	'	'
Cash and cash equivalents	2,283	3,162	3,227	2,155
Deferred policy acquisition costs	3,874	3,728	'	'
Amounts due from reinsurers	3,934	3,847	'	'
Guaranteed Minimum Income Benefit Reinsurance Contract Asset At Fair Value	6,747	11,044	'	'
Other assets	4,418	5,095	'	'
Separate Account Assets	108,857	94,139	'	'
Total Assets	183,401	176,843	'	'
LIABILITIES [Abstract]	'	'	'	'
Policyholders' account balances	30,340	28,263	'	'
Future policy benefits, policyholders account balances	21,697	22,687	'	'
Broker-dealer related payables	538	664	'	'
Short-term and long-term debt	468	523	'	'
Current and deferred income taxes	2,813	5,172	'	'
Loans from affiliates	825	1,325	'	'
Other liabilities	2,653	3,503	'	'
Separate Accounts' liabilities	108,857	94,139	'	'
Total liabilities	169,960	158,913	'	'
EQUITY [Abstract]	'	'	'	'
Common stock, $1.25 par value, 2.0 million shares authorized, issued and outstanding	2	2	'	'
Capital in excess of par value	5,934	5,992	'	'
Retained earnings	5,205	9,125	'	'
Accumulated other comprehensive income (loss)	-616	296	-310	'
Total AXA Equitable's equity	13,441	17,930	17,543	'
Total Liabilities and AXA Equitable's Equity	183,401	176,843	'	'
Parent Company [Member]	'	'	'	'
Investments [Abstract]	'	'	'	'
Fixed maturities available for sale, at fair value	29,365	33,538	'	'
Mortgage Loans On Real Estate	5,684	5,059	'	'
Equity real estate, held for the production of income	3	4	'	'
Policy Loans	3,434	3,512	'	'
Investment In And Loans To Affiliates	2,190	2,328	'	'
Trading securities	3,647	1,834	'	'
Other equity investments	1,666	1,403	'	'
Other invested assets	1,348	1,826	'	'
Total Investments	47,337	49,504	'	'
Cash and cash equivalents	1,704	2,450	2,516	1,413
Deferred policy acquisition costs	3,874	3,728	'	'
Amounts due from reinsurers	3,934	3,847	'	'
Guaranteed Minimum Income Benefit Reinsurance Contract Asset At Fair Value	6,747	11,044	'	'
Other assets	3,941	4,576	'	'
Separate Account Assets	108,857	94,139	'	'
Total Assets	176,394	169,288	'	'
LIABILITIES [Abstract]	'	'	'	'
Policyholders' account balances	30,340	28,263	'	'
Future policy benefits, policyholders account balances	21,666	22,655	'	'
Broker-dealer related payables	29	213	'	'
Short-term and long-term debt	200	200	'	'
Current and deferred income taxes	2,073	4,479	'	'
Loans from affiliates	825	1,325	'	'
Other liabilities	1,866	2,578	'	'
Separate Accounts' liabilities	108,857	94,139	'	'
Total liabilities	165,856	153,852	'	'
EQUITY [Abstract]	'	'	'	'
Common stock, $1.25 par value, 2.0 million shares authorized, issued and outstanding	2	2	'	'
Capital in excess of par value	5,934	5,992	'	'
Retained earnings	5,205	9,125	'	'
Accumulated other comprehensive income (loss)	-603	317	'	'
Total AXA Equitable's equity	10,538	15,436	'	'
Total Liabilities and AXA Equitable's Equity	$176,394	$169,288	'	'

STATEMENT_OF_FINANCIAL_POSITIO1

STATEMENT OF FINANCIAL POSITION- PARENTHETICALS (PARENT COMPANY)- SCHEDULE II (DETAILS) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, except Share data, unless otherwise specified
Condensed Financial Statements, Captions [Line Items]	'	'
Common Stock par value	$1.25	$1.25
Common Stock authorized	2,000,000	2,000,000
Common Stock issued	2,000,000	2,000,000
Common Stock outstanding	2,000,000	2,000,000
Parent Company [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis	$28,785	$30,656
Common Stock par value	$1.25	$1.25
Common Stock authorized	2,000,000	2,000,000
Common Stock issued	2,000,000	2,000,000
Common Stock outstanding	2,000,000	2,000,000

STATEMENTS_OF_EARNINGS_PARENT_1

STATEMENTS OF EARNINGS (PARENT COMPANY)- SCHEDULE II (DETAILS) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Statement Captions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Universal life and investment-type product policy fee income	'	'	'	'	'	'	'	'	$3,546	$3,334	$3,312
Premiums	'	'	'	'	'	'	'	'	496	514	533
Net investment income (loss): [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Investment income (loss) from derivative instruments	'	'	'	'	'	'	'	'	-2,866	-978	2,374
Other investment income	'	'	'	'	'	'	'	'	2,237	2,316	2,128
Net Investment Income (Loss)	'	'	'	'	'	'	'	'	-629	1,338	4,502
Investment gains (losses), net: [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Total other-than-temporary impairment losses	'	'	'	'	'	'	'	'	-81	-96	-36
Portion of loss recognized in other comprehensive income (loss)	'	'	'	'	'	'	'	'	15	2	4
Net impairment losses recognized	'	'	'	'	'	'	'	'	-66	-94	-32
Other investment gains (losses), net	'	'	'	'	'	'	'	'	-33	-3	-15
Total investment gains (losses), net	'	'	'	'	'	'	'	'	-99	-97	-47
Commissions, fees and other income	'	'	'	'	'	'	'	'	3,823	3,574	3,631
Increase (decrease) in the fair value of the reinsurance contract asset	'	'	'	'	'	'	'	'	-4,297	497	5,941
Total Revenues	1,077	834	537	392	1,909	1,728	6,475	-952	2,840	9,160	17,872
BENEFITS AND OTHER DEDUCTIONS [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Policyholders' benefits	'	'	'	'	'	'	'	'	1,691	2,989	4,360
Interest credited to policyholders' account balances	'	'	'	'	'	'	'	'	1,373	1,166	999
Compensation and benefits	'	'	'	'	'	'	'	'	1,743	1,672	2,263
Commissions	'	'	'	'	'	'	'	'	1,160	1,248	1,195
Interest expense	'	'	'	'	'	'	'	'	88	108	106
Amortization of deferred policy acquisition costs	'	'	'	'	'	'	'	'	580	576	3,620
Capitalization of deferred policy acquisition costs	'	'	'	'	'	'	'	'	-655	-718	-759
Rent expense	'	'	'	'	'	'	'	'	169	201	240
Other operating costs and expenses	'	'	'	'	'	'	'	'	1,512	1,429	1,359
Total benefits and other deductions	'	'	'	'	'	'	'	'	8,149	9,102	13,748
Earnings (loss) from continuing operations, before income taxes	'	'	'	'	'	'	'	'	-5,309	58	4,124
Income tax (expense) benefit	'	'	'	'	'	'	'	'	2,073	158	-1,298
Net earnings (loss)	'	'	'	'	'	'	'	'	-3,236	216	2,826
Less: net (earnings) loss attributable to the noncontrolling interest	'	'	'	'	'	'	'	'	-337	-121	101
Net Earnings (Loss) Attributable to AXA Equitable	-640	-878	-1,051	-1,004	-450	-241	2,421	-1,635	-3,573	95	2,927
Other comprehensive income (loss) net of income taxes:	'	'	'	'	'	'	'	'	'	'	'
Other Comprehensive Income (Loss) Attributable to AXA Equitable	'	'	'	'	'	'	'	'	-920	614	313
Comprehensive Income (Loss) Attributable to Equitable	'	'	'	'	'	'	'	'	-4,493	709	3,240
Parent Company [Member]	'	'	'	'	'	'	'	'	'	'	'
Income Statement Captions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Universal life and investment-type product policy fee income	'	'	'	'	'	'	'	'	3,546	3,334	3,312
Premiums	'	'	'	'	'	'	'	'	496	514	533
Net investment income (loss): [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Investment income (loss) from derivative instruments	'	'	'	'	'	'	'	'	-2,846	-943	2,369
Other investment income	'	'	'	'	'	'	'	'	2,146	2,208	2,186
Net Investment Income (Loss)	'	'	'	'	'	'	'	'	-700	1,265	4,555
Investment gains (losses), net: [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Total other-than-temporary impairment losses	'	'	'	'	'	'	'	'	-81	-96	-36
Portion of loss recognized in other comprehensive income (loss)	'	'	'	'	'	'	'	'	15	2	4
Net impairment losses recognized	'	'	'	'	'	'	'	'	-66	-94	-32
Other investment gains (losses), net	'	'	'	'	'	'	'	'	-25	14	-10
Total investment gains (losses), net	'	'	'	'	'	'	'	'	-91	-80	-42
Equity in earnings (loss) of subsidiaries	'	'	'	'	'	'	'	'	788	483	55
Commissions, fees and other income	'	'	'	'	'	'	'	'	219	201	338
Increase (decrease) in the fair value of the reinsurance contract asset	'	'	'	'	'	'	'	'	-4,297	497	5,941
Total Revenues	'	'	'	'	'	'	'	'	-39	6,214	14,692
BENEFITS AND OTHER DEDUCTIONS [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Policyholders' benefits	'	'	'	'	'	'	'	'	1,689	2,986	4,357
Interest credited to policyholders' account balances	'	'	'	'	'	'	'	'	1,373	1,166	999
Compensation and benefits	'	'	'	'	'	'	'	'	432	399	372
Commissions	'	'	'	'	'	'	'	'	1,173	1,265	1,212
Interest expense	'	'	'	'	'	'	'	'	87	106	106
Amortization of deferred policy acquisition costs	'	'	'	'	'	'	'	'	580	576	3,620
Capitalization of deferred policy acquisition costs	'	'	'	'	'	'	'	'	-654	-718	-759
Rent expense	'	'	'	'	'	'	'	'	35	34	47
Premium Taxes	'	'	'	'	'	'	'	'	36	42	43
Other operating costs and expenses	'	'	'	'	'	'	'	'	789	472	651
Total benefits and other deductions	'	'	'	'	'	'	'	'	5,540	6,328	10,648
Earnings (loss) from continuing operations, before income taxes	'	'	'	'	'	'	'	'	-5,579	-114	4,044
Income tax (expense) benefit	'	'	'	'	'	'	'	'	2,343	330	-1,218
Net earnings (loss)	'	'	'	'	'	'	'	'	-3,236	216	2,826
Less: net (earnings) loss attributable to the noncontrolling interest	'	'	'	'	'	'	'	'	-337	-121	101
Net Earnings (Loss) Attributable to AXA Equitable	'	'	'	'	'	'	'	'	-3,573	95	2,927
Other comprehensive income (loss) net of income taxes:	'	'	'	'	'	'	'	'	'	'	'
Other Comprehensive Income (Loss) Attributable to AXA Equitable	'	'	'	'	'	'	'	'	-920	614	313
Comprehensive Income (Loss) Attributable to Equitable	'	'	'	'	'	'	'	'	($4,493)	$709	$3,240

STATEMENTS_OF_CASH_FLOWS_PAREN1

STATEMENTS OF CASH FLOWS (PARENT COMPANY)- SCHEDULE II (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Cash Provided By Used In Operating Activities [Abstract]	'	'	'
Net earnings (loss)	($3,236)	$216	$2,826
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities: [Abstract]	'	'	'
Interest credited to policyholders' account balances	1,373	1,166	999
Universal life and investment-type product policy fee income	-3,546	-3,334	-3,312
Investment (gains) losses, net	99	97	47
Change in deferred policy acquisition costs	-74	-142	2,861
(Income) loss related to derivative instruments	2,866	978	-2,374
Change in reinsurance recoverable with affiliate	-176	-207	-242
Change in the fair value of the reinsurance contract asset	4,297	-497	-5,941
Change in current and deferred income taxes	-1,754	-254	1,226
Amortization Of Reinsurance Costs	280	47	211
Amortization and depreciation	122	157	146
Other, net	180	-122	-76
Net cash provided by (used in) operating activities	158	-780	-938
Cash flows from investing activities: [Abstract]	'	'	'
Maturities and repayments of fixed maturities and mortgage loans on real estate	3,691	3,551	3,435
Proceeds From Sale Of Investments	3,442	1,951	1,141
Purchases of investments	-7,956	-7,893	-7,970
Cash settlements related to derivative instruments	-2,500	-287	1,429
Increase In Loans Due To Affiliates	-56	0	0
Decrease in Loans Due To Affiliates	5	4	0
Change in short-term investments	0	34	16
Other, net	12	14	25
Net cash provided by (used in) investing activities	-3,429	-2,692	-2,028
Policyholders Account Balances [Abstract]	'	'	'
Policyholders account balances deposits	5,469	5,437	4,461
Policyholders account balances withdrawals and transfers to Separate Accounts	-1,188	-982	-821
Shareholder dividends paid	-234	-362	-379
Capital contribution	0	195	0
Change in collateralized pledged liabilities	-663	-288	989
Change in collateralized pledged assets	-18	-5	99
Repayments of loans from affiliates	-500	'	'
Net cash provided by (used in) financing activities	2,392	3,407	4,038
Change in cash and cash equivalents	-879	-65	1,072
Cash and cash equivalents, beginning of year	3,162	3,227	2,155
Cash and Cash Equivalents, End of Year	2,283	3,162	3,227
Supplemental Cash Flow Information [Abstract]	'	'	'
Interest Paid	91	107	107
Income Taxes (Refunded) Paid	-214	271	36
Parent Company [Member]	'	'	'
Net Cash Provided By Used In Operating Activities [Abstract]	'	'	'
Net earnings (loss)	-3,236	216	2,826
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities: [Abstract]	'	'	'
Interest credited to policyholders' account balances	1,373	1,166	999
Universal life and investment-type product policy fee income	-3,546	-3,334	-3,312
Investment (gains) losses, net	91	80	42
Equity In Net Earnings Of Subsidiaries	-788	-483	-55
Dividends from subsidiaries	467	323	332
Change in deferred policy acquisition costs	-74	-142	2,861
Change in future policy benefits and other policyholder funds	-432	876	2,229
(Income) loss related to derivative instruments	2,846	943	-2,369
Change in reinsurance recoverable with affiliate	-175	-207	-242
Change in the fair value of the reinsurance contract asset	4,297	-497	-5,941
Change in current and deferred income taxes	-1,753	-224	1,250
Amortization Of Reinsurance Costs	280	47	211
Amortization and depreciation	103	62	83
Other, net	363	-182	-190
Net cash provided by (used in) operating activities	-132	-1,356	-1,276
Cash flows from investing activities: [Abstract]	'	'	'
Maturities and repayments of fixed maturities and mortgage loans on real estate	3,681	3,547	3,427
Proceeds From Sale Of Investments	4,978	1,566	626
Purchases of investments	-9,583	-7,563	-7,462
Cash settlements related to derivative instruments	-2,479	-287	1,429
Decrease in Loans Due To Affiliates	5	4	0
Change in short-term investments	0	34	16
Change in policy loans	78	31	38
Other, net	-103	-37	-44
Net cash provided by (used in) investing activities	-3,479	-2,705	-1,970
Policyholders Account Balances [Abstract]	'	'	'
Policyholders account balances deposits	5,469	5,437	4,461
Policyholders account balances withdrawals and transfers to Separate Accounts	-1,188	-982	-821
Shareholder dividends paid	-234	-362	-379
Capital contribution	0	195	0
Change in collateralized pledged liabilities	-663	-288	989
Change in collateralized pledged assets	-19	-5	99
Net cash provided by (used in) financing activities	2,865	3,995	4,349
Change in cash and cash equivalents	-746	-66	1,103
Cash and cash equivalents, beginning of year	2,450	2,516	1,413
Cash and Cash Equivalents, End of Year	1,704	2,450	2,516
Supplemental Cash Flow Information [Abstract]	'	'	'
Interest Paid	91	107	106
Income Taxes (Refunded) Paid	($227)	$261	$15

SUPPLEMENTARY_INSURANCE_INFORM1

SUPPLEMENTARY INSURANCE INFORMATION- SCHEDULE III (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Supplementary Insurance Information By Segment [Line Items]	'	'	'
Deferred Policy Acquistion Cost	$3,874	$3,728	'
Policyholders' account balances	30,340	28,263	'
Future Policy Benefits And Other Policyholders' Funds	21,697	22,687	'
Policy Charges and Premium Revenue	4,042	3,848	3,845
Net Investment Income (Loss) (1)	-629	1,338	4,502
Policyholders' Benefit and Interest Credited	3,064	4,155	5,359
Amortization of Deferred Policy Acquisition Costs	580	576	3,620
Other Operating Expense (2)	4,505	4,371	4,769
Insurance [Member]	'	'	'
Supplementary Insurance Information By Segment [Line Items]	'	'	'
Deferred Policy Acquistion Cost	3,874	3,728	'
Policyholders' account balances	30,340	28,263	'
Future Policy Benefits And Other Policyholders' Funds	21,697	22,687	'
Policy Charges and Premium Revenue	4,042	3,848	3,845
Net Investment Income (Loss) (1)	-724	1,242	4,526
Policyholders' Benefit and Interest Credited	3,064	4,155	5,359
Amortization of Deferred Policy Acquisition Costs	580	576	3,620
Other Operating Expense (2)	2,174	1,844	1,877
Investment Management [Member]	'	'	'
Supplementary Insurance Information By Segment [Line Items]	'	'	'
Deferred Policy Acquistion Cost	0	0	'
Policyholders' account balances	0	0	'
Future Policy Benefits And Other Policyholders' Funds	0	0	'
Policy Charges and Premium Revenue	0	0	0
Net Investment Income (Loss) (1)	58	65	-58
Policyholders' Benefit and Interest Credited	0	0	0
Amortization of Deferred Policy Acquisition Costs	0	0	0
Other Operating Expense (2)	2,351	2,548	2,914
Consolidation Eliminations [Member]	'	'	'
Supplementary Insurance Information By Segment [Line Items]	'	'	'
Deferred Policy Acquistion Cost	0	0	'
Policyholders' account balances	0	0	'
Future Policy Benefits And Other Policyholders' Funds	0	0	'
Policy Charges and Premium Revenue	0	0	0
Net Investment Income (Loss) (1)	37	31	34
Policyholders' Benefit and Interest Credited	0	0	0
Amortization of Deferred Policy Acquisition Costs	0	0	0
Other Operating Expense (2)	($20)	($21)	($22)

REINSURANCE_SCHEDULE_IV_DETAIL

REINSURANCE- SCHEDULE IV (DETAILS) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Premiums Earned, Net [Abstract]	'	'	'
Direct premiums	$848	$873	$908
Reinsurance ceded	565	578	585
Reinsurance assumed	213	219	210
Premiums	496	514	533
Life Insurance In Force Net [Abstract]	'	'	'
Gross Amount	414,362	409,488	396,304
Ceded to other companies	92,252	96,869	101,926
Assumed from other companies	33,494	34,361	34,738
Net Amount	355,604	346,980	329,116
Percentage of Amount Assumed to Net	42.90%	42.60%	39.40%
Life Insurance in Force, Percentage Assumed to Net	9.40%	9.90%	10.60%
Life Insurance And Annuities Segment [Member]	'	'	'
Premiums Earned, Net [Abstract]	'	'	'
Direct premiums	770	785	815
Reinsurance ceded	511	518	521
Reinsurance assumed	201	206	195
Premiums	460	473	489
Life Insurance In Force Net [Abstract]	'	'	'
Percentage of Amount Assumed to Net	43.70%	43.50%	39.90%
Accident And Health Insurance Segment [Member]	'	'	'
Premiums Earned, Net [Abstract]	'	'	'
Direct premiums	78	88	93
Reinsurance ceded	54	60	64
Reinsurance assumed	12	13	15
Premiums	$36	$41	$44
Life Insurance In Force Net [Abstract]	'	'	'
Percentage of Amount Assumed to Net	33.30%	31.70%	34.10%